Processing 00000000.tx.1: Accumulation of 8-Hydroxy-2'-Deoxyguanosine and Mitochondrial DNA Deletion in Kidney of Diabetic Rats Maiko Kakimoto, Toyoshi Inoguchi, Toshiyo Sonta, Hai Yan Yu, Minako Imamura, Takashi Etoh, Toshihiko Hashimoto, and Hajime Nawata From the Department of Medicine and Bioregulatory Science, Graduate School of Medical Sciences, Kyushu University, Fukuoka, Japan  ABSTRACT TOP ABSTRACT INTRODUCTION RESEARCH DESIGN AND METHODS RESULTS DISCUSSION REFERENCES  Oxidative stress may contribute to the pathogenesis of diabetic nephropathy. 

Phrase: "Accumulation of 8-Hydroxy-2'-Deoxyguanosine"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   716   C0050078:8-Hydroxy-2'-deoxyguanosine [Biologically Active Substance,Nucleic Acid, Nucleoside, or Nucleotide]

Phrase: "and"

Phrase: "Mitochondrial DNA Deletion in Kidney of Diabetic Rats Maiko Kakimoto,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   782   C0948051:mitochondrial dna deletion [Cell or Molecular Dysfunction]
   739   C1442161:Deletion [Cell or Molecular Dysfunction]
   739   C1511760:Deletion [Genetic Function]
   739   C1880274:Deletion [Activity]

Phrase: "Toyoshi Inoguchi,"

Phrase: "Toshiyo Sonta,"

Phrase: "Hai Yan Yu,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C1006780:yu [Plant]

Phrase: "Minako Imamura,"

Phrase: "Takashi Etoh,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0001962:ETOH [Organic Chemical]

Phrase: "Toshihiko Hashimoto,"

Phrase: "and"

Phrase: "Hajime Nawata From the Department of Medicine"

Phrase: "and"

Phrase: "Bioregulatory Science,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0036397:Science [Occupation or Discipline]

Phrase: "Graduate School of Medical Sciences,"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   806   C0870614:graduate school [Manufactured Object,Organization]
   797   C0036378:School, Medical [Health Care Related Organization,Manufactured Object]
   760   C0036375:School [Manufactured Object,Organization]
   760   C0588053:Graduate [Population Group]
   760   C1547183:Graduate [Idea or Concept]

Phrase: "Kyushu University,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0041740:University [Manufactured Object,Organization]
   861   C0454747:Kyushu [Geographic Area]

Phrase: "Fukuoka,"

Phrase: "Japan  ABSTRACT TOP ABSTRACT INTRODUCTION RESEARCH DESIGN"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   818   C0035171:Research Design [Research Activity]
   795   C0035168:research [Research Activity]
   795   C0242481:Research [Research Activity]
   795   C1707689:Design [Activity]
   795   C2983265:DESIGN [Intellectual Product]

Phrase: "AND"

Phrase: "METHODS RESULTS DISCUSSION"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0557061:Discussion [Therapeutic or Preventive Procedure]
   827   C2584313:Discussion [Social Behavior]

Phrase: "REFERENCES"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1514811:Reference [Idea or Concept]
  1000   C1706462:Reference [Conceptual Entity]

Phrase: "Oxidative stress"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
  1000   C0242606:Oxidative Stress [Cell or Molecular Dysfunction]
   861   C0038435:Stress [Finding]
   861   C0311404:Oxidative [Functional Concept]
   789 E C0231297:Stressful [Functional Concept]

Phrase: "may"

Phrase: "contribute to the pathogenesis of diabetic nephropathy."
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   778   C0011881:Diabetic Nephropathy [Disease or Syndrome]
   778   C1442864:diabetic nephropathy [Gene or Genome]
   748   C0022658:Nephropathy [Disease or Syndrome]
   748   C0241863:DIABETIC [Finding]
   748   C0543483:pathogenesis [Functional Concept]
   748   C0699748:Pathogenesis [Pathologic Function]
   748   C1880177:Contribute [Activity]
Processing 00000000.tx.2: However, the detailed molecular mechanism remains uncertain. 

Phrase: "However,"

Phrase: "the detailed molecular mechanism"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0441712:Mechanism [Functional Concept]
   827   C1706376:Mechanism [Manufactured Object]

Phrase: "remains"

Phrase: "uncertain."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0087130:Uncertain [Idea or Concept]
Processing 00000000.tx.3: Here, we report oxidative mitochondrial DNA (mtDNA) damage and accumulation of mtDNA with a 4,834-bp deletion in kidney of streptozotocin-induced diabetic rats. 

Phrase: "Here,"

Phrase: "we"

Phrase: "report"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0684224:Report [Intellectual Product]
  1000   C0700287:Report [Health Care Activity]
  1000   C3273238:Report [Intellectual Product]

Phrase: "oxidative mitochondrial DNA (mtDNA) damage"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   875   C1096176:Mitochondrial Damage [Pathologic Function]
   861   C0012860:DNA Damage [Cell or Molecular Dysfunction]
   812   C0010957:Damage [Injury or Poisoning]
   812   C1883709:Damage [Functional Concept]

Phrase: "and"

Phrase: "accumulation of mtDNA"

Phrase: "with a 4,834-bp deletion"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   812   C1442161:Deletion [Cell or Molecular Dysfunction]
   812   C1511760:Deletion [Genetic Function]
   812   C1880274:Deletion [Activity]

Phrase: "in kidney"
Meta Candidates (Total=5; Excluded=1; Pruned=0; Remaining=4)
  1000   C0022646:Kidney [Body Part, Organ, or Organ Component]
  1000   C0227665:kidney [Body Part, Organ, or Organ Component]
  1000   C1278978:Kidney [Body Part, Organ, or Organ Component]
  1000   C1514845:KIDNEY [Tissue]
   907 E C0027697:Nephritides [Disease or Syndrome]

Phrase: "of streptozotocin-induced diabetic rats."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   812   C0034693:rats [Mammal]
   812   C0034721:Rats [Mammal]
   812   C0241863:DIABETIC [Finding]
Processing 00000000.tx.4: At 8 weeks after the onset of diabetes, levels of 8-hydroxy-2'-deoxyguanosine (8-OHdG), which is a marker of oxidative DNA damage, were significantly increased in mtDNA from kidney of diabetic rats but not in nuclear DNA, suggesting the predominant damage of mtDNA. 

Phrase: "At 8 weeks"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   861   C0439230:weeks [Temporal Concept]
   827 E C0332174:/week [Temporal Concept]

Phrase: "after the onset"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0332162:Onset [Qualitative Concept]

Phrase: "of diabetes,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0011847:Diabetes [Disease or Syndrome]
  1000   C0011849:Diabetes [Disease or Syndrome]

Phrase: "levels of 8-hydroxy-2'-deoxyguanosine (8-OHdG),"
Meta Candidates (Total=6; Excluded=3; Pruned=0; Remaining=3)
   767   C0456948:Level 2 [Intellectual Product]
   753   C0441889:Levels [Qualitative Concept]
   719 E C0456079:Level [Classification]
   719 E C1547707:Level [Geographic Area]
   719 E C2946261:Level [Pharmacologic Substance]
   716   C0050078:8-Hydroxy-2'-deoxyguanosine [Biologically Active Substance,Nucleic Acid, Nucleoside, or Nucleotide]

Phrase: "which"

Phrase: "is"

Phrase: "a marker of oxidative DNA damage,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   783   C0012872:Marker, DNA [Nucleotide Sequence]
   753   C0005516:Marker [Clinical Attribute]

Phrase: "were"

Phrase: "significantly"

Phrase: "increased in mtDNA"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   833   C0012929:DNA, Mitochondrial [Biologically Active Substance,Nucleic Acid, Nucleoside, or Nucleotide]
   833   C1819717:mitochondrial DNA [Cell Component]
   770   C0012854:DNA [Biologically Active Substance,Nucleic Acid, Nucleoside, or Nucleotide]
   770   C0026237:Mitochondrial [Cell Component]
   770   C0205217:Increased [Quantitative Concept]
   770   C0442805:Increased [Functional Concept]
   770   C0521451:Mitochondrial [Functional Concept]

Phrase: "from kidney"
Meta Candidates (Total=5; Excluded=1; Pruned=0; Remaining=4)
  1000   C0022646:Kidney [Body Part, Organ, or Organ Component]
  1000   C0227665:kidney [Body Part, Organ, or Organ Component]
  1000   C1278978:Kidney [Body Part, Organ, or Organ Component]
  1000   C1514845:KIDNEY [Tissue]
   907 E C0027697:Nephritides [Disease or Syndrome]

Phrase: "of diabetic rats"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0034693:rats [Mammal]
   861   C0034721:Rats [Mammal]
   861   C0241863:DIABETIC [Finding]

Phrase: "but"

Phrase: "not in nuclear DNA,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   833   C1179920:Nuclear DNA [Biologically Active Substance,Nucleic Acid, Nucleoside, or Nucleotide]
   770   C0012854:DNA [Biologically Active Substance,Nucleic Acid, Nucleoside, or Nucleotide]
   770   C0521447:Nuclear [Spatial Concept]
   770   C1518422:Not [Functional Concept]

Phrase: "suggesting"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1705535:Suggest [Idea or Concept]

Phrase: "the predominant damage of mtDNA."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   783   C0012860:DNA Damage [Cell or Molecular Dysfunction]
   783   C1096176:Mitochondrial Damage [Pathologic Function]
   753   C0010957:Damage [Injury or Poisoning]
   753   C1883709:Damage [Functional Concept]
Processing 00000000.tx.5: Semiquantitative analysis using PCR showed that the frequency of 4,834-bp deleted mtDNA was markedly increased in kidney of diabetic rats at 8 weeks, but it did not change at 4 weeks. 

Phrase: "Semiquantitative analysis"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0002778:Analysis [Laboratory Procedure]
   861   C0936012:Analysis [Research Activity]
   861   C1524024:analysis [Functional Concept]

Phrase: "using"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1524063:Using [Functional Concept]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "PCR"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0032520:PCR [Laboratory Procedure,Molecular Biology Research Technique]
  1000   C0677874:pCR [Finding]

Phrase: "showed"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1547282:Show [Intellectual Product]

Phrase: "that"

Phrase: "the frequency of 4,834-bp"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   753   C0376249:frequency [Quantitative Concept]
   753   C0439603:Frequency [Temporal Concept]
   753   C0871396:Frequency [Quantitative Concept]
   753   C1561548:Frequency [Qualitative Concept]
   753   C1705502:Frequency [Quantitative Concept]

Phrase: "deleted"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1880274:Deleted [Activity]

Phrase: "mtDNA"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
  1000   C0012929:DNA, Mitochondrial [Biologically Active Substance,Nucleic Acid, Nucleoside, or Nucleotide]
  1000   C1819717:mitochondrial DNA [Cell Component]
   861   C0012854:DNA [Biologically Active Substance,Nucleic Acid, Nucleoside, or Nucleotide]
   861   C0026237:Mitochondrial [Cell Component]
   861   C0521451:Mitochondrial [Functional Concept]

Phrase: "was"

Phrase: "markedly"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0522501:Markedly [Qualitative Concept]

Phrase: "increased in kidney of diabetic rats"
Meta Candidates (Total=10; Excluded=0; Pruned=0; Remaining=10)
   767   C1882714:Rat Kidney [Body Part, Organ, or Organ Component]
   753   C0022646:Kidney [Body Part, Organ, or Organ Component]
   753   C0034693:rats [Mammal]
   753   C0034721:Rats [Mammal]
   753   C0205217:Increased [Quantitative Concept]
   753   C0227665:kidney [Body Part, Organ, or Organ Component]
   753   C0241863:DIABETIC [Finding]
   753   C0442805:Increased [Functional Concept]
   753   C1278978:Kidney [Body Part, Organ, or Organ Component]
   753   C1514845:KIDNEY [Tissue]

Phrase: "at 8 weeks,"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   861   C0439230:weeks [Temporal Concept]
   827 E C0332174:/week [Temporal Concept]

Phrase: "but"

Phrase: "it"

Phrase: "did"

Phrase: "not"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1518422:Not [Functional Concept]

Phrase: "change at 4 weeks."
Meta Candidates (Total=5; Excluded=1; Pruned=0; Remaining=4)
   770   C0392747:Change [Functional Concept]
   770   C0439230:weeks [Temporal Concept]
   770   C0443172:change [Quantitative Concept]
   770   C1705241:Change [Quantitative Concept]
   737 E C0332174:/week [Temporal Concept]
Processing 00000000.tx.6: Intervention by insulin treatment starting at 8 weeks rapidly normalized an increase in renal 8-OHdG levels of diabetic rats, but it did not reverse an increase in the frequency of deleted mtDNA. 

Phrase: "Intervention by insulin treatment starting"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   760   C0886296:intervention [Health Care Activity]
   760   C1273869:Intervention [Health Care Activity]
   760   C1948041:Intervention [Therapeutic or Preventive Procedure]

Phrase: "at 8 weeks rapidly"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   827   C0439230:weeks [Temporal Concept]
   793 E C0332174:/week [Temporal Concept]

Phrase: "normalized"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1882115:Normalized [Research Activity]

Phrase: "an increase in renal 8-OHdG levels"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   742   C0442805:Increase [Functional Concept]

Phrase: "of diabetic rats,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0034693:rats [Mammal]
   861   C0034721:Rats [Mammal]
   861   C0241863:DIABETIC [Finding]

Phrase: "but"

Phrase: "it"

Phrase: "did"

Phrase: "not"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1518422:Not [Functional Concept]

Phrase: "reverse"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1555029:Reverse [Idea or Concept]

Phrase: "an increase in the frequency of deleted mtDNA."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   742   C0442805:Increase [Functional Concept]
Processing 00000000.tx.7: Our study demonstrated for the first time that oxidative mtDNA damage and subsequent mtDNA deletion may be accumulated in kidney of diabetic rats. 

Phrase: "Our study"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0557651:Study [Manufactured Object]
  1000   C2603343:Study [Research Activity]

Phrase: "demonstrated for the first time"
Meta Candidates (Total=6; Excluded=2; Pruned=0; Remaining=4)
   760   C0040223:Time [Temporal Concept]
   760   C0205435:First [Quantitative Concept]
   760   C1279901:First [Qualitative Concept]
   760   C3541383:Time [Temporal Concept]
   704 E C0442043:Temporal [Spatial Concept]
   704 E C2362314:Temporal [Temporal Concept]

Phrase: "that oxidative mtDNA damage"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   875   C1096176:Mitochondrial Damage [Pathologic Function]
   861   C0012860:DNA Damage [Cell or Molecular Dysfunction]
   812   C0010957:Damage [Injury or Poisoning]
   812   C1883709:Damage [Functional Concept]

Phrase: "and"

Phrase: "subsequent mtDNA deletion"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   923   C0948051:mitochondrial dna deletion [Cell or Molecular Dysfunction]
   812   C1442161:Deletion [Cell or Molecular Dysfunction]
   812   C1511760:Deletion [Genetic Function]
   812   C1880274:Deletion [Activity]

Phrase: "may"

Phrase: "be"

Phrase: "accumulated in kidney of diabetic rats."
Meta Candidates (Total=8; Excluded=0; Pruned=0; Remaining=8)
   767   C1882714:Rat Kidney [Body Part, Organ, or Organ Component]
   753   C0022646:Kidney [Body Part, Organ, or Organ Component]
   753   C0034693:rats [Mammal]
   753   C0034721:Rats [Mammal]
   753   C0227665:kidney [Body Part, Organ, or Organ Component]
   753   C0241863:DIABETIC [Finding]
   753   C1278978:Kidney [Body Part, Organ, or Organ Component]
   753   C1514845:KIDNEY [Tissue]
Processing 00000000.tx.8: This may be involved in the pathogenesis of diabetic nephropathy.  

Phrase: "This"

Phrase: "may"

Phrase: "be"

Phrase: "involved in the pathogenesis of diabetic nephropathy."
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   778   C0011881:Diabetic Nephropathy [Disease or Syndrome]
   778   C1442864:diabetic nephropathy [Gene or Genome]
   748   C0022658:Nephropathy [Disease or Syndrome]
   748   C0241863:DIABETIC [Finding]
   748   C0543483:pathogenesis [Functional Concept]
   748   C0699748:Pathogenesis [Pathologic Function]
   748   C1314939:Involved [Functional Concept]
Processing 00000000.tx.9: INTRODUCTION TOP ABSTRACT INTRODUCTION RESEARCH DESIGN AND METHODS RESULTS DISCUSSION REFERENCES  Diabetic nephropathy is the major cause of morbidity and mortality in diabetic patients. 

Phrase: "INTRODUCTION TOP ABSTRACT INTRODUCTION RESEARCH DESIGN"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   827   C0035171:Research Design [Research Activity]
   799   C0035168:research [Research Activity]
   799   C0242481:Research [Research Activity]
   799   C1707689:Design [Activity]
   799   C2983265:DESIGN [Intellectual Product]

Phrase: "AND"

Phrase: "METHODS RESULTS DISCUSSION"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0557061:Discussion [Therapeutic or Preventive Procedure]
   827   C2584313:Discussion [Social Behavior]

Phrase: "REFERENCES"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1514811:Reference [Idea or Concept]
  1000   C1706462:Reference [Conceptual Entity]

Phrase: "Diabetic nephropathy"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0011881:Diabetic Nephropathy [Disease or Syndrome]
  1000   C1442864:diabetic nephropathy [Gene or Genome]
   861   C0022658:Nephropathy [Disease or Syndrome]
   861   C0241863:DIABETIC [Finding]

Phrase: "is"

Phrase: "the major cause of morbidity"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   760   C0015127:cause [Functional Concept]
   760   C0205164:Major [Qualitative Concept]
   760   C1524003:Cause [Conceptual Entity]

Phrase: "and"

Phrase: "mortality in diabetic patients."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   770   C0026565:Mortality [Quantitative Concept]
   770   C0026566:mortality [Quantitative Concept]
Processing 00000000.tx.10: It is more rapidly liable to functional deterioration compared with other types of chronic renal disease and finally progresses to renal failure requiring dialysis therapy. 

Phrase: "It"

Phrase: "is"

Phrase: "more rapidly liable to functional deterioration"

Phrase: "compared with other types of chronic renal disease"
Meta Candidates (Total=13; Excluded=1; Pruned=0; Remaining=12)
   800   C0022661:Chronic Renal Disease [Disease or Syndrome]
   800   C0403447:Chronic renal disease [Disease or Syndrome]
   800   C1561643:Chronic renal disease [Disease or Syndrome]
   770   C0022658:Renal disease [Disease or Syndrome]
   767   C0008679:Chronic disease [Disease or Syndrome]
   767   C0457464:disease types [Intellectual Product]
           Types of diseases
   744   C0012634:Disease [Disease or Syndrome]
   744   C0022646:Renal [Body Part, Organ, or Organ Component]
   744   C0205191:chronic [Temporal Concept]
   744   C0332307:Types [Qualitative Concept]
   744   C1707455:Compared [Activity]
   711 E C1547052:*Type [Quantitative Concept]

Phrase: "and"

Phrase: "finally"

Phrase: "progresses to renal failure requiring dialysis therapy."
Meta Candidates (Total=17; Excluded=0; Pruned=0; Remaining=17)
   778   C0011946:Dialysis Therapy [Therapeutic or Preventive Procedure]
           dialysis
   778   C0035078:Renal Failure [Disease or Syndrome]
   778   C1963154:Renal failure [Finding]
   774   C0019004:Renal Dialysis [Therapeutic or Preventive Procedure]
   774   C0917873:Renal dialysis [Therapeutic or Preventive Procedure]
           dialysis
   748   C0011945:Dialysis [Natural Phenomenon or Process]
   748   C0022646:Renal [Body Part, Organ, or Organ Component]
   748   C0039798:therapy [Functional Concept]
   748   C0087111:Therapy [Therapeutic or Preventive Procedure]
   748   C0231174:Failure [Functional Concept]
   748   C0680095:failure [Individual Behavior]
   748   C1059964:Dialysis [Eukaryote]
   748   C1272688:progress [Functional Concept]
   748   C1280477:Progress [Functional Concept]
   748   C1363945:Therapy [Finding]
Processing 00000000.tx.11: Several mechanisms have been proposed for the pathogenesis of diabetic vascular complications that include nephropathy, such as hyperfiltration (1), increased production of advanced glycation end products (AGEs) (2), activation of protein kinase C (35), enhanced polyol pathway (6,7), and enhanced oxidative stress (810). 

Phrase: "Several mechanisms"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   861   C0441712:Mechanisms [Functional Concept]
   827 E C1706376:Mechanism [Manufactured Object]

Phrase: "have"

Phrase: "been"

Phrase: "proposed for the pathogenesis of diabetic vascular complications"
Meta Candidates (Total=14; Excluded=1; Pruned=0; Remaining=13)
   800   C0011875:Diabetic Vascular Complications [Disease or Syndrome]
   767   C0342257:Diabetic Complications [Pathologic Function]
   744   C0005847:vascular [Body Part, Organ, or Organ Component]
   744   C0009566:Complications [Pathologic Function]
   744   C0241863:DIABETIC [Finding]
   744   C0543483:pathogenesis [Functional Concept]
   744   C0699748:Pathogenesis [Pathologic Function]
   744   C1171258:complications [Pathologic Function]
   744   C1441414:PROPOSED [Idea or Concept]
   744   C1553874:Proposed [Qualitative Concept]
   744   C1558950:VASCULAR [Finding]
   744   C1578820:Proposed [Idea or Concept]
   744   C1801960:Vascular [Qualitative Concept]
   711 E C2362589:Complication [Idea or Concept]

Phrase: "that"

Phrase: "include"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0332257:include [Functional Concept]
  1000   C1552866:include [Idea or Concept]
  1000   C2700399:Include [Activity]

Phrase: "nephropathy,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0022658:Nephropathy [Disease or Syndrome]

Phrase: "such as hyperfiltration"

Phrase: "(1"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C2827734:1+ [Quantitative Concept]
  1000   C2981698:1+ [Classification]

Phrase: ")"

Phrase: ","

Phrase: "increased production of advanced glycation end products (AGEs)"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   748   C0033268:production [Occupational Activity]

Phrase: "(2"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0740116:+2 [Quantitative Concept]
  1000   C2827735:2+ [Quantitative Concept]
  1000   C2981700:2+ [Classification]

Phrase: ")"

Phrase: ","

Phrase: "activation of protein kinase C"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   900   C3546691:protein kinase C activation [Molecular Function]
   844   C1819041:protein kinase activation [Cell Function]
   797   C0599177:protein activation [Genetic Function]
   760   C1879547:Activation [Activity]

Phrase: "(35"

Phrase: ")"

Phrase: ","

Phrase: "enhanced polyol pathway"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C1704259:Pathway [Molecular Function]
   827   C1705987:Pathway [Conceptual Entity]

Phrase: "(6,"

Phrase: "7"

Phrase: ")"

Phrase: ","

Phrase: "and"

Phrase: "enhanced oxidative stress"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
   901   C0242606:Oxidative Stress [Cell or Molecular Dysfunction]
   827   C0038435:Stress [Finding]
   827   C0311404:Oxidative [Functional Concept]
   755 E C0231297:Stressful [Functional Concept]

Phrase: "(810"

Phrase: ")."
Processing 00000000.tx.12: A number of in vitro and in vivo studies suggest that oxidative stress is increased in diabetic patients and animal models of diabetes (814). 

Phrase: "A number of in vitro"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   760   C0237753:*Number [Quantitative Concept]
   760   C0449788:Number [Quantitative Concept]

Phrase: "and"

Phrase: "in vivo studies"
Meta Candidates (Total=5; Excluded=2; Pruned=0; Remaining=3)
   983   C0681829:in vivo study [Research Activity]
   827   C0947630:studies [Laboratory Procedure]
   793 E C0557651:Study [Manufactured Object]
   793 E C2603343:Study [Research Activity]
   734   C1515655:In Vivo [Spatial Concept]

Phrase: "suggest"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1705535:Suggest [Idea or Concept]

Phrase: "that oxidative stress"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
  1000   C0242606:Oxidative Stress [Cell or Molecular Dysfunction]
   861   C0038435:Stress [Finding]
   861   C0311404:Oxidative [Functional Concept]
   789 E C0231297:Stressful [Functional Concept]

Phrase: "is"

Phrase: "increased in diabetic patients"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   770   C0030705:Patients [Patient or Disabled Group]
   770   C0205217:Increased [Quantitative Concept]
   770   C0241863:DIABETIC [Finding]
   770   C0442805:Increased [Functional Concept]

Phrase: "and"

Phrase: "animal models of diabetes"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   833   C0599779:Models, Animal [Animal]
   770   C0003062:Animal [Animal]
   770   C3161035:Models [Intellectual Product]

Phrase: "(814"

Phrase: ")."
Processing 00000000.tx.13: Although enhanced oxidative stress may contribute to the initiation and development of diabetic nephropathy, the detailed molecular mechanism remains uncertain. 

Phrase: "Although"

Phrase: "enhanced oxidative stress"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
   901   C0242606:Oxidative Stress [Cell or Molecular Dysfunction]
   827   C0038435:Stress [Finding]
   827   C0311404:Oxidative [Functional Concept]
   755 E C0231297:Stressful [Functional Concept]

Phrase: "may"

Phrase: "contribute to the initiation"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   770   C0589507:Initiation [Mental Process]
   770   C1158830:Initiation [Genetic Function]
   770   C1704686:Initiation [Functional Concept]
   770   C1880177:Contribute [Activity]

Phrase: "and"

Phrase: "development of diabetic nephropathy,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   770   C0243107:development [Physiologic Function]
   770   C0678723:Development [Organism Function]
   770   C1527148:Development [Functional Concept]

Phrase: "the detailed molecular mechanism"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0441712:Mechanism [Functional Concept]
   827   C1706376:Mechanism [Manufactured Object]

Phrase: "remains"

Phrase: "uncertain."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0087130:Uncertain [Idea or Concept]
Processing 00000000.tx.14: In general, oxidative stress, including reactive oxygen species (ROS), can damage cellular macromolecules. 

Phrase: "In general, oxidative stress,"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
   901   C0242606:Oxidative Stress [Cell or Molecular Dysfunction]
   827   C0038435:Stress [Finding]
   827   C0311404:Oxidative [Functional Concept]
   755 E C0231297:Stressful [Functional Concept]

Phrase: "including"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
  1000   C0332257:Including [Functional Concept]
   966 E C1552866:include [Idea or Concept]
   966 E C2700399:Include [Activity]

Phrase: "reactive oxygen species (ROS),"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0162772:Reactive Oxygen Species [Biologically Active Substance,Element, Ion, or Isotope]
   827   C0030054:Oxygen [Element, Ion, or Isotope,Pharmacologic Substance]
   827   C0205332:Reactive [Qualitative Concept]
   827   C1705920:Species [Conceptual Entity]

Phrase: "can"

Phrase: "damage"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0010957:Damage [Injury or Poisoning]
  1000   C1883709:Damage [Functional Concept]

Phrase: "cellular macromolecules."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0178735:macromolecules [Chemical Viewed Structurally]
Processing 00000000.tx.15: Among the oxidative damages, base modifications, such as oxidation of deoxyguanosine to 8-hydroxy-2'-deoxyguanosine (8-OHdG) and subsequent mutations of mitochondrial DNA (mtDNA), have received increasing attention in recent years. 

Phrase: "Among the oxidative damages,"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   861   C0010957:damages [Injury or Poisoning]
   827 E C1883709:Damage [Functional Concept]

Phrase: "base modifications,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0392747:Modification [Functional Concept]
   827   C1554963:modification [Qualitative Concept]

Phrase: "such as oxidation"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0030011:Oxidation [Molecular Function]

Phrase: "of deoxyguanosine"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0011503:Deoxyguanosine [Nucleic Acid, Nucleoside, or Nucleotide]

Phrase: "to 8-hydroxy-2'-deoxyguanosine"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0050078:8-Hydroxy-2'-deoxyguanosine [Biologically Active Substance,Nucleic Acid, Nucleoside, or Nucleotide]
   812   C0011503:Deoxyguanosine [Nucleic Acid, Nucleoside, or Nucleotide]

Phrase: "(8-OHdG"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0050078:8-Hydroxy-2'-deoxyguanosine [Biologically Active Substance,Nucleic Acid, Nucleoside, or Nucleotide]
   812   C0011503:Deoxyguanosine [Nucleic Acid, Nucleoside, or Nucleotide]

Phrase: ")"

Phrase: "and"

Phrase: "subsequent mutations of mitochondrial DNA"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   781   C2315666:Mitochondrial mutation [Genetic Function]
   760   C0026882:Mutations [Genetic Function]
   726 E C1705285:Mutation [Cell or Molecular Dysfunction]

Phrase: "(mtDNA"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
  1000   C0012929:DNA, Mitochondrial [Biologically Active Substance,Nucleic Acid, Nucleoside, or Nucleotide]
  1000   C1819717:mitochondrial DNA [Cell Component]
   861   C0012854:DNA [Biologically Active Substance,Nucleic Acid, Nucleoside, or Nucleotide]
   861   C0026237:Mitochondrial [Cell Component]
   861   C0521451:Mitochondrial [Functional Concept]

Phrase: ")"

Phrase: ","

Phrase: "have"

Phrase: "received"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1514756:Received [Qualitative Concept]

Phrase: "increasing"
Meta Candidates (Total=8; Excluded=7; Pruned=0; Remaining=1)
  1000   C0442808:Increasing [Functional Concept]
   966 E C0442805:Increase [Functional Concept]
   928 E C1517378:Gain [Quantitative Concept]
   907 E C0205217:Increased [Quantitative Concept]
   907 E C0439661:Acquired [Temporal Concept]
   907 E C1301820:Obtain [Functional Concept]
   907 E C1706701:Acquire [Activity]
   907 E C3245488:acquired [Intellectual Product]

Phrase: "attention in recent years."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C0004268:Attention [Mental Process]
Processing 00000000.tx.16: It is widely accepted that mtDNA is 1020 times more vulnerable to oxidative damage and subsequent mutations than nuclear DNA (1517). 

Phrase: "It"

Phrase: "is"

Phrase: "widely"

Phrase: "accepted"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
  1000   C1272684:Accepted [Qualitative Concept]
  1000   C1548435:Accepted [Idea or Concept]
   966 E C1548601:Accept [Idea or Concept]

Phrase: "that mtDNA"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
  1000   C0012929:DNA, Mitochondrial [Biologically Active Substance,Nucleic Acid, Nucleoside, or Nucleotide]
  1000   C1819717:mitochondrial DNA [Cell Component]
   861   C0012854:DNA [Biologically Active Substance,Nucleic Acid, Nucleoside, or Nucleotide]
   861   C0026237:Mitochondrial [Cell Component]
   861   C0521451:Mitochondrial [Functional Concept]

Phrase: "is"

Phrase: "1020 times"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
   861   C0040223:times [Temporal Concept]
   861   C1632851:Times [Quantitative Concept]
   827 E C3541383:Time [Temporal Concept]
   789 E C0442043:Temporal [Spatial Concept]
   789 E C2362314:Temporal [Temporal Concept]

Phrase: "more vulnerable to oxidative damage"

Phrase: "and"

Phrase: "subsequent mutations than nuclear DNA (1517"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   753   C0026882:Mutations [Genetic Function]
   719 E C1705285:Mutation [Cell or Molecular Dysfunction]

Phrase: ")."
Processing 00000000.tx.17: More than 50 pathogenic mtDNA mutations associated with or responsible for specific human diseases have been reported. 

Phrase: "More than 50 pathogenic mtDNA mutations"
Meta Candidates (Total=10; Excluded=1; Pruned=0; Remaining=9)
   778   C0012929:DNA, Mitochondrial [Biologically Active Substance,Nucleic Acid, Nucleoside, or Nucleotide]
   778   C1819717:mitochondrial DNA [Cell Component]
   757   C2315666:Mitochondrial mutation [Genetic Function]
   748   C0012854:DNA [Biologically Active Substance,Nucleic Acid, Nucleoside, or Nucleotide]
   748   C0026237:Mitochondrial [Cell Component]
   748   C0026882:Mutations [Genetic Function]
   748   C0205172:More [Functional Concept]
   748   C0450254:Pathogenic [Organism]
   748   C0521451:Mitochondrial [Functional Concept]
   714 E C1705285:Mutation [Cell or Molecular Dysfunction]

Phrase: "associated with"
Meta Candidates (Total=4; Excluded=2; Pruned=0; Remaining=2)
  1000   C0332281:Associated with [Qualitative Concept]
           Associated
   799 E C0750490:Associate [Idea or Concept]
   799 E C1706221:Associate [Professional or Occupational Group]

Phrase: "or"

Phrase: "responsible for specific human diseases"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C1273518:Responsible [Finding]

Phrase: "have"

Phrase: "been"

Phrase: "reported."
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
  1000   C0684224:Reported [Intellectual Product]
  1000   C0700287:Reported [Health Care Activity]
  1000   C3496591:Reported [Clinical Attribute]
   966 E C3273238:Report [Intellectual Product]
Processing 00000000.tx.18: Congenital mtDNA mutations as well as oxidative stress-induced mtDNA mutations may be related to the pathophysiology of various diseases. 

Phrase: "Congenital mtDNA mutations"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   858   C2315666:Mitochondrial mutation [Genetic Function]
   812   C0026882:Mutations [Genetic Function]
   779 E C1705285:Mutation [Cell or Molecular Dysfunction]

Phrase: "as well as"

Phrase: "oxidative stress-induced mtDNA mutations"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
   841   C1512710:Induced Mutation [Genetic Function]
   822   C2315666:Mitochondrial mutation [Genetic Function]
   799   C0026882:Mutations [Genetic Function]
   766 E C1705285:Mutation [Cell or Molecular Dysfunction]

Phrase: "may"

Phrase: "be"

Phrase: "related to the pathophysiology of various diseases."
Meta Candidates (Total=7; Excluded=1; Pruned=0; Remaining=6)
   748   C0012634:Diseases [Disease or Syndrome]
   748   C0031847:pathophysiology [Functional Concept]
   748   C0277785:Pathophysiology [Qualitative Concept]
   748   C0439849:Related [Qualitative Concept]
   748   C0440102:Various [Indicator, Reagent, or Diagnostic Aid]
   748   C0445223:Related [Finding]
   714 E C0163712:Relate [Organic Chemical]
Processing 00000000.tx.19: It has been shown that oxidative stress-induced mtDNA mutations may be related to aging-related organ dysfunction (1823) and several degenerative diseases (24,25). 

Phrase: "It"

Phrase: "has"

Phrase: "been"

Phrase: "shown"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1547282:Show [Intellectual Product]

Phrase: "that oxidative stress-induced mtDNA mutations"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
   841   C1512710:Induced Mutation [Genetic Function]
   822   C2315666:Mitochondrial mutation [Genetic Function]
   799   C0026882:Mutations [Genetic Function]
   766 E C1705285:Mutation [Cell or Molecular Dysfunction]

Phrase: "may"

Phrase: "be"

Phrase: "related to aging-related organ dysfunction"
Meta Candidates (Total=8; Excluded=2; Pruned=0; Remaining=6)
   753   C0001811:Ageing [Organism Function]
   753   C0031847:dysfunction [Functional Concept]
   753   C0178784:Organ [Body Part, Organ, or Organ Component]
   753   C0277785:Dysfunction, NOS [Qualitative Concept]
   753   C0439849:Related [Qualitative Concept]
   753   C0445223:Related [Finding]
   719 E C0001779:Age [Organism Attribute]
   719 E C0163712:Relate [Organic Chemical]

Phrase: "(1823"

Phrase: ")"

Phrase: "and"

Phrase: "several degenerative diseases"
Meta Candidates (Total=7; Excluded=3; Pruned=0; Remaining=4)
   867   C1285162:Degenerative Disease [Disease or Syndrome]
   827   C0011164:Degenerative [Pathologic Function]
   827   C0012634:Diseases [Disease or Syndrome]
   827   C1880269:Degenerative [Functional Concept]
   755 E C1836721:MALS [Finding]
   755 E C3538764:MALS [Gene or Genome]
   755 E C3540595:MAL [Gene or Genome]

Phrase: "(24,"

Phrase: "25"

Phrase: ")."
Processing 00000000.tx.20: We speculated that enhanced oxidative stress might induce mtDNA damage and subsequent mtDNA mutations in kidney of diabetic subjects, and this might be involved in the pathogenesis of diabetic nephropathy. 

Phrase: "We"

Phrase: "speculated"

Phrase: "that enhanced oxidative stress"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
   901   C0242606:Oxidative Stress [Cell or Molecular Dysfunction]
   827   C0038435:Stress [Finding]
   827   C0311404:Oxidative [Functional Concept]
   755 E C0231297:Stressful [Functional Concept]

Phrase: "might"

Phrase: "induce"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0205263:Induce [Functional Concept]

Phrase: "mtDNA damage"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   913   C1096176:Mitochondrial Damage [Pathologic Function]
   901   C0012860:DNA Damage [Cell or Molecular Dysfunction]
   827   C0010957:Damage [Injury or Poisoning]
   827   C1883709:Damage [Functional Concept]
   734   C0012929:DNA, Mitochondrial [Biologically Active Substance,Nucleic Acid, Nucleoside, or Nucleotide]
   734   C1819717:mitochondrial DNA [Cell Component]

Phrase: "and"

Phrase: "subsequent mtDNA mutations in kidney of diabetic subjects,"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   745   C2315666:Mitochondrial mutation [Genetic Function]
   742   C0026882:Mutations [Genetic Function]
   708 E C1705285:Mutation [Cell or Molecular Dysfunction]

Phrase: "and"

Phrase: "this"

Phrase: "might"

Phrase: "be"

Phrase: "involved in the pathogenesis of diabetic nephropathy."
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   778   C0011881:Diabetic Nephropathy [Disease or Syndrome]
   778   C1442864:diabetic nephropathy [Gene or Genome]
   748   C0022658:Nephropathy [Disease or Syndrome]
   748   C0241863:DIABETIC [Finding]
   748   C0543483:pathogenesis [Functional Concept]
   748   C0699748:Pathogenesis [Pathologic Function]
   748   C1314939:Involved [Functional Concept]
Processing 00000000.tx.21: In this study, we first examined the oxidative DNA damage in kidney of streptozotocin (STZ)-induced diabetic rats by measuring the levels of 8-OHdG in kidney and urine. 

Phrase: "In this study,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0557651:Study [Manufactured Object]
  1000   C2603343:Study [Research Activity]

Phrase: "we first"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0205435:First [Quantitative Concept]
  1000   C1279901:First [Qualitative Concept]

Phrase: "examined"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0332128:Examined [Finding]

Phrase: "the oxidative DNA damage in kidney of streptozotocin (STZ)-induced diabetic rats"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   756   C0012860:DNA Damage [Cell or Molecular Dysfunction]
   738   C0010957:Damage [Injury or Poisoning]
   738   C0012854:DNA [Biologically Active Substance,Nucleic Acid, Nucleoside, or Nucleotide]
   738   C1883709:Damage [Functional Concept]

Phrase: "by measuring"
Meta Candidates (Total=4; Excluded=2; Pruned=0; Remaining=2)
  1000   C0444706:measuring [Qualitative Concept]
  1000   C0449770:measuring [Quantitative Concept]
   966 E C0079809:Measure [Quantitative Concept]
   966 E C0242485:Measure [Functional Concept]

Phrase: "the levels of 8-OHdG"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
   757   C0456948:Level 2 [Intellectual Product]
   748   C0441889:Levels [Qualitative Concept]
   714 E C0456079:Level [Classification]
   714 E C1547707:Level [Geographic Area]
   714 E C2946261:Level [Pharmacologic Substance]

Phrase: "in kidney"
Meta Candidates (Total=5; Excluded=1; Pruned=0; Remaining=4)
  1000   C0022646:Kidney [Body Part, Organ, or Organ Component]
  1000   C0227665:kidney [Body Part, Organ, or Organ Component]
  1000   C1278978:Kidney [Body Part, Organ, or Organ Component]
  1000   C1514845:KIDNEY [Tissue]
   907 E C0027697:Nephritides [Disease or Syndrome]

Phrase: "and"

Phrase: "urine."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0042036:Urine [Body Substance]
  1000   C0042037:urine [Functional Concept]
  1000   C2963137:Urine [Body Substance]
Processing 00000000.tx.22: Second, we surveyed the frequency of mtDNA with a common deletion of 4,834 bp (23,2628) in kidney of STZ-induced diabetic rats. 

Phrase: "Second,"
Meta Candidates (Total=7; Excluded=2; Pruned=0; Remaining=5)
  1000   C0205436:Second [Quantitative Concept]
  1000   C0457385:Second [Temporal Concept]
  1000   C0565930:/second [Quantitative Concept]
  1000   C1561503:second [Idea or Concept]
  1000   C1705190:Second [Qualitative Concept]
   928 E C0027627:secondary [Neoplastic Process]
   928 E C0175668:Secondary [Temporal Concept]

Phrase: "we"

Phrase: "surveyed"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C0038951:Survey [Intellectual Product]

Phrase: "the frequency of mtDNA"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   760   C0376249:frequency [Quantitative Concept]
   760   C0439603:Frequency [Temporal Concept]
   760   C0871396:Frequency [Quantitative Concept]
   760   C1561548:Frequency [Qualitative Concept]
   760   C1705502:Frequency [Quantitative Concept]

Phrase: "with a common deletion"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C1442161:Deletion [Cell or Molecular Dysfunction]
   861   C1511760:Deletion [Genetic Function]
   861   C1880274:Deletion [Activity]

Phrase: "of 4,834 bp (23,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   812   C0450348:23 [Quantitative Concept]

Phrase: "2628"

Phrase: ")"

Phrase: "in kidney"
Meta Candidates (Total=5; Excluded=1; Pruned=0; Remaining=4)
  1000   C0022646:Kidney [Body Part, Organ, or Organ Component]
  1000   C0227665:kidney [Body Part, Organ, or Organ Component]
  1000   C1278978:Kidney [Body Part, Organ, or Organ Component]
  1000   C1514845:KIDNEY [Tissue]
   907 E C0027697:Nephritides [Disease or Syndrome]

Phrase: "of STZ-induced diabetic rats."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   812   C0034693:rats [Mammal]
   812   C0034721:Rats [Mammal]
   812   C0241863:DIABETIC [Finding]
Processing 00000000.tx.23: In addition, we evaluated the effect of intervention by insulin treatment on 8-OHdG levels in mtDNA and the frequency of mtDNA with a 4,834-bp deletion in kidney of diabetic rats.  

Phrase: "In addition,"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C1883712:Addition [Functional Concept]
   928 E C1524062:Additional [Functional Concept]

Phrase: "we"

Phrase: "evaluated"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0220825:Evaluated [Functional Concept]

Phrase: "the effect of intervention"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   770   C1280500:Effect [Qualitative Concept]
   770   C2348382:Effect [Qualitative Concept]

Phrase: "by insulin treatment"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
  1000   C0745343:insulin treatment [Therapeutic or Preventive Procedure]
   861   C0039798:treatment [Functional Concept]
   861   C0087111:Treatment [Therapeutic or Preventive Procedure]
   861   C1522326:Treatment [Functional Concept]
   861   C1533734:Treatment [Therapeutic or Preventive Procedure]
   861   C1705169:Treatment [Conceptual Entity]
   861   C3538994:TREATMENT [Research Activity]

Phrase: "on 8-OHdG levels"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
   804   C0441889:Levels [Qualitative Concept]
   771   C0050078:8-Hydroxy-2'-deoxyguanosine [Biologically Active Substance,Nucleic Acid, Nucleoside, or Nucleotide]
   771 E C0456079:Level [Classification]
   771 E C1547707:Level [Geographic Area]
   771 E C2946261:Level [Pharmacologic Substance]

Phrase: "in mtDNA"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
  1000   C0012929:DNA, Mitochondrial [Biologically Active Substance,Nucleic Acid, Nucleoside, or Nucleotide]
  1000   C1819717:mitochondrial DNA [Cell Component]
   861   C0012854:DNA [Biologically Active Substance,Nucleic Acid, Nucleoside, or Nucleotide]
   861   C0026237:Mitochondrial [Cell Component]
   861   C0521451:Mitochondrial [Functional Concept]

Phrase: "and"

Phrase: "the frequency of mtDNA"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   760   C0376249:frequency [Quantitative Concept]
   760   C0439603:Frequency [Temporal Concept]
   760   C0871396:Frequency [Quantitative Concept]
   760   C1561548:Frequency [Qualitative Concept]
   760   C1705502:Frequency [Quantitative Concept]

Phrase: "with a 4,834-bp deletion"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   812   C1442161:Deletion [Cell or Molecular Dysfunction]
   812   C1511760:Deletion [Genetic Function]
   812   C1880274:Deletion [Activity]

Phrase: "in kidney"
Meta Candidates (Total=5; Excluded=1; Pruned=0; Remaining=4)
  1000   C0022646:Kidney [Body Part, Organ, or Organ Component]
  1000   C0227665:kidney [Body Part, Organ, or Organ Component]
  1000   C1278978:Kidney [Body Part, Organ, or Organ Component]
  1000   C1514845:KIDNEY [Tissue]
   907 E C0027697:Nephritides [Disease or Syndrome]

Phrase: "of diabetic rats."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0034693:rats [Mammal]
   861   C0034721:Rats [Mammal]
   861   C0241863:DIABETIC [Finding]
Processing 00000000.tx.24: RESEARCH DESIGN AND METHODS TOP ABSTRACT INTRODUCTION RESEARCH DESIGN AND METHODS RESULTS DISCUSSION REFERENCES  Animals. 

Phrase: "RESEARCH DESIGN"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
  1000   C0035171:Research Design [Research Activity]
   861   C0035168:research [Research Activity]
   861   C0242481:Research [Research Activity]
   861   C1707689:Design [Activity]
   861   C2983265:DESIGN [Intellectual Product]

Phrase: "AND"

Phrase: "METHODS TOP ABSTRACT INTRODUCTION RESEARCH DESIGN"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   876   C0086912:methods research [Research Activity]
   827   C0035171:Research Design [Research Activity]
   799   C0035168:research [Research Activity]
   799   C0242481:Research [Research Activity]
   799   C1707689:Design [Activity]
   799   C2983265:DESIGN [Intellectual Product]

Phrase: "AND"

Phrase: "METHODS RESULTS DISCUSSION"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0557061:Discussion [Therapeutic or Preventive Procedure]
   827   C2584313:Discussion [Social Behavior]

Phrase: "REFERENCES"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1514811:Reference [Idea or Concept]
  1000   C1706462:Reference [Conceptual Entity]

Phrase: "Animals."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0003062:Animals [Animal]
Processing 00000000.tx.25: Male Wister rats were bred under pathogen-free conditions at Kyushu University Animal Center, Fukuoka, Japan. 

Phrase: "Male Wister rats"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0034693:rats [Mammal]
   827   C0034721:Rats [Mammal]

Phrase: "were"

Phrase: "bred under pathogen-free conditions"
Meta Candidates (Total=9; Excluded=0; Pruned=0; Remaining=9)
   760   C0332296:free [Functional Concept]
   760   C0450254:Pathogen [Organism]
   760   C1880497:Free [Qualitative Concept]
   760   C1996904:Free [Qualitative Concept]
   726   C0006159:breed [Organism Function]
   726   C0012634:condition [Disease or Syndrome]
   726   C0348080:Condition [Qualitative Concept]
   726   C1704650:Breed [Classification]
   726   C1705253:Condition [Conceptual Entity]

Phrase: "at Kyushu University Animal Center,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   812   C0205099:Center [Spatial Concept]

Phrase: "Fukuoka,"

Phrase: "Japan."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0022341:Japan [Geographic Area]
Processing 00000000.tx.26: Two experimental groups were formed: STZ-induced diabetic rats and age-matched control rats. 

Phrase: "Two experimental groups"
Meta Candidates (Total=8; Excluded=0; Pruned=0; Remaining=8)
   827   C0441833:Group [Idea or Concept]
   827   C0687744:group [Population Group]
   827   C1257890:Group [Population Group]
   827   C1517586:Experimental [Qualitative Concept]
   827   C1552516:Group [Health Care Related Organization]
   827   C1552839:groups [Idea or Concept]
   827   C1705428:Group [Conceptual Entity]
   827   C1705429:Group [Population Group]

Phrase: "were"

Phrase: "formed"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C0205431:Formed [Functional Concept]
   966 E C0348078:Form [Qualitative Concept]
   966 E C0376315:Form [Manufactured Object]
   966 E C1522492:Form [Functional Concept]

Phrase: ":"

Phrase: "STZ-induced diabetic rats"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   812   C0034693:rats [Mammal]
   812   C0034721:Rats [Mammal]
   812   C0241863:DIABETIC [Finding]

Phrase: "and"

Phrase: "age-matched control rats."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   812   C0034693:rats [Mammal]
   812   C0034721:Rats [Mammal]
Processing 00000000.tx.27: The animals had free access to tap water and standard chow (Clea Japan, Tokyo). 

Phrase: "The animals"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0003062:Animals [Animal]

Phrase: "had"

Phrase: "free access to tap water"
Meta Candidates (Total=6; Excluded=1; Pruned=0; Remaining=5)
   840   C2919405:Tap water [Inorganic Chemical,Pharmacologic Substance]
   804   C0034115:Tap [Health Care Activity]
   804   C0043047:Water [Inorganic Chemical,Pharmacologic Substance]
   804   C0599638:WATER [Substance]
   804   C1550678:Water [Inorganic Chemical]
   733 E C0443350:Watery [Qualitative Concept]

Phrase: "and"

Phrase: "standard chow"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0324335:chow [Mammal]

Phrase: "(Clea Japan,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0022341:Japan [Geographic Area]

Phrase: "Tokyo"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0040371:Tokyo [Geographic Area]

Phrase: ")."
Processing 00000000.tx.28: At 8 weeks of age, the rats were injected intraperitoneally with STZ (Sigma, St. Louis, MO) at 80 mg/kg body wt. 

Phrase: "At 8 weeks"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   861   C0439230:weeks [Temporal Concept]
   827 E C0332174:/week [Temporal Concept]

Phrase: "of age,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0001779:Age [Organism Attribute]

Phrase: "the rats"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0034693:rats [Mammal]
  1000   C0034721:Rats [Mammal]

Phrase: "were"

Phrase: "injected"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1720154:Inject [Functional Concept]

Phrase: "intraperitoneally with STZ"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   790   C0038432:Streptozotocin [Antibiotic,Carbohydrate]

Phrase: "(Sigma,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1719918:Sigma [Intellectual Product]

Phrase: "St. Louis,"

Phrase: "MO) at 80 mg/kg body wt."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   748   C3538743:MO [Idea or Concept]
Processing 00000000.tx.29: One day after injection, the development of diabetes was verified by the presence of hyperglycemia (plasma glucose level 300 mg/dl). 

Phrase: "One day after injection,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   770   C0332173:/day [Temporal Concept]
   770   C0439228:day [Temporal Concept]
   770   C0439505:/day [Temporal Concept]

Phrase: "the development of diabetes"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   770   C0243107:development [Physiologic Function]
   770   C0678723:Development [Organism Function]
   770   C1527148:Development [Functional Concept]

Phrase: "was"

Phrase: "verified by the presence of hyperglycemia"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   753   C0020456:Hyperglycaemia [Disease or Syndrome]
   753   C0392148:Presence [Therapeutic or Preventive Procedure]
   753   C1711411:Verified [Functional Concept]

Phrase: "(plasma glucose level 300 mg/dl"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0439269:mg dl [Quantitative Concept]
   799   C3642216:/dL [Quantitative Concept]

Phrase: ")."
Processing 00000000.tx.30: The rats were used for experiments at 4 or 8 weeks after the onset of diabetes. 

Phrase: "The rats"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0034693:rats [Mammal]
  1000   C0034721:Rats [Mammal]

Phrase: "were"

Phrase: "used for experiments"
Meta Candidates (Total=7; Excluded=5; Pruned=0; Remaining=2)
   790   C0681814:Experiments [Research Activity]
   790   C1273517:used [Finding]
   756 E C0042153:use [Functional Concept]
   756 E C0457083:Use [Functional Concept]
   756 E C1706386:Experiment [Conceptual Entity]
   756 E C1947944:Use [Intellectual Product]
   706 E C1517586:Experimental [Qualitative Concept]

Phrase: "at 4"

Phrase: "or"

Phrase: "8 weeks after the onset of diabetes."
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   748   C0439230:weeks [Temporal Concept]
   714 E C0332174:/week [Temporal Concept]
Processing 00000000.tx.31: This study was approved by the Committee of the Ethics on Animal Experiments, Graduate School of Medical Sciences, Kyushu University. 

Phrase: "This study"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0557651:Study [Manufactured Object]
  1000   C2603343:Study [Research Activity]

Phrase: "was"

Phrase: "approved by the Committee of the Ethics"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   774   C0085546:Ethics Committee [Professional or Occupational Group]
   748   C0015000:Ethics [Idea or Concept]
   748   C0205540:Approved [Qualitative Concept]
   748   C1527243:ethics [Idea or Concept]
   748   C2699414:Committee [Group]

Phrase: "on Animal Experiments,"
Meta Candidates (Total=5; Excluded=2; Pruned=0; Remaining=3)
  1000   C0205664:Animal Experiments [Research Activity]
   861   C0003062:Animal [Animal]
   861   C0681814:Experiments [Research Activity]
   827 E C1706386:Experiment [Conceptual Entity]
   777 E C1517586:Experimental [Qualitative Concept]

Phrase: "Graduate School of Medical Sciences,"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   806   C0870614:graduate school [Manufactured Object,Organization]
   797   C0036378:School, Medical [Health Care Related Organization,Manufactured Object]
   760   C0036375:School [Manufactured Object,Organization]
   760   C0588053:Graduate [Population Group]
   760   C1547183:Graduate [Idea or Concept]

Phrase: "Kyushu University."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0041740:University [Manufactured Object,Organization]
   861   C0454747:Kyushu [Geographic Area]
Processing 00000000.tx.32: Measurement of urinary 8-OHdG. 

Phrase: "Measurement of urinary 8-OHdG."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   748   C0242485:Measurement [Functional Concept]
Processing 00000000.tx.33: Two-milliliter samples of well-mixed 24-h urine were collected from rats. 

Phrase: "Two-milliliter samples of well-mixed 24-h urine"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   745   C0444180:Urine sample [Body Substance]
   708   C0370003:Sample [Substance]
   708   C2347026:Sample [Conceptual Entity]

Phrase: "were"

Phrase: "collected from rats."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   790   C0034693:rats [Mammal]
   790   C0034721:Rats [Mammal]
   790   C1516695:Collected [Idea or Concept]
   790   C1516698:Collected [Functional Concept]
Processing 00000000.tx.34: The samples were purged of air with a steam of nitrogen to prevent the artificial formation of 8-OHdG and stored frozen at -80C until analyzed. 

Phrase: "The samples"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   966   C0370003:Sample [Substance]
   966   C2347026:Sample [Conceptual Entity]

Phrase: "were"

Phrase: "purged of air"
Meta Candidates (Total=5; Excluded=2; Pruned=0; Remaining=3)
   790   C0001861:Air [Substance]
   790   C1548399:purged [Idea or Concept]
   790   C3536832:Air [Inorganic Chemical,Pharmacologic Substance]
   756 E C0722910:Purge [Lipid,Pharmacologic Substance]
   706 E C0070924:AIRS [Amino Acid, Peptide, or Protein,Enzyme]

Phrase: "with a steam"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0038225:Steam [Inorganic Chemical]

Phrase: "of nitrogen to"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0028158:Nitrogen [Element, Ion, or Isotope]
   861   C1550581:nitrogen [Human-caused Phenomenon or Process]

Phrase: "prevent"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0309872:PREVENT [Pharmacologic Substance]

Phrase: "the artificial formation of 8-OHdG"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   767   C1157283:deoxyguanosine formation [Molecular Function]
   744   C0220781:formation [Biologic Function]
   744   C0439634:formation [Spatial Concept]
   744   C1522492:Formation [Functional Concept]

Phrase: "and"

Phrase: "stored"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1698986:Store [Functional Concept]

Phrase: "frozen"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0016701:Frozen [Natural Phenomenon or Process]
  1000   C0677542:Frozen [Functional Concept]

Phrase: "at -80C"

Phrase: "until"

Phrase: "analyzed."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0936012:Analyzed [Research Activity]
Processing 00000000.tx.35: Urine samples were centrifuged at 2,000g for 20 min, and after proper dilution, the supernatant was used for the determination of 8-OHdG by a competitive enzyme-linked immunosorbent assay (ELISA) kit (8-OHdG Check; Japan Institute for the Control of Aging, Fukuroi, Japan). 

Phrase: "Urine samples"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   983   C0444180:Urine sample [Body Substance]
   827   C0370003:Sample [Substance]
   827   C2347026:Sample [Conceptual Entity]

Phrase: "were"

Phrase: "centrifuged"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C0179834:centrifuge [Medical Device]

Phrase: "at 2,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C1516077:At [Spatial Concept]

Phrase: "000g for 20 min,"

Phrase: "and after proper dilution,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   770   C0079240:Dilution [Laboratory Procedure]
   770   C1515981:And [Idea or Concept]
   770   C1948037:Dilution [Functional Concept]

Phrase: "the supernatant"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1550101:Supernatant [Body Substance]

Phrase: "was"

Phrase: "used for the determination of 8-OHdG"
Meta Candidates (Total=9; Excluded=3; Pruned=0; Remaining=6)
   818   C0050078:8-Hydroxy-2'-deoxyguanosine [Biologically Active Substance,Nucleic Acid, Nucleoside, or Nucleotide]
   745   C1524063:Use of [Functional Concept]
   742   C0011503:Deoxyguanosine [Nucleic Acid, Nucleoside, or Nucleotide]
   742   C0700307:Hydroxy [Inorganic Chemical]
   742   C1148554:determination [Laboratory Procedure]
   742   C1273517:used [Finding]
   708 E C0042153:use [Functional Concept]
   708 E C0457083:Use [Functional Concept]
   708 E C1947944:Use [Intellectual Product]

Phrase: "by a competitive enzyme-linked immunosorbent assay (ELISA) kit (8-OHdG Check"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   788   C1283174:Check [Activity]
   788   C1555524:Cheque [Intellectual Product]

Phrase: "; Japan"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0022341:Japan [Geographic Area]

Phrase: "Institute for the Control of Aging,"
Meta Candidates (Total=8; Excluded=0; Pruned=0; Remaining=8)
   753   C0001811:Ageing [Organism Function]
   753   C0021622:institute [Organization]
   753   C0243148:control [Qualitative Concept]
   753   C1272753:Institute [Idea or Concept]
   753   C1550141:Control [Substance]
   753   C1882979:Control [Conceptual Entity]
   753   C2587213:Control [Functional Concept]
   753   C3274648:Control [Qualitative Concept]

Phrase: "Fukuroi,"

Phrase: "Japan"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0022341:Japan [Geographic Area]

Phrase: ")."
Processing 00000000.tx.36: The determination range was 0.5200 ng/ml. 

Phrase: "The determination range"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C1514721:Range [Quantitative Concept]
   861   C2348147:Range [Quantitative Concept]
   861   C3542016:Range [Intellectual Product]

Phrase: "was"

Phrase: "0.5200 ng/ml."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0439275:ng/mL [Quantitative Concept]
   812   C0439526:/mL [Quantitative Concept]
Processing 00000000.tx.37: The urinary 8-OHdG was expressed as total amounts excreted in 24 h. 

Phrase: "The urinary 8-OHdG"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   937   C0050078:8-Hydroxy-2'-deoxyguanosine [Biologically Active Substance,Nucleic Acid, Nucleoside, or Nucleotide]
   804   C0011503:Deoxyguanosine [Nucleic Acid, Nucleoside, or Nucleotide]

Phrase: "was"

Phrase: "expressed as total amounts"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   770   C0439175:% total [Quantitative Concept]
   770   C0439810:Total [Qualitative Concept]
   770   C1265611:amounts [Quantitative Concept]

Phrase: "excreted in 24 h."
Meta Candidates (Total=6; Excluded=1; Pruned=0; Remaining=5)
   770   C0033727:H+ [Element, Ion, or Isotope]
   770   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   770   C0441932:H+ [Classification]
   770   C0564385:/h [Quantitative Concept]
   770   C1688651:% excreted [Quantitative Concept]
   737 E C0221102:excrete [Physiologic Function]
Processing 00000000.tx.38: Mesaurement of 8-OHdG levels in kidney. 

Phrase: "Mesaurement of 8-OHdG levels"

Phrase: "in kidney."
Meta Candidates (Total=5; Excluded=1; Pruned=0; Remaining=4)
  1000   C0022646:Kidney [Body Part, Organ, or Organ Component]
  1000   C0227665:kidney [Body Part, Organ, or Organ Component]
  1000   C1278978:Kidney [Body Part, Organ, or Organ Component]
  1000   C1514845:KIDNEY [Tissue]
   907 E C0027697:Nephritides [Disease or Syndrome]
Processing 00000000.tx.39: At 8 weeks after the onset of diabetes, rats were anesthetized by intraperitoneal injection of pentobarbital (80 mg/kg) before performance of surgical procedures. 

Phrase: "At 8 weeks"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   861   C0439230:weeks [Temporal Concept]
   827 E C0332174:/week [Temporal Concept]

Phrase: "after the onset"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0332162:Onset [Qualitative Concept]

Phrase: "of diabetes,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0011847:Diabetes [Disease or Syndrome]
  1000   C0011849:Diabetes [Disease or Syndrome]

Phrase: "rats"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0034693:rats [Mammal]
  1000   C0034721:Rats [Mammal]

Phrase: "were"

Phrase: "anesthetized by intraperitoneal injection of pentobarbital"
Meta Candidates (Total=8; Excluded=0; Pruned=0; Remaining=8)
   790   C0021493:Intraperitoneal injection [Therapeutic or Preventive Procedure]
   753   C0021485:injection [Therapeutic or Preventive Procedure]
   753   C0030883:Pentobarbital [Organic Chemical,Pharmacologic Substance]
   753   C0442120:Intraperitoneal [Spatial Concept]
   753   C1272883:Injection [Biomedical or Dental Material]
   753   C1533685:Injection [Therapeutic or Preventive Procedure]
   753   C1720436:Anesthetized [Finding]
   753   C1828121:Injection [Functional Concept]

Phrase: "(80 mg/kg"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   901   C0439272:mg kg [Quantitative Concept]
   827   C0022718:KG [Geographic Area]
   827   C0439209:kg [Quantitative Concept]
   827   C0439269:mg% [Quantitative Concept]
   827   C1960952:mg % [Quantitative Concept]
   827   C2346927:Mg++ [Element, Ion, or Isotope,Pharmacologic Substance]

Phrase: ")"

Phrase: "before"

Phrase: "performance of surgical procedures."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   770   C0597198:Performance [Individual Behavior]
   770   C1882330:Performance [Activity]
Processing 00000000.tx.40: The kidney was rapidly excised and separated into cortices and papillae. 

Phrase: "The kidney"
Meta Candidates (Total=5; Excluded=1; Pruned=0; Remaining=4)
  1000   C0022646:Kidney [Body Part, Organ, or Organ Component]
  1000   C0227665:kidney [Body Part, Organ, or Organ Component]
  1000   C1278978:Kidney [Body Part, Organ, or Organ Component]
  1000   C1514845:KIDNEY [Tissue]
   907 E C0027697:Nephritides [Disease or Syndrome]

Phrase: "was"

Phrase: "rapidly"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1637379:Rapidly [Qualitative Concept]

Phrase: "excised"

Phrase: "and"

Phrase: "separated into cortices"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   790   C0086972:Separated [Finding]
   790   C0443299:separated [Spatial Concept]
   790   C0687118:Separated [Functional Concept]
   756   C0007776:Cortex [Body Part, Organ, or Organ Component]
   756   C1176472:Cortex [Body Part, Organ, or Organ Component]
   756   C2700441:Cortex [Plant]

Phrase: "and"

Phrase: "papillae."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   966   C0226964:papilla [Body Part, Organ, or Organ Component]
   966   C0227296:Papilla [Body Part, Organ, or Organ Component]
Processing 00000000.tx.41: Then, the samples were frozen in liquid nitrogen and kept at -80C until analyzed. 

Phrase: "Then,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883708:Then [Temporal Concept]

Phrase: "the samples"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   966   C0370003:Sample [Substance]
   966   C2347026:Sample [Conceptual Entity]

Phrase: "were"

Phrase: "frozen in liquid nitrogen"
Meta Candidates (Total=10; Excluded=0; Pruned=0; Remaining=10)
   833   C0260055:Liquid nitrogen [Element, Ion, or Isotope]
   833   C1550121:Liquid nitrogen [Intellectual Product]
   770   C0016701:Frozen [Natural Phenomenon or Process]
   770   C0028158:Nitrogen [Element, Ion, or Isotope]
   770   C0302908:Liquid [Substance]
   770   C0677542:Frozen [Functional Concept]
   770   C1304698:Liquid [Finding]
   770   C1546699:Liquid NOS [Intellectual Product]
   770   C1550581:nitrogen [Human-caused Phenomenon or Process]
   770   C1561501:Liquid NOS [Substance]

Phrase: "and"

Phrase: "kept"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C0333118:Keep [Functional Concept]

Phrase: "at -80C"

Phrase: "until"

Phrase: "analyzed."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0936012:Analyzed [Research Activity]
Processing 00000000.tx.42: On the day of assay, the samples were homogenized in 5 ml of 50 mmol/l Tris-HCl (pH 7.4) with 20 strokes of Dounce homogenizer. 

Phrase: "On the day"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0332173:/day [Temporal Concept]
  1000   C0439228:day [Temporal Concept]
  1000   C0439505:/day [Temporal Concept]

Phrase: "of assay,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0005507:Assay [Laboratory Procedure]
  1000   C0243073:assay [Qualitative Concept]
  1000   C1510438:Assay [Laboratory Procedure]

Phrase: "the samples"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   966   C0370003:Sample [Substance]
   966   C2347026:Sample [Conceptual Entity]

Phrase: "were"

Phrase: "homogenized in 5 ml"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C0439526:/mL [Quantitative Concept]

Phrase: "of 50 mmol/l Tris-HCl (pH 7.4"
Meta Candidates (Total=11; Excluded=0; Pruned=0; Remaining=11)
   822   C2678549:PH-4 [Gene or Genome]
   812   C1532563:mmol/L [Quantitative Concept]
   812   C1882074:pH 7 [Qualitative Concept]
   793   C0020283:[pH] [Quantitative Concept]
   793   C0041175:TRIS [Organic Chemical,Pharmacologic Substance]
   793   C0077281:Tris [Hazardous or Poisonous Substance,Organophosphorus Compound]
   793   C0439190:MMOLE [Quantitative Concept]
   793   C0450407:ph+ [Finding]
   793   C0450408:ph++ [Finding]
   793   C0450409:ph+++ [Finding]
   793   C0814229:TRI [Intellectual Product]

Phrase: ")"

Phrase: "with 20 strokes"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0038454:Strokes [Disease or Syndrome]

Phrase: "of Dounce homogenizer."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0181200:homogenizer [Medical Device]
Processing 00000000.tx.43: The homogenates were centrifuged at 800g for 10 min to precipitate nuclear fraction. 

Phrase: "The homogenates"

Phrase: "were"

Phrase: "centrifuged at 800g"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   756   C0179834:centrifuge [Medical Device]

Phrase: "for 10 min to"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   901   C0456692:/10 min [Temporal Concept]
   827   C0702093:/min [Temporal Concept]

Phrase: "precipitate"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1882443:PRECIPITATE [Phenomenon or Process]

Phrase: "nuclear fraction."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C1264633:Fraction [Quantitative Concept]
   861   C1554103:Fraction [Idea or Concept]
Processing 00000000.tx.44: The supernatant was again centrifuged at 7,000g for 10 min to yield mitochondrial fraction. 

Phrase: "The supernatant"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1550101:Supernatant [Body Substance]

Phrase: "was"

Phrase: "again"

Phrase: "centrifuged at 7,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   756   C0179834:centrifuge [Medical Device]

Phrase: "000g for 10 min to"

Phrase: "yield"

Phrase: "mitochondrial fraction."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C1264633:Fraction [Quantitative Concept]
   861   C1554103:Fraction [Idea or Concept]
Processing 00000000.tx.45: One milliliter of solution containing 10 mmol/l EDTA, 10 mmol/l Tris-HCl (pH 8.0), 150 mmol/l NaCl, and 0.2% SDS was added to each fraction. 

Phrase: "One milliliter of solution"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C0439242:milliliter [Quantitative Concept]

Phrase: "containing"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0332256:Containing [Functional Concept]
  1000   C2700400:Containing [Activity]

Phrase: "10 mmol/l EDTA,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   812   C0013618:EDTA [Organic Chemical,Pharmacologic Substance]

Phrase: "10 mmol/l Tris-HCl (pH 8.0"
Meta Candidates (Total=9; Excluded=0; Pruned=0; Remaining=9)
   812   C1532563:mmol/L [Quantitative Concept]
   793   C0020283:[pH] [Quantitative Concept]
   793   C0041175:TRIS [Organic Chemical,Pharmacologic Substance]
   793   C0077281:Tris [Hazardous or Poisonous Substance,Organophosphorus Compound]
   793   C0439190:MMOLE [Quantitative Concept]
   793   C0450407:ph+ [Finding]
   793   C0450408:ph++ [Finding]
   793   C0450409:ph+++ [Finding]
   793   C0814229:TRI [Intellectual Product]

Phrase: ")"

Phrase: ","

Phrase: "150 mmol/l NaCl,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   812   C0037494:NaCl [Biologically Active Substance,Inorganic Chemical,Pharmacologic Substance]
   812   C1959973:% NaCl [Quantitative Concept]

Phrase: "and"

Phrase: "0.2% SDS"

Phrase: "was"

Phrase: "added to each fraction."
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
   770   C1264633:Fraction [Quantitative Concept]
   770   C1524062:Added [Functional Concept]
   770   C1554103:Fraction [Idea or Concept]
   737 E C1883712:Add [Functional Concept]
Processing 00000000.tx.46: After homogenization, the mixture was incubated at 56C for 70 min with proteinase K (700 g/ml) and then heated at 95C for 10 min. 

Phrase: "After homogenization,"

Phrase: "the mixture"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0439962:Mixture [Substance]

Phrase: "was"

Phrase: "incubated at 56C"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   790   C1439852:Incubated [Laboratory Procedure]

Phrase: "for 70 min"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0702093:/min [Temporal Concept]

Phrase: "with proteinase K"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
  1000   C0059256:Proteinase K [Amino Acid, Peptide, or Protein,Enzyme]
   861   C0030946:Proteinase [Amino Acid, Peptide, or Protein,Enzyme,Pharmacologic Substance]
   861   C0597277:K+ [Element, Ion, or Isotope,Pharmacologic Substance]
   861   C1622131:proteinase [Molecular Function]
   861   C1708601:K' [Quantitative Concept]
   861   C1947941:Proteinase [Enzyme]

Phrase: "(700 g/"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0439267:g% [Quantitative Concept]

Phrase: "ml)"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0439526:/mL [Quantitative Concept]

Phrase: "and"

Phrase: "then"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883708:Then [Temporal Concept]

Phrase: "heated at 95C"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   756   C0018837:Heat [Natural Phenomenon or Process]

Phrase: "for 10 min."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0456692:/10 min [Temporal Concept]
   861   C0702093:/min [Temporal Concept]
Processing 00000000.tx.47: DNA was extracted with equal volumes of phenol, chloroform, and isoamyl alcohol (25:24:1) and then with chloroform. 

Phrase: "DNA"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0012854:DNA [Biologically Active Substance,Nucleic Acid, Nucleoside, or Nucleotide]

Phrase: "was"

Phrase: "extracted with equal volumes of phenol,"
Meta Candidates (Total=11; Excluded=4; Pruned=0; Remaining=7)
   753   C0031428:phenol [Organic Chemical,Pharmacologic Substance]
   753   C0070570:phenol [Organic Chemical,Pharmacologic Substance]
   753   C0185115:Extracted [Therapeutic or Preventive Procedure]
   753   C0205163:Equal [Qualitative Concept]
   753   C0449468:volumes [Quantitative Concept]
   753   C1549782:Equal [Idea or Concept]
   753   C3541890:EXTRACTED [Finding]
   719 E C1690016:% volume [Qualitative Concept]
   719 E C1705102:Volume [Intellectual Product]
   719 E C2700258:Volume [Laboratory Procedure]
   719 E C2828366:Extract [Substance]

Phrase: "chloroform,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0008238:Chloroform [Hazardous or Poisonous Substance,Indicator, Reagent, or Diagnostic Aid,Organic Chemical]

Phrase: "and"

Phrase: "isoamyl alcohol"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
  1000   C0064032:Isoamyl alcohol [Organic Chemical]
   861   C0001962:ALCOHOL [Organic Chemical]
   861   C0001975:Alcohol [Organic Chemical,Pharmacologic Substance]
   789 E C0687725:Alcoholic [Patient or Disabled Group]

Phrase: "(25"

Phrase: ":"

Phrase: "24"

Phrase: ":"

Phrase: "1"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C2827734:1+ [Quantitative Concept]
  1000   C2981698:1+ [Classification]

Phrase: ")"

Phrase: "and"

Phrase: "then with chloroform."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   790   C0008238:Chloroform [Hazardous or Poisonous Substance,Indicator, Reagent, or Diagnostic Aid,Organic Chemical]
   790   C1883708:Then [Temporal Concept]
Processing 00000000.tx.48: DNA was precipitated with a one-tenth volume of 2 mol/l NaCl and two volumes of 70% ethanol at -20C for 2 h and rinsed with ethanol. 

Phrase: "DNA"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0012854:DNA [Biologically Active Substance,Nucleic Acid, Nucleoside, or Nucleotide]

Phrase: "was"

Phrase: "precipitated with a one-tenth volume of 2 mol/l NaCl"
Meta Candidates (Total=16; Excluded=0; Pruned=0; Remaining=16)
   756   C0347982:mol/L [Quantitative Concept]
   754   C0808397:Volume 2 [Quantitative Concept]
   738   C0027960:Mole [Neoplastic Process]
   738   C0037494:NaCl [Biologically Active Substance,Inorganic Chemical,Pharmacologic Substance]
   738   C0205444:Tenth [Quantitative Concept]
   738   C0205447:One [Quantitative Concept]
   738   C0324740:Mole [Mammal]
   738   C0439189:Mole [Quantitative Concept]
   738   C0449468:*Volume [Quantitative Concept]
   738   C1456781:mole [Neoplastic Process]
   738   C1690016:% volume [Qualitative Concept]
   738   C1705102:Volume [Intellectual Product]
   738   C1824986:mol [Gene or Genome]
   738   C1959973:% NaCl [Quantitative Concept]
   738   C2700258:Volume [Laboratory Procedure]
   704   C1882443:PRECIPITATE [Phenomenon or Process]

Phrase: "and"

Phrase: "two volumes of 70% ethanol at -20C"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
   748   C0449468:volumes [Quantitative Concept]
   714 E C1690016:% volume [Qualitative Concept]
   714 E C1705102:Volume [Intellectual Product]
   714 E C2700258:Volume [Laboratory Procedure]

Phrase: "for 2 h"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
  1000   C0011744:2 H [Element, Ion, or Isotope]
   861   C0033727:H+ [Element, Ion, or Isotope]
   861   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441932:H+ [Classification]
   861   C0564385:/h [Quantitative Concept]

Phrase: "and"

Phrase: "rinsed with ethanol."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   790   C0001962:Ethanol [Organic Chemical]
   756   C1701810:Rinse [Functional Concept]
   756   C1882955:Rinse [Activity]
Processing 00000000.tx.49: DNA was resuspended in 10 mmol/l Tris-HCl and 0.1 mmol/l EDTA (pH 8.0). 

Phrase: "DNA"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0012854:DNA [Biologically Active Substance,Nucleic Acid, Nucleoside, or Nucleotide]

Phrase: "was"

Phrase: "resuspended in 10 mmol/l Tris-HCl"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   778   C1532563:mmol/L [Quantitative Concept]
   748   C0041175:TRIS [Organic Chemical,Pharmacologic Substance]
   748   C0077281:Tris [Hazardous or Poisonous Substance,Organophosphorus Compound]
   748   C0439190:MMOLE [Quantitative Concept]
   748   C0814229:TRI [Intellectual Product]

Phrase: "and"

Phrase: "0.1 mmol/l EDTA (pH 8.0"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   812   C1532563:mmol/L [Quantitative Concept]
   793   C0013618:EDTA [Organic Chemical,Pharmacologic Substance]
   793   C0020283:[pH] [Quantitative Concept]
   793   C0439190:MMOLE [Quantitative Concept]
   793   C0450407:ph+ [Finding]
   793   C0450408:ph++ [Finding]
   793   C0450409:ph+++ [Finding]

Phrase: ")."
Processing 00000000.tx.50: Five microliters of 200 mmol/l sodium acetate buffer (pH 4.8) and 5 g nuclease P1 (USB, Cleveland, OH) (1 mg/ml in 10 mmol/l sodium acetate) were added to 45-l DNA samples. 

Phrase: "Five microliters of 200 mmol/l sodium acetate buffer"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   742   C0439243:microliter [Quantitative Concept]

Phrase: "(pH 4.8"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   901   C2678549:PH-4 [Gene or Genome]
   827   C0020283:[pH] [Quantitative Concept]
   827   C0450407:ph+ [Finding]
   827   C0450408:ph++ [Finding]
   827   C0450409:ph+++ [Finding]

Phrase: ")"

Phrase: "and"

Phrase: "5 g nuclease P1 (USB,"

Phrase: "Cleveland,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0454845:Cleveland [Geographic Area]

Phrase: "OH) (1 mg/ml in 10 mmol/l sodium acetate"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   760   C0439294:mg ml [Quantitative Concept]
   757   C0347982:mmol/mL [Quantitative Concept]
   757   C1635169:mL/L [Quantitative Concept]
   757   C2827854:mL/mmol [Quantitative Concept]
   739   C0439526:/mL [Quantitative Concept]

Phrase: ")"

Phrase: "were"

Phrase: "added to 45-l DNA samples."
Meta Candidates (Total=5; Excluded=1; Pruned=0; Remaining=4)
   753   C0012854:DNA [Biologically Active Substance,Nucleic Acid, Nucleoside, or Nucleotide]
   753   C1524062:Added [Functional Concept]
   719   C0370003:Sample [Substance]
   719 E C1883712:Add [Functional Concept]
   719   C2347026:Sample [Conceptual Entity]
Processing 00000000.tx.51: After purging with a nitrogen steam, the mixtures were incubated at 37C for 1 h to digest the DNA to nucleotides. 

Phrase: "After purging"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0855227:purging [Disease or Syndrome]
   966 E C0722910:Purge [Lipid,Pharmacologic Substance]

Phrase: "with a nitrogen steam,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0038225:Steam [Inorganic Chemical]

Phrase: "the mixtures"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0439962:mixtures [Substance]

Phrase: "were"

Phrase: "incubated at 37C"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   790   C1439852:Incubated [Laboratory Procedure]

Phrase: "for 1 h to"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   901   C0700308:1 H [Element, Ion, or Isotope]
   827   C0033727:H+ [Element, Ion, or Isotope]
   827   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   827   C0441932:H+ [Classification]
   827   C0564385:/h [Quantitative Concept]

Phrase: "digest"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0868946:digest [Physiologic Function]

Phrase: "the DNA to nucleotides."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C0012854:DNA [Biologically Active Substance,Nucleic Acid, Nucleoside, or Nucleotide]
Processing 00000000.tx.52: Then, 5 l of 500 mmol/l Tris-HCl (pH 8.0), 10 mmol/l MgCl2, and 0.6 units Escherichia coli alkaline phosphatase (Toyobo, Osaka, Japan) were added to the samples. 

Phrase: "Then,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883708:Then [Temporal Concept]

Phrase: "5 l"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2348935:.5 L [Quantitative Concept]

Phrase: "of 500 mmol/l Tris-HCl (pH 8.0"
Meta Candidates (Total=9; Excluded=0; Pruned=0; Remaining=9)
   812   C1532563:mmol/L [Quantitative Concept]
   793   C0020283:[pH] [Quantitative Concept]
   793   C0041175:TRIS [Organic Chemical,Pharmacologic Substance]
   793   C0077281:Tris [Hazardous or Poisonous Substance,Organophosphorus Compound]
   793   C0439190:MMOLE [Quantitative Concept]
   793   C0450407:ph+ [Finding]
   793   C0450408:ph++ [Finding]
   793   C0450409:ph+++ [Finding]
   793   C0814229:TRI [Intellectual Product]

Phrase: ")"

Phrase: ","

Phrase: "10 mmol/l MgCl2,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   812   C0024472:MgCl2 [Inorganic Chemical,Pharmacologic Substance]

Phrase: "and"

Phrase: "0.6 units Escherichia coli alkaline phosphatase"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   818   C0002059:Alkaline Phosphatase [Amino Acid, Peptide, or Protein,Enzyme]
   818   C1318717:Alkaline phosphatase [Indicator, Reagent, or Diagnostic Aid,Organic Chemical]
   795   C0031678:Phosphatase [Amino Acid, Peptide, or Protein,Enzyme]
   795   C1149880:phosphatase [Molecular Function]
   795   C1979842:Alkaline [Qualitative Concept]

Phrase: "(Toyobo,"

Phrase: "Osaka,"

Phrase: "Japan"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0022341:Japan [Geographic Area]

Phrase: ")"

Phrase: "were"

Phrase: "added to the samples."
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
   770   C1524062:Added [Functional Concept]
   737   C0370003:Sample [Substance]
   737 E C1883712:Add [Functional Concept]
   737   C2347026:Sample [Conceptual Entity]
Processing 00000000.tx.53: After purging with a nitrogen steam, the mixtures were incubated at 37C for 1 h to hydrolyze the nucleotides to nucleosides. 

Phrase: "After purging"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0855227:purging [Disease or Syndrome]
   966 E C0722910:Purge [Lipid,Pharmacologic Substance]

Phrase: "with a nitrogen steam,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0038225:Steam [Inorganic Chemical]

Phrase: "the mixtures"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0439962:mixtures [Substance]

Phrase: "were"

Phrase: "incubated at 37C"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   790   C1439852:Incubated [Laboratory Procedure]

Phrase: "for 1 h to"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   901   C0700308:1 H [Element, Ion, or Isotope]
   827   C0033727:H+ [Element, Ion, or Isotope]
   827   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   827   C0441932:H+ [Classification]
   827   C0564385:/h [Quantitative Concept]

Phrase: "hydrolyze"

Phrase: "the nucleotides to nucleosides."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C0028630:Nucleotides [Nucleic Acid, Nucleoside, or Nucleotide]
Processing 00000000.tx.54: The nucleoside samples were used for the determination of 8-OHdG by competitive ELISA kit as described above. 

Phrase: "The nucleoside samples"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0370003:Sample [Substance]
   827   C2347026:Sample [Conceptual Entity]

Phrase: "were"

Phrase: "used for the determination of 8-OHdG"
Meta Candidates (Total=9; Excluded=3; Pruned=0; Remaining=6)
   818   C0050078:8-Hydroxy-2'-deoxyguanosine [Biologically Active Substance,Nucleic Acid, Nucleoside, or Nucleotide]
   745   C1524063:Use of [Functional Concept]
   742   C0011503:Deoxyguanosine [Nucleic Acid, Nucleoside, or Nucleotide]
   742   C0700307:Hydroxy [Inorganic Chemical]
   742   C1148554:determination [Laboratory Procedure]
   742   C1273517:used [Finding]
   708 E C0042153:use [Functional Concept]
   708 E C0457083:Use [Functional Concept]
   708 E C1947944:Use [Intellectual Product]

Phrase: "by competitive ELISA kit"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   799   C0812225:KIT [Medical Device]
   799   C1150635:KIT [Molecular Function]
   799   C1705212:Kit [Medical Device]
   799   C1705213:KIT [Medical Device]
   799   C3273202:Kit [Manufactured Object]
   734   C0014441:Enzyme-Linked Immunosorbent Assay [Laboratory Procedure]

Phrase: "as described above."
Processing 00000000.tx.55: Semiquantitation of mtDNA deletion using PCR. 

Phrase: "Semiquantitation of mtDNA deletion"

Phrase: "using"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1524063:Using [Functional Concept]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "PCR."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0032520:PCR [Laboratory Procedure,Molecular Biology Research Technique]
  1000   C0677874:pCR [Finding]
Processing 00000000.tx.56: Total DNA was isolated from kidneys as described above at 4 or 8 weeks after the onset of diabetes. 

Phrase: "Total DNA"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0012854:DNA [Biologically Active Substance,Nucleic Acid, Nucleoside, or Nucleotide]
   861   C0439175:% total [Quantitative Concept]
   861   C0439810:Total [Qualitative Concept]

Phrase: "was"

Phrase: "isolated from kidneys"
Meta Candidates (Total=8; Excluded=4; Pruned=0; Remaining=4)
   790   C0022646:Kidneys [Body Part, Organ, or Organ Component]
   790   C0205409:Isolated [Functional Concept]
   790   C0227665:kidneys [Body Part, Organ, or Organ Component]
   790   C1548221:Isolated [Idea or Concept]
   756 E C0370215:Isolate [Substance]
   756 E C1278978:Kidney [Body Part, Organ, or Organ Component]
   756 E C1514845:KIDNEY [Tissue]
   756 E C1875400:ISOLATE [Pharmacologic Substance]

Phrase: "as described above"

Phrase: "at 4"

Phrase: "or"

Phrase: "8 weeks after the onset of diabetes."
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   748   C0439230:weeks [Temporal Concept]
   714 E C0332174:/week [Temporal Concept]
Processing 00000000.tx.57: Primers for the PCR amplifications used are shown in Table 1. 

Phrase: "Primers for the PCR amplifications"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   726   C0206415:Primer [Nucleic Acid, Nucleoside, or Nucleotide]

Phrase: "used"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1273517:used [Finding]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "are"

Phrase: "shown in Table 1."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   770   C0039224:Table [Manufactured Object]
   770   C1706073:Table [Medical Device]
   770   C1706074:Table [Intellectual Product]
   737   C1547282:Show [Intellectual Product]
Processing 00000000.tx.58: The primer sets for amplification of 4,834-bp deletion mtDNA were L782 and H1309, L768 and H1296, and L797 and H1309. 

Phrase: "The primer"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0206415:Primer [Nucleic Acid, Nucleoside, or Nucleotide]

Phrase: "sets for amplification of 4,834-bp deletion mtDNA"
Meta Candidates (Total=17; Excluded=0; Pruned=0; Remaining=17)
   777   C0948051:mitochondrial dna deletion [Cell or Molecular Dysfunction]
   760   C0012929:DNA, Mitochondrial [Biologically Active Substance,Nucleic Acid, Nucleoside, or Nucleotide]
   760   C1819717:mitochondrial DNA [Cell Component]
   757   C0683230:DNA amplification [Genetic Function]
   757   C1334095:BP-4 [Gene or Genome]
   739   C0012854:DNA [Biologically Active Substance,Nucleic Acid, Nucleoside, or Nucleotide]
   739   C0026237:Mitochondrial [Cell Component]
   739   C0036849:Set [Mental Process]
   739   C0521451:Mitochondrial [Functional Concept]
   739   C1442161:Deletion [Cell or Molecular Dysfunction]
   739   C1442518:Set [Functional Concept]
   739   C1511760:Deletion [Genetic Function]
   739   C1517480:Amplification [Molecular Biology Research Technique]
   739   C1521871:Amplification [Phenomenon or Process]
   739   C1705195:Set [Conceptual Entity]
   739   C1705759:Amplification [Cell or Molecular Dysfunction]
   739   C1880274:Deletion [Activity]

Phrase: "were"

Phrase: "L782"

Phrase: "and"

Phrase: "H1309,"

Phrase: "L768"

Phrase: "and"

Phrase: "H1296,"

Phrase: "and"

Phrase: "L797"

Phrase: "and"

Phrase: "H1309."
Processing 00000000.tx.59: The primer set for control amplification of wild-type mtDNA was L1576 and H1626. 

Phrase: "The primer"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0206415:Primer [Nucleic Acid, Nucleoside, or Nucleotide]

Phrase: "set for control amplification of wild-type mtDNA"
Meta Candidates (Total=24; Excluded=0; Pruned=0; Remaining=24)
   764   C0012929:DNA, Mitochondrial [Biologically Active Substance,Nucleic Acid, Nucleoside, or Nucleotide]
   764   C1819717:mitochondrial DNA [Cell Component]
   764   C1883559:Wild Type [Organism Attribute]
   762   C0079247:type dna [Molecular Biology Research Technique]
   762   C0683230:DNA amplification [Genetic Function]
   762   C1707504:Control Type [Research Activity]
   762   C1879930:Control Type [Intellectual Product]
   742   C0012854:DNA [Biologically Active Substance,Nucleic Acid, Nucleoside, or Nucleotide]
   742   C0026237:Mitochondrial [Cell Component]
   742   C0036849:Set [Mental Process]
   742   C0243148:control [Qualitative Concept]
   742   C0332307:Type [Qualitative Concept]
   742   C0445392:Wild [Intellectual Product]
   742   C0521451:Mitochondrial [Functional Concept]
   742   C1442518:Set [Functional Concept]
   742   C1517480:Amplification [Molecular Biology Research Technique]
   742   C1521871:Amplification [Phenomenon or Process]
   742   C1547052:*Type [Quantitative Concept]
   742   C1550141:Control [Substance]
   742   C1705195:Set [Conceptual Entity]
   742   C1705759:Amplification [Cell or Molecular Dysfunction]
   742   C1882979:Control [Conceptual Entity]
   742   C2587213:Control [Functional Concept]
   742   C3274648:Control [Qualitative Concept]

Phrase: "was"

Phrase: "L1576"

Phrase: "and"

Phrase: "H1626."
Processing 00000000.tx.60: For amplification of a longer mtDNA fragment (5,88115,142), a primer set of L588 and H1511 (29) was used. 

Phrase: "For amplification"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C1517480:Amplification [Molecular Biology Research Technique]
  1000   C1521871:Amplification [Phenomenon or Process]
  1000   C1705759:Amplification [Cell or Molecular Dysfunction]

Phrase: "of a longer mtDNA fragment"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   812   C0332255:fragment [Functional Concept]
   812   C1708096:Fragment [Qualitative Concept]

Phrase: "(5,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0439084:>5 [Quantitative Concept]
  1000   C0728893:+5 [Quantitative Concept]

Phrase: "88115,"

Phrase: "142"

Phrase: ")"

Phrase: ","

Phrase: "a primer"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0206415:Primer [Nucleic Acid, Nucleoside, or Nucleotide]

Phrase: "set of L588"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   790   C0036849:Set [Mental Process]
   790   C1442518:Set [Functional Concept]
   790   C1705195:Set [Conceptual Entity]

Phrase: "and"

Phrase: "H1511"

Phrase: "(29"

Phrase: ")"

Phrase: "was"

Phrase: "used."
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1273517:used [Finding]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]
Processing 00000000.tx.61: All primers were synthesized by Invitrogen (Tokyo). 

Phrase: "All primers"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C0206415:Primer [Nucleic Acid, Nucleoside, or Nucleotide]

Phrase: "were"

Phrase: "synthesized by Invitrogen"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   790   C1883254:Synthesized [Activity]

Phrase: "(Tokyo"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0040371:Tokyo [Geographic Area]

Phrase: ")."
Processing 00000000.tx.62: Sequence and numbering are based on the published rat mtDNA sequence (23,26). 

Phrase: "Sequence"
Meta Candidates (Total=6; Excluded=2; Pruned=0; Remaining=4)
  1000   C0004793:Sequence [Nucleotide Sequence]
  1000   C0162326:Sequence [Nucleotide Sequence]
  1000   C0162327:Sequence [Nucleotide Sequence]
  1000   C1519249:Sequence [Functional Concept]
   928 E C1548958:Sequential [Idea or Concept]
   928 E C1705294:Sequential [Qualitative Concept]

Phrase: "and"

Phrase: "numbering"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0449788:numbering [Quantitative Concept]
   966 E C0237753:*Number [Quantitative Concept]

Phrase: "are"

Phrase: "based on the published rat mtDNA sequence"
Meta Candidates (Total=20; Excluded=3; Pruned=0; Remaining=17)
   770   C0012929:DNA, Mitochondrial [Biologically Active Substance,Nucleic Acid, Nucleoside, or Nucleotide]
   770   C0162326:DNA Sequence [Nucleotide Sequence]
           Sequence
   770   C1819717:mitochondrial DNA [Cell Component]
   750   C0004793:Base Sequence [Nucleotide Sequence]
           Sequence
   744   C0012854:DNA [Biologically Active Substance,Nucleic Acid, Nucleoside, or Nucleotide]
   744   C0026237:Mitochondrial [Cell Component]
   744   C0034037:Published [Occupational Activity]
   744   C0034693:Rat, NOS [Mammal]
   744   C0034721:Rat [Mammal]
   744   C0162327:Sequence [Nucleotide Sequence]
   744   C0521451:Mitochondrial [Functional Concept]
   744   C1519249:Sequence [Functional Concept]
   744   C1527178:Based [Functional Concept]
   744   C1704324:Published [Intellectual Product]
   744   C1705938:Based [Idea or Concept]
   711 E C0002055:base [Inorganic Chemical]
   711 E C0178499:Base [Chemical Viewed Functionally]
   711 E C1880279:Base [Biomedical or Dental Material]

Phrase: "(23,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0450348:23 [Quantitative Concept]

Phrase: "26"

Phrase: ")."
Processing 00000000.tx.63: View this table: [in this window] [in a new window]  TABLE 1 Primers used for PCR amplification of deleted mtDNA and wild-type mtDNA  PCRs contained 0.2 mmol/l dNTP, 0.3 mol/l of each primer, 1.0 unit Taq polymerase (Toyobo), and various amounts (0.010.2 g) of starting total DNA as template in a 50 l reaction solution. 

Phrase: "View"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0449911:View [Spatial Concept]

Phrase: "this table"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0039224:Table [Manufactured Object]
  1000   C1706073:Table [Medical Device]
  1000   C1706074:Table [Intellectual Product]

Phrase: ":"

Phrase: "["

Phrase: "in this window"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0557702:Window [Manufactured Object]
  1000   C1272706:Window [Temporal Concept]
  1000   C1704674:Window [Manufactured Object]

Phrase: "]"

Phrase: "["

Phrase: "in a new window"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0557702:Window [Manufactured Object]
   861   C1272706:Window [Temporal Concept]
   861   C1704674:Window [Manufactured Object]

Phrase: "]  TABLE 1 Primers"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   793   C0206415:Primer [Nucleic Acid, Nucleoside, or Nucleotide]

Phrase: "used for PCR amplification of deleted mtDNA"
Meta Candidates (Total=17; Excluded=3; Pruned=0; Remaining=14)
   770   C0012929:DNA, Mitochondrial [Biologically Active Substance,Nucleic Acid, Nucleoside, or Nucleotide]
   770   C1819717:mitochondrial DNA [Cell Component]
   767   C0683230:DNA amplification [Genetic Function]
   750   C1524063:Use of [Functional Concept]
   744   C0012854:DNA [Biologically Active Substance,Nucleic Acid, Nucleoside, or Nucleotide]
   744   C0026237:Mitochondrial [Cell Component]
   744   C0032520:PCR [Laboratory Procedure,Molecular Biology Research Technique]
   744   C0521451:Mitochondrial [Functional Concept]
   744   C0677874:pCR [Finding]
   744   C1273517:used [Finding]
   744   C1517480:Amplification [Molecular Biology Research Technique]
   744   C1521871:Amplification [Phenomenon or Process]
   744   C1705759:Amplification [Cell or Molecular Dysfunction]
   744   C1880274:Deleted [Activity]
   711 E C0042153:use [Functional Concept]
   711 E C0457083:Use [Functional Concept]
   711 E C1947944:Use [Intellectual Product]

Phrase: "and"

Phrase: "wild-type mtDNA  PCRs"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   771   C0032520:PCR [Laboratory Procedure,Molecular Biology Research Technique]
   771   C0677874:pCR [Finding]

Phrase: "contained"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0332256:contained [Functional Concept]
  1000   C2700400:Contained [Activity]

Phrase: "0.2 mmol/l dNTP,"

Phrase: "0.3 mol/l of each primer,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   778   C0347982:mol/L [Quantitative Concept]

Phrase: "1.0 unit Taq polymerase"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   840   C0075813:Taq Polymerase [Amino Acid, Peptide, or Protein,Enzyme]
   804   C1335439:Polymerase [Amino Acid, Peptide, or Protein,Enzyme]

Phrase: "(Toyobo"

Phrase: ")"

Phrase: ","

Phrase: "and"

Phrase: "various amounts"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C1265611:amounts [Quantitative Concept]

Phrase: "(0.010.2 g) of starting total DNA"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   744   C0439267:g% [Quantitative Concept]

Phrase: "as template"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0728990:TEMPLATE [Medical Device]
  1000   C1514575:Template [Conceptual Entity]
  1000   C1705542:Template [Idea or Concept]

Phrase: "in a 50 l reaction solution."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   812   C0037633:Solution [Substance]
   812   C0525069:Solution [Biomedical or Dental Material]
Processing 00000000.tx.64: The thermal cycling condition was started with one cycle at 94C for 2 min. 

Phrase: "The thermal cycling condition"
Meta Candidates (Total=7; Excluded=4; Pruned=0; Remaining=3)
   827   C0012634:condition [Disease or Syndrome]
   827   C0348080:Condition [Qualitative Concept]
   827   C1705253:Condition [Conceptual Entity]
   755 E C0009647:Conditioned [Mental Process]
   755 E C1701901:Conditional [Qualitative Concept]
   755 E C1963686:Conditional [Functional Concept]
   727 E C1519605:Conditionality [Conceptual Entity]

Phrase: "was"

Phrase: "started with one cycle"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
   770   C0205447:One [Quantitative Concept]
   770   C1272689:Started [Qualitative Concept]
   770   C1511572:Cycle [Temporal Concept]
   737 E C0439659:Start [Temporal Concept]

Phrase: "at 94C"

Phrase: "for 2 min."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0702093:/min [Temporal Concept]
Processing 00000000.tx.65: This was followed by 35 cycles at 94C for 15 s, 60C for 30 s, 68C for 1 min, and 68C for final extension for 5 min. 

Phrase: "This"

Phrase: "was"

Phrase: "followed by 35 cycles"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
   833   C0332283:Followed by [Temporal Concept]
           followed
   737   C1511572:Cycle [Temporal Concept]
   737 E C1719822:Follow [Intellectual Product]

Phrase: "at 94C"

Phrase: "for 15 s,"

Phrase: "60C for 30 s,"

Phrase: "68C for 1 min,"

Phrase: "and"

Phrase: "68C for final extension"

Phrase: "for 5 min."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0702093:/min [Temporal Concept]
Processing 00000000.tx.66: Amplification was carried out in a Thermal Cycler system (Astec, Fukuoka, Japan). 

Phrase: "Amplification"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C1517480:Amplification [Molecular Biology Research Technique]
  1000   C1521871:Amplification [Phenomenon or Process]
  1000   C1705759:Amplification [Cell or Molecular Dysfunction]

Phrase: "was"

Phrase: "carried"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0206243:carried [Activity]
  1000   C0699809:carried [Finding]

Phrase: "out in a Thermal Cycler system"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   790   C1611676:Thermal Cycler [Medical Device]
   753   C0439787:Out [Spatial Concept]
   753   C0449913:System [Functional Concept]
   753   C0849355:Out [Qualitative Concept]
   753   C1553451:System [Manufactured Object]
   753   C1704459:System [Medical Device]

Phrase: "(Astec,"

Phrase: "Fukuoka,"

Phrase: "Japan"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0022341:Japan [Geographic Area]

Phrase: ")."
Processing 00000000.tx.67: PCR products were electrophoresed on a 5% polyacrylamide gel and visualized by bistragreen staining. 

Phrase: "PCR products"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   861   C1514468:Products [Entity]
   827 E C1704444:Product [Quantitative Concept]

Phrase: "were"

Phrase: "electrophoresed on a 5% polyacrylamide gel"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   790   C0071500:Polyacrylamide Gel [Biomedical or Dental Material,Pharmacologic Substance]
   753   C0017243:Gel [Biomedical or Dental Material]
   753   C0071499:polyacrylamide [Biomedical or Dental Material,Organic Chemical]
   753   C1382104:Gel [Substance]
   719   C0013855:electrophorese [Laboratory Procedure]

Phrase: "and"

Phrase: "visualized by bistragreen staining."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   770   C0234621:Visualized [Functional Concept]
   770   C0487602:Staining [Laboratory Procedure]
   770   C1704680:Staining [Finding]
Processing 00000000.tx.68: The number of mtDNA deletion products was determined for each sample by densitometry. 

Phrase: "The number of mtDNA deletion products"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   748   C0237753:*Number [Quantitative Concept]
   748   C0449788:Number [Quantitative Concept]

Phrase: "was"

Phrase: "determined for each sample"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   770   C0370003:Sample [Substance]
   770   C2347026:Sample [Conceptual Entity]

Phrase: "by densitometry."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0011321:Densitometry [Laboratory Procedure]
Processing 00000000.tx.69: Using primer sets of L588 and H1511, multiple PCR products were amplified from mtDNA templates isolated from diabetic kidney but not from mtDNA templates isolated from control kidney (Fig. 1A). 

Phrase: "Using"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1524063:Using [Functional Concept]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "primer"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0206415:Primer [Nucleic Acid, Nucleoside, or Nucleotide]

Phrase: "sets of L588"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   790   C0036849:Set [Mental Process]
   790   C1442518:Set [Functional Concept]
   790   C1705195:Set [Conceptual Entity]

Phrase: "and"

Phrase: "H1511,"

Phrase: "multiple PCR products"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   827   C1514468:Products [Entity]
   793 E C1704444:Product [Quantitative Concept]

Phrase: "were"

Phrase: "amplified from mtDNA templates"
Meta Candidates (Total=9; Excluded=2; Pruned=0; Remaining=7)
   806   C0012929:DNA, Mitochondrial [Biologically Active Substance,Nucleic Acid, Nucleoside, or Nucleotide]
   806   C1819717:mitochondrial DNA [Cell Component]
   790   C0678713:DNA template [Genetic Function]
   760   C0012854:DNA [Biologically Active Substance,Nucleic Acid, Nucleoside, or Nucleotide]
   760   C0026237:Mitochondrial [Cell Component]
   760   C0521451:Mitochondrial [Functional Concept]
   760   C0728990:templates [Medical Device]
   726 E C1514575:Template [Conceptual Entity]
   726 E C1705542:Template [Idea or Concept]

Phrase: "isolated from diabetic kidney"
Meta Candidates (Total=9; Excluded=2; Pruned=0; Remaining=7)
   770   C0022646:Kidney [Body Part, Organ, or Organ Component]
   770   C0205409:Isolated [Functional Concept]
   770   C0227665:kidney [Body Part, Organ, or Organ Component]
   770   C0241863:DIABETIC [Finding]
   770   C1278978:Kidney [Body Part, Organ, or Organ Component]
   770   C1514845:KIDNEY [Tissue]
   770   C1548221:Isolated [Idea or Concept]
   737 E C0370215:Isolate [Substance]
   737 E C1875400:ISOLATE [Pharmacologic Substance]

Phrase: "but"

Phrase: "not from mtDNA templates"
Meta Candidates (Total=10; Excluded=2; Pruned=0; Remaining=8)
   806   C0012929:DNA, Mitochondrial [Biologically Active Substance,Nucleic Acid, Nucleoside, or Nucleotide]
   806   C1819717:mitochondrial DNA [Cell Component]
   790   C0678713:DNA template [Genetic Function]
   760   C0012854:DNA [Biologically Active Substance,Nucleic Acid, Nucleoside, or Nucleotide]
   760   C0026237:Mitochondrial [Cell Component]
   760   C0521451:Mitochondrial [Functional Concept]
   760   C0728990:templates [Medical Device]
   760   C1518422:Not [Functional Concept]
   726 E C1514575:Template [Conceptual Entity]
   726 E C1705542:Template [Idea or Concept]

Phrase: "isolated from control kidney"
Meta Candidates (Total=13; Excluded=2; Pruned=0; Remaining=11)
   770   C0022646:Kidney [Body Part, Organ, or Organ Component]
   770   C0205409:Isolated [Functional Concept]
   770   C0227665:kidney [Body Part, Organ, or Organ Component]
   770   C0243148:control [Qualitative Concept]
   770   C1278978:Kidney [Body Part, Organ, or Organ Component]
   770   C1514845:KIDNEY [Tissue]
   770   C1548221:Isolated [Idea or Concept]
   770   C1550141:Control [Substance]
   770   C1882979:Control [Conceptual Entity]
   770   C2587213:Control [Functional Concept]
   770   C3274648:Control [Qualitative Concept]
   737 E C0370215:Isolate [Substance]
   737 E C1875400:ISOLATE [Pharmacologic Substance]

Phrase: "(Fig. 1A"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0450344:1A [Intellectual Product]
   861   C1553633:1a [Medical Device]

Phrase: ")."
Processing 00000000.tx.70: These results suggest that multiple mtDNA deletions might exist in diabetic kidney. 

Phrase: "These results"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   966   C1274040:Result [Functional Concept]
   966   C1546471:Result [Idea or Concept]
   966   C2825142:Result [Finding]

Phrase: "suggest"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1705535:Suggest [Idea or Concept]

Phrase: "that multiple mtDNA deletions"
Meta Candidates (Total=5; Excluded=2; Pruned=0; Remaining=3)
   923   C0948051:Mitochondrial DNA deletions [Cell or Molecular Dysfunction]
   875   C3151954:Mitochondrial deletions [Finding]
   812   C1880274:Deletions [Activity]
   779 E C1442161:Deletion [Cell or Molecular Dysfunction]
   779 E C1511760:Deletion [Genetic Function]

Phrase: "might"

Phrase: "exist in diabetic kidney."
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   770   C0022646:Kidney [Body Part, Organ, or Organ Component]
   770   C0227665:kidney [Body Part, Organ, or Organ Component]
   770   C0241863:DIABETIC [Finding]
   770   C1278978:Kidney [Body Part, Organ, or Organ Component]
   770   C1514845:KIDNEY [Tissue]
   770   C2987476:Exist [Conceptual Entity]
Processing 00000000.tx.71: Therefore, in the present study, the frequency of 4,834 mtDNA deletion, which was reported to be one of the most frequent deletions (2628), was evaluated for quantitation. 

Phrase: "Therefore,"

Phrase: "in the present study,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   861   C0150312:Present [Quantitative Concept]
   861   C0449450:Present [Idea or Concept]
   861   C0557651:Study [Manufactured Object]
   861   C2603343:Study [Research Activity]

Phrase: "the frequency of 4,834 mtDNA deletion,"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   744   C0376249:frequency [Quantitative Concept]
   744   C0439603:Frequency [Temporal Concept]
   744   C0871396:Frequency [Quantitative Concept]
   744   C1561548:Frequency [Qualitative Concept]
   744   C1705502:Frequency [Quantitative Concept]

Phrase: "which"

Phrase: "was"

Phrase: "reported"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
  1000   C0684224:Reported [Intellectual Product]
  1000   C0700287:Reported [Health Care Activity]
  1000   C3496591:Reported [Clinical Attribute]
   966 E C3273238:Report [Intellectual Product]

Phrase: "to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "be"

Phrase: "one of the most frequent deletions"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   753   C0205447:One [Quantitative Concept]

Phrase: "(2628"

Phrase: ")"

Phrase: ","

Phrase: "was"

Phrase: "evaluated for quantitation."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   790   C0220825:Evaluated [Functional Concept]
   790   C1709793:Quantitation [Quantitative Concept]
Processing 00000000.tx.72: Three different sets of primers were used on all samples to ensure that the PCR products seen were not the result of primer misannealing. 

Phrase: "Three different sets of primers"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   760   C0036849:Set [Mental Process]
   760   C1442518:Set [Functional Concept]
   760   C1705195:Set [Conceptual Entity]

Phrase: "were"

Phrase: "used on all samples to"
Meta Candidates (Total=6; Excluded=3; Pruned=0; Remaining=3)
   760   C1273517:used [Finding]
   726 E C0042153:use [Functional Concept]
   726   C0370003:Sample [Substance]
   726 E C0457083:Use [Functional Concept]
   726 E C1947944:Use [Intellectual Product]
   726   C2347026:Sample [Conceptual Entity]

Phrase: "ensure"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0218063:Ensure [Food]

Phrase: "that"

Phrase: "the PCR products"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   861   C1514468:Products [Entity]
   827 E C1704444:Product [Quantitative Concept]

Phrase: "seen"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
  1000   C0205397:Seen [Qualitative Concept]
   966 E C0042789:see [Organism Function]
   966 E C1947903:See [Activity]

Phrase: "were"

Phrase: "not"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1518422:Not [Functional Concept]

Phrase: "the result of primer misannealing."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   760   C1274040:Result [Functional Concept]
   760   C1546471:Result [Idea or Concept]
   760   C2825142:Result [Finding]
Processing 00000000.tx.73: The 4,834 mtDNA deletion products shifted appropriately in size when different sets of primers were used, as shown in Fig. 

Phrase: "The 4,834 mtDNA deletion products"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   799   C1514468:Products [Entity]
   766 E C1704444:Product [Quantitative Concept]

Phrase: "shifted"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0333051:shifted [Functional Concept]
   966 E C2347509:Shift [Phenomenon or Process]

Phrase: "appropriately in size"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   790   C0456389:size [Spatial Concept]

Phrase: "when"

Phrase: "different sets of primers"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   770   C0036849:Set [Mental Process]
   770   C1442518:Set [Functional Concept]
   770   C1705195:Set [Conceptual Entity]

Phrase: "were"

Phrase: "used"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1273517:used [Finding]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: ","

Phrase: "as"

Phrase: "shown in Fig."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   790   C0349966:Fig [Food]
   790   C1337208:FIG [Food]
   756   C1547282:Show [Intellectual Product]
Processing 00000000.tx.74: 1B. 

Phrase: "1B."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0450345:1B [Intellectual Product]
Processing 00000000.tx.75: Levels of the 4,834-deleted mtDNA were expressed as the ratio of the signal intensity relative to that for the wild-type mtDNA. 

Phrase: "Levels of the 4,834-deleted mtDNA"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
   750   C0456950:Level 4 [Qualitative Concept]
   744   C0441889:Levels [Qualitative Concept]
   711 E C0456079:Level [Classification]
   711 E C1547707:Level [Geographic Area]
   711 E C2946261:Level [Pharmacologic Substance]

Phrase: "were"

Phrase: "expressed as the ratio of the signal intensity"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   770   C0871362:signal intensity [Quantitative Concept]
   744   C0456603:Ratio [Quantitative Concept]
   744   C0522510:Intensity [Qualitative Concept]
   744   C1547037:Ratio [Intellectual Product]
   744   C1710082:Signal [Phenomenon or Process]

Phrase: "relative to that"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   790   C0080103:Relative [Family Group]
   790   C0205345:Relative [Qualitative Concept]
   790   C1547039:*Relative [Quantitative Concept]

Phrase: "for the wild-type mtDNA."
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   875   C0079247:type dna [Molecular Biology Research Technique]
   861   C0012929:DNA, Mitochondrial [Biologically Active Substance,Nucleic Acid, Nucleoside, or Nucleotide]
   861   C1819717:mitochondrial DNA [Cell Component]
   812   C0012854:DNA [Biologically Active Substance,Nucleic Acid, Nucleoside, or Nucleotide]
   812   C0026237:Mitochondrial [Cell Component]
   812   C0521451:Mitochondrial [Functional Concept]
Processing 00000000.tx.76: View larger version (52K): [in this window] [in a new window]  FIG. 

Phrase: "View"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0449911:View [Spatial Concept]

Phrase: "larger version"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0333052:Version [Functional Concept]
   861   C2607870:Version [Spatial Concept]

Phrase: "(52K"

Phrase: ")"

Phrase: ":"

Phrase: "["

Phrase: "in this window"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0557702:Window [Manufactured Object]
  1000   C1272706:Window [Temporal Concept]
  1000   C1704674:Window [Manufactured Object]

Phrase: "]"

Phrase: "["

Phrase: "in a new window"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0557702:Window [Manufactured Object]
   861   C1272706:Window [Temporal Concept]
   861   C1704674:Window [Manufactured Object]

Phrase: "]  FIG."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0349966:Fig [Food]
  1000   C1337208:FIG [Food]
Processing 00000000.tx.77: 1. 

Phrase: "1."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C2827734:1+ [Quantitative Concept]
  1000   C2981698:1+ [Classification]
Processing 00000000.tx.78: A: Multiple PCR products amplified from mtDNA using primer sets of L588 and H1511. 

Phrase: "A"

Phrase: ":"

Phrase: "Multiple PCR products"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   827   C1514468:Products [Entity]
   793 E C1704444:Product [Quantitative Concept]

Phrase: "amplified from mtDNA"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   833   C0012929:DNA, Mitochondrial [Biologically Active Substance,Nucleic Acid, Nucleoside, or Nucleotide]
   833   C1819717:mitochondrial DNA [Cell Component]
   770   C0012854:DNA [Biologically Active Substance,Nucleic Acid, Nucleoside, or Nucleotide]
   770   C0026237:Mitochondrial [Cell Component]
   770   C0521451:Mitochondrial [Functional Concept]

Phrase: "using"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1524063:Using [Functional Concept]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "primer"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0206415:Primer [Nucleic Acid, Nucleoside, or Nucleotide]

Phrase: "sets of L588"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   790   C0036849:Set [Mental Process]
   790   C1442518:Set [Functional Concept]
   790   C1705195:Set [Conceptual Entity]

Phrase: "and"

Phrase: "H1511."
Processing 00000000.tx.79: The total DNA extracted from kidney of control and diabetic rats (DM) were used as a template. 

Phrase: "The total DNA"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0012854:DNA [Biologically Active Substance,Nucleic Acid, Nucleoside, or Nucleotide]
   861   C0439175:% total [Quantitative Concept]
   861   C0439810:Total [Qualitative Concept]

Phrase: "extracted from kidney of control"
Meta Candidates (Total=12; Excluded=1; Pruned=0; Remaining=11)
   760   C0022646:Kidney [Body Part, Organ, or Organ Component]
   760   C0185115:Extracted [Therapeutic or Preventive Procedure]
   760   C0227665:kidney [Body Part, Organ, or Organ Component]
   760   C0243148:control [Qualitative Concept]
   760   C1278978:Kidney [Body Part, Organ, or Organ Component]
   760   C1514845:KIDNEY [Tissue]
   760   C1550141:Control [Substance]
   760   C1882979:Control [Conceptual Entity]
   760   C2587213:Control [Functional Concept]
   760   C3274648:Control [Qualitative Concept]
   760   C3541890:EXTRACTED [Finding]
   726 E C2828366:Extract [Substance]

Phrase: "and"

Phrase: "diabetic rats"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0034693:rats [Mammal]
   861   C0034721:Rats [Mammal]
   861   C0241863:DIABETIC [Finding]

Phrase: "(DM)"

Phrase: "were"

Phrase: "used as a template."
Meta Candidates (Total=7; Excluded=3; Pruned=0; Remaining=4)
   770   C0728990:TEMPLATE [Medical Device]
   770   C1273517:used [Finding]
   770   C1514575:Template [Conceptual Entity]
   770   C1705542:Template [Idea or Concept]
   737 E C0042153:use [Functional Concept]
   737 E C0457083:Use [Functional Concept]
   737 E C1947944:Use [Intellectual Product]
Processing 00000000.tx.80: B: PCR products amplified from mtDNA with a 4,834-bp deletion using three different sets of primers. 

Phrase: "B"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2347469:/B [Quantitative Concept]

Phrase: ":"

Phrase: "PCR products"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   861   C1514468:Products [Entity]
   827 E C1704444:Product [Quantitative Concept]

Phrase: "amplified from mtDNA"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   833   C0012929:DNA, Mitochondrial [Biologically Active Substance,Nucleic Acid, Nucleoside, or Nucleotide]
   833   C1819717:mitochondrial DNA [Cell Component]
   770   C0012854:DNA [Biologically Active Substance,Nucleic Acid, Nucleoside, or Nucleotide]
   770   C0026237:Mitochondrial [Cell Component]
   770   C0521451:Mitochondrial [Functional Concept]

Phrase: "with a 4,834-bp deletion"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   812   C1442161:Deletion [Cell or Molecular Dysfunction]
   812   C1511760:Deletion [Genetic Function]
   812   C1880274:Deletion [Activity]

Phrase: "using"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1524063:Using [Functional Concept]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "three different sets of primers."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   760   C0036849:Set [Mental Process]
   760   C1442518:Set [Functional Concept]
   760   C1705195:Set [Conceptual Entity]
Processing 00000000.tx.81: The total DNA extracted from kidney of diabetic rats was used as a template. 

Phrase: "The total DNA"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0012854:DNA [Biologically Active Substance,Nucleic Acid, Nucleoside, or Nucleotide]
   861   C0439175:% total [Quantitative Concept]
   861   C0439810:Total [Qualitative Concept]

Phrase: "extracted from kidney of diabetic rats"
Meta Candidates (Total=11; Excluded=1; Pruned=0; Remaining=10)
   767   C1882714:Rat Kidney [Body Part, Organ, or Organ Component]
   753   C0022646:Kidney [Body Part, Organ, or Organ Component]
   753   C0034693:rats [Mammal]
   753   C0034721:Rats [Mammal]
   753   C0185115:Extracted [Therapeutic or Preventive Procedure]
   753   C0227665:kidney [Body Part, Organ, or Organ Component]
   753   C0241863:DIABETIC [Finding]
   753   C1278978:Kidney [Body Part, Organ, or Organ Component]
   753   C1514845:KIDNEY [Tissue]
   753   C3541890:EXTRACTED [Finding]
   719 E C2828366:Extract [Substance]

Phrase: "was"

Phrase: "used as a template."
Meta Candidates (Total=7; Excluded=3; Pruned=0; Remaining=4)
   770   C0728990:TEMPLATE [Medical Device]
   770   C1273517:used [Finding]
   770   C1514575:Template [Conceptual Entity]
   770   C1705542:Template [Idea or Concept]
   737 E C0042153:use [Functional Concept]
   737 E C0457083:Use [Functional Concept]
   737 E C1947944:Use [Intellectual Product]
Processing 00000000.tx.82: PCR products amplified from mtDNA with a 4,834-bp deletion were the 459-, 306-, and 461-bp fragments corresponding to three different primer sets of L768 and H1296, L782 and H1309, and L797 and H1309, respectively. 

Phrase: "PCR products"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   861   C1514468:Products [Entity]
   827 E C1704444:Product [Quantitative Concept]

Phrase: "amplified from mtDNA"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   833   C0012929:DNA, Mitochondrial [Biologically Active Substance,Nucleic Acid, Nucleoside, or Nucleotide]
   833   C1819717:mitochondrial DNA [Cell Component]
   770   C0012854:DNA [Biologically Active Substance,Nucleic Acid, Nucleoside, or Nucleotide]
   770   C0026237:Mitochondrial [Cell Component]
   770   C0521451:Mitochondrial [Functional Concept]

Phrase: "with a 4,834-bp deletion"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   812   C1442161:Deletion [Cell or Molecular Dysfunction]
   812   C1511760:Deletion [Genetic Function]
   812   C1880274:Deletion [Activity]

Phrase: "were"

Phrase: "the 459-,"

Phrase: "306-,"

Phrase: "and"

Phrase: "461-bp fragments"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   827   C0332255:fragments [Functional Concept]
   827   C0486805:Fragments [Body Substance]
   793 E C1708096:Fragment [Qualitative Concept]

Phrase: "corresponding to three different primer"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   760   C0205449:Three [Quantitative Concept]
   760   C0206415:Primer [Nucleic Acid, Nucleoside, or Nucleotide]
   760   C1705242:Different [Qualitative Concept]

Phrase: "sets of L768"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   790   C0036849:Set [Mental Process]
   790   C1442518:Set [Functional Concept]
   790   C1705195:Set [Conceptual Entity]

Phrase: "and"

Phrase: "H1296,"

Phrase: "L782"

Phrase: "and"

Phrase: "H1309,"

Phrase: "and"

Phrase: "L797"

Phrase: "and"

Phrase: "H1309,"

Phrase: "respectively."
Processing 00000000.tx.83: PCR amplification was carried out as described in RESEARCH DESIGN AND METHODS. 

Phrase: "PCR amplification"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C1517480:Amplification [Molecular Biology Research Technique]
   861   C1521871:Amplification [Phenomenon or Process]
   861   C1705759:Amplification [Cell or Molecular Dysfunction]

Phrase: "was"

Phrase: "carried"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0206243:carried [Activity]
  1000   C0699809:carried [Finding]

Phrase: "out"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0439787:Out [Spatial Concept]
  1000   C0849355:Out [Qualitative Concept]

Phrase: "as"

Phrase: "described in RESEARCH DESIGN"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   833   C0035171:Research Design [Research Activity]
   770   C0035168:research [Research Activity]
   770   C0242481:Research [Research Activity]
   770   C1552738:described [Idea or Concept]
   770   C1707689:Design [Activity]
   770   C2983265:DESIGN [Intellectual Product]

Phrase: "AND"

Phrase: "METHODS."
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
  1000   C0025663:Methods [Intellectual Product]
  1000   C0025664:methods [Intellectual Product]
  1000   C0449851:Methods [Functional Concept]
   966 E C0871511:METHOD [Intellectual Product]
Processing 00000000.tx.84: PCR products were electrophoresed on a 5% polyacrylamide gel and visualized by bistragreen staining. 

Phrase: "PCR products"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   861   C1514468:Products [Entity]
   827 E C1704444:Product [Quantitative Concept]

Phrase: "were"

Phrase: "electrophoresed on a 5% polyacrylamide gel"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   790   C0071500:Polyacrylamide Gel [Biomedical or Dental Material,Pharmacologic Substance]
   753   C0017243:Gel [Biomedical or Dental Material]
   753   C0071499:polyacrylamide [Biomedical or Dental Material,Organic Chemical]
   753   C1382104:Gel [Substance]
   719   C0013855:electrophorese [Laboratory Procedure]

Phrase: "and"

Phrase: "visualized by bistragreen staining."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   770   C0234621:Visualized [Functional Concept]
   770   C0487602:Staining [Laboratory Procedure]
   770   C1704680:Staining [Finding]
Processing 00000000.tx.85: Similar results were obtained on all samples.  

Phrase: "Similar results"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   827   C1274040:Result [Functional Concept]
   827   C1546471:Result [Idea or Concept]
   827   C2825142:Result [Finding]

Phrase: "were"

Phrase: "obtained on all samples."
Meta Candidates (Total=5; Excluded=1; Pruned=0; Remaining=4)
   802   C1277697:Sample obtained [Finding]
   770   C1301820:Obtained [Functional Concept]
   737   C0370003:Sample [Substance]
   737 E C1706701:Obtain [Activity]
   737   C2347026:Sample [Conceptual Entity]
Processing 00000000.tx.86: Immunoblotting of cytochrome c oxidase. 

Phrase: "Immunoblotting of cytochrome c oxidase."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C0020985:Immunoblotting [Laboratory Procedure]
Processing 00000000.tx.87: Powdered frozen tissues from kidney, as described above, were homogenized on ice with a Polytron for 20 s in a buffer containing 50 mmol/l Tris-HCl (pH 7.4), 2% SDS, 1 mmol/l phenylmethylsulfonyl fluoride, and 10 g/ml aprotinin and then homogenized again with 20 strokes of a Dounce homogenizer. 

Phrase: "Powdered"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   966   C0032861:Powder [Biomedical or Dental Material]
   966   C1382110:Powder [Substance]

Phrase: "frozen tissues from kidney,"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   775   C1514845:Renal Tissue [Tissue]
   770   C0040300:Tissues [Tissue]
   737 E C1547928:Tissue [Intellectual Product]

Phrase: "as"

Phrase: "described above,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   833   C1552738:described [Idea or Concept]

Phrase: "were"

Phrase: "homogenized on ice"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   790   C0020746:Ice [Inorganic Chemical]

Phrase: "with a Polytron"

Phrase: "for 20 s"

Phrase: "in a buffer"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0006353:Buffer [Indicator, Reagent, or Diagnostic Aid,Pharmacologic Substance]

Phrase: "containing"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0332256:Containing [Functional Concept]
  1000   C2700400:Containing [Activity]

Phrase: "50 mmol/l Tris-HCl (pH 7.4"
Meta Candidates (Total=11; Excluded=0; Pruned=0; Remaining=11)
   822   C2678549:PH-4 [Gene or Genome]
   812   C1532563:mmol/L [Quantitative Concept]
   812   C1882074:pH 7 [Qualitative Concept]
   793   C0020283:[pH] [Quantitative Concept]
   793   C0041175:TRIS [Organic Chemical,Pharmacologic Substance]
   793   C0077281:Tris [Hazardous or Poisonous Substance,Organophosphorus Compound]
   793   C0439190:MMOLE [Quantitative Concept]
   793   C0450407:ph+ [Finding]
   793   C0450408:ph++ [Finding]
   793   C0450409:ph+++ [Finding]
   793   C0814229:TRI [Intellectual Product]

Phrase: ")"

Phrase: ","

Phrase: "2% SDS,"

Phrase: "1 mmol/l phenylmethylsulfonyl fluoride,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   840   C0031493:Phenylmethylsulfonyl Fluoride [Organic Chemical,Pharmacologic Substance]
   804   C0016327:Fluoride [Inorganic Chemical,Pharmacologic Substance]

Phrase: "and"

Phrase: "10 g/ml aprotinin"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   812   C0003641:Aprotinin [Amino Acid, Peptide, or Protein,Biologically Active Substance,Pharmacologic Substance]

Phrase: "and"

Phrase: "then"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883708:Then [Temporal Concept]

Phrase: "homogenized"

Phrase: "again with 20 strokes of a Dounce homogenizer."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   744   C0038454:Strokes [Disease or Syndrome]
   744   C0181200:homogenizer [Medical Device]
Processing 00000000.tx.88: The homogenates were centrifuged at 10,000g for 20 min to precipitate cell debris. 

Phrase: "The homogenates"

Phrase: "were"

Phrase: "centrifuged at 10,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   756   C0179834:centrifuge [Medical Device]

Phrase: "000g for 20 min to"

Phrase: "precipitate"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1882443:PRECIPITATE [Phenomenon or Process]

Phrase: "cell debris."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0440266:Debris [Substance]
Processing 00000000.tx.89: The samples were separated on 12% SDS gel under reducing conditions and then immunoblotted with monoclonal anti-cytochrome C oxidase (COX) subunit I or anti-COX subunit IV antibody (Molecular Probe, Eugene, OR). 

Phrase: "The samples"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   966   C0370003:Sample [Substance]
   966   C2347026:Sample [Conceptual Entity]

Phrase: "were"

Phrase: "separated on 12% SDS gel"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   760   C0017243:Gel [Biomedical or Dental Material]
   760   C0086972:Separated [Finding]
   760   C0443299:separated [Spatial Concept]
   760   C0687118:Separated [Functional Concept]
   760   C1382104:Gel [Substance]

Phrase: "under reducing conditions"
Meta Candidates (Total=7; Excluded=4; Pruned=0; Remaining=3)
   827   C0012634:condition [Disease or Syndrome]
   827   C0348080:Condition [Qualitative Concept]
   827   C1705253:Condition [Conceptual Entity]
   777 E C0009647:Conditioned [Mental Process]
   777 E C1701901:Conditional [Qualitative Concept]
   777 E C1963686:Conditional [Functional Concept]
   755 E C1519605:Conditionality [Conceptual Entity]

Phrase: "and"

Phrase: "then"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883708:Then [Temporal Concept]

Phrase: "immunoblotted with monoclonal anti-cytochrome C oxidase (COX) subunit I"
Meta Candidates (Total=19; Excluded=0; Pruned=0; Remaining=19)
   810   C1537985:CYTOCHROME c OXIDASE I [Gene or Genome]
   790   C0010760:CYTOCHROME C OXIDASE [Amino Acid, Peptide, or Protein,Enzyme]
           Cytochrome Oxidase
   764   C0010749:Cytochrome c [Amino Acid, Peptide, or Protein,Enzyme]
   764   C0010754:Cytochrome c' [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   764   C0653778:cytochrome c'' [Amino Acid, Peptide, or Protein]
   764   C1153524:cytochrome c [Molecular Function]
   764   C1426584:CYTOCHROME C [Gene or Genome]
   762   C0370188:Anti i [Amino Acid, Peptide, or Protein,Immunologic Factor]
   762   C0432624:Anti C [Amino Acid, Peptide, or Protein,Immunologic Factor]
   762   C0432626:Anti c [Amino Acid, Peptide, or Protein,Immunologic Factor]
   742   C0010798:Cytochrome [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   742   C0021966:I- [Inorganic Chemical]
   742   C0221138:I NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   742   C0242417:Oxidase [Amino Acid, Peptide, or Protein,Enzyme]
   742   C0746619:monoclonal [Finding]
   742   C1325304:cytochrome [Molecular Function]
   742   C1711351:Subunit [Quantitative Concept]
   708   C0020985:Immunoblot [Laboratory Procedure]

Phrase: "or"

Phrase: "anti-COX subunit IV antibody"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   895   C0051967:anti-c antibody [Immunologic Factor]
   893   C0003242:anti antibody [Amino Acid, Peptide, or Protein,Immunologic Factor]
   795   C0003241:Antibody [Amino Acid, Peptide, or Protein,Cell Component,Immunologic Factor]
   795   C0021027:Antibody [Amino Acid, Peptide, or Protein,Immunologic Factor,Pharmacologic Substance]
   747   C0751066:Cytochrome-c Oxidase Subunit IV [Amino Acid, Peptide, or Protein,Enzyme]

Phrase: "(Molecular Probe,"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
  1000   C0026381:Probe, Molecular [Indicator, Reagent, or Diagnostic Aid]
   861   C0182400:Probe [Medical Device]
   861   C1704681:Probe [Gene or Genome]
   861   C2347609:Probe [Chemical Viewed Functionally]
   861   C3536729:Probe [Manufactured Object]

Phrase: "Eugene,"

Phrase: "OR"

Phrase: ")."
Processing 00000000.tx.90: The blots were then incubated with horseradish peroxidase-linked second antibody followed by chemiluminescence detection, according to the manufactures instructions (Pierce, Rockford, IL) Intervention by insulin treatment. 

Phrase: "The blots"

Phrase: "were"

Phrase: "then"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883708:Then [Temporal Concept]

Phrase: "incubated with horseradish peroxidase-linked second antibody"
Meta Candidates (Total=17; Excluded=0; Pruned=0; Remaining=17)
   778   C0019941:Horseradish Peroxidase [Amino Acid, Peptide, or Protein,Enzyme,Indicator, Reagent, or Diagnostic Aid]
   748   C0003241:Antibody [Amino Acid, Peptide, or Protein,Cell Component,Immunologic Factor]
   748   C0021027:Antibody [Amino Acid, Peptide, or Protein,Immunologic Factor,Pharmacologic Substance]
   748   C0027021:Peroxidase [Amino Acid, Peptide, or Protein,Enzyme]
   748   C0031179:Peroxidase [Amino Acid, Peptide, or Protein,Enzyme]
   748   C0205436:Second [Quantitative Concept]
   748   C0330510:Horseradish [Food]
   748   C0457385:Second [Temporal Concept]
   748   C0565930:/second [Quantitative Concept]
   748   C0939835:HORSERADISH [Organic Chemical,Pharmacologic Substance]
   748   C1110641:Horseradish [Plant]
   748   C1318719:Peroxidase [Indicator, Reagent, or Diagnostic Aid]
   748   C1439852:Incubated [Laboratory Procedure]
   748   C1561503:second [Idea or Concept]
   748   C1705190:Second [Qualitative Concept]
   714   C1517892:Link [Intellectual Product]
   714   C1704666:Link [Intellectual Product]

Phrase: "followed by chemiluminescence detection,"
Meta Candidates (Total=6; Excluded=1; Pruned=0; Remaining=5)
   833   C0332283:Followed by [Temporal Concept]
           followed
   770   C0162524:Chemiluminescence [Natural Phenomenon or Process]
   770   C1450278:Chemiluminescence [Natural Phenomenon or Process]
   770   C1511790:Detection [Therapeutic or Preventive Procedure]
   737 E C1719822:Follow [Intellectual Product]

Phrase: "according to the manufactures instructions"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
   861   C0302828:instructions [Intellectual Product]
   861   C1442085:Instructions [Idea or Concept]
   861   C3263700:Instructions [Clinical Attribute]
   827 E C0039401:Instruction [Educational Activity]

Phrase: "(Pierce,"

Phrase: "Rockford,"

Phrase: "IL) Intervention by insulin treatment."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   760   C0886296:intervention [Health Care Activity]
   760   C1273869:Intervention [Health Care Activity]
   760   C1948041:Intervention [Therapeutic or Preventive Procedure]
Processing 00000000.tx.91: Starting at 8 weeks after the onset of diabetes, STZ-induced diabetic rats were treated with insulin. 

Phrase: "Starting at 8 weeks"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   737   C0439659:Start [Temporal Concept]

Phrase: "after the onset"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0332162:Onset [Qualitative Concept]

Phrase: "of diabetes,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0011847:Diabetes [Disease or Syndrome]
  1000   C0011849:Diabetes [Disease or Syndrome]

Phrase: "STZ-induced diabetic rats"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   812   C0034693:rats [Mammal]
   812   C0034721:Rats [Mammal]
   812   C0241863:DIABETIC [Finding]

Phrase: "were"

Phrase: "treated with insulin."
Meta Candidates (Total=9; Excluded=3; Pruned=0; Remaining=6)
   882   C0332293:Treated with [Therapeutic or Preventive Procedure]
           treated
   790   C0021641:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   790   C1522326:Treated [Functional Concept]
   790   C1533581:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   790   C1579433:Insulin [Pharmacologic Substance]
   756 E C1292734:TREAT [Functional Concept]
   734 E C0020884:Iletin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   706 E C3537244:Insulins [Pharmacologic Substance]
Processing 00000000.tx.92: Intermediate-acting insulin (Novolin N; Novo Nordisk, Tokyo) was subcutaneously administered twice a day until the animals were killed. 

Phrase: "Intermediate-acting insulin"
Meta Candidates (Total=6; Excluded=2; Pruned=0; Remaining=4)
  1000   C0304869:Intermediate-acting insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   827   C0021641:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   827   C1533581:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   827   C1579433:Insulin [Pharmacologic Substance]
   771 E C0020884:Iletin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   743 E C3537244:Insulins [Pharmacologic Substance]

Phrase: "(Novolin N"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0307071:Novolin N [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]

Phrase: "; Novo Nordisk,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0331875:Novo Nordisk [Health Care Related Organization]

Phrase: "Tokyo"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0040371:Tokyo [Geographic Area]

Phrase: ")"

Phrase: "was"

Phrase: "subcutaneously"

Phrase: "administered"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C1521801:Administered [Functional Concept]
   966 E C1621583:Administer [Functional Concept]

Phrase: "twice"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1720725:Twice [Intellectual Product]
  1000   C1948050:Twice [Quantitative Concept]

Phrase: "a day until the animals"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   760   C0332173:/day [Temporal Concept]
   760   C0439228:day [Temporal Concept]
   760   C0439505:/day [Temporal Concept]

Phrase: "were"

Phrase: "killed."
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
  1000   C0162388:killed [Social Behavior]
   966 E C0681205:Kill [Idea or Concept]
   966 E C1550555:kill [Functional Concept]
Processing 00000000.tx.93: The doses of insulin to be given were determined each time from a sliding scale, according to blood glucose levels, to achieve strict glucose control. 

Phrase: "The doses of insulin to"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
   760   C0178602:Doses [Quantitative Concept]
   726 E C0869039:Dose [Quantitative Concept]
   726 E C1114758:Dose # [Clinical Attribute]
   726 E C1428722:DOS [Gene or Genome]

Phrase: "be"

Phrase: "given"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
  1000   C1442162:GIVEN [Conceptual Entity]
  1000   C1550718:given [Idea or Concept]
  1000   C3244317:given [Intellectual Product]
   966 E C1947971:Give [Functional Concept]

Phrase: "were"

Phrase: "determined"

Phrase: "each time from a sliding scale,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   753   C0040223:Time [Temporal Concept]
   753   C3541383:Time [Temporal Concept]

Phrase: "according to blood glucose levels,"
Meta Candidates (Total=19; Excluded=11; Pruned=0; Remaining=8)
  1000   C0428554:blood glucose levels [Laboratory or Test Result]
   901   C0005802:Blood Glucose [Carbohydrate]
   901   C0428548:glucose levels [Laboratory or Test Result]
   867 E C0337438:glucose level [Laboratory Procedure]
   827   C0005767:Blood [Tissue]
   827   C0005768:blood [Body Substance]
   827   C0017725:Glucose [Biologically Active Substance,Carbohydrate,Pharmacologic Substance]
   827   C0229664:Blood [Body Substance]
   827   C0441889:Levels [Qualitative Concept]
   793 E C0456079:Level [Classification]
   793 E C1547707:Level [Geographic Area]
   793 E C2946261:Level [Pharmacologic Substance]
   755 E C0333275:Bloody [Qualitative Concept]
   743 E C0005847:Blood Vessel [Body Part, Organ, or Organ Component]
   743 E C0392895:Bloods [Population Group]
   743 E C1283786:Blood vessel [Body Part, Organ, or Organ Component]
   743 E C1511228:VESSEL, BLOOD [Tissue]
   727 E C1558950:VASCULAR [Finding]
   727 E C1801960:Vascular [Qualitative Concept]

Phrase: "to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "achieve"

Phrase: "strict glucose control."
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   901   C0726398:GLUCOSE CONTROL [Indicator, Reagent, or Diagnostic Aid]
   827   C0017725:Glucose [Biologically Active Substance,Carbohydrate,Pharmacologic Substance]
   827   C0243148:control [Qualitative Concept]
   827   C1550141:Control [Substance]
   827   C1882979:Control [Conceptual Entity]
   827   C2587213:Control [Functional Concept]
   827   C3274648:Control [Qualitative Concept]
Processing 00000000.tx.94: At 1 and 2 weeks after the induction of insulin treatment, the 8-OHdG levels in urine and kidney and the frequency of mtDNA deletion in kidney were measured. 

Phrase: "At 1"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1412113:AT-1 [Gene or Genome]
   861   C1516077:At [Spatial Concept]

Phrase: "and"

Phrase: "2 weeks after the induction of insulin treatment,"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   770   C1442457:2 Weeks [Temporal Concept]
   744   C0439230:weeks [Temporal Concept]
   711 E C0332174:/week [Temporal Concept]

Phrase: "the 8-OHdG levels in urine"
Meta Candidates (Total=7; Excluded=3; Pruned=0; Remaining=4)
   767   C0428152:Urine levels NOS [Laboratory Procedure]
   767   C1318110:levels urine [Laboratory or Test Result]
   750   C0456948:Level 2 [Intellectual Product]
   744   C0441889:Levels [Qualitative Concept]
   711 E C0456079:Level [Classification]
   711 E C1547707:Level [Geographic Area]
   711 E C2946261:Level [Pharmacologic Substance]

Phrase: "and"

Phrase: "kidney"
Meta Candidates (Total=5; Excluded=1; Pruned=0; Remaining=4)
  1000   C0022646:Kidney [Body Part, Organ, or Organ Component]
  1000   C0227665:kidney [Body Part, Organ, or Organ Component]
  1000   C1278978:Kidney [Body Part, Organ, or Organ Component]
  1000   C1514845:KIDNEY [Tissue]
   907 E C0027697:Nephritides [Disease or Syndrome]

Phrase: "and"

Phrase: "the frequency of mtDNA deletion"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   753   C0376249:frequency [Quantitative Concept]
   753   C0439603:Frequency [Temporal Concept]
   753   C0871396:Frequency [Quantitative Concept]
   753   C1561548:Frequency [Qualitative Concept]
   753   C1705502:Frequency [Quantitative Concept]

Phrase: "in kidney"
Meta Candidates (Total=5; Excluded=1; Pruned=0; Remaining=4)
  1000   C0022646:Kidney [Body Part, Organ, or Organ Component]
  1000   C0227665:kidney [Body Part, Organ, or Organ Component]
  1000   C1278978:Kidney [Body Part, Organ, or Organ Component]
  1000   C1514845:KIDNEY [Tissue]
   907 E C0027697:Nephritides [Disease or Syndrome]

Phrase: "were"

Phrase: "measured."
Meta Candidates (Total=4; Excluded=2; Pruned=0; Remaining=2)
  1000   C0444706:Measured [Qualitative Concept]
  1000   C3541902:MEASURED [Diagnostic Procedure]
   966 E C0079809:Measure [Quantitative Concept]
   966 E C0242485:Measure [Functional Concept]
Processing 00000000.tx.95: Statistical analysis. 

Phrase: "Statistical analysis."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0871424:statistical analysis [Research Activity]
   861   C0002778:Analysis [Laboratory Procedure]
   861   C0936012:Analysis [Research Activity]
   861   C1524024:analysis [Functional Concept]
Processing 00000000.tx.96: All values shown are expressed as means  SE. 

Phrase: "All values"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0042295:Values [Qualitative Concept]
   966 E C1522609:Value [Quantitative Concept]

Phrase: "shown"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1547282:Show [Intellectual Product]

Phrase: "are"

Phrase: "expressed as means  SE."
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
   770   C1704970:Means [Conceptual Entity]
   737 E C0444504:Mean [Quantitative Concept]
   737 E C2347634:Mean [Quantitative Concept]
   737 E C2348143:Mean [Quantitative Concept]
Processing 00000000.tx.97: Statistical analysis was performed by ANOVA followed by Fishers comparison test.  

Phrase: "Statistical analysis"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0871424:statistical analysis [Research Activity]
   861   C0002778:Analysis [Laboratory Procedure]
   861   C0936012:Analysis [Research Activity]
   861   C1524024:analysis [Functional Concept]

Phrase: "was"

Phrase: "performed by ANOVA"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   882   C1550369:Performed By [Qualitative Concept]
   790   C0884358:Performed [Functional Concept]
   756 E C2947996:Perform [Pharmacologic Substance]

Phrase: "followed by Fishers comparison test."
Meta Candidates (Total=9; Excluded=1; Pruned=0; Remaining=8)
   806   C0332283:Followed by [Temporal Concept]
           followed
   781   C1708064:Fisher's Test [Intellectual Product]
   760   C0022885:Test [Laboratory Procedure]
   760   C0039593:Test [Functional Concept]
   760   C0392366:test [Intellectual Product]
   760   C1707455:Comparison [Activity]
   726   C0325045:Fisher [Mammal]
   726 E C1719822:Follow [Intellectual Product]
Processing 00000000.tx.98: RESULTS TOP ABSTRACT INTRODUCTION RESEARCH DESIGN AND METHODS RESULTS DISCUSSION REFERENCES  Urinary 8-OHdG excretion. 

Phrase: "RESULTS TOP ABSTRACT INTRODUCTION RESEARCH DESIGN"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   827   C0035171:Research Design [Research Activity]
   799   C0035168:research [Research Activity]
   799   C0242481:Research [Research Activity]
   799   C1707689:Design [Activity]
   799   C2983265:DESIGN [Intellectual Product]

Phrase: "AND"

Phrase: "METHODS RESULTS DISCUSSION"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0557061:Discussion [Therapeutic or Preventive Procedure]
   827   C2584313:Discussion [Social Behavior]

Phrase: "REFERENCES"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1514811:Reference [Idea or Concept]
  1000   C1706462:Reference [Conceptual Entity]

Phrase: "Urinary 8-OHdG excretion."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   799   C0221102:Excretion [Physiologic Function]
   799   C0504085:Excretion [Body Substance]
   799   C2699704:EXCRETION [Regulation or Law]
   734   C0050078:8-Hydroxy-2'-deoxyguanosine [Biologically Active Substance,Nucleic Acid, Nucleoside, or Nucleotide]
Processing 00000000.tx.99: The total amounts of urinary 8-OHdG excretion were significantly greater in STZ induced diabetic rats than in age-matched control rats at both 4 weeks (2,089  259 ng/day, n = 6 vs. 793  44 ng/day, n = 6, P < 0.01) and 8 weeks after the onset of diabetes (2,280  230 ng/day, n = 6 vs. 632  56 ng/day, n = 6, P < 0.001). 

Phrase: "The total amounts of urinary 8-OHdG excretion"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   739   C1265611:amounts [Quantitative Concept]

Phrase: "were"

Phrase: "significantly greater in STZ"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   770   C0443228:greater [Quantitative Concept]
   770   C1704243:Greater [Quantitative Concept]
   737 E C0549177:Great [Quantitative Concept]

Phrase: "induced"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0205263:Induced [Functional Concept]

Phrase: "diabetic rats than"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   790   C0034693:rats [Mammal]
   790   C0034721:Rats [Mammal]
   790   C0241863:DIABETIC [Finding]

Phrase: "in age-matched control rats"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   812   C0034693:rats [Mammal]
   812   C0034721:Rats [Mammal]

Phrase: "at both 4 weeks"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
  1000   C1442465:4 Weeks [Temporal Concept]
   861   C0439230:weeks [Temporal Concept]
   827 E C0332174:/week [Temporal Concept]

Phrase: "(2,089  259 ng/day,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   840   C1636666:ng/day [Quantitative Concept]
   804   C0332173:/day [Temporal Concept]
   804   C0439228:day [Temporal Concept]
   804   C0439505:/day [Temporal Concept]

Phrase: "n = 6"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0369718:N NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441922:N+ [Intellectual Product]
   861   C1553036:[n] [Quantitative Concept]

Phrase: "vs. 793  44 ng/day,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   861   C1636666:ng/day [Quantitative Concept]
   812   C0332173:/day [Temporal Concept]
   812   C0439228:day [Temporal Concept]
   812   C0439505:/day [Temporal Concept]

Phrase: "n = 6,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0369718:N NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441922:N+ [Intellectual Product]
   861   C1553036:[n] [Quantitative Concept]

Phrase: "P < 0.01"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0369773:P NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   827   C2603361:P' [Clinical Attribute]

Phrase: ")"

Phrase: "and"

Phrase: "8 weeks after the onset of diabetes"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   748   C0439230:weeks [Temporal Concept]
   714 E C0332174:/week [Temporal Concept]

Phrase: "(2,280  230 ng/day,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   840   C1636666:ng/day [Quantitative Concept]
   804   C0332173:/day [Temporal Concept]
   804   C0439228:day [Temporal Concept]
   804   C0439505:/day [Temporal Concept]

Phrase: "n = 6"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0369718:N NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441922:N+ [Intellectual Product]
   861   C1553036:[n] [Quantitative Concept]

Phrase: "vs. 632  56 ng/day,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   861   C1636666:ng/day [Quantitative Concept]
   812   C0332173:/day [Temporal Concept]
   812   C0439228:day [Temporal Concept]
   812   C0439505:/day [Temporal Concept]

Phrase: "n = 6,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0369718:N NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441922:N+ [Intellectual Product]
   861   C1553036:[n] [Quantitative Concept]

Phrase: "P < 0.001"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0369773:P NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   827   C2603361:P' [Clinical Attribute]

Phrase: ")."
Processing 00000000.tx.100: 8-OHdG contents in kidney tissues. 

Phrase: "8-OHdG contents in kidney tissues."
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   744   C0456205:Contents [Conceptual Entity]
   744   C1552853:contents [Idea or Concept]
   711 E C0423896:Content [Mental Process]
Processing 00000000.tx.101: The levels of 8-OHdG in the mtDNA were significantly increased in both renal cortices and papillae of diabetic rats as compared with those from the control rats at 8 weeks after the onset of diabetes (cortices: 11.8  1.1 ng/mg DNA, n = 6 vs. 

Phrase: "The levels of 8-OHdG"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
   757   C0456948:Level 2 [Intellectual Product]
   748   C0441889:Levels [Qualitative Concept]
   714 E C0456079:Level [Classification]
   714 E C1547707:Level [Geographic Area]
   714 E C2946261:Level [Pharmacologic Substance]

Phrase: "in the mtDNA"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
  1000   C0012929:DNA, Mitochondrial [Biologically Active Substance,Nucleic Acid, Nucleoside, or Nucleotide]
  1000   C1819717:mitochondrial DNA [Cell Component]
   861   C0012854:DNA [Biologically Active Substance,Nucleic Acid, Nucleoside, or Nucleotide]
   861   C0026237:Mitochondrial [Cell Component]
   861   C0521451:Mitochondrial [Functional Concept]

Phrase: "were"

Phrase: "significantly"

Phrase: "increased in both renal cortices"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   773   C0022655:Renal cortex [Body Part, Organ, or Organ Component]
   760   C0022646:Renal [Body Part, Organ, or Organ Component]
   760   C0205217:Increased [Quantitative Concept]
   760   C0442805:Increased [Functional Concept]
   726   C0007776:Cortex [Body Part, Organ, or Organ Component]
   726   C1176472:Cortex [Body Part, Organ, or Organ Component]
   726   C2700441:Cortex [Plant]

Phrase: "and"

Phrase: "papillae of diabetic rats"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   737   C0226964:papilla [Body Part, Organ, or Organ Component]
   737   C0227296:Papilla [Body Part, Organ, or Organ Component]

Phrase: "as"

Phrase: "compared with those from the control rats"
Meta Candidates (Total=8; Excluded=0; Pruned=0; Remaining=8)
   748   C0034693:rats [Mammal]
   748   C0034721:Rats [Mammal]
   748   C0243148:control [Qualitative Concept]
   748   C1550141:Control [Substance]
   748   C1707455:Compared [Activity]
   748   C1882979:Control [Conceptual Entity]
   748   C2587213:Control [Functional Concept]
   748   C3274648:Control [Qualitative Concept]

Phrase: "at 8 weeks"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   861   C0439230:weeks [Temporal Concept]
   827 E C0332174:/week [Temporal Concept]

Phrase: "after the onset"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0332162:Onset [Qualitative Concept]

Phrase: "of diabetes"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0011847:Diabetes [Disease or Syndrome]
  1000   C0011849:Diabetes [Disease or Syndrome]

Phrase: "(cortices"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   966   C0007776:Cortex [Body Part, Organ, or Organ Component]
   966   C1176472:Cortex [Body Part, Organ, or Organ Component]
   966   C2700441:Cortex [Plant]

Phrase: ":"

Phrase: "11.8  1.1 ng/mg DNA,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   795   C0012854:DNA [Biologically Active Substance,Nucleic Acid, Nucleoside, or Nucleotide]

Phrase: "n = 6"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0369718:N NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441922:N+ [Intellectual Product]
   861   C1553036:[n] [Quantitative Concept]

Phrase: "vs."
Processing 00000000.tx.102: 4.2  0.9 ng/mg DNA, P < 0.01; 

Phrase: "4.2  0.9 ng/mg DNA,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   795   C0012854:DNA [Biologically Active Substance,Nucleic Acid, Nucleoside, or Nucleotide]

Phrase: "P < 0.01"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0369773:P NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   827   C2603361:P' [Clinical Attribute]

Phrase: ";"
Processing 00000000.tx.103: papillae: 19.2  3.3 ng/mg DNA, n = 6 vs. 

Phrase: "papillae"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   966   C0226964:papilla [Body Part, Organ, or Organ Component]
   966   C0227296:Papilla [Body Part, Organ, or Organ Component]

Phrase: ":"

Phrase: "19.2  3.3 ng/mg DNA,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   795   C0012854:DNA [Biologically Active Substance,Nucleic Acid, Nucleoside, or Nucleotide]

Phrase: "n = 6"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0369718:N NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441922:N+ [Intellectual Product]
   861   C1553036:[n] [Quantitative Concept]

Phrase: "vs."
Processing 00000000.tx.104: 5.2  2.1 ng/mg DNA, P < 0.01) (Fig. 2A). 

Phrase: "5.2  2.1 ng/mg DNA,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   795   C0012854:DNA [Biologically Active Substance,Nucleic Acid, Nucleoside, or Nucleotide]

Phrase: "P < 0.01"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0369773:P NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   827   C2603361:P' [Clinical Attribute]

Phrase: ")"

Phrase: "(Fig. 2A"

Phrase: ")."
Processing 00000000.tx.105: In contrast, the levels of 8-OHdG in nuclear DNA were not significantly increased in either renal cortices or papillae from diabetic rats (Fig. 2B). 

Phrase: "In contrast,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1979874:Contrast [Qualitative Concept]

Phrase: "the levels of 8-OHdG"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
   757   C0456948:Level 2 [Intellectual Product]
   748   C0441889:Levels [Qualitative Concept]
   714 E C0456079:Level [Classification]
   714 E C1547707:Level [Geographic Area]
   714 E C2946261:Level [Pharmacologic Substance]

Phrase: "in nuclear DNA"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C1179920:Nuclear DNA [Biologically Active Substance,Nucleic Acid, Nucleoside, or Nucleotide]
   861   C0012854:DNA [Biologically Active Substance,Nucleic Acid, Nucleoside, or Nucleotide]
   861   C0521447:Nuclear [Spatial Concept]

Phrase: "were"

Phrase: "not significantly"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C1518422:Not [Functional Concept]

Phrase: "increased in either renal cortices"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   773   C0022655:Renal cortex [Body Part, Organ, or Organ Component]
   760   C0022646:Renal [Body Part, Organ, or Organ Component]
   760   C0205217:Increased [Quantitative Concept]
   760   C0442805:Increased [Functional Concept]
   726   C0007776:Cortex [Body Part, Organ, or Organ Component]
   726   C1176472:Cortex [Body Part, Organ, or Organ Component]
   726   C2700441:Cortex [Plant]

Phrase: "or"

Phrase: "papillae from diabetic rats"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   737   C0226964:papilla [Body Part, Organ, or Organ Component]
   737   C0227296:Papilla [Body Part, Organ, or Organ Component]

Phrase: "(Fig. 2B"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0450354:2b [Intellectual Product]
   861   C1706096:2B [Research Activity]

Phrase: ")."
Processing 00000000.tx.106: View larger version (17K): [in this window] [in a new window]  FIG. 

Phrase: "View"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0449911:View [Spatial Concept]

Phrase: "larger version"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0333052:Version [Functional Concept]
   861   C2607870:Version [Spatial Concept]

Phrase: "(17K"

Phrase: ")"

Phrase: ":"

Phrase: "["

Phrase: "in this window"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0557702:Window [Manufactured Object]
  1000   C1272706:Window [Temporal Concept]
  1000   C1704674:Window [Manufactured Object]

Phrase: "]"

Phrase: "["

Phrase: "in a new window"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0557702:Window [Manufactured Object]
   861   C1272706:Window [Temporal Concept]
   861   C1704674:Window [Manufactured Object]

Phrase: "]  FIG."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0349966:Fig [Food]
  1000   C1337208:FIG [Food]
Processing 00000000.tx.107: 2. 

Phrase: "2."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0740116:+2 [Quantitative Concept]
  1000   C2827735:2+ [Quantitative Concept]
  1000   C2981700:2+ [Classification]
Processing 00000000.tx.108: Levels of 8-OHdG in mtDNA (A) and nuclear DNA (B) from kidney of control and STZ-induced diabetic rats (DM). 

Phrase: "Levels of 8-OHdG"
Meta Candidates (Total=6; Excluded=3; Pruned=0; Remaining=3)
   767   C0456948:Level 2 [Intellectual Product]
   753   C0441889:Levels [Qualitative Concept]
   719 E C0456079:Level [Classification]
   719 E C1547707:Level [Geographic Area]
   719 E C2946261:Level [Pharmacologic Substance]
   716   C0050078:8-Hydroxy-2'-deoxyguanosine [Biologically Active Substance,Nucleic Acid, Nucleoside, or Nucleotide]

Phrase: "in mtDNA"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
  1000   C0012929:DNA, Mitochondrial [Biologically Active Substance,Nucleic Acid, Nucleoside, or Nucleotide]
  1000   C1819717:mitochondrial DNA [Cell Component]
   861   C0012854:DNA [Biologically Active Substance,Nucleic Acid, Nucleoside, or Nucleotide]
   861   C0026237:Mitochondrial [Cell Component]
   861   C0521451:Mitochondrial [Functional Concept]

Phrase: "(A)"

Phrase: "and"

Phrase: "nuclear DNA ("
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C1179920:Nuclear DNA [Biologically Active Substance,Nucleic Acid, Nucleoside, or Nucleotide]
   861   C0012854:DNA [Biologically Active Substance,Nucleic Acid, Nucleoside, or Nucleotide]
   861   C0521447:Nuclear [Spatial Concept]

Phrase: "B) from kidney of control"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C2347469:/B [Quantitative Concept]

Phrase: "and"

Phrase: "STZ-induced diabetic rats"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   812   C0034693:rats [Mammal]
   812   C0034721:Rats [Mammal]
   812   C0241863:DIABETIC [Finding]

Phrase: "(DM"

Phrase: ")."
Processing 00000000.tx.109: mtDNA and nuclear DNA were extracted separately from renal cortices and papillae of control and diabetic rats. 

Phrase: "mtDNA"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
  1000   C0012929:DNA, Mitochondrial [Biologically Active Substance,Nucleic Acid, Nucleoside, or Nucleotide]
  1000   C1819717:mitochondrial DNA [Cell Component]
   861   C0012854:DNA [Biologically Active Substance,Nucleic Acid, Nucleoside, or Nucleotide]
   861   C0026237:Mitochondrial [Cell Component]
   861   C0521451:Mitochondrial [Functional Concept]

Phrase: "and"

Phrase: "nuclear DNA"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C1179920:Nuclear DNA [Biologically Active Substance,Nucleic Acid, Nucleoside, or Nucleotide]
   861   C0012854:DNA [Biologically Active Substance,Nucleic Acid, Nucleoside, or Nucleotide]
   861   C0521447:Nuclear [Spatial Concept]

Phrase: "were"

Phrase: "extracted"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
  1000   C0185115:Extracted [Therapeutic or Preventive Procedure]
  1000   C3541890:EXTRACTED [Finding]
   966 E C2828366:Extract [Substance]

Phrase: "separately from renal cortices"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   799   C0022655:Renal cortex [Body Part, Organ, or Organ Component]
   770   C0022646:Renal [Body Part, Organ, or Organ Component]
   737   C0007776:Cortex [Body Part, Organ, or Organ Component]
   737   C1176472:Cortex [Body Part, Organ, or Organ Component]
   737   C2700441:Cortex [Plant]

Phrase: "and"

Phrase: "papillae of control"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   756   C0226964:papilla [Body Part, Organ, or Organ Component]
   756   C0227296:Papilla [Body Part, Organ, or Organ Component]

Phrase: "and"

Phrase: "diabetic rats."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0034693:rats [Mammal]
   861   C0034721:Rats [Mammal]
   861   C0241863:DIABETIC [Finding]
Processing 00000000.tx.110: Both extracted DNAs were enzymatically hydrolyzed into nucleosides, and levels of 8-OHdG were measured by ELISA kit. 

Phrase: "Both extracted DNAs"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0012854:DNA [Biologically Active Substance,Nucleic Acid, Nucleoside, or Nucleotide]

Phrase: "were"

Phrase: "enzymatically"

Phrase: "hydrolyzed into nucleosides,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   790   C0028621:Nucleosides [Nucleic Acid, Nucleoside, or Nucleotide]

Phrase: "and"

Phrase: "levels of 8-OHdG"
Meta Candidates (Total=6; Excluded=3; Pruned=0; Remaining=3)
   767   C0456948:Level 2 [Intellectual Product]
   753   C0441889:Levels [Qualitative Concept]
   719 E C0456079:Level [Classification]
   719 E C1547707:Level [Geographic Area]
   719 E C2946261:Level [Pharmacologic Substance]
   716   C0050078:8-Hydroxy-2'-deoxyguanosine [Biologically Active Substance,Nucleic Acid, Nucleoside, or Nucleotide]

Phrase: "were"

Phrase: "measured by ELISA kit."
Meta Candidates (Total=18; Excluded=2; Pruned=0; Remaining=16)
   853   C0014441:Enzyme-Linked Immunosorbent Assay [Laboratory Procedure]
   774   C2717977:Enzyme Assay [Laboratory Procedure]
   748   C0005507:Assay [Laboratory Procedure]
   748   C0014442:Enzyme [Enzyme,Organic Chemical]
   748   C0021075:immunosorbent [Indicator, Reagent, or Diagnostic Aid]
   748   C0243073:assay [Qualitative Concept]
   748   C0444706:Measured [Qualitative Concept]
   748   C0812225:KIT [Medical Device]
   748   C1150635:KIT [Molecular Function]
   748   C1510438:Assay [Laboratory Procedure]
   748   C1705212:Kit [Medical Device]
   748   C1705213:KIT [Medical Device]
   748   C3273202:Kit [Manufactured Object]
   748   C3541902:MEASURED [Diagnostic Procedure]
   714 E C0079809:Measure [Quantitative Concept]
   714 E C0242485:Measure [Functional Concept]
   714   C1517892:Link [Intellectual Product]
   714   C1704666:Link [Intellectual Product]
Processing 00000000.tx.111: NS, not significant. 

Phrase: "NS,"

Phrase: "not significant."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C1273937:Not significant [Finding]
   861   C0237881:significant [Quantitative Concept]
   861   C0750502:Significant [Idea or Concept]
   861   C1546944:Significant [Qualitative Concept]
Processing 00000000.tx.112: Data are means  SE.  

Phrase: "Data"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1511726:Data [Idea or Concept]
  1000   C3245479:data [Medical Device]

Phrase: "are"

Phrase: "means  SE."
Processing 00000000.tx.113: mtDNA deletion in kidney tissues. 

Phrase: "mtDNA deletion in kidney tissues."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   833   C0948051:mitochondrial dna deletion [Cell or Molecular Dysfunction]
   753   C1442161:Deletion [Cell or Molecular Dysfunction]
   753   C1511760:Deletion [Genetic Function]
   753   C1880274:Deletion [Activity]
Processing 00000000.tx.114: PCR amplification showed that the 4,834 mtDNA deletion products from diabetic kidney were increased in a dose-dependent manner from 0.01 to 0.2 g of template DNA, but those from control kidney had very low levels at the same doses of starting template DNA (Fig. 3). 

Phrase: "PCR amplification"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C1517480:Amplification [Molecular Biology Research Technique]
   861   C1521871:Amplification [Phenomenon or Process]
   861   C1705759:Amplification [Cell or Molecular Dysfunction]

Phrase: "showed"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1547282:Show [Intellectual Product]

Phrase: "that"

Phrase: "the 4,834 mtDNA deletion products from diabetic kidney"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   739   C1514468:Products [Entity]
   706 E C1704444:Product [Quantitative Concept]

Phrase: "were"

Phrase: "increased in a dose-dependent manner"
Meta Candidates (Total=10; Excluded=0; Pruned=0; Remaining=10)
   790   C1512045:Dose-dependent [Quantitative Concept]
   783   C1707810:Dose Increased [Therapeutic or Preventive Procedure]
   753   C0178602:Dose [Quantitative Concept]
   753   C0205217:Increased [Quantitative Concept]
   753   C0442805:Increased [Functional Concept]
   753   C0851827:Dependent [Qualitative Concept]
   753   C0869039:Dose [Quantitative Concept]
   753   C1114758:Dose # [Clinical Attribute]
   753   C1701901:Dependent [Qualitative Concept]
   753   C3244310:dependent [Functional Concept]

Phrase: "from 0.01"

Phrase: "to 0.2 g"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0439267:g% [Quantitative Concept]

Phrase: "of template DNA,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0012854:DNA [Biologically Active Substance,Nucleic Acid, Nucleoside, or Nucleotide]

Phrase: "but"

Phrase: "those from control kidney"
Meta Candidates (Total=9; Excluded=0; Pruned=0; Remaining=9)
   770   C0022646:Kidney [Body Part, Organ, or Organ Component]
   770   C0227665:kidney [Body Part, Organ, or Organ Component]
   770   C0243148:control [Qualitative Concept]
   770   C1278978:Kidney [Body Part, Organ, or Organ Component]
   770   C1514845:KIDNEY [Tissue]
   770   C1550141:Control [Substance]
   770   C1882979:Control [Conceptual Entity]
   770   C2587213:Control [Functional Concept]
   770   C3274648:Control [Qualitative Concept]

Phrase: "had"

Phrase: "very low levels at the same doses of starting template DNA"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
   738   C0441889:Levels [Qualitative Concept]
   721   C0178602:Dose Level [Quantitative Concept]
   704 E C0456079:Level [Classification]
   704 E C1547707:Level [Geographic Area]
   704 E C2946261:Level [Pharmacologic Substance]

Phrase: "(Fig. 3"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0349966:Fig [Food]
   861   C1337208:FIG [Food]

Phrase: ")."
Processing 00000000.tx.115: The mtDNA deletion products from diabetic kidney were increased in a cycle-dependent manner from 25 to 37 cycles as well (Fig. 3). 

Phrase: "The mtDNA deletion products from diabetic kidney"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   744   C1514468:Products [Entity]
   711 E C1704444:Product [Quantitative Concept]

Phrase: "were"

Phrase: "increased in a cycle-dependent manner"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   753   C0205217:Increased [Quantitative Concept]
   753   C0442805:Increased [Functional Concept]
   753   C0851827:Dependent [Qualitative Concept]
   753   C1511572:Cycle [Temporal Concept]
   753   C1701901:Dependent [Qualitative Concept]
   753   C3244310:dependent [Functional Concept]

Phrase: "from 25"

Phrase: "to 37 cycles"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C1511572:Cycle [Temporal Concept]

Phrase: "as well"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0205170:Well [Qualitative Concept]
  1000   C3146287:Well [Manufactured Object]

Phrase: "(Fig. 3"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0349966:Fig [Food]
   861   C1337208:FIG [Food]

Phrase: ")."
Processing 00000000.tx.116: The wild-type mtDNA products were also increased in a cycle dependency from 10 to 30 cycles (Fig. 3). 

Phrase: "The wild-type mtDNA products"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   804   C1514468:Products [Entity]
   771 E C1704444:Product [Quantitative Concept]

Phrase: "were"

Phrase: "also"

Phrase: "increased in a cycle dependency"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   760   C0011546:Dependency [Mental Process]
   760   C0205217:Increased [Quantitative Concept]
   760   C0442805:Increased [Functional Concept]
   760   C1511572:Cycle [Temporal Concept]
   760   C1546937:Dependency [Idea or Concept]

Phrase: "from 10"

Phrase: "to 30 cycles"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C1511572:Cycle [Temporal Concept]

Phrase: "(Fig. 3"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0349966:Fig [Food]
   861   C1337208:FIG [Food]

Phrase: ")."
Processing 00000000.tx.117: Similar results were obtained on all samples. 

Phrase: "Similar results"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   827   C1274040:Result [Functional Concept]
   827   C1546471:Result [Idea or Concept]
   827   C2825142:Result [Finding]

Phrase: "were"

Phrase: "obtained on all samples."
Meta Candidates (Total=5; Excluded=1; Pruned=0; Remaining=4)
   802   C1277697:Sample obtained [Finding]
   770   C1301820:Obtained [Functional Concept]
   737   C0370003:Sample [Substance]
   737 E C1706701:Obtain [Activity]
   737   C2347026:Sample [Conceptual Entity]
Processing 00000000.tx.118: View larger version (73K): [in this window] [in a new window]  FIG. 

Phrase: "View"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0449911:View [Spatial Concept]

Phrase: "larger version"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0333052:Version [Functional Concept]
   861   C2607870:Version [Spatial Concept]

Phrase: "(73K"

Phrase: ")"

Phrase: ":"

Phrase: "["

Phrase: "in this window"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0557702:Window [Manufactured Object]
  1000   C1272706:Window [Temporal Concept]
  1000   C1704674:Window [Manufactured Object]

Phrase: "]"

Phrase: "["

Phrase: "in a new window"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0557702:Window [Manufactured Object]
   861   C1272706:Window [Temporal Concept]
   861   C1704674:Window [Manufactured Object]

Phrase: "]  FIG."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0349966:Fig [Food]
  1000   C1337208:FIG [Food]
Processing 00000000.tx.119: 3. 

Phrase: "3."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0439086:<3 [Quantitative Concept]
  1000   C2827736:3+ [Quantitative Concept]
  1000   C2981702:3+ [Classification]
Processing 00000000.tx.120: PCR amplification of mtDNA with a 4,834 deletion from kidney of control and STZ-induced diabetic rats (DM). 

Phrase: "PCR amplification of mtDNA"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   797   C0683230:DNA amplification [Genetic Function]
   760   C1517480:Amplification [Molecular Biology Research Technique]
   760   C1521871:Amplification [Phenomenon or Process]
   760   C1705759:Amplification [Cell or Molecular Dysfunction]

Phrase: "with a 4,834 deletion"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   827   C1442161:Deletion [Cell or Molecular Dysfunction]
   827   C1511760:Deletion [Genetic Function]
   827   C1880274:Deletion [Activity]

Phrase: "from kidney"
Meta Candidates (Total=5; Excluded=1; Pruned=0; Remaining=4)
  1000   C0022646:Kidney [Body Part, Organ, or Organ Component]
  1000   C0227665:kidney [Body Part, Organ, or Organ Component]
  1000   C1278978:Kidney [Body Part, Organ, or Organ Component]
  1000   C1514845:KIDNEY [Tissue]
   907 E C0027697:Nephritides [Disease or Syndrome]

Phrase: "of control"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
  1000   C0243148:control [Qualitative Concept]
  1000   C1550141:Control [Substance]
  1000   C1882979:Control [Conceptual Entity]
  1000   C2587213:Control [Functional Concept]
  1000   C3274648:Control [Qualitative Concept]

Phrase: "and"

Phrase: "STZ-induced diabetic rats"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   812   C0034693:rats [Mammal]
   812   C0034721:Rats [Mammal]
   812   C0241863:DIABETIC [Finding]

Phrase: "(DM"

Phrase: ")."
Processing 00000000.tx.121: PCR products from mtDNA with a 4,834 deletion were electrophoresed on a 5% polyacrylamide gel containing bistragreen and analyzed by densitometry. 

Phrase: "PCR products from mtDNA"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   760   C1514468:Products [Entity]
   726 E C1704444:Product [Quantitative Concept]

Phrase: "with a 4,834 deletion"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   827   C1442161:Deletion [Cell or Molecular Dysfunction]
   827   C1511760:Deletion [Genetic Function]
   827   C1880274:Deletion [Activity]

Phrase: "were"

Phrase: "electrophoresed on a 5% polyacrylamide gel containing bistragreen"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   770   C0071500:Polyacrylamide Gel [Biomedical or Dental Material,Pharmacologic Substance]
   744   C0017243:Gel [Biomedical or Dental Material]
   744   C0071499:polyacrylamide [Biomedical or Dental Material,Organic Chemical]
   744   C0332256:Containing [Functional Concept]
   744   C1382104:Gel [Substance]
   744   C2700400:Containing [Activity]
   711   C0013855:electrophorese [Laboratory Procedure]

Phrase: "and"

Phrase: "analyzed by densitometry."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   790   C0011321:Densitometry [Laboratory Procedure]
   790   C0936012:Analyzed [Research Activity]
Processing 00000000.tx.122: A: PCR amplification of mtDNA with a 4,834 deletion was carried out using various doses (0.01, 0.05, 0.1, and 0.2 g) of starting DNA template from kidney of control and diabetic rats. 

Phrase: "A"

Phrase: ":"

Phrase: "PCR amplification of mtDNA"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   797   C0683230:DNA amplification [Genetic Function]
   760   C1517480:Amplification [Molecular Biology Research Technique]
   760   C1521871:Amplification [Phenomenon or Process]
   760   C1705759:Amplification [Cell or Molecular Dysfunction]

Phrase: "with a 4,834 deletion"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   827   C1442161:Deletion [Cell or Molecular Dysfunction]
   827   C1511760:Deletion [Genetic Function]
   827   C1880274:Deletion [Activity]

Phrase: "was"

Phrase: "carried"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0206243:carried [Activity]
  1000   C0699809:carried [Finding]

Phrase: "out"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0439787:Out [Spatial Concept]
  1000   C0849355:Out [Qualitative Concept]

Phrase: "using"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1524063:Using [Functional Concept]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "various doses"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
   861   C0178602:Doses [Quantitative Concept]
   827 E C0869039:Dose [Quantitative Concept]
   827 E C1114758:Dose # [Clinical Attribute]
   827 E C1428722:DOS [Gene or Genome]

Phrase: "(0.01,"

Phrase: "0.05,"

Phrase: "0.1,"

Phrase: "and"

Phrase: "0.2 g) of starting DNA template"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   748   C0439267:g% [Quantitative Concept]

Phrase: "from kidney"
Meta Candidates (Total=5; Excluded=1; Pruned=0; Remaining=4)
  1000   C0022646:Kidney [Body Part, Organ, or Organ Component]
  1000   C0227665:kidney [Body Part, Organ, or Organ Component]
  1000   C1278978:Kidney [Body Part, Organ, or Organ Component]
  1000   C1514845:KIDNEY [Tissue]
   907 E C0027697:Nephritides [Disease or Syndrome]

Phrase: "of control"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
  1000   C0243148:control [Qualitative Concept]
  1000   C1550141:Control [Substance]
  1000   C1882979:Control [Conceptual Entity]
  1000   C2587213:Control [Functional Concept]
  1000   C3274648:Control [Qualitative Concept]

Phrase: "and"

Phrase: "diabetic rats."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0034693:rats [Mammal]
   861   C0034721:Rats [Mammal]
   861   C0241863:DIABETIC [Finding]
Processing 00000000.tx.123: B: PCR amplification of wild-type mtDNA and deleted mtDNA was carried out in a condition of various cycles (10, 15, 20, 25, and 30 cycles for wild-type mtDNA and 25, 28, 31, 34, and 37 cycles for deleted mtDNA). 

Phrase: "B"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2347469:/B [Quantitative Concept]

Phrase: ":"

Phrase: "PCR amplification of wild-type mtDNA"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   774   C0683230:DNA amplification [Genetic Function]
   748   C1517480:Amplification [Molecular Biology Research Technique]
   748   C1521871:Amplification [Phenomenon or Process]
   748   C1705759:Amplification [Cell or Molecular Dysfunction]

Phrase: "and"

Phrase: "deleted mtDNA"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   901   C0012929:DNA, Mitochondrial [Biologically Active Substance,Nucleic Acid, Nucleoside, or Nucleotide]
   901   C1819717:mitochondrial DNA [Cell Component]
   827   C0012854:DNA [Biologically Active Substance,Nucleic Acid, Nucleoside, or Nucleotide]
   827   C0026237:Mitochondrial [Cell Component]
   827   C0521451:Mitochondrial [Functional Concept]

Phrase: "was"

Phrase: "carried"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0206243:carried [Activity]
  1000   C0699809:carried [Finding]

Phrase: "out in a condition of various cycles"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   748   C0012634:condition [Disease or Syndrome]
   748   C0348080:Condition [Qualitative Concept]
   748   C0439787:Out [Spatial Concept]
   748   C0440102:Various [Indicator, Reagent, or Diagnostic Aid]
   748   C0849355:Out [Qualitative Concept]
   748   C1705253:Condition [Conceptual Entity]
   714   C1511572:Cycle [Temporal Concept]

Phrase: "(10,"

Phrase: "15,"

Phrase: "20,"

Phrase: "25,"

Phrase: "and"

Phrase: "30 cycles for wild-type mtDNA"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   714   C1511572:Cycle [Temporal Concept]

Phrase: "and"

Phrase: "25,"

Phrase: "28,"

Phrase: "31,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0450355:31 [Intellectual Product]

Phrase: "34,"

Phrase: "and"

Phrase: "37 cycles for deleted mtDNA"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   719   C1511572:Cycle [Temporal Concept]

Phrase: ")."
Processing 00000000.tx.124: A primer set of L768 and H1296 was used for amplification of deleted mtDNA, and a primer set of L1576 and H1626 was used for wild-type mtDNA.  

Phrase: "A primer"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0206415:Primer [Nucleic Acid, Nucleoside, or Nucleotide]

Phrase: "set of L768"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   790   C0036849:Set [Mental Process]
   790   C1442518:Set [Functional Concept]
   790   C1705195:Set [Conceptual Entity]

Phrase: "and"

Phrase: "H1296"

Phrase: "was"

Phrase: "used for amplification of deleted mtDNA,"
Meta Candidates (Total=15; Excluded=3; Pruned=0; Remaining=12)
   778   C0012929:DNA, Mitochondrial [Biologically Active Substance,Nucleic Acid, Nucleoside, or Nucleotide]
   778   C1819717:mitochondrial DNA [Cell Component]
   774   C0683230:DNA amplification [Genetic Function]
   757   C1524063:Use of [Functional Concept]
   748   C0012854:DNA [Biologically Active Substance,Nucleic Acid, Nucleoside, or Nucleotide]
   748   C0026237:Mitochondrial [Cell Component]
   748   C0521451:Mitochondrial [Functional Concept]
   748   C1273517:used [Finding]
   748   C1517480:Amplification [Molecular Biology Research Technique]
   748   C1521871:Amplification [Phenomenon or Process]
   748   C1705759:Amplification [Cell or Molecular Dysfunction]
   748   C1880274:Deleted [Activity]
   714 E C0042153:use [Functional Concept]
   714 E C0457083:Use [Functional Concept]
   714 E C1947944:Use [Intellectual Product]

Phrase: "and"

Phrase: "a primer"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0206415:Primer [Nucleic Acid, Nucleoside, or Nucleotide]

Phrase: "set of L1576"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   790   C0036849:Set [Mental Process]
   790   C1442518:Set [Functional Concept]
   790   C1705195:Set [Conceptual Entity]

Phrase: "and"

Phrase: "H1626"

Phrase: "was"

Phrase: "used for wild-type mtDNA."
Meta Candidates (Total=14; Excluded=3; Pruned=0; Remaining=11)
   790   C0012929:DNA, Mitochondrial [Biologically Active Substance,Nucleic Acid, Nucleoside, or Nucleotide]
   790   C1819717:mitochondrial DNA [Cell Component]
   790   C1883559:Wild Type [Organism Attribute]
   783   C0079247:type dna [Molecular Biology Research Technique]
   753   C0012854:DNA [Biologically Active Substance,Nucleic Acid, Nucleoside, or Nucleotide]
   753   C0026237:Mitochondrial [Cell Component]
   753   C0332307:Type [Qualitative Concept]
   753   C0445392:Wild [Intellectual Product]
   753   C0521451:Mitochondrial [Functional Concept]
   753   C1273517:used [Finding]
   753   C1547052:*Type [Quantitative Concept]
   719 E C0042153:use [Functional Concept]
   719 E C0457083:Use [Functional Concept]
   719 E C1947944:Use [Intellectual Product]
Processing 00000000.tx.125: To compare the frequency of mtDNA deletion between diabetic and control rats, the PCR products amplified in a condition of 0.2 g template DNA and 35 cycles were quantified by densitometoric analysis. 

Phrase: "To"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "compare"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1707455:Compare [Activity]

Phrase: "the frequency of mtDNA deletion"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   753   C0376249:frequency [Quantitative Concept]
   753   C0439603:Frequency [Temporal Concept]
   753   C0871396:Frequency [Quantitative Concept]
   753   C1561548:Frequency [Qualitative Concept]
   753   C1705502:Frequency [Quantitative Concept]

Phrase: "between diabetic"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0241863:DIABETIC [Finding]

Phrase: "and"

Phrase: "control rats,"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   861   C0034693:rats [Mammal]
   861   C0034721:Rats [Mammal]
   861   C0243148:control [Qualitative Concept]
   861   C1550141:Control [Substance]
   861   C1882979:Control [Conceptual Entity]
   861   C2587213:Control [Functional Concept]
   861   C3274648:Control [Qualitative Concept]

Phrase: "the PCR products"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   861   C1514468:Products [Entity]
   827 E C1704444:Product [Quantitative Concept]

Phrase: "amplified in a condition of 0.2 g template DNA"
Meta Candidates (Total=9; Excluded=0; Pruned=0; Remaining=9)
   757   C0678713:DNA template [Genetic Function]
   739   C0012634:condition [Disease or Syndrome]
   739   C0012854:DNA [Biologically Active Substance,Nucleic Acid, Nucleoside, or Nucleotide]
   739   C0348080:Condition [Qualitative Concept]
   739   C0439267:g% [Quantitative Concept]
   739   C0728990:TEMPLATE [Medical Device]
   739   C1514575:Template [Conceptual Entity]
   739   C1705253:Condition [Conceptual Entity]
   739   C1705542:Template [Idea or Concept]

Phrase: "and"

Phrase: "35 cycles"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C1511572:Cycle [Temporal Concept]

Phrase: "were"

Phrase: "quantified by densitometoric analysis."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   770   C0002778:Analysis [Laboratory Procedure]
   770   C0936012:Analysis [Research Activity]
   770   C1524024:analysis [Functional Concept]
   737   C1709793:Quantify [Quantitative Concept]
Processing 00000000.tx.126: These semiquantitative analysis showed that the kidneys from diabetic rats had low levels of the mtDNA deletion products at 4 weeks after the onset of diabetes and that the difference between diabetic and control rats was not statistically significant. 

Phrase: "These semiquantitative analysis"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0002778:Analysis [Laboratory Procedure]
   861   C0936012:Analysis [Research Activity]
   861   C1524024:analysis [Functional Concept]

Phrase: "showed"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1547282:Show [Intellectual Product]

Phrase: "that"

Phrase: "the kidneys from diabetic rats"
Meta Candidates (Total=5; Excluded=2; Pruned=0; Remaining=3)
   764   C1882714:Rat Kidney [Body Part, Organ, or Organ Component]
   760   C0022646:Kidneys [Body Part, Organ, or Organ Component]
   760   C0227665:kidneys [Body Part, Organ, or Organ Component]
   726 E C1278978:Kidney [Body Part, Organ, or Organ Component]
   726 E C1514845:KIDNEY [Tissue]

Phrase: "had"

Phrase: "low levels of the mtDNA deletion products"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
   744   C0441889:Levels [Qualitative Concept]
   711 E C0456079:Level [Classification]
   711 E C1547707:Level [Geographic Area]
   711 E C2946261:Level [Pharmacologic Substance]

Phrase: "at 4 weeks"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
  1000   C1442465:4 Weeks [Temporal Concept]
   861   C0439230:weeks [Temporal Concept]
   827 E C0332174:/week [Temporal Concept]

Phrase: "after the onset"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0332162:Onset [Qualitative Concept]

Phrase: "of diabetes"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0011847:Diabetes [Disease or Syndrome]
  1000   C0011849:Diabetes [Disease or Syndrome]

Phrase: "and"

Phrase: "that"

Phrase: "the difference between diabetic"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   770   C1705241:*Difference [Quantitative Concept]
   770   C1705242:Difference [Qualitative Concept]

Phrase: "and"

Phrase: "control rats"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   861   C0034693:rats [Mammal]
   861   C0034721:Rats [Mammal]
   861   C0243148:control [Qualitative Concept]
   861   C1550141:Control [Substance]
   861   C1882979:Control [Conceptual Entity]
   861   C2587213:Control [Functional Concept]
   861   C3274648:Control [Qualitative Concept]

Phrase: "was"

Phrase: "not statistically significant."
Meta Candidates (Total=7; Excluded=1; Pruned=0; Remaining=6)
   913   C1273937:Not significant [Finding]
   901   C0237881:statistically significant [Quantitative Concept]
           significant
   829 E C1709380:Statistical Significance [Quantitative Concept]
   827   C0038215:Statistically [Occupation or Discipline]
   827   C0750502:Significant [Idea or Concept]
   827   C1546944:Significant [Qualitative Concept]
Processing 00000000.tx.127: In contrast, at 8 weeks, the kidneys from diabetic rats exhibited markedly higher levels of mtDNA deletion products compared with those from control rats, as shown in Fig. 

Phrase: "In contrast,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1979874:Contrast [Qualitative Concept]

Phrase: "at 8 weeks,"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   861   C0439230:weeks [Temporal Concept]
   827 E C0332174:/week [Temporal Concept]

Phrase: "the kidneys from diabetic rats"
Meta Candidates (Total=5; Excluded=2; Pruned=0; Remaining=3)
   764   C1882714:Rat Kidney [Body Part, Organ, or Organ Component]
   760   C0022646:Kidneys [Body Part, Organ, or Organ Component]
   760   C0227665:kidneys [Body Part, Organ, or Organ Component]
   726 E C1278978:Kidney [Body Part, Organ, or Organ Component]
   726 E C1514845:KIDNEY [Tissue]

Phrase: "exhibited"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C0015272:Exhibit [Intellectual Product]

Phrase: "markedly higher levels of mtDNA deletion products"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
   744   C0441889:Levels [Qualitative Concept]
   711 E C0456079:Level [Classification]
   711 E C1547707:Level [Geographic Area]
   711 E C2946261:Level [Pharmacologic Substance]

Phrase: "compared with those from control rats,"
Meta Candidates (Total=8; Excluded=0; Pruned=0; Remaining=8)
   753   C0034693:rats [Mammal]
   753   C0034721:Rats [Mammal]
   753   C0243148:control [Qualitative Concept]
   753   C1550141:Control [Substance]
   753   C1707455:Compared [Activity]
   753   C1882979:Control [Conceptual Entity]
   753   C2587213:Control [Functional Concept]
   753   C3274648:Control [Qualitative Concept]

Phrase: "as"

Phrase: "shown in Fig."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   790   C0349966:Fig [Food]
   790   C1337208:FIG [Food]
   756   C1547282:Show [Intellectual Product]
Processing 00000000.tx.128: 4. 

Phrase: "4."
Processing 00000000.tx.129: View larger version (20K): [in this window] [in a new window]  FIG. 

Phrase: "View"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0449911:View [Spatial Concept]

Phrase: "larger version"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0333052:Version [Functional Concept]
   861   C2607870:Version [Spatial Concept]

Phrase: "(20K"

Phrase: ")"

Phrase: ":"

Phrase: "["

Phrase: "in this window"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0557702:Window [Manufactured Object]
  1000   C1272706:Window [Temporal Concept]
  1000   C1704674:Window [Manufactured Object]

Phrase: "]"

Phrase: "["

Phrase: "in a new window"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0557702:Window [Manufactured Object]
   861   C1272706:Window [Temporal Concept]
   861   C1704674:Window [Manufactured Object]

Phrase: "]  FIG."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0349966:Fig [Food]
  1000   C1337208:FIG [Food]
Processing 00000000.tx.130: 4. 

Phrase: "4."
Processing 00000000.tx.131: Semiquantitive analysis of mtDNA with a 4,834 deletion in kidney of control rats and STZ-induced diabetic rats (DM). 

Phrase: "Semiquantitive analysis of mtDNA"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   797   C0200898:DNA analysis [Laboratory Procedure]
   760   C0002778:Analysis [Laboratory Procedure]
   760   C0936012:Analysis [Research Activity]
   760   C1524024:analysis [Functional Concept]

Phrase: "with a 4,834 deletion"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   827   C1442161:Deletion [Cell or Molecular Dysfunction]
   827   C1511760:Deletion [Genetic Function]
   827   C1880274:Deletion [Activity]

Phrase: "in kidney"
Meta Candidates (Total=5; Excluded=1; Pruned=0; Remaining=4)
  1000   C0022646:Kidney [Body Part, Organ, or Organ Component]
  1000   C0227665:kidney [Body Part, Organ, or Organ Component]
  1000   C1278978:Kidney [Body Part, Organ, or Organ Component]
  1000   C1514845:KIDNEY [Tissue]
   907 E C0027697:Nephritides [Disease or Syndrome]

Phrase: "of control rats"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   861   C0034693:rats [Mammal]
   861   C0034721:Rats [Mammal]
   861   C0243148:control [Qualitative Concept]
   861   C1550141:Control [Substance]
   861   C1882979:Control [Conceptual Entity]
   861   C2587213:Control [Functional Concept]
   861   C3274648:Control [Qualitative Concept]

Phrase: "and"

Phrase: "STZ-induced diabetic rats"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   812   C0034693:rats [Mammal]
   812   C0034721:Rats [Mammal]
   812   C0241863:DIABETIC [Finding]

Phrase: "(DM"

Phrase: ")."
Processing 00000000.tx.132: PCR products from mtDNA with a 4,834 deletion were electrophoresed on a 5% polyacrylamide gel containing bistragreen and analyzed by densitometry. 

Phrase: "PCR products from mtDNA"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   760   C1514468:Products [Entity]
   726 E C1704444:Product [Quantitative Concept]

Phrase: "with a 4,834 deletion"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   827   C1442161:Deletion [Cell or Molecular Dysfunction]
   827   C1511760:Deletion [Genetic Function]
   827   C1880274:Deletion [Activity]

Phrase: "were"

Phrase: "electrophoresed on a 5% polyacrylamide gel containing bistragreen"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   770   C0071500:Polyacrylamide Gel [Biomedical or Dental Material,Pharmacologic Substance]
   744   C0017243:Gel [Biomedical or Dental Material]
   744   C0071499:polyacrylamide [Biomedical or Dental Material,Organic Chemical]
   744   C0332256:Containing [Functional Concept]
   744   C1382104:Gel [Substance]
   744   C2700400:Containing [Activity]
   711   C0013855:electrophorese [Laboratory Procedure]

Phrase: "and"

Phrase: "analyzed by densitometry."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   790   C0011321:Densitometry [Laboratory Procedure]
   790   C0936012:Analyzed [Research Activity]
Processing 00000000.tx.133: The columns show the relative densities of PCR products from deleted mtDNA from kidney of control and diabetic rats at 4 or 8 weeks after the onset of diabetes. 

Phrase: "The columns"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   966   C1185738:Column [Body Part, Organ, or Organ Component]
   966   C1706132:Column [Idea or Concept]

Phrase: "show"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1547282:Show [Intellectual Product]

Phrase: "the relative densities of PCR products"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   790   C0037786:Relative Densities [Quantitative Concept]
   773 E C1576416:*Relative Density [Qualitative Concept]
   753   C0178587:densities [Quantitative Concept]

Phrase: "from deleted mtDNA"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   901   C0012929:DNA, Mitochondrial [Biologically Active Substance,Nucleic Acid, Nucleoside, or Nucleotide]
   901   C1819717:mitochondrial DNA [Cell Component]
   827   C0012854:DNA [Biologically Active Substance,Nucleic Acid, Nucleoside, or Nucleotide]
   827   C0026237:Mitochondrial [Cell Component]
   827   C0521451:Mitochondrial [Functional Concept]

Phrase: "from kidney"
Meta Candidates (Total=5; Excluded=1; Pruned=0; Remaining=4)
  1000   C0022646:Kidney [Body Part, Organ, or Organ Component]
  1000   C0227665:kidney [Body Part, Organ, or Organ Component]
  1000   C1278978:Kidney [Body Part, Organ, or Organ Component]
  1000   C1514845:KIDNEY [Tissue]
   907 E C0027697:Nephritides [Disease or Syndrome]

Phrase: "of control"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
  1000   C0243148:control [Qualitative Concept]
  1000   C1550141:Control [Substance]
  1000   C1882979:Control [Conceptual Entity]
  1000   C2587213:Control [Functional Concept]
  1000   C3274648:Control [Qualitative Concept]

Phrase: "and"

Phrase: "diabetic rats at 4"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   770   C0034693:rats [Mammal]
   770   C0034721:Rats [Mammal]
   770   C0241863:DIABETIC [Finding]

Phrase: "or"

Phrase: "8 weeks after the onset of diabetes."
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   748   C0439230:weeks [Temporal Concept]
   714 E C0332174:/week [Temporal Concept]
Processing 00000000.tx.134: Data are means  SE.  

Phrase: "Data"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1511726:Data [Idea or Concept]
  1000   C3245479:data [Medical Device]

Phrase: "are"

Phrase: "means  SE."
Processing 00000000.tx.135: Effect of intervention by insulin treatment. 

Phrase: "Effect of intervention"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   790   C1280500:Effect [Qualitative Concept]
   790   C2348382:Effect [Qualitative Concept]

Phrase: "by insulin treatment."
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
  1000   C0745343:insulin treatment [Therapeutic or Preventive Procedure]
   861   C0039798:treatment [Functional Concept]
   861   C0087111:Treatment [Therapeutic or Preventive Procedure]
   861   C1522326:Treatment [Functional Concept]
   861   C1533734:Treatment [Therapeutic or Preventive Procedure]
   861   C1705169:Treatment [Conceptual Entity]
   861   C3538994:TREATMENT [Research Activity]
Processing 00000000.tx.136: STZ induced diabetic rats were treated with insulin, starting 8 weeks after the onset of diabetes. 

Phrase: "STZ"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0038432:Streptozotocin [Antibiotic,Carbohydrate]

Phrase: "induced"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0205263:Induced [Functional Concept]

Phrase: "diabetic rats"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0034693:rats [Mammal]
   861   C0034721:Rats [Mammal]
   861   C0241863:DIABETIC [Finding]

Phrase: "were"

Phrase: "treated with insulin,"
Meta Candidates (Total=9; Excluded=3; Pruned=0; Remaining=6)
   882   C0332293:Treated with [Therapeutic or Preventive Procedure]
           treated
   790   C0021641:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   790   C1522326:Treated [Functional Concept]
   790   C1533581:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   790   C1579433:Insulin [Pharmacologic Substance]
   756 E C1292734:TREAT [Functional Concept]
   734 E C0020884:Iletin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   706 E C3537244:Insulins [Pharmacologic Substance]

Phrase: "starting"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C0439659:Start [Temporal Concept]

Phrase: "8 weeks after the onset of diabetes."
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   748   C0439230:weeks [Temporal Concept]
   714 E C0332174:/week [Temporal Concept]
Processing 00000000.tx.137: Glycemic control was achieved as follows: mean plasma glucose levels and fructosamine levels on the last day were 113.5  6.7 mg/dl and 169.0  1.2 mol/l in control rats, 474.5  33.9 mg/dl and 292.0  15.32 mol/l in nontreated diabetic rats, and 109.5  2.0 mg/dl and 160.3  2.5 mol/l in insulin-treated diabetic rats, respectively. 

Phrase: "Glycemic control"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   861   C0243148:control [Qualitative Concept]
   861   C1550141:Control [Substance]
   861   C1882979:Control [Conceptual Entity]
   861   C2587213:Control [Functional Concept]
   861   C3274648:Control [Qualitative Concept]
   789   C0005802:glycemia [Carbohydrate]

Phrase: "was"

Phrase: "achieved"

Phrase: "as"

Phrase: "follows"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0332283:follow [Temporal Concept]
  1000   C1719822:Follow [Intellectual Product]

Phrase: ":"

Phrase: "mean plasma glucose levels"
Meta Candidates (Total=12; Excluded=4; Pruned=0; Remaining=8)
   890   C0455280:plasma glucose level [Laboratory or Test Result]
           plasma glucose
   861   C0202042:Plasma glucose [Laboratory Procedure]
   861   C0428548:glucose levels [Laboratory or Test Result]
   827 E C0337438:glucose level [Laboratory Procedure]
   812   C0017725:Glucose [Biologically Active Substance,Carbohydrate,Pharmacologic Substance]
   812   C0032105:Plasma [Body Substance]
   812   C0441889:Levels [Qualitative Concept]
   812   C1550098:Plasma, NOS (not otherwise specified) [Body Substance]
   779 E C0456079:Level [Classification]
   779 E C1547707:Level [Geographic Area]
   779 E C2946261:Level [Pharmacologic Substance]

Phrase: "and"

Phrase: "fructosamine levels on the last day"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
   790   C0428529:fructosamine levels [Laboratory or Test Result]
   753   C0441889:Levels [Qualitative Concept]
   719 E C0456079:Level [Classification]
   719 E C1547707:Level [Geographic Area]
   719 E C2946261:Level [Pharmacologic Substance]

Phrase: "were"

Phrase: "113.5  6.7 mg/dl"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0439269:mg dl [Quantitative Concept]
   799   C3642216:/dL [Quantitative Concept]

Phrase: "and"

Phrase: "169.0  1.2 mol/l in control rats,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   764   C0347982:mol/L [Quantitative Concept]

Phrase: "474.5  33.9 mg/dl"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0439269:mg dl [Quantitative Concept]
   799   C3642216:/dL [Quantitative Concept]

Phrase: "and"

Phrase: "292.0  15.32 mol/l in nontreated diabetic rats,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C0347982:mol/L [Quantitative Concept]

Phrase: "and"

Phrase: "109.5  2.0 mg/dl"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0439269:mg dl [Quantitative Concept]
   799   C3642216:/dL [Quantitative Concept]

Phrase: "and"

Phrase: "160.3  2.5 mol/l"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0347982:mol/L [Quantitative Concept]

Phrase: "in insulin-treated diabetic rats,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   812   C0034693:rats [Mammal]
   812   C0034721:Rats [Mammal]
   812   C0241863:DIABETIC [Finding]

Phrase: "respectively."
Processing 00000000.tx.138: In nontreated diabetic rats, total amounts of urinary 8-OHdG were gradually increased, at least up to 10 weeks after the onset of diabetes, as shown in Fig. 

Phrase: "In nontreated diabetic rats,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   827   C0034693:rats [Mammal]
   827   C0034721:Rats [Mammal]
   827   C0241863:DIABETIC [Finding]

Phrase: "total amounts of urinary 8-OHdG"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   744   C1265611:amounts [Quantitative Concept]

Phrase: "were"

Phrase: "gradually"

Phrase: "increased"
Meta Candidates (Total=8; Excluded=6; Pruned=0; Remaining=2)
  1000   C0205217:Increased [Quantitative Concept]
  1000   C0442805:Increased [Functional Concept]
   928 E C1517378:Gain [Quantitative Concept]
   907 E C0439661:Acquired [Temporal Concept]
   907 E C0442808:Increasing [Functional Concept]
   907 E C1301820:Obtain [Functional Concept]
   907 E C1706701:Acquire [Activity]
   907 E C3245488:acquired [Intellectual Product]

Phrase: ","

Phrase: "at least"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   966   C0439092:less [Intellectual Product]
   966   C0547044:Less [Qualitative Concept]

Phrase: "up to 10 weeks"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   861   C0439230:weeks [Temporal Concept]
   827 E C0332174:/week [Temporal Concept]

Phrase: "after the onset"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0332162:Onset [Qualitative Concept]

Phrase: "of diabetes,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0011847:Diabetes [Disease or Syndrome]
  1000   C0011849:Diabetes [Disease or Syndrome]

Phrase: "as"

Phrase: "shown in Fig."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   790   C0349966:Fig [Food]
   790   C1337208:FIG [Food]
   756   C1547282:Show [Intellectual Product]
Processing 00000000.tx.139: 5. 

Phrase: "5."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0439084:>5 [Quantitative Concept]
  1000   C0728893:+5 [Quantitative Concept]
Processing 00000000.tx.140: Insulin treatment completely reversed the increased amounts of urinary 8-OHdG to control levels after 1 and 2 weeks. 

Phrase: "Insulin treatment completely"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   901   C0745343:insulin treatment [Therapeutic or Preventive Procedure]
   827   C0039798:treatment [Functional Concept]
   827   C0087111:Treatment [Therapeutic or Preventive Procedure]
   827   C1522326:Treatment [Functional Concept]
   827   C1533734:Treatment [Therapeutic or Preventive Procedure]
   827   C1705169:Treatment [Conceptual Entity]
   827   C3538994:TREATMENT [Research Activity]

Phrase: "reversed"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1555029:Reverse [Idea or Concept]

Phrase: "the increased amounts"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C1265611:amounts [Quantitative Concept]

Phrase: "of urinary 8-OHdG to control levels"
Meta Candidates (Total=12; Excluded=3; Pruned=0; Remaining=9)
   892   C0243173:urinary levels [Functional Concept]
   878   C0542565:Urinary control [Organism Function]
   878   C0876938:urinary control [Finding]
   793   C0243148:control [Qualitative Concept]
   793   C0441889:Levels [Qualitative Concept]
   793   C1550141:Control [Substance]
   793   C1882979:Control [Conceptual Entity]
   793   C2587213:Control [Functional Concept]
   793   C3274648:Control [Qualitative Concept]
   760 E C0456079:Level [Classification]
   760 E C1547707:Level [Geographic Area]
   760 E C2946261:Level [Pharmacologic Substance]

Phrase: "after 1"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C2827734:1+ [Quantitative Concept]
  1000   C2981698:1+ [Classification]

Phrase: "and"

Phrase: "2 weeks."
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
  1000   C1442457:2 Weeks [Temporal Concept]
   861   C0439230:weeks [Temporal Concept]
   827 E C0332174:/week [Temporal Concept]
Processing 00000000.tx.141: View larger version (21K): [in this window] [in a new window]  FIG. 

Phrase: "View"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0449911:View [Spatial Concept]

Phrase: "larger version"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0333052:Version [Functional Concept]
   861   C2607870:Version [Spatial Concept]

Phrase: "(21K"

Phrase: ")"

Phrase: ":"

Phrase: "["

Phrase: "in this window"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0557702:Window [Manufactured Object]
  1000   C1272706:Window [Temporal Concept]
  1000   C1704674:Window [Manufactured Object]

Phrase: "]"

Phrase: "["

Phrase: "in a new window"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0557702:Window [Manufactured Object]
   861   C1272706:Window [Temporal Concept]
   861   C1704674:Window [Manufactured Object]

Phrase: "]  FIG."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0349966:Fig [Food]
  1000   C1337208:FIG [Food]
Processing 00000000.tx.142: 5. 

Phrase: "5."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0439084:>5 [Quantitative Concept]
  1000   C0728893:+5 [Quantitative Concept]
Processing 00000000.tx.143: Effect of intervention by insulin treatment on the increase in urinary 8-OHdG excretion in diabetic rats. 

Phrase: "Effect of intervention"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   790   C1280500:Effect [Qualitative Concept]
   790   C2348382:Effect [Qualitative Concept]

Phrase: "by insulin treatment"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
  1000   C0745343:insulin treatment [Therapeutic or Preventive Procedure]
   861   C0039798:treatment [Functional Concept]
   861   C0087111:Treatment [Therapeutic or Preventive Procedure]
   861   C1522326:Treatment [Functional Concept]
   861   C1533734:Treatment [Therapeutic or Preventive Procedure]
   861   C1705169:Treatment [Conceptual Entity]
   861   C3538994:TREATMENT [Research Activity]

Phrase: "on the increase"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0442805:Increase [Functional Concept]

Phrase: "in urinary 8-OHdG excretion"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   799   C0221102:Excretion [Physiologic Function]
   799   C0504085:Excretion [Body Substance]
   799   C2699704:EXCRETION [Regulation or Law]
   734   C0050078:8-Hydroxy-2'-deoxyguanosine [Biologically Active Substance,Nucleic Acid, Nucleoside, or Nucleotide]

Phrase: "in diabetic rats."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0034693:rats [Mammal]
   861   C0034721:Rats [Mammal]
   861   C0241863:DIABETIC [Finding]
Processing 00000000.tx.144: Diabetic rats were treated by insulin starting at 8 weeks after the onset of diabetes. 

Phrase: "Diabetic rats"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0034693:rats [Mammal]
   861   C0034721:Rats [Mammal]
   861   C0241863:DIABETIC [Finding]

Phrase: "were"

Phrase: "treated by insulin starting"
Meta Candidates (Total=8; Excluded=2; Pruned=0; Remaining=6)
   770   C0021641:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   770   C0332293:treated [Therapeutic or Preventive Procedure]
   770   C1522326:Treated [Functional Concept]
   770   C1533581:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   770   C1579433:Insulin [Pharmacologic Substance]
   737   C0439659:Start [Temporal Concept]
   737 E C1292734:TREAT [Functional Concept]
   715 E C0020884:Iletin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]

Phrase: "at 8 weeks"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   861   C0439230:weeks [Temporal Concept]
   827 E C0332174:/week [Temporal Concept]

Phrase: "after the onset"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0332162:Onset [Qualitative Concept]

Phrase: "of diabetes."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0011847:Diabetes [Disease or Syndrome]
  1000   C0011849:Diabetes [Disease or Syndrome]
Processing 00000000.tx.145: The amounts of urinary 8-OHdG were measured by ELISA kit as described in RESEARCH DESIGN AND METHODS. 

Phrase: "The amounts of urinary 8-OHdG"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   744   C1265611:amounts [Quantitative Concept]

Phrase: "were"

Phrase: "measured by ELISA kit"
Meta Candidates (Total=18; Excluded=2; Pruned=0; Remaining=16)
   853   C0014441:Enzyme-Linked Immunosorbent Assay [Laboratory Procedure]
   774   C2717977:Enzyme Assay [Laboratory Procedure]
   748   C0005507:Assay [Laboratory Procedure]
   748   C0014442:Enzyme [Enzyme,Organic Chemical]
   748   C0021075:immunosorbent [Indicator, Reagent, or Diagnostic Aid]
   748   C0243073:assay [Qualitative Concept]
   748   C0444706:Measured [Qualitative Concept]
   748   C0812225:KIT [Medical Device]
   748   C1150635:KIT [Molecular Function]
   748   C1510438:Assay [Laboratory Procedure]
   748   C1705212:Kit [Medical Device]
   748   C1705213:KIT [Medical Device]
   748   C3273202:Kit [Manufactured Object]
   748   C3541902:MEASURED [Diagnostic Procedure]
   714 E C0079809:Measure [Quantitative Concept]
   714 E C0242485:Measure [Functional Concept]
   714   C1517892:Link [Intellectual Product]
   714   C1704666:Link [Intellectual Product]

Phrase: "as"

Phrase: "described in RESEARCH DESIGN"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   833   C0035171:Research Design [Research Activity]
   770   C0035168:research [Research Activity]
   770   C0242481:Research [Research Activity]
   770   C1552738:described [Idea or Concept]
   770   C1707689:Design [Activity]
   770   C2983265:DESIGN [Intellectual Product]

Phrase: "AND"

Phrase: "METHODS."
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
  1000   C0025663:Methods [Intellectual Product]
  1000   C0025664:methods [Intellectual Product]
  1000   C0449851:Methods [Functional Concept]
   966 E C0871511:METHOD [Intellectual Product]
Processing 00000000.tx.146: , control rats (n = 4); 

Phrase: ", control rats"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   861   C0034693:rats [Mammal]
   861   C0034721:Rats [Mammal]
   861   C0243148:control [Qualitative Concept]
   861   C1550141:Control [Substance]
   861   C1882979:Control [Conceptual Entity]
   861   C2587213:Control [Functional Concept]
   861   C3274648:Control [Qualitative Concept]

Phrase: "(n = 4"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0369718:N NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441922:N+ [Intellectual Product]
   861   C1553036:[n] [Quantitative Concept]

Phrase: ")"

Phrase: ";"
Processing 00000000.tx.147: , nontreated diabetic rats (n = 4); 

Phrase: ", nontreated diabetic rats"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   827   C0034693:rats [Mammal]
   827   C0034721:Rats [Mammal]
   827   C0241863:DIABETIC [Finding]

Phrase: "(n = 4"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0369718:N NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441922:N+ [Intellectual Product]
   861   C1553036:[n] [Quantitative Concept]

Phrase: ")"

Phrase: ";"
Processing 00000000.tx.148: , insulin-treated diabetic rats (n = 4). 

Phrase: ", insulin-treated diabetic rats"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   812   C0034693:rats [Mammal]
   812   C0034721:Rats [Mammal]
   812   C0241863:DIABETIC [Finding]

Phrase: "(n = 4"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0369718:N NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441922:N+ [Intellectual Product]
   861   C1553036:[n] [Quantitative Concept]

Phrase: ")."
Processing 00000000.tx.149: *P value versus control rats; 

Phrase: "*P value"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1709380:P-Value [Quantitative Concept]
   861   C1522609:Value [Quantitative Concept]

Phrase: "versus"

Phrase: "control rats"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   861   C0034693:rats [Mammal]
   861   C0034721:Rats [Mammal]
   861   C0243148:control [Qualitative Concept]
   861   C1550141:Control [Substance]
   861   C1882979:Control [Conceptual Entity]
   861   C2587213:Control [Functional Concept]
   861   C3274648:Control [Qualitative Concept]

Phrase: ";"
Processing 00000000.tx.150: P value versus nontreated diabetic rats. 

Phrase: "P value"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1709380:P-Value [Quantitative Concept]
   861   C1522609:Value [Quantitative Concept]

Phrase: "versus"

Phrase: "nontreated diabetic rats."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   827   C0034693:rats [Mammal]
   827   C0034721:Rats [Mammal]
   827   C0241863:DIABETIC [Finding]
Processing 00000000.tx.151: Data are means  SE.  

Phrase: "Data"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1511726:Data [Idea or Concept]
  1000   C3245479:data [Medical Device]

Phrase: "are"

Phrase: "means  SE."
Processing 00000000.tx.152: In parallel, the levels of 8-OHdG in the mtDNA from kidney were also completely normalized to control levels after 2 weeks of insulin treatment (Figs. 6A and B). 

Phrase: "In parallel,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   861   C0150312:In [Quantitative Concept]
   861   C0332285:In [Spatial Concept]
   861   C2348042:Parallel [Qualitative Concept]
   861   C2826345:PARALLEL [Research Activity]

Phrase: "the levels of 8-OHdG"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
   757   C0456948:Level 2 [Intellectual Product]
   748   C0441889:Levels [Qualitative Concept]
   714 E C0456079:Level [Classification]
   714 E C1547707:Level [Geographic Area]
   714 E C2946261:Level [Pharmacologic Substance]

Phrase: "in the mtDNA"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
  1000   C0012929:DNA, Mitochondrial [Biologically Active Substance,Nucleic Acid, Nucleoside, or Nucleotide]
  1000   C1819717:mitochondrial DNA [Cell Component]
   861   C0012854:DNA [Biologically Active Substance,Nucleic Acid, Nucleoside, or Nucleotide]
   861   C0026237:Mitochondrial [Cell Component]
   861   C0521451:Mitochondrial [Functional Concept]

Phrase: "from kidney"
Meta Candidates (Total=5; Excluded=1; Pruned=0; Remaining=4)
  1000   C0022646:Kidney [Body Part, Organ, or Organ Component]
  1000   C0227665:kidney [Body Part, Organ, or Organ Component]
  1000   C1278978:Kidney [Body Part, Organ, or Organ Component]
  1000   C1514845:KIDNEY [Tissue]
   907 E C0027697:Nephritides [Disease or Syndrome]

Phrase: "were"

Phrase: "also completely"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0205197:Completely [Qualitative Concept]

Phrase: "normalized"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1882115:Normalized [Research Activity]

Phrase: "to control levels after 2 weeks of insulin treatment"
Meta Candidates (Total=12; Excluded=3; Pruned=0; Remaining=9)
   762   C0202098:insulin levels [Laboratory Procedure]
   762   C0428405:insulin levels [Laboratory or Test Result]
   745   C0456948:Level 2 [Intellectual Product]
   742   C0243148:control [Qualitative Concept]
   742   C0441889:Levels [Qualitative Concept]
   742   C1550141:Control [Substance]
   742   C1882979:Control [Conceptual Entity]
   742   C2587213:Control [Functional Concept]
   742   C3274648:Control [Qualitative Concept]
   708 E C0456079:Level [Classification]
   708 E C1547707:Level [Geographic Area]
   708 E C2946261:Level [Pharmacologic Substance]

Phrase: "(Figs. 6A"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C1553638:6a [Medical Device]

Phrase: "and"

Phrase: "B"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2347469:/B [Quantitative Concept]

Phrase: ")."
Processing 00000000.tx.153: However, the increased frequency of deleted mtDNA in kidney of diabetic rats remained elevated to a similar degree as that in nontreated diabetic rats, even after 2 weeks of insulin treatment (Fig. 6C). 

Phrase: "However,"

Phrase: "the increased frequency of deleted mtDNA"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   748   C0376249:frequency [Quantitative Concept]
   748   C0439603:Frequency [Temporal Concept]
   748   C0871396:Frequency [Quantitative Concept]
   748   C1561548:Frequency [Qualitative Concept]
   748   C1705502:Frequency [Quantitative Concept]

Phrase: "in kidney"
Meta Candidates (Total=5; Excluded=1; Pruned=0; Remaining=4)
  1000   C0022646:Kidney [Body Part, Organ, or Organ Component]
  1000   C0227665:kidney [Body Part, Organ, or Organ Component]
  1000   C1278978:Kidney [Body Part, Organ, or Organ Component]
  1000   C1514845:KIDNEY [Tissue]
   907 E C0027697:Nephritides [Disease or Syndrome]

Phrase: "of diabetic rats"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0034693:rats [Mammal]
   861   C0034721:Rats [Mammal]
   861   C0241863:DIABETIC [Finding]

Phrase: "remained"

Phrase: "elevated to a similar degree"
Meta Candidates (Total=8; Excluded=0; Pruned=0; Remaining=8)
   760   C0205250:Elevated [Qualitative Concept]
   760   C0441889:Degree [Qualitative Concept]
   760   C0449286:Degree [Quantitative Concept]
   760   C0542560:Degree [Intellectual Product]
   760   C1561545:degree [Quantitative Concept]
   760   C2348088:Degree [Quantitative Concept]
   760   C2348205:Similar [Qualitative Concept]
   760   C3163633:Elevated [Qualitative Concept]

Phrase: "as that"

Phrase: "in nontreated diabetic rats,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   827   C0034693:rats [Mammal]
   827   C0034721:Rats [Mammal]
   827   C0241863:DIABETIC [Finding]

Phrase: "even after 2 weeks of insulin treatment"
Meta Candidates (Total=12; Excluded=1; Pruned=0; Remaining=11)
   778   C0745343:insulin treatment [Therapeutic or Preventive Procedure]
   748   C0021641:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   748   C0039798:treatment [Functional Concept]
   748   C0087111:Treatment [Therapeutic or Preventive Procedure]
   748   C0439230:weeks [Temporal Concept]
   748   C1522326:Treatment [Functional Concept]
   748   C1533581:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   748   C1533734:Treatment [Therapeutic or Preventive Procedure]
   748   C1579433:Insulin [Pharmacologic Substance]
   748   C1705169:Treatment [Conceptual Entity]
   748   C3538994:TREATMENT [Research Activity]
   714 E C0332174:/week [Temporal Concept]

Phrase: "(Fig. 6C"

Phrase: ")."
Processing 00000000.tx.154: Therefore, to exclude the effect of STZ on this deletion, insulin treatment was also performed between 4 and 8 weeks after the onset of diabetes. 

Phrase: "Therefore,"

Phrase: "to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "exclude"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0332196:Exclude [Functional Concept]
  1000   C2828389:Exclude [Activity]

Phrase: "the effect of STZ"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   770   C1280500:Effect [Qualitative Concept]
   770   C2348382:Effect [Qualitative Concept]

Phrase: "on this deletion,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C1442161:Deletion [Cell or Molecular Dysfunction]
  1000   C1511760:Deletion [Genetic Function]
  1000   C1880274:Deletion [Activity]

Phrase: "insulin treatment"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
  1000   C0745343:insulin treatment [Therapeutic or Preventive Procedure]
   861   C0039798:treatment [Functional Concept]
   861   C0087111:Treatment [Therapeutic or Preventive Procedure]
   861   C1522326:Treatment [Functional Concept]
   861   C1533734:Treatment [Therapeutic or Preventive Procedure]
   861   C1705169:Treatment [Conceptual Entity]
   861   C3538994:TREATMENT [Research Activity]

Phrase: "was"

Phrase: "also"

Phrase: "performed between 4"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   790   C0884358:Performed [Functional Concept]
   756 E C2947996:Perform [Pharmacologic Substance]

Phrase: "and"

Phrase: "8 weeks after the onset of diabetes."
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   748   C0439230:weeks [Temporal Concept]
   714 E C0332174:/week [Temporal Concept]
Processing 00000000.tx.155: The institution of glycemic control with insulin treatment achieved near euglycemia between 4 and 8 weeks after the onset of diabetes and completely prevented the increased frequency of deleted mtDNA as well as increased the 8-OHdG levels in kidney of diabetic rats to control levels. 

Phrase: "The institution of glycemic control"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   760   C0018704:Institution [Health Care Related Organization,Manufactured Object]
   760   C1272753:Institution [Idea or Concept]
   760   C2607850:Institution [Health Care Related Organization]

Phrase: "with insulin treatment"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
  1000   C0745343:insulin treatment [Therapeutic or Preventive Procedure]
   861   C0039798:treatment [Functional Concept]
   861   C0087111:Treatment [Therapeutic or Preventive Procedure]
   861   C1522326:Treatment [Functional Concept]
   861   C1533734:Treatment [Therapeutic or Preventive Procedure]
   861   C1705169:Treatment [Conceptual Entity]
   861   C3538994:TREATMENT [Research Activity]

Phrase: "achieved near euglycemia"

Phrase: "between 4"

Phrase: "and"

Phrase: "8 weeks after the onset of diabetes"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   748   C0439230:weeks [Temporal Concept]
   714 E C0332174:/week [Temporal Concept]

Phrase: "and"

Phrase: "completely"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0205197:Completely [Qualitative Concept]

Phrase: "prevented"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C0309872:PREVENT [Pharmacologic Substance]

Phrase: "the increased frequency of deleted mtDNA"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   748   C0376249:frequency [Quantitative Concept]
   748   C0439603:Frequency [Temporal Concept]
   748   C0871396:Frequency [Quantitative Concept]
   748   C1561548:Frequency [Qualitative Concept]
   748   C1705502:Frequency [Quantitative Concept]

Phrase: "as well as"

Phrase: "increased"
Meta Candidates (Total=8; Excluded=6; Pruned=0; Remaining=2)
  1000   C0205217:Increased [Quantitative Concept]
  1000   C0442805:Increased [Functional Concept]
   928 E C1517378:Gain [Quantitative Concept]
   907 E C0439661:Acquired [Temporal Concept]
   907 E C0442808:Increasing [Functional Concept]
   907 E C1301820:Obtain [Functional Concept]
   907 E C1706701:Acquire [Activity]
   907 E C3245488:acquired [Intellectual Product]

Phrase: "the 8-OHdG levels in kidney"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
   750   C0456948:Level 2 [Intellectual Product]
   744   C0441889:Levels [Qualitative Concept]
   711 E C0456079:Level [Classification]
   711 E C1547707:Level [Geographic Area]
   711 E C2946261:Level [Pharmacologic Substance]

Phrase: "of diabetic rats to control levels."
Meta Candidates (Total=9; Excluded=3; Pruned=0; Remaining=6)
   804   C0243148:control [Qualitative Concept]
   804   C0441889:Levels [Qualitative Concept]
   804   C1550141:Control [Substance]
   804   C1882979:Control [Conceptual Entity]
   804   C2587213:Control [Functional Concept]
   804   C3274648:Control [Qualitative Concept]
   771 E C0456079:Level [Classification]
   771 E C1547707:Level [Geographic Area]
   771 E C2946261:Level [Pharmacologic Substance]
Processing 00000000.tx.156: View larger version (29K): [in this window] [in a new window]  FIG. 

Phrase: "View"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0449911:View [Spatial Concept]

Phrase: "larger version"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0333052:Version [Functional Concept]
   861   C2607870:Version [Spatial Concept]

Phrase: "(29K"

Phrase: ")"

Phrase: ":"

Phrase: "["

Phrase: "in this window"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0557702:Window [Manufactured Object]
  1000   C1272706:Window [Temporal Concept]
  1000   C1704674:Window [Manufactured Object]

Phrase: "]"

Phrase: "["

Phrase: "in a new window"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0557702:Window [Manufactured Object]
   861   C1272706:Window [Temporal Concept]
   861   C1704674:Window [Manufactured Object]

Phrase: "]  FIG."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0349966:Fig [Food]
  1000   C1337208:FIG [Food]
Processing 00000000.tx.157: 6. 

Phrase: "6."
Processing 00000000.tx.158: Effect of intervention by insulin treatment on 8-OHdG levels and mtDNA deletion in diabetic kidney. 

Phrase: "Effect of intervention"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   790   C1280500:Effect [Qualitative Concept]
   790   C2348382:Effect [Qualitative Concept]

Phrase: "by insulin treatment"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
  1000   C0745343:insulin treatment [Therapeutic or Preventive Procedure]
   861   C0039798:treatment [Functional Concept]
   861   C0087111:Treatment [Therapeutic or Preventive Procedure]
   861   C1522326:Treatment [Functional Concept]
   861   C1533734:Treatment [Therapeutic or Preventive Procedure]
   861   C1705169:Treatment [Conceptual Entity]
   861   C3538994:TREATMENT [Research Activity]

Phrase: "on 8-OHdG levels"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
   804   C0441889:Levels [Qualitative Concept]
   771   C0050078:8-Hydroxy-2'-deoxyguanosine [Biologically Active Substance,Nucleic Acid, Nucleoside, or Nucleotide]
   771 E C0456079:Level [Classification]
   771 E C1547707:Level [Geographic Area]
   771 E C2946261:Level [Pharmacologic Substance]

Phrase: "and"

Phrase: "mtDNA deletion in diabetic kidney."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   833   C0948051:mitochondrial dna deletion [Cell or Molecular Dysfunction]
   753   C1442161:Deletion [Cell or Molecular Dysfunction]
   753   C1511760:Deletion [Genetic Function]
   753   C1880274:Deletion [Activity]
Processing 00000000.tx.159: Diabetic rats were treated by insulin starting at 8 weeks after the onset of diabetes. 

Phrase: "Diabetic rats"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0034693:rats [Mammal]
   861   C0034721:Rats [Mammal]
   861   C0241863:DIABETIC [Finding]

Phrase: "were"

Phrase: "treated by insulin starting"
Meta Candidates (Total=8; Excluded=2; Pruned=0; Remaining=6)
   770   C0021641:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   770   C0332293:treated [Therapeutic or Preventive Procedure]
   770   C1522326:Treated [Functional Concept]
   770   C1533581:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   770   C1579433:Insulin [Pharmacologic Substance]
   737   C0439659:Start [Temporal Concept]
   737 E C1292734:TREAT [Functional Concept]
   715 E C0020884:Iletin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]

Phrase: "at 8 weeks"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   861   C0439230:weeks [Temporal Concept]
   827 E C0332174:/week [Temporal Concept]

Phrase: "after the onset"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0332162:Onset [Qualitative Concept]

Phrase: "of diabetes."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0011847:Diabetes [Disease or Syndrome]
  1000   C0011849:Diabetes [Disease or Syndrome]
Processing 00000000.tx.160: The amounts of 8-OHdG levels in mtDNA from renal cortices (A) and papillae (B) were measured by ELISA kit, as described in RESEARCH DESIGN AND METHODS. 

Phrase: "The amounts of 8-OHdG levels"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   744   C1265611:amounts [Quantitative Concept]

Phrase: "in mtDNA"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
  1000   C0012929:DNA, Mitochondrial [Biologically Active Substance,Nucleic Acid, Nucleoside, or Nucleotide]
  1000   C1819717:mitochondrial DNA [Cell Component]
   861   C0012854:DNA [Biologically Active Substance,Nucleic Acid, Nucleoside, or Nucleotide]
   861   C0026237:Mitochondrial [Cell Component]
   861   C0521451:Mitochondrial [Functional Concept]

Phrase: "from renal cortices"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   966   C0022655:Renal cortex [Body Part, Organ, or Organ Component]
   861   C0022646:Renal [Body Part, Organ, or Organ Component]
   827   C0007776:Cortex [Body Part, Organ, or Organ Component]
   827   C1176472:Cortex [Body Part, Organ, or Organ Component]
   827   C2700441:Cortex [Plant]

Phrase: "(A)"

Phrase: "and"

Phrase: "papillae"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   966   C0226964:papilla [Body Part, Organ, or Organ Component]
   966   C0227296:Papilla [Body Part, Organ, or Organ Component]

Phrase: "(B)"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2347469:/B [Quantitative Concept]

Phrase: "were"

Phrase: "measured by ELISA kit,"
Meta Candidates (Total=18; Excluded=2; Pruned=0; Remaining=16)
   853   C0014441:Enzyme-Linked Immunosorbent Assay [Laboratory Procedure]
   774   C2717977:Enzyme Assay [Laboratory Procedure]
   748   C0005507:Assay [Laboratory Procedure]
   748   C0014442:Enzyme [Enzyme,Organic Chemical]
   748   C0021075:immunosorbent [Indicator, Reagent, or Diagnostic Aid]
   748   C0243073:assay [Qualitative Concept]
   748   C0444706:Measured [Qualitative Concept]
   748   C0812225:KIT [Medical Device]
   748   C1150635:KIT [Molecular Function]
   748   C1510438:Assay [Laboratory Procedure]
   748   C1705212:Kit [Medical Device]
   748   C1705213:KIT [Medical Device]
   748   C3273202:Kit [Manufactured Object]
   748   C3541902:MEASURED [Diagnostic Procedure]
   714 E C0079809:Measure [Quantitative Concept]
   714 E C0242485:Measure [Functional Concept]
   714   C1517892:Link [Intellectual Product]
   714   C1704666:Link [Intellectual Product]

Phrase: "as"

Phrase: "described in RESEARCH DESIGN"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   833   C0035171:Research Design [Research Activity]
   770   C0035168:research [Research Activity]
   770   C0242481:Research [Research Activity]
   770   C1552738:described [Idea or Concept]
   770   C1707689:Design [Activity]
   770   C2983265:DESIGN [Intellectual Product]

Phrase: "AND"

Phrase: "METHODS."
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
  1000   C0025663:Methods [Intellectual Product]
  1000   C0025664:methods [Intellectual Product]
  1000   C0449851:Methods [Functional Concept]
   966 E C0871511:METHOD [Intellectual Product]
Processing 00000000.tx.161: C: PCR products from mtDNA with a 4,834 deletion were electrophoresed on a 5% polyacrylamide gel containing bistragreen and analyzed by densitometry. 

Phrase: "C"

Phrase: ":"

Phrase: "PCR products from mtDNA"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   760   C1514468:Products [Entity]
   726 E C1704444:Product [Quantitative Concept]

Phrase: "with a 4,834 deletion"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   827   C1442161:Deletion [Cell or Molecular Dysfunction]
   827   C1511760:Deletion [Genetic Function]
   827   C1880274:Deletion [Activity]

Phrase: "were"

Phrase: "electrophoresed on a 5% polyacrylamide gel containing bistragreen"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   770   C0071500:Polyacrylamide Gel [Biomedical or Dental Material,Pharmacologic Substance]
   744   C0017243:Gel [Biomedical or Dental Material]
   744   C0071499:polyacrylamide [Biomedical or Dental Material,Organic Chemical]
   744   C0332256:Containing [Functional Concept]
   744   C1382104:Gel [Substance]
   744   C2700400:Containing [Activity]
   711   C0013855:electrophorese [Laboratory Procedure]

Phrase: "and"

Phrase: "analyzed by densitometry."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   790   C0011321:Densitometry [Laboratory Procedure]
   790   C0936012:Analyzed [Research Activity]
Processing 00000000.tx.162: The columns show the relative densities of PCR products from deleted mtDNA from kidney of control, nontreated diabetic rats (DM), and insulin-treated diabetic rats (insulin) at 8 weeks after the onset of diabetes. 

Phrase: "The columns"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   966   C1185738:Column [Body Part, Organ, or Organ Component]
   966   C1706132:Column [Idea or Concept]

Phrase: "show"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1547282:Show [Intellectual Product]

Phrase: "the relative densities of PCR products"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   790   C0037786:Relative Densities [Quantitative Concept]
   773 E C1576416:*Relative Density [Qualitative Concept]
   753   C0178587:densities [Quantitative Concept]

Phrase: "from deleted mtDNA"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   901   C0012929:DNA, Mitochondrial [Biologically Active Substance,Nucleic Acid, Nucleoside, or Nucleotide]
   901   C1819717:mitochondrial DNA [Cell Component]
   827   C0012854:DNA [Biologically Active Substance,Nucleic Acid, Nucleoside, or Nucleotide]
   827   C0026237:Mitochondrial [Cell Component]
   827   C0521451:Mitochondrial [Functional Concept]

Phrase: "from kidney"
Meta Candidates (Total=5; Excluded=1; Pruned=0; Remaining=4)
  1000   C0022646:Kidney [Body Part, Organ, or Organ Component]
  1000   C0227665:kidney [Body Part, Organ, or Organ Component]
  1000   C1278978:Kidney [Body Part, Organ, or Organ Component]
  1000   C1514845:KIDNEY [Tissue]
   907 E C0027697:Nephritides [Disease or Syndrome]

Phrase: "of control,"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
  1000   C0243148:control [Qualitative Concept]
  1000   C1550141:Control [Substance]
  1000   C1882979:Control [Conceptual Entity]
  1000   C2587213:Control [Functional Concept]
  1000   C3274648:Control [Qualitative Concept]

Phrase: "nontreated diabetic rats"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   827   C0034693:rats [Mammal]
   827   C0034721:Rats [Mammal]
   827   C0241863:DIABETIC [Finding]

Phrase: "(DM"

Phrase: ")"

Phrase: ","

Phrase: "and"

Phrase: "insulin-treated diabetic rats"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   812   C0034693:rats [Mammal]
   812   C0034721:Rats [Mammal]
   812   C0241863:DIABETIC [Finding]

Phrase: "(insulin"
Meta Candidates (Total=5; Excluded=2; Pruned=0; Remaining=3)
  1000   C0021641:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
  1000   C1533581:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
  1000   C1579433:Insulin [Pharmacologic Substance]
   944 E C0020884:Iletin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   916 E C3537244:Insulins [Pharmacologic Substance]

Phrase: ")"

Phrase: "at 8 weeks"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   861   C0439230:weeks [Temporal Concept]
   827 E C0332174:/week [Temporal Concept]

Phrase: "after the onset"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0332162:Onset [Qualitative Concept]

Phrase: "of diabetes."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0011847:Diabetes [Disease or Syndrome]
  1000   C0011849:Diabetes [Disease or Syndrome]
Processing 00000000.tx.163: Data are means  SE.  

Phrase: "Data"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1511726:Data [Idea or Concept]
  1000   C3245479:data [Medical Device]

Phrase: "are"

Phrase: "means  SE."
Processing 00000000.tx.164: Western blot analysis of COX. 

Phrase: "Western blot analysis of COX."
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   814   C0949466:Western blot analysis [Laboratory Procedure]
           Western Blot
   778   C0005863:Western Blot [Laboratory Procedure,Molecular Biology Research Technique]
   748   C0002778:Analysis [Laboratory Procedure]
   748   C0936012:Analysis [Research Activity]
   748   C1524024:analysis [Functional Concept]
   748   C1705493:Western [Spatial Concept]
Processing 00000000.tx.165: According to Western blot analysis, the amounts of mtDNA-encoded COX subunit I were significantly decreased (P < 0.01) in kidney from diabetic rats compared with those from control rats (Fig. 7). 

Phrase: "According to Western blot analysis,"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
  1000   C0949466:Western blot analysis [Laboratory Procedure]
           Western Blot
   901   C0005863:Western Blot [Laboratory Procedure,Molecular Biology Research Technique]
   827   C0002778:Analysis [Laboratory Procedure]
   827   C0936012:Analysis [Research Activity]
   827   C1524024:analysis [Functional Concept]
   827   C1705493:Western [Spatial Concept]

Phrase: "the amounts of mtDNA-encoded COX subunit I"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   738   C1265611:amounts [Quantitative Concept]

Phrase: "were"

Phrase: "significantly"

Phrase: "decreased"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
  1000   C0205216:Decreased [Quantitative Concept]
  1000   C0392756:Decreased [Qualitative Concept]
  1000   C0442797:decreased [Qualitative Concept]
   966 E C0547047:Decrease [Quantitative Concept]

Phrase: "(P < 0.01"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0369773:P NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   827   C2603361:P' [Clinical Attribute]

Phrase: ")"

Phrase: "in kidney"
Meta Candidates (Total=5; Excluded=1; Pruned=0; Remaining=4)
  1000   C0022646:Kidney [Body Part, Organ, or Organ Component]
  1000   C0227665:kidney [Body Part, Organ, or Organ Component]
  1000   C1278978:Kidney [Body Part, Organ, or Organ Component]
  1000   C1514845:KIDNEY [Tissue]
   907 E C0027697:Nephritides [Disease or Syndrome]

Phrase: "from diabetic rats"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0034693:rats [Mammal]
   861   C0034721:Rats [Mammal]
   861   C0241863:DIABETIC [Finding]

Phrase: "compared with those from control rats"
Meta Candidates (Total=8; Excluded=0; Pruned=0; Remaining=8)
   753   C0034693:rats [Mammal]
   753   C0034721:Rats [Mammal]
   753   C0243148:control [Qualitative Concept]
   753   C1550141:Control [Substance]
   753   C1707455:Compared [Activity]
   753   C1882979:Control [Conceptual Entity]
   753   C2587213:Control [Functional Concept]
   753   C3274648:Control [Qualitative Concept]

Phrase: "(Fig. 7"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0349966:Fig [Food]
   861   C1337208:FIG [Food]

Phrase: ")."
Processing 00000000.tx.166: In contrast, the amounts of nuclear DNA-encoded COX subunit IV did not differ between diabetic and control rats (Fig. 7). 

Phrase: "In contrast,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1979874:Contrast [Qualitative Concept]

Phrase: "the amounts of nuclear DNA-encoded COX subunit IV"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   738   C1265611:amounts [Quantitative Concept]

Phrase: "did"

Phrase: "not"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1518422:Not [Functional Concept]

Phrase: "differ between diabetic"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   790   C0241863:DIABETIC [Finding]

Phrase: "and"

Phrase: "control rats"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   861   C0034693:rats [Mammal]
   861   C0034721:Rats [Mammal]
   861   C0243148:control [Qualitative Concept]
   861   C1550141:Control [Substance]
   861   C1882979:Control [Conceptual Entity]
   861   C2587213:Control [Functional Concept]
   861   C3274648:Control [Qualitative Concept]

Phrase: "(Fig. 7"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0349966:Fig [Food]
   861   C1337208:FIG [Food]

Phrase: ")."
Processing 00000000.tx.167: In parallel with the changes of mtDNA deletion, increased amounts of COX subunit I in diabetic rats were completely normalized to control levels by preventive insulin treatment, and they remained elevated to a similar degree as those in nontreated diabetic rats after 2 weeks of interventive insulin treatment. 

Phrase: "In parallel with the changes of mtDNA deletion,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   742   C0150312:In [Quantitative Concept]
   742   C0332285:In [Spatial Concept]
   742   C2348042:Parallel [Qualitative Concept]
   742   C2826345:PARALLEL [Research Activity]

Phrase: "increased amounts of COX subunit I"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   744   C1265611:amounts [Quantitative Concept]

Phrase: "in diabetic rats"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0034693:rats [Mammal]
   861   C0034721:Rats [Mammal]
   861   C0241863:DIABETIC [Finding]

Phrase: "were"

Phrase: "completely"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0205197:Completely [Qualitative Concept]

Phrase: "normalized"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1882115:Normalized [Research Activity]

Phrase: "to control levels by preventive insulin treatment,"
Meta Candidates (Total=11; Excluded=3; Pruned=0; Remaining=8)
   774   C0202098:insulin levels [Laboratory Procedure]
   774   C0428405:insulin levels [Laboratory or Test Result]
   748   C0243148:control [Qualitative Concept]
   748   C0441889:Levels [Qualitative Concept]
   748   C1550141:Control [Substance]
   748   C1882979:Control [Conceptual Entity]
   748   C2587213:Control [Functional Concept]
   748   C3274648:Control [Qualitative Concept]
   714 E C0456079:Level [Classification]
   714 E C1547707:Level [Geographic Area]
   714 E C2946261:Level [Pharmacologic Substance]

Phrase: "and"

Phrase: "they"

Phrase: "remained"

Phrase: "elevated to a similar degree"
Meta Candidates (Total=8; Excluded=0; Pruned=0; Remaining=8)
   760   C0205250:Elevated [Qualitative Concept]
   760   C0441889:Degree [Qualitative Concept]
   760   C0449286:Degree [Quantitative Concept]
   760   C0542560:Degree [Intellectual Product]
   760   C1561545:degree [Quantitative Concept]
   760   C2348088:Degree [Quantitative Concept]
   760   C2348205:Similar [Qualitative Concept]
   760   C3163633:Elevated [Qualitative Concept]

Phrase: "as those in nontreated diabetic rats"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   812   C0034693:rats [Mammal]
   812   C0034721:Rats [Mammal]
   812   C0241863:DIABETIC [Finding]

Phrase: "after 2 weeks"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
  1000   C1442457:2 Weeks [Temporal Concept]
   861   C0439230:weeks [Temporal Concept]
   827 E C0332174:/week [Temporal Concept]

Phrase: "of interventive insulin treatment."
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   901   C0745343:insulin treatment [Therapeutic or Preventive Procedure]
   827   C0039798:treatment [Functional Concept]
   827   C0087111:Treatment [Therapeutic or Preventive Procedure]
   827   C1522326:Treatment [Functional Concept]
   827   C1533734:Treatment [Therapeutic or Preventive Procedure]
   827   C1705169:Treatment [Conceptual Entity]
   827   C3538994:TREATMENT [Research Activity]
Processing 00000000.tx.168: View larger version (26K): [in this window] [in a new window]  FIG. 

Phrase: "View"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0449911:View [Spatial Concept]

Phrase: "larger version"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0333052:Version [Functional Concept]
   861   C2607870:Version [Spatial Concept]

Phrase: "(26K"

Phrase: ")"

Phrase: ":"

Phrase: "["

Phrase: "in this window"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0557702:Window [Manufactured Object]
  1000   C1272706:Window [Temporal Concept]
  1000   C1704674:Window [Manufactured Object]

Phrase: "]"

Phrase: "["

Phrase: "in a new window"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0557702:Window [Manufactured Object]
   861   C1272706:Window [Temporal Concept]
   861   C1704674:Window [Manufactured Object]

Phrase: "]  FIG."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0349966:Fig [Food]
  1000   C1337208:FIG [Food]
Processing 00000000.tx.169: 7. 

Phrase: "7."
Processing 00000000.tx.170: Western blot analysis of COX I and COX IV in kidney from control and diabetic rats (DM). 

Phrase: "Western blot analysis of COX I"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   800   C0949466:Western blot analysis [Laboratory Procedure]
           Western Blot
   770   C0005863:Western Blot [Laboratory Procedure,Molecular Biology Research Technique]
   744   C0002778:Analysis [Laboratory Procedure]
   744   C0936012:Analysis [Research Activity]
   744   C1524024:analysis [Functional Concept]
   744   C1705493:Western [Spatial Concept]

Phrase: "and"

Phrase: "COX IV in kidney"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   783   C0444972:IV/C [Intellectual Product]

Phrase: "from control"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
  1000   C0243148:control [Qualitative Concept]
  1000   C1550141:Control [Substance]
  1000   C1882979:Control [Conceptual Entity]
  1000   C2587213:Control [Functional Concept]
  1000   C3274648:Control [Qualitative Concept]

Phrase: "and"

Phrase: "diabetic rats"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0034693:rats [Mammal]
   861   C0034721:Rats [Mammal]
   861   C0241863:DIABETIC [Finding]

Phrase: "(DM"

Phrase: ")."
Processing 00000000.tx.171: A: Western blots of representative experiment. 

Phrase: "A"

Phrase: ":"

Phrase: "Western blots of representative experiment."
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   806   C0949466:Western Blots [Laboratory Procedure]
   773 E C0005863:Western Blot [Laboratory Procedure,Molecular Biology Research Technique]
   760   C1705493:Western [Spatial Concept]
Processing 00000000.tx.172: B: densitometry analysis of Western blots. 

Phrase: "B"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2347469:/B [Quantitative Concept]

Phrase: ":"

Phrase: "densitometry analysis of Western blots."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   827   C0949466:Western blot analysis [Laboratory Procedure]
   760   C0002778:Analysis [Laboratory Procedure]
   760   C0936012:Analysis [Research Activity]
   760   C1524024:analysis [Functional Concept]
Processing 00000000.tx.173: Data are mean percentage of control  SE.   

Phrase: "Data"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1511726:Data [Idea or Concept]
  1000   C3245479:data [Medical Device]

Phrase: "are"

Phrase: "mean percentage of control  SE."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   760   C0439165:Percentage [Quantitative Concept]
   760   C1549488:Percentage [Idea or Concept]
   760   C1561533:Percentage [Idea or Concept]
Processing 00000000.tx.174: DISCUSSION TOP ABSTRACT INTRODUCTION RESEARCH DESIGN AND METHODS RESULTS DISCUSSION REFERENCES  Enhanced oxidative stress has been considered to contribute to the pathological processes of diabetic complications, including nephropathy. 

Phrase: "DISCUSSION TOP ABSTRACT INTRODUCTION RESEARCH DESIGN"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   827   C0035171:Research Design [Research Activity]
   799   C0035168:research [Research Activity]
   799   C0242481:Research [Research Activity]
   799   C1707689:Design [Activity]
   799   C2983265:DESIGN [Intellectual Product]

Phrase: "AND"

Phrase: "METHODS RESULTS DISCUSSION"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0557061:Discussion [Therapeutic or Preventive Procedure]
   827   C2584313:Discussion [Social Behavior]

Phrase: "REFERENCES"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1514811:Reference [Idea or Concept]
  1000   C1706462:Reference [Conceptual Entity]

Phrase: "Enhanced oxidative stress"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
   901   C0242606:Oxidative Stress [Cell or Molecular Dysfunction]
   827   C0038435:Stress [Finding]
   827   C0311404:Oxidative [Functional Concept]
   755 E C0231297:Stressful [Functional Concept]

Phrase: "has"

Phrase: "been"

Phrase: "considered"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0750591:considered [Idea or Concept]

Phrase: "to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "contribute to the pathological processes of diabetic complications,"
Meta Candidates (Total=12; Excluded=2; Pruned=0; Remaining=10)
   770   C0030660:Pathological Processes [Pathologic Function]
   770   C0342257:Diabetic Complications [Pathologic Function]
   744   C0009566:Complications [Pathologic Function]
   744   C0030664:Pathological [Biomedical Occupation or Discipline]
   744   C0241863:DIABETIC [Finding]
   744   C1171258:complications [Pathologic Function]
   744   C1521733:Pathological [Functional Concept]
   744   C1880177:Contribute [Activity]
   735 E C0677042:Pathology processes [Pathologic Function]
   711   C1184743:Process [Body Part, Organ, or Organ Component]
   711   C1522240:Process [Phenomenon or Process]
   711 E C2362589:Complication [Idea or Concept]

Phrase: "including"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
  1000   C0332257:Including [Functional Concept]
   966 E C1552866:include [Idea or Concept]
   966 E C2700399:Include [Activity]

Phrase: "nephropathy."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0022658:Nephropathy [Disease or Syndrome]
Processing 00000000.tx.175: However, the detailed biomolecular mechanism remains to be elucidated. 

Phrase: "However,"

Phrase: "the detailed biomolecular mechanism"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0441712:Mechanism [Functional Concept]
   827   C1706376:Mechanism [Manufactured Object]

Phrase: "remains"

Phrase: "to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "be"

Phrase: "elucidated."
Processing 00000000.tx.176: In general, oxidative stress can affect nucleic acids and generate various modified bases in DNA. 

Phrase: "In general, oxidative stress"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
   901   C0242606:Oxidative Stress [Cell or Molecular Dysfunction]
   827   C0038435:Stress [Finding]
   827   C0311404:Oxidative [Functional Concept]
   755 E C0231297:Stressful [Functional Concept]

Phrase: "can"

Phrase: "affect"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0001721:Affect [Mental Process]

Phrase: "nucleic acids"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
  1000   C0028606:Nucleic Acids [Biologically Active Substance,Nucleic Acid, Nucleoside, or Nucleotide]
   861   C0001128:Acids [Chemical]
   861   C0007610:Nucleic [Cell Component]
   827 E C0202406:Acid [Laboratory Procedure]

Phrase: "and"

Phrase: "generate"

Phrase: "various modified bases in DNA."
Meta Candidates (Total=6; Excluded=4; Pruned=0; Remaining=2)
   760   C0178499:bases [Chemical Viewed Functionally]
   760   C1626935:Bases [Quantitative Concept]
   726 E C0002055:base [Inorganic Chemical]
   726 E C1527178:Basis [Functional Concept]
   726 E C1874451:Basis [Pharmacologic Substance]
   726 E C1880279:Base [Biomedical or Dental Material]
Processing 00000000.tx.177: Among the latter, 8-OHdG is the most abundant and appears to play a crucial role in mutagenesis (30). 

Phrase: "Among the latter,"

Phrase: "8-OHdG"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0050078:8-Hydroxy-2'-deoxyguanosine [Biologically Active Substance,Nucleic Acid, Nucleoside, or Nucleotide]
   812   C0011503:Deoxyguanosine [Nucleic Acid, Nucleoside, or Nucleotide]

Phrase: "is"

Phrase: "the most abundant"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C2346714:Abundant [Qualitative Concept]

Phrase: "and"

Phrase: "appears"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0700364:APPEAR [Qualitative Concept]

Phrase: "to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "play"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0032214:Play [Daily or Recreational Activity]
  1000   C0600138:play [Finding]

Phrase: "a crucial role in mutagenesis"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   760   C0035820:Role [Social Behavior]
   760   C1705810:Role [Conceptual Entity]

Phrase: "(30"

Phrase: ")."
Processing 00000000.tx.178: Increased levels of 8-OHdG have been reported in urine (11,31), mononuclear cells (11,32), and skeletal muscles (12) of diabetic patients. 

Phrase: "Increased levels of 8-OHdG"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
   757   C0456948:Level 2 [Intellectual Product]
   748   C0441889:Levels [Qualitative Concept]
   714 E C0456079:Level [Classification]
   714 E C1547707:Level [Geographic Area]
   714 E C2946261:Level [Pharmacologic Substance]

Phrase: "have"

Phrase: "been"

Phrase: "reported in urine"
Meta Candidates (Total=7; Excluded=1; Pruned=0; Remaining=6)
   790   C0042036:Urine [Body Substance]
   790   C0042037:urine [Functional Concept]
   790   C0684224:Reported [Intellectual Product]
   790   C0700287:Reported [Health Care Activity]
   790   C2963137:Urine [Body Substance]
   790   C3496591:Reported [Clinical Attribute]
   756 E C3273238:Report [Intellectual Product]

Phrase: "(11,"

Phrase: "31"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0450355:31 [Intellectual Product]

Phrase: ")"

Phrase: ","

Phrase: "mononuclear cells"
Meta Candidates (Total=7; Excluded=3; Pruned=0; Remaining=4)
  1000   C0806987:Mononuclear cells [Cell]
   861   C0007634:Cells [Cell]
   861   C1513475:Mononuclear [Clinical Attribute]
   861   C3282337:Cells [Cell]
   827 E C1269647:Cell [Cell]
   827 E C1704653:Cell [Medical Device]
   827 E C1948049:Cell [Spatial Concept]

Phrase: "(11,"

Phrase: "32"

Phrase: ")"

Phrase: ","

Phrase: "and"

Phrase: "skeletal muscles"
Meta Candidates (Total=7; Excluded=2; Pruned=0; Remaining=5)
  1000   C0242692:Skeletal muscles, NOS [Tissue]
   966 E C1280260:Skeletal muscle [Body Part, Organ, or Organ Component]
   861   C0026845:Muscles [Tissue]
   861   C0037253:skeletal [Body System]
   861   C0521324:Skeletal [Spatial Concept]
   861   C1995013:Muscles [Body Part, Organ, or Organ Component]
   777 E C0442025:Muscular [Spatial Concept]

Phrase: "(12"

Phrase: ")"

Phrase: "of diabetic patients."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0030705:Patients [Patient or Disabled Group]
Processing 00000000.tx.179: Ha et al. 

Phrase: "Ha et al."
Processing 00000000.tx.180: (13) have also shown that the levels of 8-OHdG are increased in kidney tissues of STZ-induced diabetic rats. 

Phrase: "(13"

Phrase: ")"

Phrase: "have"

Phrase: "also"

Phrase: "shown"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1547282:Show [Intellectual Product]

Phrase: "that"

Phrase: "the levels of 8-OHdG"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
   757   C0456948:Level 2 [Intellectual Product]
   748   C0441889:Levels [Qualitative Concept]
   714 E C0456079:Level [Classification]
   714 E C1547707:Level [Geographic Area]
   714 E C2946261:Level [Pharmacologic Substance]

Phrase: "are"

Phrase: "increased in kidney tissues of STZ-induced diabetic rats."
Meta Candidates (Total=15; Excluded=1; Pruned=0; Remaining=14)
   745   C1882714:Rat Kidney [Body Part, Organ, or Organ Component]
   742   C0022646:Kidney [Body Part, Organ, or Organ Component]
   742   C0034693:rats [Mammal]
   742   C0034721:Rats [Mammal]
   742   C0038432:Streptozotocin [Antibiotic,Carbohydrate]
   742   C0040300:Tissues [Tissue]
   742   C0205217:Increased [Quantitative Concept]
   742   C0205263:Induced [Functional Concept]
   742   C0227665:kidney [Body Part, Organ, or Organ Component]
   742   C0241863:DIABETIC [Finding]
   742   C0442805:Increased [Functional Concept]
   742   C1278978:Kidney [Body Part, Organ, or Organ Component]
   742   C1514845:KIDNEY [Tissue]
           Renal Tissue
   708 E C1547928:Tissue [Intellectual Product]
Processing 00000000.tx.181: In the present study, we further revealed that levels of 8-OHdG were increased in mtDNA from both cortices and papillae of diabetic rats at 8 weeks after the onset of diabetes. 

Phrase: "In the present study,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   861   C0150312:Present [Quantitative Concept]
   861   C0449450:Present [Idea or Concept]
   861   C0557651:Study [Manufactured Object]
   861   C2603343:Study [Research Activity]

Phrase: "we further"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C1517331:Further [Spatial Concept]
   966 E C0205108:far [Spatial Concept]

Phrase: "revealed"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0443289:Revealed [Qualitative Concept]

Phrase: "that levels of 8-OHdG"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
   757   C0456948:Level 2 [Intellectual Product]
   748   C0441889:Levels [Qualitative Concept]
   714 E C0456079:Level [Classification]
   714 E C1547707:Level [Geographic Area]
   714 E C2946261:Level [Pharmacologic Substance]

Phrase: "were"

Phrase: "increased in mtDNA"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   833   C0012929:DNA, Mitochondrial [Biologically Active Substance,Nucleic Acid, Nucleoside, or Nucleotide]
   833   C1819717:mitochondrial DNA [Cell Component]
   770   C0012854:DNA [Biologically Active Substance,Nucleic Acid, Nucleoside, or Nucleotide]
   770   C0026237:Mitochondrial [Cell Component]
   770   C0205217:Increased [Quantitative Concept]
   770   C0442805:Increased [Functional Concept]
   770   C0521451:Mitochondrial [Functional Concept]

Phrase: "from both cortices"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   966   C0007776:Cortex [Body Part, Organ, or Organ Component]
   966   C1176472:Cortex [Body Part, Organ, or Organ Component]
   966   C2700441:Cortex [Plant]

Phrase: "and"

Phrase: "papillae of diabetic rats"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   737   C0226964:papilla [Body Part, Organ, or Organ Component]
   737   C0227296:Papilla [Body Part, Organ, or Organ Component]

Phrase: "at 8 weeks"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   861   C0439230:weeks [Temporal Concept]
   827 E C0332174:/week [Temporal Concept]

Phrase: "after the onset"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0332162:Onset [Qualitative Concept]

Phrase: "of diabetes."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0011847:Diabetes [Disease or Syndrome]
  1000   C0011849:Diabetes [Disease or Syndrome]
Processing 00000000.tx.182: In contrast, the levels of 8-OHdG in nuclear DNA were not significantly increased in either cortices or papillae of diabetic rats, consistent with the previous finding that mtDNA is more sensitive to oxidative stress compared with nuclear DNA. 

Phrase: "In contrast,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1979874:Contrast [Qualitative Concept]

Phrase: "the levels of 8-OHdG"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
   757   C0456948:Level 2 [Intellectual Product]
   748   C0441889:Levels [Qualitative Concept]
   714 E C0456079:Level [Classification]
   714 E C1547707:Level [Geographic Area]
   714 E C2946261:Level [Pharmacologic Substance]

Phrase: "in nuclear DNA"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C1179920:Nuclear DNA [Biologically Active Substance,Nucleic Acid, Nucleoside, or Nucleotide]
   861   C0012854:DNA [Biologically Active Substance,Nucleic Acid, Nucleoside, or Nucleotide]
   861   C0521447:Nuclear [Spatial Concept]

Phrase: "were"

Phrase: "not significantly"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C1518422:Not [Functional Concept]

Phrase: "increased in either cortices"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   770   C0205217:Increased [Quantitative Concept]
   770   C0442805:Increased [Functional Concept]
   737   C0007776:Cortex [Body Part, Organ, or Organ Component]
   737   C1176472:Cortex [Body Part, Organ, or Organ Component]
   737   C2700441:Cortex [Plant]

Phrase: "or"

Phrase: "papillae of diabetic rats,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   737   C0226964:papilla [Body Part, Organ, or Organ Component]
   737   C0227296:Papilla [Body Part, Organ, or Organ Component]

Phrase: "consistent with the previous finding"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   806   C0332290:Consistent with [Idea or Concept]
           Consistent
   762   C0332529:Consistency finding [Qualitative Concept]

Phrase: "that mtDNA"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
  1000   C0012929:DNA, Mitochondrial [Biologically Active Substance,Nucleic Acid, Nucleoside, or Nucleotide]
  1000   C1819717:mitochondrial DNA [Cell Component]
   861   C0012854:DNA [Biologically Active Substance,Nucleic Acid, Nucleoside, or Nucleotide]
   861   C0026237:Mitochondrial [Cell Component]
   861   C0521451:Mitochondrial [Functional Concept]

Phrase: "is"

Phrase: "more sensitive to oxidative stress"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   806   C0332324:Sensitive to [Functional Concept]
           Sensitive
   760   C1550474:sensitive [Idea or Concept]

Phrase: "compared with nuclear DNA."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   833   C1179920:Nuclear DNA [Biologically Active Substance,Nucleic Acid, Nucleoside, or Nucleotide]
   770   C0012854:DNA [Biologically Active Substance,Nucleic Acid, Nucleoside, or Nucleotide]
   770   C0521447:Nuclear [Spatial Concept]
   770   C1707455:Compared [Activity]
Processing 00000000.tx.183: Changes in cortical mtDNA as well as papillary mtDNA might reflect those occurring in tubular cells, given the relative mass of the tubular cells versus glomerular cells in renal cortices. 

Phrase: "Changes in cortical mtDNA"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   760   C0392747:changes [Functional Concept]
   760   C0443172:changes [Quantitative Concept]
   726 E C1705241:Change [Quantitative Concept]

Phrase: "as well as"

Phrase: "papillary mtDNA"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   901   C0012929:DNA, Mitochondrial [Biologically Active Substance,Nucleic Acid, Nucleoside, or Nucleotide]
   901   C1819717:mitochondrial DNA [Cell Component]
   827   C0012854:DNA [Biologically Active Substance,Nucleic Acid, Nucleoside, or Nucleotide]
   827   C0026237:Mitochondrial [Cell Component]
   827   C0521451:Mitochondrial [Functional Concept]

Phrase: "might"

Phrase: "reflect"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0558058:reflect [Mental Process]

Phrase: "those occurring in tubular cells,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   726   C1709305:Occur [Activity]
   726   C2745955:OCCUR [Temporal Concept]

Phrase: "given"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
  1000   C1442162:GIVEN [Conceptual Entity]
  1000   C1550718:given [Idea or Concept]
  1000   C3244317:given [Intellectual Product]
   966 E C1947971:Give [Functional Concept]

Phrase: "the relative mass of the tubular cells"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   748   C0577559:Mass [Finding]
   748   C1306372:*Mass [Quantitative Concept]
   748   C3152252:Mass [Quantitative Concept]

Phrase: "versus"

Phrase: "glomerular cells in renal cortices."
Meta Candidates (Total=10; Excluded=3; Pruned=0; Remaining=7)
   781   C0553257:Renal cell [Cell]
   764   C1166657:cell cortex [Cell Component]
   762   C0022663:Renal Glomerulus [Body Part, Organ, or Organ Component]
           Glomerular
   760   C0007634:Cells [Cell]
   760   C0268731:GLOMERULAR [Disease or Syndrome]
   760   C3282337:Cells [Cell]
   726 E C1269647:Cell [Cell]
   726 E C1704653:Cell [Medical Device]
   726 E C1948049:Cell [Spatial Concept]
Processing 00000000.tx.184: Changes in glomerular mtDNA remain to be elucidated. 

Phrase: "Changes in glomerular mtDNA"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   760   C0392747:changes [Functional Concept]
   760   C0443172:changes [Quantitative Concept]
   726 E C1705241:Change [Quantitative Concept]

Phrase: "remain"

Phrase: "to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "be"

Phrase: "elucidated."
Processing 00000000.tx.185: In parallel with the results of renal tissues, the amounts of urinary 8-OHdG excretion were markedly increased in diabetic rats, and those increases were reversed by insulin treatment. 

Phrase: "In parallel with the results of renal tissues,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   744   C0150312:In [Quantitative Concept]
   744   C0332285:In [Spatial Concept]
   744   C2348042:Parallel [Qualitative Concept]
   744   C2826345:PARALLEL [Research Activity]

Phrase: "the amounts of urinary 8-OHdG excretion"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   742   C1265611:amounts [Quantitative Concept]

Phrase: "were"

Phrase: "markedly"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0522501:Markedly [Qualitative Concept]

Phrase: "increased in diabetic rats,"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   770   C0034693:rats [Mammal]
   770   C0034721:Rats [Mammal]
   770   C0205217:Increased [Quantitative Concept]
   770   C0241863:DIABETIC [Finding]
   770   C0442805:Increased [Functional Concept]

Phrase: "and"

Phrase: "those increases"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0442805:increases [Functional Concept]

Phrase: "were"

Phrase: "reversed by insulin treatment."
Meta Candidates (Total=12; Excluded=1; Pruned=0; Remaining=11)
   833   C0745343:insulin treatment [Therapeutic or Preventive Procedure]
   770   C0021641:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   770   C0039798:treatment [Functional Concept]
   770   C0087111:Treatment [Therapeutic or Preventive Procedure]
   770   C1522326:Treatment [Functional Concept]
   770   C1533581:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   770   C1533734:Treatment [Therapeutic or Preventive Procedure]
   770   C1579433:Insulin [Pharmacologic Substance]
   770   C1705169:Treatment [Conceptual Entity]
   770   C3538994:TREATMENT [Research Activity]
   737   C1555029:Reverse [Idea or Concept]
   715 E C0020884:Iletin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
Processing 00000000.tx.186: Although urinary 8-OHdG (33) and serum 8-hydroxy-guanine levels (34) are supposed to be markers of the total systemic oxidative stress in vivo, the relative contribution of renal 8-OHdG to urinary 8-OHdG should be evaluated in future studies. 

Phrase: "Although"

Phrase: "urinary 8-OHdG"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   937   C0050078:8-Hydroxy-2'-deoxyguanosine [Biologically Active Substance,Nucleic Acid, Nucleoside, or Nucleotide]
   804   C0011503:Deoxyguanosine [Nucleic Acid, Nucleoside, or Nucleotide]

Phrase: "(33"

Phrase: ")"

Phrase: "and"

Phrase: "serum 8-hydroxy-guanine levels"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
   804   C0441889:Levels [Qualitative Concept]
   771 E C0456079:Level [Classification]
   771 E C1547707:Level [Geographic Area]
   771 E C2946261:Level [Pharmacologic Substance]

Phrase: "(34"

Phrase: ")"

Phrase: "are"

Phrase: "supposed"

Phrase: "to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "be"

Phrase: "markers of the total systemic oxidative stress"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   714   C0005516:Marker [Clinical Attribute]

Phrase: "in vivo,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1515655:In Vivo [Spatial Concept]
           vivo

Phrase: "the relative contribution of renal 8-OHdG"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   742   C1880177:Contribution [Activity]

Phrase: "to urinary 8-OHdG"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   937   C0050078:8-Hydroxy-2'-deoxyguanosine [Biologically Active Substance,Nucleic Acid, Nucleoside, or Nucleotide]
   804   C0011503:Deoxyguanosine [Nucleic Acid, Nucleoside, or Nucleotide]

Phrase: "should"

Phrase: "be"

Phrase: "evaluated in future studies."
Meta Candidates (Total=5; Excluded=2; Pruned=0; Remaining=3)
   770   C0016884:Future [Temporal Concept]
   770   C0220825:Evaluated [Functional Concept]
   770   C0947630:studies [Laboratory Procedure]
   737 E C0557651:Study [Manufactured Object]
   737 E C2603343:Study [Research Activity]
Processing 00000000.tx.187: As the possible consequence of increased formation of 8-OHdG, we showed the increase in mtDNA with a 4,834 deletion in kidney of diabetic rats. 

Phrase: "As the possible consequence"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0686907:Consequence [Functional Concept]

Phrase: "of increased formation"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0220781:formation [Biologic Function]
   861   C0439634:formation [Spatial Concept]
   861   C1522492:Formation [Functional Concept]

Phrase: "of 8-OHdG,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0050078:8-Hydroxy-2'-deoxyguanosine [Biologically Active Substance,Nucleic Acid, Nucleoside, or Nucleotide]
   812   C0011503:Deoxyguanosine [Nucleic Acid, Nucleoside, or Nucleotide]

Phrase: "we"

Phrase: "showed"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1547282:Show [Intellectual Product]

Phrase: "the increase in mtDNA"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C0442805:Increase [Functional Concept]

Phrase: "with a 4,834 deletion"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   827   C1442161:Deletion [Cell or Molecular Dysfunction]
   827   C1511760:Deletion [Genetic Function]
   827   C1880274:Deletion [Activity]

Phrase: "in kidney"
Meta Candidates (Total=5; Excluded=1; Pruned=0; Remaining=4)
  1000   C0022646:Kidney [Body Part, Organ, or Organ Component]
  1000   C0227665:kidney [Body Part, Organ, or Organ Component]
  1000   C1278978:Kidney [Body Part, Organ, or Organ Component]
  1000   C1514845:KIDNEY [Tissue]
   907 E C0027697:Nephritides [Disease or Syndrome]

Phrase: "of diabetic rats."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0034693:rats [Mammal]
   861   C0034721:Rats [Mammal]
   861   C0241863:DIABETIC [Finding]
Processing 00000000.tx.188: The kidneys of diabetic rats exhibited markedly higher levels of deleted mtDNA compared with those of control rats at 8 weeks after the onset of diabetes, but not at 4 weeks. 

Phrase: "The kidneys of diabetic rats"
Meta Candidates (Total=5; Excluded=2; Pruned=0; Remaining=3)
   764   C1882714:Rat Kidney [Body Part, Organ, or Organ Component]
   760   C0022646:Kidneys [Body Part, Organ, or Organ Component]
   760   C0227665:kidneys [Body Part, Organ, or Organ Component]
   726 E C1278978:Kidney [Body Part, Organ, or Organ Component]
   726 E C1514845:KIDNEY [Tissue]

Phrase: "exhibited"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C0015272:Exhibit [Intellectual Product]

Phrase: "markedly higher levels of deleted mtDNA"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
   748   C0441889:Levels [Qualitative Concept]
   714 E C0456079:Level [Classification]
   714 E C1547707:Level [Geographic Area]
   714 E C2946261:Level [Pharmacologic Substance]

Phrase: "compared with those of control rats"
Meta Candidates (Total=8; Excluded=0; Pruned=0; Remaining=8)
   753   C0034693:rats [Mammal]
   753   C0034721:Rats [Mammal]
   753   C0243148:control [Qualitative Concept]
   753   C1550141:Control [Substance]
   753   C1707455:Compared [Activity]
   753   C1882979:Control [Conceptual Entity]
   753   C2587213:Control [Functional Concept]
   753   C3274648:Control [Qualitative Concept]

Phrase: "at 8 weeks"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   861   C0439230:weeks [Temporal Concept]
   827 E C0332174:/week [Temporal Concept]

Phrase: "after the onset"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0332162:Onset [Qualitative Concept]

Phrase: "of diabetes,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0011847:Diabetes [Disease or Syndrome]
  1000   C0011849:Diabetes [Disease or Syndrome]

Phrase: "but"

Phrase: "not at 4 weeks."
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   770   C0439230:weeks [Temporal Concept]
   770   C1518422:Not [Functional Concept]
   737 E C0332174:/week [Temporal Concept]
Processing 00000000.tx.189: These results suggest that deleted mtDNA may be accumulated with duration of diabetes in kidney tissues of diabetic rats. 

Phrase: "These results"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   966   C1274040:Result [Functional Concept]
   966   C1546471:Result [Idea or Concept]
   966   C2825142:Result [Finding]

Phrase: "suggest"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1705535:Suggest [Idea or Concept]

Phrase: "that deleted mtDNA"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   901   C0012929:DNA, Mitochondrial [Biologically Active Substance,Nucleic Acid, Nucleoside, or Nucleotide]
   901   C1819717:mitochondrial DNA [Cell Component]
   827   C0012854:DNA [Biologically Active Substance,Nucleic Acid, Nucleoside, or Nucleotide]
   827   C0026237:Mitochondrial [Cell Component]
   827   C0521451:Mitochondrial [Functional Concept]

Phrase: "may"

Phrase: "be"

Phrase: "accumulated with duration of diabetes"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   760   C0011847:Diabetes [Disease or Syndrome]
   760   C0011849:Diabetes [Disease or Syndrome]
   760   C0449238:Duration [Temporal Concept]
   760   C2926735:Duration [Pharmacologic Substance]

Phrase: "in kidney tissues"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   955   C1514845:Renal Tissue [Tissue]
   861   C0040300:Tissues [Tissue]
   827 E C1547928:Tissue [Intellectual Product]

Phrase: "of diabetic rats."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0034693:rats [Mammal]
   861   C0034721:Rats [Mammal]
   861   C0241863:DIABETIC [Finding]
Processing 00000000.tx.190: This specific large-scale deletion of mtDNA has been reported to exist in organs of aged rats (2628). 

Phrase: "This specific large-scale deletion of mtDNA"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   793   C0948051:mitochondrial dna deletion [Cell or Molecular Dysfunction]
   744   C1442161:Deletion [Cell or Molecular Dysfunction]
   744   C1511760:Deletion [Genetic Function]
   744   C1880274:Deletion [Activity]

Phrase: "has"

Phrase: "been"

Phrase: "reported"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
  1000   C0684224:Reported [Intellectual Product]
  1000   C0700287:Reported [Health Care Activity]
  1000   C3496591:Reported [Clinical Attribute]
   966 E C3273238:Report [Intellectual Product]

Phrase: "to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "exist in organs of aged rats"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   753   C0001779:Aged [Organism Attribute]
   753   C0001792:Aged [Population Group]
   753   C0034693:rats [Mammal]
   753   C0034721:Rats [Mammal]
   753   C0178784:organs [Body Part, Organ, or Organ Component]
   753   C1999167:aged [Population Group]
   753   C2987476:Exist [Conceptual Entity]

Phrase: "(2628"

Phrase: ")."
Processing 00000000.tx.191: The age-associated large-scale deletions seen most often in humans are the 4,977- and 7,436-bp deletions, which are among the many mtDNA deletions first reported in the muscle of patients with Kearns-Sayer syndrome or chronic progressive external ophthalmoplegia syndrome (3537). 

Phrase: "The age-associated large-scale deletions"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
   804   C1880274:Deletions [Activity]
   771 E C1442161:Deletion [Cell or Molecular Dysfunction]
   771 E C1511760:Deletion [Genetic Function]

Phrase: "seen"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
  1000   C0205397:Seen [Qualitative Concept]
   966 E C0042789:see [Organism Function]
   966 E C1947903:See [Activity]

Phrase: "most often in humans"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   770   C0086418:Humans [Human]
   770   C0205393:Most [Quantitative Concept]
   770   C0332183:Often [Temporal Concept]

Phrase: "are"

Phrase: "the 4,977-"

Phrase: "and"

Phrase: "7,436-bp deletions,"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
   812   C1880274:Deletions [Activity]
   779 E C1442161:Deletion [Cell or Molecular Dysfunction]
   779 E C1511760:Deletion [Genetic Function]

Phrase: "which"

Phrase: "are among the"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   790   C1551058:Are [Quantitative Concept]

Phrase: "many mtDNA deletions first"
Meta Candidates (Total=5; Excluded=2; Pruned=0; Remaining=3)
   923   C0948051:Mitochondrial DNA deletions [Cell or Molecular Dysfunction]
   875   C3151954:Mitochondrial deletions [Finding]
   812   C1880274:Deletions [Activity]
   779 E C1442161:Deletion [Cell or Molecular Dysfunction]
   779 E C1511760:Deletion [Genetic Function]

Phrase: "reported in the muscle of patients"
Meta Candidates (Total=7; Excluded=1; Pruned=0; Remaining=6)
   767   C0747307:patients report [Intellectual Product]
   753   C0026845:Muscle [Tissue]
   753   C0030705:Patients [Patient or Disabled Group]
   753   C0684224:Reported [Intellectual Product]
   753   C0700287:Reported [Health Care Activity]
   753   C3496591:Reported [Clinical Attribute]
   719 E C3273238:Report [Intellectual Product]

Phrase: "with Kearns-Sayer syndrome"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0022541:kearns-sayer syndrome [Disease or Syndrome]
           Kearns Syndrome
   827   C0039082:Syndrome [Disease or Syndrome]

Phrase: "or"

Phrase: "chronic progressive external ophthalmoplegia syndrome"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   884   C0162292:Ophthalmoplegia syndrome, external [Disease or Syndrome]
   840   C0029089:Ophthalmoplegia syndrome [Sign or Symptom]
   804   C0039082:Syndrome [Disease or Syndrome]
   771   C0162674:Chronic progressive external ophthalmoplegia [Disease or Syndrome]
           Chronic progressive ophthalmoplegia
           Progressive External Ophthalmoplegia

Phrase: "(3537"

Phrase: ")."
Processing 00000000.tx.192: These deletions in rats and humans are flanked by two homologous repeats. 

Phrase: "These deletions in rats"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
   770   C1880274:Deletions [Activity]
   737 E C1442161:Deletion [Cell or Molecular Dysfunction]
   737 E C1511760:Deletion [Genetic Function]

Phrase: "and"

Phrase: "humans"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0086418:Humans [Human]

Phrase: "are"

Phrase: "flanked by two homologous repeats."
Meta Candidates (Total=6; Excluded=1; Pruned=0; Remaining=5)
   760   C0205341:repeats [Functional Concept]
   760   C0205448:Two [Quantitative Concept]
   760   C1334043:Homologous [Gene or Genome]
   760   C1705914:Repeats [Conceptual Entity]
   726   C0230171:Flank [Body Location or Region]
   726 E C1547730:Repeat [Temporal Concept]
Processing 00000000.tx.193: These homologous repeats are supposed to induce such specific large-scale deletions by slip-mispairing during DNA replication (38). 

Phrase: "These homologous repeats"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   861   C0205341:repeats [Functional Concept]
   861   C1705914:Repeats [Conceptual Entity]
   827 E C1547730:Repeat [Temporal Concept]

Phrase: "are"

Phrase: "supposed"

Phrase: "to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "induce"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0205263:Induce [Functional Concept]

Phrase: "such specific large-scale deletions by slip-mispairing"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
   744   C1880274:Deletions [Activity]
   711 E C1442161:Deletion [Cell or Molecular Dysfunction]
   711 E C1511760:Deletion [Genetic Function]

Phrase: "during DNA replication"
Meta Candidates (Total=7; Excluded=2; Pruned=0; Remaining=5)
  1000   C0598312:DNA Replication [Genetic Function]
           Replication
  1000   C2984261:DNA replication [Functional Concept]
   861   C0012854:DNA [Biologically Active Substance,Nucleic Acid, Nucleoside, or Nucleotide]
   861   C1883725:replication [Qualitative Concept]
   789 E C0205173:Replicate [Functional Concept]
   789 E C0205341:Replicate [Functional Concept]

Phrase: "(38"

Phrase: ")."
Processing 00000000.tx.194: Because these deletions span a region that encodes five kinds of tRNA, respiratory enzyme subunits in complex I, complex IV, and complex V, the functions of the respiratory enzymes containing deleted mtDNA-encoded proteins subunits may decline gradually in the tissue cells as the deleted mtDNA are accumulated. 

Phrase: "Because"

Phrase: "these deletions"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
  1000   C1880274:Deletions [Activity]
   966 E C1442161:Deletion [Cell or Molecular Dysfunction]
   966 E C1511760:Deletion [Genetic Function]

Phrase: "span"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1711300:Span [Conceptual Entity]
  1000   C2700613:Span [Quantitative Concept]

Phrase: "a region"
Meta Candidates (Total=4; Excluded=2; Pruned=0; Remaining=2)
  1000   C0017446:Region [Geographic Area]
  1000   C0205147:Region [Spatial Concept]
   928 E C0205276:Regional [Spatial Concept]
   928 E C1947913:Regional [Spatial Concept]

Phrase: "that"

Phrase: "encodes"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2700640:Encode [Activity]

Phrase: "five kinds of tRNA,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   737   C0332307:Kind [Qualitative Concept]

Phrase: "respiratory enzyme subunits in complex I,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   719   C1711351:Subunit [Quantitative Concept]

Phrase: "complex IV,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0010760:Complex IV [Amino Acid, Peptide, or Protein,Enzyme]

Phrase: "and"

Phrase: "complex V,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0069436:complex V [Amino Acid, Peptide, or Protein,Enzyme]

Phrase: "the functions of the respiratory enzymes"
Meta Candidates (Total=6; Excluded=3; Pruned=0; Remaining=3)
   767   C0035203:Respiratory function [Physiologic Function]
   767   C0035245:respiratory function [Organ or Tissue Function]
   753   C0542341:Functions [Functional Concept]
   719 E C0031843:function [Physiologic Function]
   719 E C0700205:FUNCTION [Classification]
   719 E C1705273:Function [Intellectual Product]

Phrase: "containing"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0332256:Containing [Functional Concept]
  1000   C2700400:Containing [Activity]

Phrase: "deleted mtDNA-encoded proteins subunits"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   810   C0599220:Protein Subunits [Amino Acid, Peptide, or Protein]
   766   C1711351:Subunit [Quantitative Concept]

Phrase: "may"

Phrase: "decline"

Phrase: "gradually in the tissue cells"
Meta Candidates (Total=7; Excluded=3; Pruned=0; Remaining=4)
   760   C0007634:Cells [Cell]
   760   C0040300:Tissue [Tissue]
   760   C1547928:Tissue [Intellectual Product]
   760   C3282337:Cells [Cell]
   726 E C1269647:Cell [Cell]
   726 E C1704653:Cell [Medical Device]
   726 E C1948049:Cell [Spatial Concept]

Phrase: "as the deleted mtDNA"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   901   C0012929:DNA, Mitochondrial [Biologically Active Substance,Nucleic Acid, Nucleoside, or Nucleotide]
   901   C1819717:mitochondrial DNA [Cell Component]
   827   C0012854:DNA [Biologically Active Substance,Nucleic Acid, Nucleoside, or Nucleotide]
   827   C0026237:Mitochondrial [Cell Component]
   827   C0521451:Mitochondrial [Functional Concept]

Phrase: "are"

Phrase: "accumulated."
Processing 00000000.tx.195: The present results show that the proportion of deleted mtDNA to the total mtDNA reached 0.1% at 8 weeks after the onset of diabetes, using a kinetic PCR analysis. 

Phrase: "The present results"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   827   C1274040:Result [Functional Concept]
   827   C1546471:Result [Idea or Concept]
   827   C2825142:Result [Finding]

Phrase: "show"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1547282:Show [Intellectual Product]

Phrase: "that"

Phrase: "the proportion of deleted mtDNA"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   753   C1709707:Proportion [Quantitative Concept]

Phrase: "to the total mtDNA"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   901   C0012929:DNA, Mitochondrial [Biologically Active Substance,Nucleic Acid, Nucleoside, or Nucleotide]
   901   C1819717:mitochondrial DNA [Cell Component]
   827   C0012854:DNA [Biologically Active Substance,Nucleic Acid, Nucleoside, or Nucleotide]
   827   C0026237:Mitochondrial [Cell Component]
   827   C0521451:Mitochondrial [Functional Concept]

Phrase: "reached"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C2584321:Reach [Organism Function]

Phrase: "0.1% at 8 weeks"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   760   C0439230:weeks [Temporal Concept]
   726 E C0332174:/week [Temporal Concept]

Phrase: "after the onset"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0332162:Onset [Qualitative Concept]

Phrase: "of diabetes,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0011847:Diabetes [Disease or Syndrome]
  1000   C0011849:Diabetes [Disease or Syndrome]

Phrase: "using"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1524063:Using [Functional Concept]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "a kinetic PCR analysis."
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   901   C0200931:PCR analysis [Laboratory Procedure]
   827   C0002778:Analysis [Laboratory Procedure]
   827   C0032520:PCR [Laboratory Procedure,Molecular Biology Research Technique]
   827   C0677874:pCR [Finding]
   827   C0936012:Analysis [Research Activity]
   827   C1524024:analysis [Functional Concept]
Processing 00000000.tx.196: This level of deletion observed in kidney tissues of diabetic rats may still be too low to affect overall organ function. 

Phrase: "This level of deletion"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   770   C0441889:Level [Qualitative Concept]
   770   C0456079:Level [Classification]
   770   C1547707:Level [Geographic Area]
   770   C2946261:Level [Pharmacologic Substance]

Phrase: "observed in kidney tissues of diabetic rats"
Meta Candidates (Total=12; Excluded=1; Pruned=0; Remaining=11)
   757   C1882714:Rat Kidney [Body Part, Organ, or Organ Component]
   748   C0022646:Kidney [Body Part, Organ, or Organ Component]
   748   C0034693:rats [Mammal]
   748   C0034721:Rats [Mammal]
   748   C0040300:Tissues [Tissue]
   748   C0227665:kidney [Body Part, Organ, or Organ Component]
   748   C0241863:DIABETIC [Finding]
   748   C1278978:Kidney [Body Part, Organ, or Organ Component]
   748   C1441672:Observed [Functional Concept]
   748   C1514845:KIDNEY [Tissue]
           Renal Tissue
   714 E C1547928:Tissue [Intellectual Product]

Phrase: "may"

Phrase: "still"

Phrase: "be"

Phrase: "too low to"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   827   C0205251:low [Qualitative Concept]
   827   C1299352:Low [Qualitative Concept]
   827   C1550472:low [Idea or Concept]

Phrase: "affect"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0001721:Affect [Mental Process]

Phrase: "overall organ function."
Meta Candidates (Total=7; Excluded=2; Pruned=0; Remaining=5)
   827   C0031843:function [Physiologic Function]
   827   C0178784:Organ [Body Part, Organ, or Organ Component]
   827   C0542341:Function [Functional Concept]
   827   C0700205:FUNCTION [Classification]
   827   C1705273:Function [Intellectual Product]
   755 E C0205245:Functional [Functional Concept]
   755 E C2700217:Functional [Conceptual Entity]
Processing 00000000.tx.197: However, it is likely that this common deletion in mtDNA may be accompanied by other multiple deletions, as previously shown in aging tissues (3941). 

Phrase: "However,"

Phrase: "it"

Phrase: "is"

Phrase: "likely"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0332148:Likely [Qualitative Concept]
  1000   C0750492:Likely [Idea or Concept]

Phrase: "that"

Phrase: "this common deletion in mtDNA"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   820   C0948051:mitochondrial dna deletion [Cell or Molecular Dysfunction]
   753   C1442161:Deletion [Cell or Molecular Dysfunction]
   753   C1511760:Deletion [Genetic Function]
   753   C1880274:Deletion [Activity]

Phrase: "may"

Phrase: "be"

Phrase: "accompanied by other multiple deletions,"
Meta Candidates (Total=4; Excluded=2; Pruned=0; Remaining=2)
   760   C0439064:Multiple [Quantitative Concept]
   760   C1880274:Deletions [Activity]
   726 E C1442161:Deletion [Cell or Molecular Dysfunction]
   726 E C1511760:Deletion [Genetic Function]

Phrase: "as"

Phrase: "previously"

Phrase: "shown in aging tissues"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
   770   C0001811:Ageing [Organism Function]
   770   C0040300:Tissues [Tissue]
   737   C1547282:Show [Intellectual Product]
   737 E C1547928:Tissue [Intellectual Product]

Phrase: "(3941"

Phrase: ")."
Processing 00000000.tx.198: According to Katsumata et al. 

Phrase: "According to Katsumata et al."
Processing 00000000.tx.199: (41), the total detection system for mtDNA deletions revealed that 235 types of deletions existed with various sizes in the heart of a 78-year-old human. 

Phrase: "(41"

Phrase: ")"

Phrase: ","

Phrase: "the total detection system for mtDNA deletions"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   744   C0449913:System [Functional Concept]
   744   C1553451:System [Manufactured Object]
   744   C1704459:System [Medical Device]

Phrase: "revealed"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0443289:Revealed [Qualitative Concept]

Phrase: "that 235 types of deletions"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   760   C0332307:Types [Qualitative Concept]
   726 E C1547052:*Type [Quantitative Concept]

Phrase: "existed with various sizes"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   770   C0440102:Various [Indicator, Reagent, or Diagnostic Aid]
   770   C0456389:SIZES [Spatial Concept]
   737   C2987476:Exist [Conceptual Entity]

Phrase: "in the heart"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0018787:Heart [Body Part, Organ, or Organ Component]
  1000   C1281570:Heart [Body Part, Organ, or Organ Component]

Phrase: "of a 78-year-old human."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   812   C0086418:Human [Human]
Processing 00000000.tx.200: The present study also suggested that multiple deletions might exist in kidney tissues of diabetic rats. 

Phrase: "The present study also"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   827   C0150312:Present [Quantitative Concept]
   827   C0449450:Present [Idea or Concept]
   827   C0557651:Study [Manufactured Object]
   827   C2603343:Study [Research Activity]

Phrase: "suggested"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1705535:Suggest [Idea or Concept]

Phrase: "that multiple deletions"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
   861   C1880274:Deletions [Activity]
   827 E C1442161:Deletion [Cell or Molecular Dysfunction]
   827 E C1511760:Deletion [Genetic Function]

Phrase: "might"

Phrase: "exist in kidney tissues of diabetic rats."
Meta Candidates (Total=12; Excluded=1; Pruned=0; Remaining=11)
   757   C1882714:Rat Kidney [Body Part, Organ, or Organ Component]
   748   C0022646:Kidney [Body Part, Organ, or Organ Component]
   748   C0034693:rats [Mammal]
   748   C0034721:Rats [Mammal]
   748   C0040300:Tissues [Tissue]
   748   C0227665:kidney [Body Part, Organ, or Organ Component]
   748   C0241863:DIABETIC [Finding]
   748   C1278978:Kidney [Body Part, Organ, or Organ Component]
   748   C1514845:KIDNEY [Tissue]
           Renal Tissue
   748   C2987476:Exist [Conceptual Entity]
   714 E C1547928:Tissue [Intellectual Product]
Processing 00000000.tx.201: Furthermore, the present study showed that the amounts of mtDNA-encoded COX subunit were significantly decreased in kidney tissues of diabetic rats as one of the possible consequences of mtDNA deletions. 

Phrase: "Furthermore,"

Phrase: "the present study"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   861   C0150312:Present [Quantitative Concept]
   861   C0449450:Present [Idea or Concept]
   861   C0557651:Study [Manufactured Object]
   861   C2603343:Study [Research Activity]

Phrase: "showed"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1547282:Show [Intellectual Product]

Phrase: "that"

Phrase: "the amounts of mtDNA-encoded COX subunit"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   739   C1265611:amounts [Quantitative Concept]

Phrase: "were"

Phrase: "significantly"

Phrase: "decreased in kidney tissues of diabetic rats"
Meta Candidates (Total=15; Excluded=2; Pruned=0; Remaining=13)
   757   C1882714:Rat Kidney [Body Part, Organ, or Organ Component]
   748   C0022646:Kidney [Body Part, Organ, or Organ Component]
   748   C0034693:rats [Mammal]
   748   C0034721:Rats [Mammal]
   748   C0040300:Tissues [Tissue]
   748   C0205216:Decreased [Quantitative Concept]
   748   C0227665:kidney [Body Part, Organ, or Organ Component]
   748   C0241863:DIABETIC [Finding]
   748   C0392756:Decreased [Qualitative Concept]
   748   C0442797:decreased [Qualitative Concept]
   748   C1278978:Kidney [Body Part, Organ, or Organ Component]
   748   C1514845:KIDNEY [Tissue]
           Renal Tissue
   714 E C0547047:Decrease [Quantitative Concept]
   714 E C1547928:Tissue [Intellectual Product]

Phrase: "as one"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0205447:One [Quantitative Concept]

Phrase: "of the possible consequences"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0686907:consequences [Functional Concept]

Phrase: "of mtDNA deletions."
Meta Candidates (Total=7; Excluded=2; Pruned=0; Remaining=5)
  1000   C0948051:Mitochondrial DNA deletions [Cell or Molecular Dysfunction]
   913   C3151954:Mitochondrial deletions [Finding]
   827   C1880274:Deletions [Activity]
   793 E C1442161:Deletion [Cell or Molecular Dysfunction]
   793 E C1511760:Deletion [Genetic Function]
   734   C0012929:DNA, Mitochondrial [Biologically Active Substance,Nucleic Acid, Nucleoside, or Nucleotide]
   734   C1819717:mitochondrial DNA [Cell Component]
Processing 00000000.tx.202: Thus, the defective respiratory chain induced by mtDNA mutations may generate more ROS and free radicals, which further enhance the oxidative damage to mtDNA as well as other biomolecules. 

Phrase: "Thus,"

Phrase: "the defective respiratory chain"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   901   C0162362:Respiratory Chain [Molecular Function]
   901   C1325653:respiratory chain [Cell Component]
   827   C0337112:Chain [Manufactured Object]
   827   C1524075:Chain [Idea or Concept]

Phrase: "induced by mtDNA mutations"
Meta Candidates (Total=10; Excluded=1; Pruned=0; Remaining=9)
   806   C0012929:DNA, Mitochondrial [Biologically Active Substance,Nucleic Acid, Nucleoside, or Nucleotide]
   806   C1819717:mitochondrial DNA [Cell Component]
   781   C1512710:Induced Mutation [Genetic Function]
   781   C2315666:Mitochondrial mutation [Genetic Function]
   760   C0012854:DNA [Biologically Active Substance,Nucleic Acid, Nucleoside, or Nucleotide]
   760   C0026237:Mitochondrial [Cell Component]
   760   C0026882:Mutations [Genetic Function]
   760   C0205263:Induced [Functional Concept]
   760   C0521451:Mitochondrial [Functional Concept]
   726 E C1705285:Mutation [Cell or Molecular Dysfunction]

Phrase: "may"

Phrase: "generate"

Phrase: "more ROS"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   923   C0162772:Reactive Oxygen Species [Biologically Active Substance,Element, Ion, or Isotope]
   812   C0030054:Oxygen [Element, Ion, or Isotope,Pharmacologic Substance]
   812   C0205332:Reactive [Qualitative Concept]
   812   C1705920:Species [Conceptual Entity]

Phrase: "and"

Phrase: "free radicals,"
Meta Candidates (Total=6; Excluded=1; Pruned=0; Remaining=5)
  1000   C0016693:Free Radicals [Biologically Active Substance,Chemical Viewed Structurally]
   861   C0302912:radicals [Chemical Viewed Structurally]
   861   C0332296:free [Functional Concept]
   861   C1880497:Free [Qualitative Concept]
   861   C1996904:Free [Qualitative Concept]
   827 E C0439807:Radical [Qualitative Concept]

Phrase: "which further"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C1517331:Further [Spatial Concept]
   966 E C0205108:far [Spatial Concept]

Phrase: "enhance"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2349975:Enhance [Activity]

Phrase: "the oxidative damage to mtDNA"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   783   C0012860:DNA Damage [Cell or Molecular Dysfunction]
   783   C1096176:Mitochondrial Damage [Pathologic Function]
   753   C0010957:Damage [Injury or Poisoning]
   753   C1883709:Damage [Functional Concept]

Phrase: "as well as"

Phrase: "other biomolecules."
Processing 00000000.tx.203: Finally, such a vicious cycle of oxidative damage may result in deterioration in ATP synthesis and lead to cellular dysfunction and apoptosis (42,43). 

Phrase: "Finally,"

Phrase: "such"

Phrase: "a vicious cycle of oxidative damage"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   753   C1511572:Cycle [Temporal Concept]

Phrase: "may"

Phrase: "result in deterioration"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   790   C0868945:Deterioration [Phenomenon or Process]
   790   C1274040:Result [Functional Concept]
   790   C1546471:Result [Idea or Concept]
   790   C2825142:Result [Finding]

Phrase: "in ATP synthesis"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C1157223:ATP synthesis [Molecular Function]
  1000   C1510700:ATP Synthesis [Functional Concept]
   861   C0220781:synthesis [Biologic Function]
   861   C1883254:Synthesis [Activity]

Phrase: "and"

Phrase: "lead to cellular dysfunction"
Meta Candidates (Total=11; Excluded=2; Pruned=0; Remaining=9)
   770   C0007634:Cellular [Cell]
   770   C0023175:???lead [Element, Ion, or Isotope,Hazardous or Poisonous Substance]
   770   C0031847:dysfunction [Functional Concept]
   770   C0178539:Cellular [Functional Concept]
   770   C0277785:Dysfunction, NOS [Qualitative Concept]
   770   C1442948:lead [Inorganic Chemical,Pharmacologic Substance]
   770   C1522538:Lead [Functional Concept]
   770   C2348269:Lead [Element, Ion, or Isotope]
   770   C3275067:LEAD [Therapeutic or Preventive Procedure]
   715 E C0231174:Malfunction [Functional Concept]
   715 E C1881681:MALFUNCTION [Phenomenon or Process]

Phrase: "and"

Phrase: "apoptosis"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0162638:Apoptosis [Cell Function]
   928 E C1516044:Apoptotic [Qualitative Concept]

Phrase: "(42,"

Phrase: "43"

Phrase: ")."
Processing 00000000.tx.204: Oxidative stress and subsequent mtDNA mutations may contribute to the development of diabetic nephropathy. 

Phrase: "Oxidative stress"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
  1000   C0242606:Oxidative Stress [Cell or Molecular Dysfunction]
   861   C0038435:Stress [Finding]
   861   C0311404:Oxidative [Functional Concept]
   789 E C0231297:Stressful [Functional Concept]

Phrase: "and"

Phrase: "subsequent mtDNA mutations"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   858   C2315666:Mitochondrial mutation [Genetic Function]
   812   C0026882:Mutations [Genetic Function]
   779 E C1705285:Mutation [Cell or Molecular Dysfunction]

Phrase: "may"

Phrase: "contribute to the development of diabetic nephropathy."
Meta Candidates (Total=8; Excluded=0; Pruned=0; Remaining=8)
   778   C0011881:Diabetic Nephropathy [Disease or Syndrome]
   778   C1442864:diabetic nephropathy [Gene or Genome]
   748   C0022658:Nephropathy [Disease or Syndrome]
   748   C0241863:DIABETIC [Finding]
   748   C0243107:development [Physiologic Function]
   748   C0678723:Development [Organism Function]
   748   C1527148:Development [Functional Concept]
   748   C1880177:Contribute [Activity]
Processing 00000000.tx.205: The correlation between cumulative effect of total multiple deletions and functional changes in kidney tissues of diabetes should be evaluated in future studies. 

Phrase: "The correlation between cumulative effect of total multiple deletions"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   742   C1707520:Correlation [Qualitative Concept]

Phrase: "and"

Phrase: "functional changes in kidney tissues of diabetes"
Meta Candidates (Total=6; Excluded=1; Pruned=0; Remaining=5)
   748   C0205245:Functional [Functional Concept]
   748   C0392747:changes [Functional Concept]
   748   C0443172:changes [Quantitative Concept]
   748   C0542341:Functional [Functional Concept]
   748   C2700217:Functional [Conceptual Entity]
   714 E C1705241:Change [Quantitative Concept]

Phrase: "should"

Phrase: "be"

Phrase: "evaluated in future studies."
Meta Candidates (Total=5; Excluded=2; Pruned=0; Remaining=3)
   770   C0016884:Future [Temporal Concept]
   770   C0220825:Evaluated [Functional Concept]
   770   C0947630:studies [Laboratory Procedure]
   737 E C0557651:Study [Manufactured Object]
   737 E C2603343:Study [Research Activity]
Processing 00000000.tx.206: In addition, we examined the effect of intervention by insulin treatment on the increases in 8-OHdG level and deleted mtDNA in kidney tissues of diabetes. 

Phrase: "In addition,"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C1883712:Addition [Functional Concept]
   928 E C1524062:Additional [Functional Concept]

Phrase: "we"

Phrase: "examined"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0332128:Examined [Finding]

Phrase: "the effect of intervention"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   770   C1280500:Effect [Qualitative Concept]
   770   C2348382:Effect [Qualitative Concept]

Phrase: "by insulin treatment"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
  1000   C0745343:insulin treatment [Therapeutic or Preventive Procedure]
   861   C0039798:treatment [Functional Concept]
   861   C0087111:Treatment [Therapeutic or Preventive Procedure]
   861   C1522326:Treatment [Functional Concept]
   861   C1533734:Treatment [Therapeutic or Preventive Procedure]
   861   C1705169:Treatment [Conceptual Entity]
   861   C3538994:TREATMENT [Research Activity]

Phrase: "on the increases"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0442805:increases [Functional Concept]

Phrase: "in 8-OHdG level"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   804   C0441889:Level [Qualitative Concept]
   804   C0456079:Level [Classification]
   804   C1547707:Level [Geographic Area]
   804   C2946261:Level [Pharmacologic Substance]
   771   C0050078:8-Hydroxy-2'-deoxyguanosine [Biologically Active Substance,Nucleic Acid, Nucleoside, or Nucleotide]

Phrase: "and"

Phrase: "deleted mtDNA in kidney tissues of diabetes."
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   770   C0012929:DNA, Mitochondrial [Biologically Active Substance,Nucleic Acid, Nucleoside, or Nucleotide]
   770   C1819717:mitochondrial DNA [Cell Component]
   744   C0012854:DNA [Biologically Active Substance,Nucleic Acid, Nucleoside, or Nucleotide]
   744   C0026237:Mitochondrial [Cell Component]
   744   C0521451:Mitochondrial [Functional Concept]
Processing 00000000.tx.207: It is of great interest that intervention by insulin treatment starting at 8 weeks after the onset of diabetes rapidly normalized both increases in urinary 8-OHdG excretion and 8-OHdG levels in kidney of diabetic rats. 

Phrase: "It"

Phrase: "is of great"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   790   C0549177:Great [Quantitative Concept]
   790   C1704243:Great [Quantitative Concept]

Phrase: "interest"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0543488:Interest [Mental Process]

Phrase: "that intervention by insulin treatment starting"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   753   C0886296:intervention [Health Care Activity]
   753   C1273869:Intervention [Health Care Activity]
   753   C1948041:Intervention [Therapeutic or Preventive Procedure]

Phrase: "at 8 weeks"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   861   C0439230:weeks [Temporal Concept]
   827 E C0332174:/week [Temporal Concept]

Phrase: "after the onset"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0332162:Onset [Qualitative Concept]

Phrase: "of diabetes rapidly"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0011847:Diabetes [Disease or Syndrome]
   861   C0011849:Diabetes [Disease or Syndrome]

Phrase: "normalized"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1882115:Normalized [Research Activity]

Phrase: "both"

Phrase: "increases in urinary 8-OHdG excretion"
Meta Candidates (Total=9; Excluded=0; Pruned=0; Remaining=9)
   833   C0050078:8-Hydroxy-2'-deoxyguanosine [Biologically Active Substance,Nucleic Acid, Nucleoside, or Nucleotide]
   744   C0011503:Deoxyguanosine [Nucleic Acid, Nucleoside, or Nucleotide]
   744   C0042027:Urinary [Body Part, Organ, or Organ Component]
   744   C0221102:Excretion [Physiologic Function]
   744   C0442805:Increase [Functional Concept]
   744   C0504085:Excretion [Body Substance]
   744   C0700307:Hydroxy [Inorganic Chemical]
   744   C1524119:urinary [Qualitative Concept]
   744   C2699704:EXCRETION [Regulation or Law]

Phrase: "and"

Phrase: "8-OHdG levels in kidney"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
   757   C0456948:Level 2 [Intellectual Product]
   748   C0441889:Levels [Qualitative Concept]
   714 E C0456079:Level [Classification]
   714 E C1547707:Level [Geographic Area]
   714 E C2946261:Level [Pharmacologic Substance]

Phrase: "of diabetic rats."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0034693:rats [Mammal]
   861   C0034721:Rats [Mammal]
   861   C0241863:DIABETIC [Finding]
Processing 00000000.tx.208: This result clearly confirmed that the increases in urinary 8-OHdG excretion and 8-OHdG levels in mtDNA were caused by the diabetic state and not by a direct toxic effect of STZ. 

Phrase: "This result clearly"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C1274040:Result [Functional Concept]
   861   C1546471:Result [Idea or Concept]
   861   C2825142:Result [Finding]

Phrase: "confirmed"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
  1000   C0521093:confirmed [Qualitative Concept]
  1000   C0750484:Confirmed [Idea or Concept]
   966 E C1456348:Confirm [Qualitative Concept]

Phrase: "that"

Phrase: "the increases in urinary 8-OHdG excretion"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   742   C0442805:increases [Functional Concept]

Phrase: "and"

Phrase: "8-OHdG levels in mtDNA"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
   750   C0456948:Level 2 [Intellectual Product]
   744   C0441889:Levels [Qualitative Concept]
   711 E C0456079:Level [Classification]
   711 E C1547707:Level [Geographic Area]
   711 E C2946261:Level [Pharmacologic Substance]

Phrase: "were"

Phrase: "caused by the diabetic state"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   760   C0241863:DIABETIC [Finding]
   760   C1301808:State [Geographic Area]
   760   C1442792:State [Functional Concept]
   760   C3148680:State [Geographic Area]
   726   C0015127:cause [Functional Concept]
   726   C1524003:Cause [Conceptual Entity]

Phrase: "and"

Phrase: "not by a direct toxic effect of STZ."
Meta Candidates (Total=9; Excluded=0; Pruned=0; Remaining=9)
   770   C0600688:Toxic effect [Injury or Poisoning]
           toxic
   744   C0038432:Streptozotocin [Antibiotic,Carbohydrate]
   744   C0439851:Direct [Qualitative Concept]
   744   C1280500:Effect [Qualitative Concept]
   744   C1407029:Toxic [Qualitative Concept]
   744   C1518422:Not [Functional Concept]
   744   C1947931:Direct [Qualitative Concept]
   744   C2348382:Effect [Qualitative Concept]
Processing 00000000.tx.209: Hyperglycemia, a key clinical manifestation of diabetes, is supposed to generate ROS through various mechanisms, such as increased formation of AGEs (2), enhanced polyol pathway (6,7), increased superoxide release from mitochondria (44), and activation of NAD(P)H oxidase (45). 

Phrase: "Hyperglycemia,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0020456:Hyperglycaemia [Disease or Syndrome]

Phrase: "a key clinical manifestation of diabetes,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   790   C1280464:Manifestation of [Qualitative Concept]
           manifestation
   753   C0205319:manifestation [Functional Concept]

Phrase: "is"

Phrase: "supposed"

Phrase: "to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "generate"

Phrase: "ROS through various mechanisms,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   833   C0162772:Reactive Oxygen Species [Biologically Active Substance,Element, Ion, or Isotope]
   753   C0030054:Oxygen [Element, Ion, or Isotope,Pharmacologic Substance]
   753   C0205332:Reactive [Qualitative Concept]
   753   C1705920:Species [Conceptual Entity]

Phrase: "such as increased formation"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0220781:formation [Biologic Function]
   861   C0439634:formation [Spatial Concept]
   861   C1522492:Formation [Functional Concept]

Phrase: "of AGEs"
Meta Candidates (Total=11; Excluded=5; Pruned=0; Remaining=6)
  1000   C0162574:Glycation End Products, Advanced [Biologically Active Substance,Organic Chemical]
   812   C0205179:Advanced [Qualitative Concept]
   812   C0444930:End [Spatial Concept]
   812   C0598528:glycation [Phenomenon or Process]
   812   C1514468:Products [Entity]
   812   C2746065:End [Temporal Concept]
   779 E C0725066:Advance [Medical Device]
   779 E C1704444:Product [Quantitative Concept]
   756 E C0205088:Terminal [Temporal Concept]
   756 E C1705314:Terminal [Manufactured Object]
   756 E C1705315:Terminal [Spatial Concept]

Phrase: "(2"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0740116:+2 [Quantitative Concept]
  1000   C2827735:2+ [Quantitative Concept]
  1000   C2981700:2+ [Classification]

Phrase: ")"

Phrase: ","

Phrase: "enhanced polyol pathway"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C1704259:Pathway [Molecular Function]
   827   C1705987:Pathway [Conceptual Entity]

Phrase: "(6,"

Phrase: "7"

Phrase: ")"

Phrase: ","

Phrase: "increased superoxide release from mitochondria"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   806   C1158882:superoxide release [Molecular Function]
   760   C0030685:Release [Health Care Activity]
   760   C0391871:Release [Functional Concept]
   760   C0439180:% release [Quantitative Concept]
   760   C0680255:release [Health Care Activity]
   760   C1283071:Release [Functional Concept]
   760   C1963578:Release [Therapeutic or Preventive Procedure]

Phrase: "(44"

Phrase: ")"

Phrase: ","

Phrase: "and"

Phrase: "activation of NAD(P)H oxidase"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   753   C1879547:Activation [Activity]
   716   C0068355:NAD(P)H oxidase [Amino Acid, Peptide, or Protein,Enzyme]

Phrase: "(45"

Phrase: ")."
Processing 00000000.tx.210: Such rapid reversibility at least suggests that the contribution of AGEs to enhanced oxidative stress may not be very strong, considering that it would take longer to reverse the AGE level. 

Phrase: "Such rapid reversibility at least"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C0449261:Reversibility [Temporal Concept]

Phrase: "suggests"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1705535:Suggest [Idea or Concept]

Phrase: "that"

Phrase: "the contribution of AGEs"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   748   C1880177:Contribution [Activity]

Phrase: "to enhanced oxidative stress"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
   901   C0242606:Oxidative Stress [Cell or Molecular Dysfunction]
   827   C0038435:Stress [Finding]
   827   C0311404:Oxidative [Functional Concept]
   755 E C0231297:Stressful [Functional Concept]

Phrase: "may"

Phrase: "not"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1518422:Not [Functional Concept]

Phrase: "be"

Phrase: "very strong,"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
   861   C0442821:Strong [Qualitative Concept]
   789 E C0237897:Strength [Quantitative Concept]
   789 E C0808080:Strength [Idea or Concept]
   789 E C1705922:Strength [Qualitative Concept]

Phrase: "considering"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0750591:considering [Idea or Concept]

Phrase: "that"

Phrase: "it"

Phrase: "would"

Phrase: "take"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1515187:Take [Health Care Activity]

Phrase: "longer to"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0205166:Long [Qualitative Concept]
   827   C1706317:Long [Qualitative Concept]

Phrase: "reverse"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1555029:Reverse [Idea or Concept]

Phrase: "the AGE level."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   861   C0441889:Level [Qualitative Concept]
   861   C0456079:Level [Classification]
   861   C1547707:Level [Geographic Area]
   861   C2946261:Level [Pharmacologic Substance]
Processing 00000000.tx.211: The present results also suggest that repair of oxidative mtDNA damage induced by diabetes is very active. 

Phrase: "The present results also"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   793   C1274040:Result [Functional Concept]
   793   C1546471:Result [Idea or Concept]
   793   C2825142:Result [Finding]

Phrase: "suggest"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1705535:Suggest [Idea or Concept]

Phrase: "that repair of oxidative mtDNA"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   820   C1624043:mitochondrial DNA repair [Genetic Function]
   783   C0012899:DNA Repair [Genetic Function]
   753   C0043240:Repair, NOS [Organism Function]
   753   C0374711:Repair [Therapeutic or Preventive Procedure]

Phrase: "damage induced by diabetes"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   770   C0010957:Damage [Injury or Poisoning]
   770   C0205263:Induced [Functional Concept]
   770   C1883709:Damage [Functional Concept]

Phrase: "is"

Phrase: "very active."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0205177:Active [Functional Concept]
Processing 00000000.tx.212: This finding is in agreement with recent reports (46,47) showing that the repair system of mtDNA damage may be more active than previously thought. 

Phrase: "This finding"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0037088:Finding [Sign or Symptom]
  1000   C0243095:Finding [Finding]
  1000   C2825141:Finding [Finding]

Phrase: "is in agreement"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   790   C0680240:Agreement [Social Behavior]

Phrase: "with recent reports"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   861   C0684224:Reports [Intellectual Product]
   861   C0700287:reports [Health Care Activity]
   827 E C3273238:Report [Intellectual Product]

Phrase: "(46,"

Phrase: "47"

Phrase: ")"

Phrase: "showing"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1547282:Show [Intellectual Product]

Phrase: "that"

Phrase: "the repair system of mtDNA damage"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   748   C0449913:System [Functional Concept]
   748   C1553451:System [Manufactured Object]
   748   C1704459:System [Medical Device]

Phrase: "may"

Phrase: "be"

Phrase: "more active than previously"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C0205177:Active [Functional Concept]

Phrase: "thought."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0039869:Thought [Mental Process]
Processing 00000000.tx.213: The levels of 8-OHdG may represent the dynamic steady-state levels determined by the balance of oxidative attack and repair in mtDNA rather than simple accumulation of 8-OHdG. 

Phrase: "The levels of 8-OHdG"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
   757   C0456948:Level 2 [Intellectual Product]
   748   C0441889:Levels [Qualitative Concept]
   714 E C0456079:Level [Classification]
   714 E C1547707:Level [Geographic Area]
   714 E C2946261:Level [Pharmacologic Substance]

Phrase: "may"

Phrase: "represent"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1882932:Represent [Activity]

Phrase: "the dynamic steady-state levels"
Meta Candidates (Total=10; Excluded=3; Pruned=0; Remaining=7)
   861   C0678587:steady state [Natural Phenomenon or Process]
   844   C0683927:state level [Spatial Concept]
   812   C0205361:Steady [Qualitative Concept]
   812   C0441889:Levels [Qualitative Concept]
   812   C1301808:State [Geographic Area]
   812   C1442792:State [Functional Concept]
   812   C3148680:State [Geographic Area]
   779 E C0456079:Level [Classification]
   779 E C1547707:Level [Geographic Area]
   779 E C2946261:Level [Pharmacologic Substance]

Phrase: "determined by the balance of oxidative attack"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   748   C0014653:Balance [Organism Function]
   748   C0205415:Balance [Functional Concept]
   748   C0277793:Attack, NOS [Temporal Concept]
   748   C0311404:Oxidative [Functional Concept]
   748   C0560184:Balance [Finding]
   748   C1261512:attack [Social Behavior]
   748   C1304680:Attack [Finding]

Phrase: "and"

Phrase: "repair in mtDNA"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   881   C1624043:mitochondrial DNA repair [Genetic Function]
   819   C0012899:DNA Repair [Genetic Function]
   770   C0043240:Repair, NOS [Organism Function]
   770   C0374711:Repair [Therapeutic or Preventive Procedure]

Phrase: "rather than"

Phrase: "simple accumulation of 8-OHdG."
Processing 00000000.tx.214: In contrast to 8-OHdG levels, an increased level of deleted mtDNA in diabetic kidney was not reversed by interventive insulin treatment. 

Phrase: "In contrast to 8-OHdG levels,"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
   804   C0441889:Levels [Qualitative Concept]
   771   C0050078:8-Hydroxy-2'-deoxyguanosine [Biologically Active Substance,Nucleic Acid, Nucleoside, or Nucleotide]
   771 E C0456079:Level [Classification]
   771 E C1547707:Level [Geographic Area]
   771 E C2946261:Level [Pharmacologic Substance]

Phrase: "an increased level of deleted mtDNA"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   748   C0441889:Level [Qualitative Concept]
   748   C0456079:Level [Classification]
   748   C1547707:Level [Geographic Area]
   748   C2946261:Level [Pharmacologic Substance]

Phrase: "in diabetic kidney"
Meta Candidates (Total=5; Excluded=1; Pruned=0; Remaining=4)
   861   C0022646:Kidney [Body Part, Organ, or Organ Component]
   861   C0227665:kidney [Body Part, Organ, or Organ Component]
   861   C1278978:Kidney [Body Part, Organ, or Organ Component]
   861   C1514845:KIDNEY [Tissue]
   768 E C0027697:Nephritides [Disease or Syndrome]

Phrase: "was"

Phrase: "not"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1518422:Not [Functional Concept]

Phrase: "reversed by interventive insulin treatment."
Meta Candidates (Total=12; Excluded=1; Pruned=0; Remaining=11)
   806   C0745343:insulin treatment [Therapeutic or Preventive Procedure]
   760   C0021641:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   760   C0039798:treatment [Functional Concept]
   760   C0087111:Treatment [Therapeutic or Preventive Procedure]
   760   C1522326:Treatment [Functional Concept]
   760   C1533581:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   760   C1533734:Treatment [Therapeutic or Preventive Procedure]
   760   C1579433:Insulin [Pharmacologic Substance]
   760   C1705169:Treatment [Conceptual Entity]
   760   C3538994:TREATMENT [Research Activity]
   726   C1555029:Reverse [Idea or Concept]
   704 E C0020884:Iletin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
Processing 00000000.tx.215: This result suggests that mtDNA mutations are not easily reversed by glycemic control after they have been established. 

Phrase: "This result"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C1274040:Result [Functional Concept]
  1000   C1546471:Result [Idea or Concept]
  1000   C2825142:Result [Finding]

Phrase: "suggests"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1705535:Suggest [Idea or Concept]

Phrase: "that mtDNA mutations"
Meta Candidates (Total=5; Excluded=1; Pruned=0; Remaining=4)
   896   C2315666:Mitochondrial mutation [Genetic Function]
   827   C0026882:Mutations [Genetic Function]
   793 E C1705285:Mutation [Cell or Molecular Dysfunction]
   734   C0012929:DNA, Mitochondrial [Biologically Active Substance,Nucleic Acid, Nucleoside, or Nucleotide]
   734   C1819717:mitochondrial DNA [Cell Component]

Phrase: "are"

Phrase: "not easily"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0332219:Easily [Qualitative Concept]
   861   C1518422:Not [Functional Concept]

Phrase: "reversed by glycemic control"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   770   C0243148:control [Qualitative Concept]
   770   C1550141:Control [Substance]
   770   C1882979:Control [Conceptual Entity]
   770   C2587213:Control [Functional Concept]
   770   C3274648:Control [Qualitative Concept]
   737   C1555029:Reverse [Idea or Concept]

Phrase: "after"

Phrase: "they"

Phrase: "have"

Phrase: "been"

Phrase: "established."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0443211:Established [Qualitative Concept]
  1000   C1272684:Established [Qualitative Concept]
Processing 00000000.tx.216: This might be related to the phenomenon known as "the point of no return" observed in the progression of diabetic nephropathy. 

Phrase: "This"

Phrase: "might"

Phrase: "be"

Phrase: "related to the phenomenon"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
   770   C0439849:Related [Qualitative Concept]
   770   C0445223:Related [Finding]
   770   C1882365:Phenomenon [Phenomenon or Process]
   737 E C0163712:Relate [Organic Chemical]

Phrase: "known"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0205309:Known [Qualitative Concept]

Phrase: "as """

Phrase: "the point of no return"""
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   760   C1552961:Point [Quantitative Concept]
   760   C2347617:point [Quantitative Concept]

Phrase: "observed in the progression of diabetic nephropathy."
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   778   C0011881:Diabetic Nephropathy [Disease or Syndrome]
   778   C1442864:diabetic nephropathy [Gene or Genome]
   748   C0022658:Nephropathy [Disease or Syndrome]
   748   C0241863:DIABETIC [Finding]
   748   C0242656:progression [Pathologic Function]
   748   C0449258:Progression [Functional Concept]
   748   C1441672:Observed [Functional Concept]
Processing 00000000.tx.217: Further study regarding the effect of insulin treatment for a longer period is needed to prove this hypothesis. 

Phrase: "Further"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C1517331:Further [Spatial Concept]
   966 E C0205108:far [Spatial Concept]

Phrase: "study"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0557651:Study [Manufactured Object]
  1000   C2603343:Study [Research Activity]

Phrase: "regarding"

Phrase: "the effect of insulin treatment"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   797   C1518681:Treatment Effect [Finding]
   760   C1280500:Effect [Qualitative Concept]
   760   C2348382:Effect [Qualitative Concept]

Phrase: "for a longer period"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
   861   C0439531:/period [Temporal Concept]
   861   C1948053:Period [Temporal Concept]
   789 E C0332182:Periodic [Temporal Concept]
   789 E C1706381:PERIODIC [Intellectual Product]
   761 E C0031084:Periodicities [Temporal Concept]

Phrase: "is"

Phrase: "needed"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0027552:Needed [Qualitative Concept]
  1000   C0686904:needed [Functional Concept]

Phrase: "to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "prove"

Phrase: "this hypothesis."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1512571:Hypothesis [Idea or Concept]
Processing 00000000.tx.218: In conclusion, our study demonstrated for the first time that the 4,834-bp deleted mtDNA was accumulated in parallel with an increased level of 8-OHdG in kidney of STZ-induced diabetic rats. 

Phrase: "In conclusion,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1707478:Conclusion [Idea or Concept]

Phrase: "our study"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0557651:Study [Manufactured Object]
  1000   C2603343:Study [Research Activity]

Phrase: "demonstrated for the first time"
Meta Candidates (Total=6; Excluded=2; Pruned=0; Remaining=4)
   760   C0040223:Time [Temporal Concept]
   760   C0205435:First [Quantitative Concept]
   760   C1279901:First [Qualitative Concept]
   760   C3541383:Time [Temporal Concept]
   704 E C0442043:Temporal [Spatial Concept]
   704 E C2362314:Temporal [Temporal Concept]

Phrase: "that"

Phrase: "the 4,834-bp"

Phrase: "deleted"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1880274:Deleted [Activity]

Phrase: "mtDNA"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
  1000   C0012929:DNA, Mitochondrial [Biologically Active Substance,Nucleic Acid, Nucleoside, or Nucleotide]
  1000   C1819717:mitochondrial DNA [Cell Component]
   861   C0012854:DNA [Biologically Active Substance,Nucleic Acid, Nucleoside, or Nucleotide]
   861   C0026237:Mitochondrial [Cell Component]
   861   C0521451:Mitochondrial [Functional Concept]

Phrase: "was"

Phrase: "accumulated"

Phrase: "in parallel with an increased level"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   753   C0150312:In [Quantitative Concept]
   753   C0332285:In [Spatial Concept]
   753   C2348042:Parallel [Qualitative Concept]
   753   C2826345:PARALLEL [Research Activity]

Phrase: "of 8-OHdG"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0050078:8-Hydroxy-2'-deoxyguanosine [Biologically Active Substance,Nucleic Acid, Nucleoside, or Nucleotide]
   812   C0011503:Deoxyguanosine [Nucleic Acid, Nucleoside, or Nucleotide]

Phrase: "in kidney"
Meta Candidates (Total=5; Excluded=1; Pruned=0; Remaining=4)
  1000   C0022646:Kidney [Body Part, Organ, or Organ Component]
  1000   C0227665:kidney [Body Part, Organ, or Organ Component]
  1000   C1278978:Kidney [Body Part, Organ, or Organ Component]
  1000   C1514845:KIDNEY [Tissue]
   907 E C0027697:Nephritides [Disease or Syndrome]

Phrase: "of STZ-induced diabetic rats."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   812   C0034693:rats [Mammal]
   812   C0034721:Rats [Mammal]
   812   C0241863:DIABETIC [Finding]
Processing 00000000.tx.219: This might be involved in the pathogenesis of diabetic nephropathy, and mtDNA might be a new therapeutic target for preventing the development of diabetic nephropathy.  

Phrase: "This"

Phrase: "might"

Phrase: "be"

Phrase: "involved in the pathogenesis of diabetic nephropathy,"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   778   C0011881:Diabetic Nephropathy [Disease or Syndrome]
   778   C1442864:diabetic nephropathy [Gene or Genome]
   748   C0022658:Nephropathy [Disease or Syndrome]
   748   C0241863:DIABETIC [Finding]
   748   C0543483:pathogenesis [Functional Concept]
   748   C0699748:Pathogenesis [Pathologic Function]
   748   C1314939:Involved [Functional Concept]

Phrase: "and"

Phrase: "mtDNA"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
  1000   C0012929:DNA, Mitochondrial [Biologically Active Substance,Nucleic Acid, Nucleoside, or Nucleotide]
  1000   C1819717:mitochondrial DNA [Cell Component]
   861   C0012854:DNA [Biologically Active Substance,Nucleic Acid, Nucleoside, or Nucleotide]
   861   C0026237:Mitochondrial [Cell Component]
   861   C0521451:Mitochondrial [Functional Concept]

Phrase: "might"

Phrase: "be"

Phrase: "a new therapeutic target for preventing"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   753   C1521840:Target [Functional Concept]
   753   C2986546:TARGET [Diagnostic Procedure]

Phrase: "the development of diabetic nephropathy."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   760   C0243107:development [Physiologic Function]
   760   C0678723:Development [Organism Function]
   760   C1527148:Development [Functional Concept]
Processing 00000000.tx.220: ACKNOWLEDGMENTS  This work was supported by a Grant-in-Aid for Scientific Research (no. 11671126) from the Ministry of Education, Science and Culture, Japan, and was supported in part by the Takeda Medical fund. 

Phrase: "ACKNOWLEDGMENTS"

Phrase: "This work"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0043227:Work [Occupational Activity]

Phrase: "was"

Phrase: "supported by a Grant-in-Aid"
Meta Candidates (Total=7; Excluded=1; Pruned=0; Remaining=6)
   753   C0018173:Grant [Quantitative Concept]
   753   C0018896:Aid [Social Behavior]
   753   C0449435:Aid [Manufactured Object]
   753   C1521721:Supported [Conceptual Entity]
   753   C1548284:Grant [Idea or Concept]
   753   C3540469:AID [Gene or Genome]
   719 E C0183683:Support [Medical Device]

Phrase: "for Scientific Research"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0683933:scientific research [Research Activity]
   861   C0035168:research [Research Activity]
   861   C0036397:Scientific [Occupation or Discipline]
   861   C0242481:Research [Research Activity]

Phrase: "("

Phrase: "no. 11671126"

Phrase: ")"

Phrase: "from the Ministry"

Phrase: "of Education,"
Meta Candidates (Total=5; Excluded=1; Pruned=0; Remaining=4)
  1000   C0013621:Education [Educational Activity]
  1000   C0013622:education [Classification]
  1000   C0013658:Education, NOS [Finding]
  1000   C0039401:Education [Educational Activity]
   928 E C1555905:Educational [Intellectual Product]

Phrase: "Science"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0036397:Science [Occupation or Discipline]

Phrase: "and"

Phrase: "Culture,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0010453:Culture [Idea or Concept]
  1000   C0220814:culture [Functional Concept]
  1000   C0430400:Culture [Laboratory Procedure]
  1000   C2242979:Culture [Laboratory Procedure]

Phrase: "Japan,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0022341:Japan [Geographic Area]

Phrase: "and"

Phrase: "was"

Phrase: "supported in part"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
   790   C0449719:Part [Spatial Concept]
   790   C1521721:Supported [Conceptual Entity]
   790   C1709471:Part [Quantitative Concept]
   756 E C0183683:Support [Medical Device]

Phrase: "by the Takeda Medical fund."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0016820:Fund [Quantitative Concept]
Processing 00000000.tx.221: This work was performed in part at Kyushu University Station for Collaborative Research.  

Phrase: "This work"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0043227:Work [Occupational Activity]

Phrase: "was"

Phrase: "performed in part"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
   790   C0449719:Part [Spatial Concept]
   790   C0884358:Performed [Functional Concept]
   790   C1709471:Part [Quantitative Concept]
   756 E C2947996:Perform [Pharmacologic Substance]

Phrase: "at Kyushu University Station"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   827   C1883167:Station [Manufactured Object]
   755 E C0439835:Stationary [Qualitative Concept]

Phrase: "for Collaborative Research."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0035168:research [Research Activity]
   861   C0242481:Research [Research Activity]
Processing 00000000.tx.222: FOOTNOTES  Address correspondence and reprint requests to Toyoshi Inoguchi, MD, Department of Medicine and Bioregulatory Science, Graduate School of Medical Sciences, Kyushu University, Fukuoka 812-8582, Japan. 

Phrase: "FOOTNOTES  Address correspondence"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0282413:Correspondence [Intellectual Product]

Phrase: "and"

Phrase: "reprint"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C3273171:Reprint [Intellectual Product]

Phrase: "requests to Toyoshi Inoguchi,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   770   C0686900:request [Functional Concept]
   770   C1272683:Request [Functional Concept]
   770   C1522634:Request [Intellectual Product]

Phrase: "MD,"

Phrase: "Department of Medicine"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   790   C1704729:Department [Organization]

Phrase: "and"

Phrase: "Bioregulatory Science,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0036397:Science [Occupation or Discipline]

Phrase: "Graduate School of Medical Sciences,"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   806   C0870614:graduate school [Manufactured Object,Organization]
   797   C0036378:School, Medical [Health Care Related Organization,Manufactured Object]
   760   C0036375:School [Manufactured Object,Organization]
   760   C0588053:Graduate [Population Group]
   760   C1547183:Graduate [Idea or Concept]

Phrase: "Kyushu University,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0041740:University [Manufactured Object,Organization]
   861   C0454747:Kyushu [Geographic Area]

Phrase: "Fukuoka 812-8582,"

Phrase: "Japan."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0022341:Japan [Geographic Area]
Processing 00000000.tx.223: E-mail: toyoshi{at}intmed3.med.kyushu-u.ac.jp . Received for publication 7 August 2001 and accepted in revised form 8 February 2002. 

Phrase: "E-mail"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
  1000   C0013849:E-Mail [Intellectual Product]
  1000   C1705961:E-mail [Intellectual Product]
   861   C0024492:Mail [Manufactured Object]
   861   C1538057:MAIL [Gene or Genome]
   861   C1547565:Mail [Idea or Concept]

Phrase: ":"

Phrase: "toyoshi{at}intmed3.med.kyushu-u.ac.jp ."

Phrase: "Received for publication 7 August 2001"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   753   C0034036:Publication [Intellectual Product,Manufactured Object]
   753   C0034037:Publication [Occupational Activity]
   753   C1514756:Received [Qualitative Concept]
   753   C1704324:Publication [Intellectual Product]

Phrase: "and"

Phrase: "accepted in revised form 8 February 2002."
Meta Candidates (Total=7; Excluded=1; Pruned=0; Remaining=6)
   748   C0348078:Form [Qualitative Concept]
   748   C0376315:Form [Manufactured Object]
   748   C1272684:Accepted [Qualitative Concept]
   748   C1522492:Form [Functional Concept]
   748   C1527075:Revised [Therapeutic or Preventive Procedure]
   748   C1548435:Accepted [Idea or Concept]
   714 E C1548601:Accept [Idea or Concept]
Processing 00000000.tx.224: 8-OHdG, 8-hydroxy-2'-deoxyguanosine; 

Phrase: "8-OHdG,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0050078:8-Hydroxy-2'-deoxyguanosine [Biologically Active Substance,Nucleic Acid, Nucleoside, or Nucleotide]
   812   C0011503:Deoxyguanosine [Nucleic Acid, Nucleoside, or Nucleotide]

Phrase: "8-hydroxy-2'-deoxyguanosine"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0050078:8-Hydroxy-2'-deoxyguanosine [Biologically Active Substance,Nucleic Acid, Nucleoside, or Nucleotide]
   812   C0011503:Deoxyguanosine [Nucleic Acid, Nucleoside, or Nucleotide]

Phrase: ";"
Processing 00000000.tx.225: AGE, advanced glycation end product; 

Phrase: "AGE,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0001779:Age [Organism Attribute]

Phrase: "advanced glycation end product"
Meta Candidates (Total=10; Excluded=4; Pruned=0; Remaining=6)
   812   C0205179:Advanced [Qualitative Concept]
   812   C0444930:End [Spatial Concept]
   812   C0598528:glycation [Phenomenon or Process]
   812   C1514468:product [Entity]
   812   C1704444:Product [Quantitative Concept]
   812   C2746065:End [Temporal Concept]
   779 E C0725066:Advance [Medical Device]
   756 E C0205088:Terminal [Temporal Concept]
   756 E C1705314:Terminal [Manufactured Object]
   756 E C1705315:Terminal [Spatial Concept]

Phrase: ";"
Processing 00000000.tx.226: COX, cytochrome C oxidase; 

Phrase: "COX,"
Meta Candidates (Total=10; Excluded=0; Pruned=0; Remaining=10)
  1000   C0010760:CYTOCHROME C OXIDASE [Amino Acid, Peptide, or Protein,Enzyme]
           Cytochrome Oxidase
   901   C0010749:Cytochrome c [Amino Acid, Peptide, or Protein,Enzyme]
   901   C0010754:Cytochrome c' [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   901   C0653778:cytochrome c'' [Amino Acid, Peptide, or Protein]
   901   C1153524:cytochrome c [Molecular Function]
   901   C1426584:CYTOCHROME C [Gene or Genome]
   827   C0010798:Cytochrome [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   827   C0242417:Oxidase [Amino Acid, Peptide, or Protein,Enzyme]
   827   C1325304:cytochrome [Molecular Function]

Phrase: "cytochrome C oxidase"
Meta Candidates (Total=10; Excluded=0; Pruned=0; Remaining=10)
  1000   C0010760:CYTOCHROME C OXIDASE [Amino Acid, Peptide, or Protein,Enzyme]
           Cytochrome Oxidase
   901   C0010749:Cytochrome c [Amino Acid, Peptide, or Protein,Enzyme]
   901   C0010754:Cytochrome c' [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   901   C0653778:cytochrome c'' [Amino Acid, Peptide, or Protein]
   901   C1153524:cytochrome c [Molecular Function]
   901   C1426584:CYTOCHROME C [Gene or Genome]
   827   C0010798:Cytochrome [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   827   C0242417:Oxidase [Amino Acid, Peptide, or Protein,Enzyme]
   827   C1325304:cytochrome [Molecular Function]

Phrase: ";"
Processing 00000000.tx.227: ELISA, enzyme-linked immunosorbent assay; 

Phrase: "ELISA,"
Meta Candidates (Total=10; Excluded=1; Pruned=0; Remaining=9)
  1000   C0014441:Enzyme-Linked Immunosorbent Assay [Laboratory Procedure]
   902   C2717977:Enzyme Assay [Laboratory Procedure]
   812   C0005507:Assay [Laboratory Procedure]
   812   C0014442:Enzyme [Enzyme,Organic Chemical]
   812   C0021075:immunosorbent [Indicator, Reagent, or Diagnostic Aid]
   812   C0243073:assay [Qualitative Concept]
   812   C1510438:Assay [Laboratory Procedure]
   779   C1517892:Link [Intellectual Product]
   779   C1704666:Link [Intellectual Product]
   729 E C0014445:enzymes [Functional Concept]

Phrase: "enzyme-linked immunosorbent assay"
Meta Candidates (Total=10; Excluded=1; Pruned=0; Remaining=9)
  1000   C0014441:Enzyme-Linked Immunosorbent Assay [Laboratory Procedure]
   902   C2717977:Enzyme Assay [Laboratory Procedure]
   812   C0005507:Assay [Laboratory Procedure]
   812   C0014442:Enzyme [Enzyme,Organic Chemical]
   812   C0021075:immunosorbent [Indicator, Reagent, or Diagnostic Aid]
   812   C0243073:assay [Qualitative Concept]
   812   C1510438:Assay [Laboratory Procedure]
   779   C1517892:Link [Intellectual Product]
   779   C1704666:Link [Intellectual Product]
   729 E C0014445:enzymes [Functional Concept]

Phrase: ";"
Processing 00000000.tx.228: mtDNA, mitochondrial DNA; 

Phrase: "mtDNA,"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
  1000   C0012929:DNA, Mitochondrial [Biologically Active Substance,Nucleic Acid, Nucleoside, or Nucleotide]
  1000   C1819717:mitochondrial DNA [Cell Component]
   861   C0012854:DNA [Biologically Active Substance,Nucleic Acid, Nucleoside, or Nucleotide]
   861   C0026237:Mitochondrial [Cell Component]
   861   C0521451:Mitochondrial [Functional Concept]

Phrase: "mitochondrial DNA"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
  1000   C0012929:DNA, Mitochondrial [Biologically Active Substance,Nucleic Acid, Nucleoside, or Nucleotide]
  1000   C1819717:mitochondrial DNA [Cell Component]
   861   C0012854:DNA [Biologically Active Substance,Nucleic Acid, Nucleoside, or Nucleotide]
   861   C0026237:Mitochondrial [Cell Component]
   861   C0521451:Mitochondrial [Functional Concept]

Phrase: ";"
Processing 00000000.tx.229: ROS, reactive oxygen species; 

Phrase: "ROS,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0162772:Reactive Oxygen Species [Biologically Active Substance,Element, Ion, or Isotope]
   827   C0030054:Oxygen [Element, Ion, or Isotope,Pharmacologic Substance]
   827   C0205332:Reactive [Qualitative Concept]
   827   C1705920:Species [Conceptual Entity]

Phrase: "reactive oxygen species"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0162772:Reactive Oxygen Species [Biologically Active Substance,Element, Ion, or Isotope]
   827   C0030054:Oxygen [Element, Ion, or Isotope,Pharmacologic Substance]
   827   C0205332:Reactive [Qualitative Concept]
   827   C1705920:Species [Conceptual Entity]

Phrase: ";"
Processing 00000000.tx.230: STZ, streptozotocin.  

Phrase: "STZ,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0038432:Streptozotocin [Antibiotic,Carbohydrate]

Phrase: "streptozotocin."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0038432:Streptozotocin [Antibiotic,Carbohydrate]
Processing 00000000.tx.231: REFERENCES TOP ABSTRACT INTRODUCTION RESEARCH DESIGN AND METHODS RESULTS DISCUSSION REFERENCES  Hostetter TH, Rennke HG, Brenner BM: The case for intrarenal hypertension in the initiation and progression of diabetic and glomerulonephritis. 

Phrase: "REFERENCES"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1514811:Reference [Idea or Concept]
  1000   C1706462:Reference [Conceptual Entity]

Phrase: "TOP ABSTRACT INTRODUCTION RESEARCH DESIGN"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   840   C0035171:Research Design [Research Activity]
   804   C0035168:research [Research Activity]
   804   C0242481:Research [Research Activity]
   804   C1707689:Design [Activity]
   804   C2983265:DESIGN [Intellectual Product]

Phrase: "AND"

Phrase: "METHODS RESULTS DISCUSSION"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0557061:Discussion [Therapeutic or Preventive Procedure]
   827   C2584313:Discussion [Social Behavior]

Phrase: "REFERENCES"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1514811:Reference [Idea or Concept]
  1000   C1706462:Reference [Conceptual Entity]

Phrase: "Hostetter TH,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0039725:TH [Geographic Area]
   861   C0039738:Th [Element, Ion, or Isotope]
   861   C1420718:TH [Gene or Genome]

Phrase: "Rennke HG,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   861   C0025424:Hg [Element, Ion, or Isotope,Hazardous or Poisonous Substance]
   861   C2347108:Hg+ [Element, Ion, or Isotope]
   861   C2347109:Hg++ [Element, Ion, or Isotope]
   861   C2348272:Hg [Element, Ion, or Isotope]

Phrase: "Brenner BM"

Phrase: ":"

Phrase: "The case for intrarenal hypertension"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   760   C0868928:Case [Functional Concept]
   760   C1706255:CASE [Medical Device]
   760   C1706256:Case [Conceptual Entity]

Phrase: "in the initiation"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0589507:Initiation [Mental Process]
  1000   C1158830:Initiation [Genetic Function]
  1000   C1704686:Initiation [Functional Concept]

Phrase: "and"

Phrase: "progression of diabetic"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   790   C0242656:progression [Pathologic Function]
   790   C0449258:Progression [Functional Concept]

Phrase: "and"

Phrase: "glomerulonephritis."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0017658:Glomerulonephritis [Disease or Syndrome]
Processing 00000000.tx.232: Am J Med72 :375 380,1982[Medline] Brownlee M, Cerami A, Vlassara H: Advanced glycosylation end products in tissue and the biochemical basis of diabetic complication. 

Phrase: "Am"

Phrase: "J Med72"

Phrase: ":"

Phrase: "375 380,"

Phrase: "1982"

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "] Brownlee M,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441923:M+ [Intellectual Product]

Phrase: "Cerami A,"

Phrase: "Vlassara H"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   861   C0033727:H+ [Element, Ion, or Isotope]
   861   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441932:H+ [Classification]
   861   C0564385:/h [Quantitative Concept]

Phrase: ":"

Phrase: "Advanced glycosylation end products in tissue"
Meta Candidates (Total=10; Excluded=2; Pruned=0; Remaining=8)
   882   C0162574:Glycosylation End Products, Advanced [Biologically Active Substance,Organic Chemical]
   756   C3158557:terminal glycosylation [Molecular Function]
   753   C0017982:glycosylation [Natural Phenomenon or Process]
   753   C0205179:Advanced [Qualitative Concept]
   753   C0376322:Glycosylation [Molecular Function]
   753   C0444930:End [Spatial Concept]
   753   C1514468:Products [Entity]
   753   C2746065:End [Temporal Concept]
   719 E C0725066:Advance [Medical Device]
   719 E C1704444:Product [Quantitative Concept]

Phrase: "and"

Phrase: "the biochemical basis of diabetic complication."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   753   C1527178:Basis [Functional Concept]
   753   C1874451:Basis [Pharmacologic Substance]
Processing 00000000.tx.233: N Engl J Med318 :1315 1321,1988[Medline] Craven PA, DeRuberitis FR: Protein kinase C is activated in glomeruli from storeptozotocin diabetic rats: possible mediation by glucose. 

Phrase: "N Engl J Med318"

Phrase: ":"

Phrase: "1315 1321,"

Phrase: "1988"

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "] Craven PA,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C3541314:PA [Idea or Concept]

Phrase: "DeRuberitis FR"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C2348513:Fr. [Conceptual Entity]
   861   C3538902:FR [Gene or Genome]

Phrase: ":"

Phrase: "Protein kinase C"
Meta Candidates (Total=8; Excluded=0; Pruned=0; Remaining=8)
  1000   C0033634:Protein Kinase C [Amino Acid, Peptide, or Protein,Enzyme]
   913   C0033621:Protein C [Amino Acid, Peptide, or Protein,Biologically Active Substance,Pharmacologic Substance]
   913   C1168438:Protein C [Laboratory Procedure]
   913   C1418943:PROTEIN C [Gene or Genome]
   913   C3540567:Protein C [Amino Acid, Peptide, or Protein,Enzyme]
   901   C0033640:PROTEIN KINASE [Amino Acid, Peptide, or Protein,Enzyme]
   827   C0031727:Kinase [Amino Acid, Peptide, or Protein,Enzyme]
   827   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "is"

Phrase: "activated in glomeruli"
Meta Candidates (Total=4; Excluded=2; Pruned=0; Remaining=2)
   790   C1879547:Activated [Activity]
   756   C0022663:Glomerulus [Body Part, Organ, or Organ Component]
   756 E C1515877:Activate [Functional Concept]
   706 E C0268731:GLOMERULAR [Disease or Syndrome]

Phrase: "from storeptozotocin diabetic rats"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   827   C0034693:rats [Mammal]
   827   C0034721:Rats [Mammal]
   827   C0241863:DIABETIC [Finding]

Phrase: ":"

Phrase: "possible mediation by glucose."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C0680727:Mediation [Social Behavior]
Processing 00000000.tx.234: J Clin Invest83 :1667 1675,1989[Medline] Inoguchi T, Battan R, Handler E, Sportsman JR, Health W, King GL: Preferential elevation of protein kinase C isoform beta II and diacylglycerol levels in the aorta and heart of diabetic rats: differential reversibility to glycemic control by islet cell transplantation. 

Phrase: "J Clin Invest83"

Phrase: ":"

Phrase: "1667 1675,"

Phrase: "1989"

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "] Inoguchi T,"

Phrase: "Battan R,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0205090:R- [Spatial Concept]
   861   C0684010:R. [Professional or Occupational Group]
   861   C2603358:R' [Clinical Attribute]

Phrase: "Handler E,"

Phrase: "Sportsman JR,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C1708595:Jr [Idea or Concept]
   861   C3280986:JR [Disease or Syndrome]

Phrase: "Health W,"

Phrase: "King"

Phrase: "GL"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0018229:GL [Geographic Area]
  1000   C1423073:GL [Gene or Genome]
  1000   C1427674:GL [Gene or Genome]

Phrase: ":"

Phrase: "Preferential elevation of protein kinase C isoform beta II"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   742   C0439775:Elevation [Therapeutic or Preventive Procedure]
   742   C0702240:Elevation [Spatial Concept]

Phrase: "and"

Phrase: "diacylglycerol levels in the aorta"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
   760   C0441889:Levels [Qualitative Concept]
   726 E C0456079:Level [Classification]
   726 E C1547707:Level [Geographic Area]
   726 E C2946261:Level [Pharmacologic Substance]

Phrase: "and"

Phrase: "heart of diabetic rats"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   802   C1882687:Rat Heart [Body Part, Organ, or Organ Component]
   770   C0018787:Heart [Body Part, Organ, or Organ Component]
   770   C1281570:Heart [Body Part, Organ, or Organ Component]

Phrase: ":"

Phrase: "differential reversibility to glycemic control"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C0449261:Reversibility [Temporal Concept]

Phrase: "by islet cell transplantation."
Meta Candidates (Total=8; Excluded=0; Pruned=0; Remaining=8)
  1000   C0079646:Islet Cell Transplantation [Therapeutic or Preventive Procedure]
           Transplantation, Islet
   901   C0206153:Cell Transplantation [Therapeutic or Preventive Procedure]
   827   C0029216:Transplantation [Therapeutic or Preventive Procedure]
   827   C0040732:Transplantation [Therapeutic or Preventive Procedure]
   827   C0040733:transplantation [Functional Concept]
   734   C0022131:Islet cell [Body Part, Organ, or Organ Component]
   734   C1522529:Islet Cell [Cell]
Processing 00000000.tx.235: Proc Natl Acad Sci U S A89 :11059 11063,1992[Abstract] Koya D, King GL: Protein kinase C activation and the development of diabetic complications. 

Phrase: "Proc Natl Acad Sci U S A89"

Phrase: ":"

Phrase: "11059 11063,"

Phrase: "1992"

Phrase: "[Abstract"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0000857:Abstract [Occupational Activity]
  1000   C0600678:Abstract [Intellectual Product]
  1000   C1552863:Abstract [Idea or Concept]

Phrase: "] Koya D,"

Phrase: "King"

Phrase: "GL"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0018229:GL [Geographic Area]
  1000   C1423073:GL [Gene or Genome]
  1000   C1427674:GL [Gene or Genome]

Phrase: ":"

Phrase: "Protein kinase C activation"
Meta Candidates (Total=9; Excluded=0; Pruned=0; Remaining=9)
  1000   C3546691:protein kinase C activation [Molecular Function]
   923   C1819041:protein kinase activation [Cell Function]
   902   C0599177:protein activation [Genetic Function]
   812   C1879547:Activation [Activity]
   756   C0033634:Protein Kinase C [Amino Acid, Peptide, or Protein,Enzyme]
   708   C0033621:Protein C [Amino Acid, Peptide, or Protein,Biologically Active Substance,Pharmacologic Substance]
   708   C1168438:Protein C [Laboratory Procedure]
   708   C1418943:PROTEIN C [Gene or Genome]
   708   C3540567:Protein C [Amino Acid, Peptide, or Protein,Enzyme]

Phrase: "and"

Phrase: "the development of diabetic complications."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   760   C0243107:development [Physiologic Function]
   760   C0678723:Development [Organism Function]
   760   C1527148:Development [Functional Concept]
Processing 00000000.tx.236: Diabetes47 :859 866,1998[Abstract] Greene DA, Latimmer SA, Sima AA: Sorbitol, phosphoinositides, and sodium-potassium-ATPase in the pathogenesis of diabetic complications. 

Phrase: "Diabetes47"

Phrase: ":"

Phrase: "859 866,"

Phrase: "1998"

Phrase: "[Abstract"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0000857:Abstract [Occupational Activity]
  1000   C0600678:Abstract [Intellectual Product]
  1000   C1552863:Abstract [Idea or Concept]

Phrase: "] Greene DA,"

Phrase: "Latimmer SA,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   861   C0036243:SA [Geographic Area]
   861   C1539696:SA [Gene or Genome]
   861   C1825840:SA [Gene or Genome]
   861   C3539736:Sa [Spatial Concept]

Phrase: "Sima AA"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C1235746:Aa [Plant]
   861   C1882141:aa [Qualitative Concept]

Phrase: ":"

Phrase: "Sorbitol,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0037688:Sorbitol [Carbohydrate,Pharmacologic Substance]

Phrase: "phosphoinositides,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0031621:Phosphoinositides [Biologically Active Substance,Lipid]

Phrase: "and"

Phrase: "sodium-potassium-ATPase in the pathogenesis of diabetic complications."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   790   C0001479:sodium-potassium ATPase [Amino Acid, Peptide, or Protein,Enzyme]
   762   C0525416:sodium ATPase [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   742   C0001473:ATPase [Amino Acid, Peptide, or Protein,Enzyme]
   742   C1706373:ATPase [Amino Acid, Peptide, or Protein,Enzyme]
Processing 00000000.tx.237: N Engl J Med316 :599 606,1987[Abstract] Kikkawa R, Umemura K, Haneda M, Arimura T, Ebata K, Shigeta Y: Evidence for existence of polyol pathway in cultured rat mesangial cells. 

Phrase: "N Engl J Med316"

Phrase: ":"

Phrase: "599 606,"

Phrase: "1987"

Phrase: "[Abstract"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0000857:Abstract [Occupational Activity]
  1000   C0600678:Abstract [Intellectual Product]
  1000   C1552863:Abstract [Idea or Concept]

Phrase: "] Kikkawa R,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0205090:R- [Spatial Concept]
   861   C0684010:R. [Professional or Occupational Group]
   861   C2603358:R' [Clinical Attribute]

Phrase: "Umemura K,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0597277:K+ [Element, Ion, or Isotope,Pharmacologic Substance]
   861   C1708601:K' [Quantitative Concept]

Phrase: "Haneda M,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441923:M+ [Intellectual Product]

Phrase: "Arimura T,"

Phrase: "Ebata K,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0597277:K+ [Element, Ion, or Isotope,Pharmacologic Substance]
   861   C1708601:K' [Quantitative Concept]

Phrase: "Shigeta Y"

Phrase: ":"

Phrase: "Evidence for existence of polyol pathway"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   783   C0332120:Evidence of [Functional Concept]
           Evidence

Phrase: "in cultured rat mesangial cells."
Meta Candidates (Total=12; Excluded=3; Pruned=0; Remaining=9)
   902   C0007600:cultured cells [Cell]
   902   C0007635:Cultured Cells [Cell]
   902   C3282338:Cells, Cultured [Cell]
   861   C0227651:Mesangial Cells [Cell]
   812   C0007634:Cells [Cell]
   812   C0034693:Rat, NOS [Mammal]
   812   C0034721:Rat [Mammal]
   812   C3282337:Cells [Cell]
   779 E C1269647:Cell [Cell]
   779 E C1704653:Cell [Medical Device]
   779 E C1948049:Cell [Spatial Concept]
   741   C0017655:Mesangium [Body Part, Organ, or Organ Component]
Processing 00000000.tx.238: Diabetes240 243,1987 Oberley LW: Free radicals and diabetes. 

Phrase: "Diabetes240 243,"

Phrase: "1987 Oberley LW"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C1415842:LW [Gene or Genome]

Phrase: ":"

Phrase: "Free radicals"
Meta Candidates (Total=6; Excluded=1; Pruned=0; Remaining=5)
  1000   C0016693:Free Radicals [Biologically Active Substance,Chemical Viewed Structurally]
   861   C0302912:radicals [Chemical Viewed Structurally]
   861   C0332296:free [Functional Concept]
   861   C1880497:Free [Qualitative Concept]
   861   C1996904:Free [Qualitative Concept]
   827 E C0439807:Radical [Qualitative Concept]

Phrase: "and"

Phrase: "diabetes."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0011847:Diabetes [Disease or Syndrome]
  1000   C0011849:Diabetes [Disease or Syndrome]
Processing 00000000.tx.239: Free Rad Biol Med5 :113 124,1988[Medline] Wolf SP, Jiang, ZY, Hunt JV: Protein glycation and oxidative stress in diabetes mellitus and aging. 

Phrase: "Free Rad Biol Med5"

Phrase: ":"

Phrase: "113 124,"

Phrase: "1988"

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "] Wolf SP,"

Phrase: "Jiang,"

Phrase: "ZY,"

Phrase: "Hunt JV"

Phrase: ":"

Phrase: "Protein glycation"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0598528:glycation [Phenomenon or Process]

Phrase: "and"

Phrase: "oxidative stress in diabetes mellitus"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   806   C0242606:Oxidative Stress [Cell or Molecular Dysfunction]
   760   C0038435:Stress [Finding]
   760   C0311404:Oxidative [Functional Concept]

Phrase: "and"

Phrase: "aging."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0001811:Ageing [Organism Function]
Processing 00000000.tx.240: Free Radic Biol Med10 :339 352,1991[Medline] Baynes JW: Role of oxidative stress in development of complications in diabetes. 

Phrase: "Free Radic Biol Med10"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   812   C1825959:MED10 [Gene or Genome]

Phrase: ":"

Phrase: "339 352,"

Phrase: "1991"

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "] Baynes JW"

Phrase: ":"

Phrase: "Role of oxidative stress"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   770   C0035820:Role [Social Behavior]
   770   C1705810:Role [Conceptual Entity]

Phrase: "in development"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
  1000   C0243107:development [Physiologic Function]
  1000   C0678723:Development [Organism Function]
  1000   C1527148:Development [Functional Concept]
   928 E C0458003:Developmental [Qualitative Concept]

Phrase: "of complications"
Meta Candidates (Total=4; Excluded=2; Pruned=0; Remaining=2)
  1000   C0009566:Complications [Pathologic Function]
  1000   C1171258:complications [Pathologic Function]
   966 E C2362589:Complication [Idea or Concept]
   916 E C0231242:Complicated [Functional Concept]

Phrase: "in diabetes."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0011847:Diabetes [Disease or Syndrome]
  1000   C0011849:Diabetes [Disease or Syndrome]
Processing 00000000.tx.241: Diabetes40 :405 412,1991[Abstract] Hinokio Y, Suzuki S, Hirai M, Chiba M, Hirai A, Toyota T: Oxidative DNA damage in diabetes mellitus: its association with diabetic complications. 

Phrase: "Diabetes40"

Phrase: ":"

Phrase: "405 412,"

Phrase: "1991"

Phrase: "[Abstract"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0000857:Abstract [Occupational Activity]
  1000   C0600678:Abstract [Intellectual Product]
  1000   C1552863:Abstract [Idea or Concept]

Phrase: "] Hinokio Y,"

Phrase: "Suzuki S,"

Phrase: "Hirai M,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441923:M+ [Intellectual Product]

Phrase: "Chiba M,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441923:M+ [Intellectual Product]

Phrase: "Hirai A,"

Phrase: "Toyota T"

Phrase: ":"

Phrase: "Oxidative DNA damage in diabetes mellitus"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   790   C0012860:DNA Damage [Cell or Molecular Dysfunction]
   753   C0010957:Damage [Injury or Poisoning]
   753   C0012854:DNA [Biologically Active Substance,Nucleic Acid, Nucleoside, or Nucleotide]
   753   C1883709:Damage [Functional Concept]

Phrase: ":"

Phrase: "its association with diabetic complications."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   760   C0004083:Association [Mental Process]
   760   C0439849:Association [Qualitative Concept]
   760   C0596306:Association [Phenomenon or Process]
   760   C0699792:association [Social Behavior]
Processing 00000000.tx.242: Diabetologia42 :995 998,1999[Medline] Suzuki S, Hinokio Y, Komatu K, Ohtomo M, Onoda M, Hirai S, Hirai M, Hirai A, Chiba M, Kasuga S, Akai H, Toyota T: Oxidative damage to mitochondrial DNA and its relationship to diabetic complications. 

Phrase: "Diabetologia42"

Phrase: ":"

Phrase: "995 998,"

Phrase: "1999"

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "] Suzuki S,"

Phrase: "Hinokio Y,"

Phrase: "Komatu K,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0597277:K+ [Element, Ion, or Isotope,Pharmacologic Substance]
   861   C1708601:K' [Quantitative Concept]

Phrase: "Ohtomo M,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441923:M+ [Intellectual Product]

Phrase: "Onoda M,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441923:M+ [Intellectual Product]

Phrase: "Hirai S,"

Phrase: "Hirai M,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441923:M+ [Intellectual Product]

Phrase: "Hirai A,"

Phrase: "Chiba M,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441923:M+ [Intellectual Product]

Phrase: "Kasuga S,"

Phrase: "Akai H,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   861   C0033727:H+ [Element, Ion, or Isotope]
   861   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441932:H+ [Classification]
   861   C0564385:/h [Quantitative Concept]

Phrase: "Toyota T"

Phrase: ":"

Phrase: "Oxidative damage to mitochondrial DNA"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   797   C0012860:DNA Damage [Cell or Molecular Dysfunction]
   797   C1096176:Mitochondrial Damage [Pathologic Function]
   760   C0010957:Damage [Injury or Poisoning]
   760   C1883709:Damage [Functional Concept]

Phrase: "and"

Phrase: "its relationship to diabetic complications."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   760   C0439849:Relationship [Qualitative Concept]
   760   C1705630:Relationship [Idea or Concept]
   760   C1706279:Relationship [Idea or Concept]
   760   C3540605:Relationship [Intellectual Product]
Processing 00000000.tx.243: Diabetes Res Clin Pract45 :161 168,1999[Medline] Ha H, Kim C, Son Y, Chung MH, Kim KH: DNA damage in the kidneys of diabetic rats exhibiting microalbuminuria. 

Phrase: "Diabetes Res Clin Pract45"

Phrase: ":"

Phrase: "161 168,"

Phrase: "1999"

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "] Ha H,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   861   C0033727:H+ [Element, Ion, or Isotope]
   861   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441932:H+ [Classification]
   861   C0564385:/h [Quantitative Concept]

Phrase: "Kim C,"

Phrase: "Son Y,"

Phrase: "Chung MH,"

Phrase: "Kim KH"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0006797:KH [Geographic Area]

Phrase: ":"

Phrase: "DNA damage in the kidneys of diabetic rats"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   770   C0012860:DNA Damage [Cell or Molecular Dysfunction]
   744   C0010957:Damage [Injury or Poisoning]
   744   C0012854:DNA [Biologically Active Substance,Nucleic Acid, Nucleoside, or Nucleotide]
   744   C1883709:Damage [Functional Concept]

Phrase: "exhibiting"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0015272:exhibiting [Intellectual Product]

Phrase: "microalbuminuria."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0730345:Microalbuminuria [Disease or Syndrome]
Processing 00000000.tx.244: Free Radic Biol Med16 :271 274,1994[Medline] Sano T, Umeda F, Hashimoto T, Nawata H, Utsumi H: Oxidative stress measurement by in vivo electron spin resonance spectroscopy in rats with streptozotocin-induced diabetes. 

Phrase: "Free Radic Biol Med16"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   812   C1424995:MED16 [Gene or Genome]

Phrase: ":"

Phrase: "271 274,"

Phrase: "1994"

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "] Sano T,"

Phrase: "Umeda F,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0016327:F- [Inorganic Chemical,Pharmacologic Substance]
   861   C0439133:(f) [Intellectual Product]
   861   C1553038:[f] [Quantitative Concept]

Phrase: "Hashimoto T,"

Phrase: "Nawata H,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   861   C0033727:H+ [Element, Ion, or Isotope]
   861   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441932:H+ [Classification]
   861   C0564385:/h [Quantitative Concept]

Phrase: "Utsumi H"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   861   C0033727:H+ [Element, Ion, or Isotope]
   861   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441932:H+ [Classification]
   861   C0564385:/h [Quantitative Concept]

Phrase: ":"

Phrase: "Oxidative stress measurement by in vivo electron spin resonance spectroscopy"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   799   C0013845:Electron spin resonance measurement [Laboratory Procedure]
   777   C0545277:Electron spin measurement [Laboratory Procedure]
   739   C0242485:Measurement [Functional Concept]

Phrase: "in rats"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0034693:rats [Mammal]
  1000   C0034721:Rats [Mammal]

Phrase: "with streptozotocin-induced diabetes."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   913   C0038433:Streptozotocin Diabetes [Experimental Model of Disease]
   827   C0011847:Diabetes [Disease or Syndrome]
   827   C0011849:Diabetes [Disease or Syndrome]
Processing 00000000.tx.245: Diabetologia41 :1355 1360,1998[Medline] Fraga CG, Shigenaga MK, Park JW, Degan P, Ames BN: Oxidative damage to DNA during aging: 8-hydroxy-2'-deoxyguanosine in rat organ DNA and urine. 

Phrase: "Diabetologia41"

Phrase: ":"

Phrase: "1355 1360,"

Phrase: "1998"

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "] Fraga CG,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0054868:CG [Amino Acid, Peptide, or Protein,Enzyme]
   861   C3540479:CG [Gene or Genome]

Phrase: "Shigenaga MK,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C3539059:MK [Idea or Concept]

Phrase: "Park JW,"

Phrase: "Degan P,"

Phrase: "Ames BN"

Phrase: ":"

Phrase: "Oxidative damage to DNA"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   819   C0012860:DNA Damage [Cell or Molecular Dysfunction]
   770   C0010957:Damage [Injury or Poisoning]
   770   C1883709:Damage [Functional Concept]

Phrase: "during aging"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0001811:Ageing [Organism Function]

Phrase: ":"

Phrase: "8-hydroxy-2'-deoxyguanosine in rat organ DNA"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   833   C0050078:8-Hydroxy-2'-deoxyguanosine [Biologically Active Substance,Nucleic Acid, Nucleoside, or Nucleotide]
   744   C0011503:Deoxyguanosine [Nucleic Acid, Nucleoside, or Nucleotide]

Phrase: "and"

Phrase: "urine."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0042036:Urine [Body Substance]
  1000   C0042037:urine [Functional Concept]
  1000   C2963137:Urine [Body Substance]
Processing 00000000.tx.246: Proc Natl Acad Sci U S A87 :4533 4537,1990[Abstract] Merriwether DA, Clark AG, Ballinger SW, Schurr TG, Soodyall H, Jenkins T, Sheny ST, Wallace DC: The structure of human mitochondrial DNA variation. 

Phrase: "Proc Natl Acad Sci U S A87"

Phrase: ":"

Phrase: "4533 4537,"

Phrase: "1990"

Phrase: "[Abstract"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0000857:Abstract [Occupational Activity]
  1000   C0600678:Abstract [Intellectual Product]
  1000   C1552863:Abstract [Idea or Concept]

Phrase: "] Merriwether DA,"

Phrase: "Clark AG,"

Phrase: "Ballinger SW,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C1420193:SW [Gene or Genome]
   861   C1832169:SW [Body System]
   861   C3538902:SW [Gene or Genome]

Phrase: "Schurr TG,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0337445:TG [Laboratory Procedure]

Phrase: "Soodyall H,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   861   C0033727:H+ [Element, Ion, or Isotope]
   861   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441932:H+ [Classification]
   861   C0564385:/h [Quantitative Concept]

Phrase: "Jenkins T,"

Phrase: "Sheny ST,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C3272372:ST [Intellectual Product]

Phrase: "Wallace DC"

Phrase: ":"

Phrase: "The structure of human mitochondrial DNA variation."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   774   C0026237:Mitochondrial structure [Cell Component]
   774   C1511699:DNA Structure [Nucleic Acid, Nucleoside, or Nucleotide]
   748   C0678594:Structure [Spatial Concept]
Processing 00000000.tx.247: J Mol Evol33 :543 555,1991[Medline] Richter C, Park JW, Ames BN: Normal oxidative damage to mitochondrial and nuclear DNA is extensive. 

Phrase: "J Mol Evol33"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   734   C2346604:J/mol [Quantitative Concept]

Phrase: ":"

Phrase: "543 555,"

Phrase: "1991"

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "] Richter C,"

Phrase: "Park JW,"

Phrase: "Ames BN"

Phrase: ":"

Phrase: "Normal oxidative damage to mitochondrial"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   797   C1096176:Mitochondrial Damage [Pathologic Function]
   760   C0010957:Damage [Injury or Poisoning]
   760   C1883709:Damage [Functional Concept]

Phrase: "and"

Phrase: "nuclear DNA"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C1179920:Nuclear DNA [Biologically Active Substance,Nucleic Acid, Nucleoside, or Nucleotide]
   861   C0012854:DNA [Biologically Active Substance,Nucleic Acid, Nucleoside, or Nucleotide]
   861   C0521447:Nuclear [Spatial Concept]

Phrase: "is"

Phrase: "extensive."
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0205231:Extensive [Qualitative Concept]
   928 E C0439795:Extensiveness [Qualitative Concept]
Processing 00000000.tx.248: Proc Natl Acad Sci U S A85 :6465 6467,1988[Abstract] Hattori K, Tanaka M, Sugiyama S, Obayashi T, Ito T, Satake T, Hanaki Y, Asai J, Nagano M, Ozawa T: Age-dependent increase in deleted mitochondrial DNA in human heart: possible contributory factor to presbycardia. 

Phrase: "Proc Natl Acad Sci U S A85"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   795   C0445540:A85 [Intellectual Product]

Phrase: ":"

Phrase: "6465 6467,"

Phrase: "1988"

Phrase: "[Abstract"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0000857:Abstract [Occupational Activity]
  1000   C0600678:Abstract [Intellectual Product]
  1000   C1552863:Abstract [Idea or Concept]

Phrase: "] Hattori K,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0597277:K+ [Element, Ion, or Isotope,Pharmacologic Substance]
   861   C1708601:K' [Quantitative Concept]

Phrase: "Tanaka M,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441923:M+ [Intellectual Product]

Phrase: "Sugiyama S,"

Phrase: "Obayashi T,"

Phrase: "Ito T,"

Phrase: "Satake T,"

Phrase: "Hanaki Y,"

Phrase: "Asai J,"

Phrase: "Nagano M,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441923:M+ [Intellectual Product]

Phrase: "Ozawa T"

Phrase: ":"

Phrase: "Age-dependent increase in deleted mitochondrial DNA"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   748   C0442805:Increase [Functional Concept]

Phrase: "in human heart"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0018787:Heart [Body Part, Organ, or Organ Component]
   861   C1281570:Heart [Body Part, Organ, or Organ Component]

Phrase: ":"

Phrase: "possible contributory factor to presbycardia."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   760   C1521761:Factor [Functional Concept]
   760   C2827422:Factor [Conceptual Entity]
Processing 00000000.tx.249: Am Heart J121 :1735 1742,1991[Medline] Corral-Debrinski M, Horton T, Lott MT, Shoffner JM, Beal MF, Wallace DC: Mitochondrial DNA deletions in human brain: regional variability and increase with advanced age. 

Phrase: "Am"

Phrase: "Heart J121"

Phrase: ":"

Phrase: "1735 1742,"

Phrase: "1991"

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "] Corral-Debrinski M,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   827   C0441923:M+ [Intellectual Product]

Phrase: "Horton T,"

Phrase: "Lott MT,"

Phrase: "Shoffner JM,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0022337:JM [Geographic Area]

Phrase: "Beal MF,"

Phrase: "Wallace DC"

Phrase: ":"

Phrase: "Mitochondrial DNA deletions in human brain"
Meta Candidates (Total=5; Excluded=2; Pruned=0; Remaining=3)
   833   C0948051:Mitochondrial DNA deletions [Cell or Molecular Dysfunction]
   783   C3151954:Mitochondrial deletions [Finding]
   753   C1880274:Deletions [Activity]
   719 E C1442161:Deletion [Cell or Molecular Dysfunction]
   719 E C1511760:Deletion [Genetic Function]

Phrase: ":"

Phrase: "regional variability"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   861   C2827666:Variability [Conceptual Entity]
   789 E C0439828:Variable [Qualitative Concept]

Phrase: "and"

Phrase: "increase with advanced age."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C0442805:Increase [Functional Concept]
Processing 00000000.tx.250: Nat Genet2 :324 329,1992[Medline] Sugiyama S, Hattori K, Hayakawa M, Ozawa T: Quantitative analysis of age-associated accumulation of mitochondrial DNA with deletion in human hearts. 

Phrase: "Nat Genet2"

Phrase: ":"

Phrase: "324 329,"

Phrase: "1992"

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "] Sugiyama S,"

Phrase: "Hattori K,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0597277:K+ [Element, Ion, or Isotope,Pharmacologic Substance]
   861   C1708601:K' [Quantitative Concept]

Phrase: "Hayakawa M,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441923:M+ [Intellectual Product]

Phrase: "Ozawa T"

Phrase: ":"

Phrase: "Quantitative analysis of age-associated accumulation of mitochondrial DNA"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   762   C0200898:DNA analysis [Laboratory Procedure]
   742   C0002778:Analysis [Laboratory Procedure]
   742   C0392762:Quantitative [Quantitative Concept]
   742   C0936012:Analysis [Research Activity]
   742   C1524024:analysis [Functional Concept]

Phrase: "with deletion"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C1442161:Deletion [Cell or Molecular Dysfunction]
  1000   C1511760:Deletion [Genetic Function]
  1000   C1880274:Deletion [Activity]

Phrase: "in human hearts."
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   861   C0018787:Hearts [Body Part, Organ, or Organ Component]
   827 E C1281570:Heart [Body Part, Organ, or Organ Component]
Processing 00000000.tx.251: Biochem Biophys Res Commun180 :894 899,1991[Medline] Hayakawa M, Hattori K, Sugiyama S, Ozawa T: Age-associated oxygen damage and mutations in mitochondrial DNA in human hearts. 

Phrase: "Biochem Biophys Res Commun180"

Phrase: ":"

Phrase: "894 899,"

Phrase: "1991"

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "] Hayakawa M,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441923:M+ [Intellectual Product]

Phrase: "Hattori K,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0597277:K+ [Element, Ion, or Isotope,Pharmacologic Substance]
   861   C1708601:K' [Quantitative Concept]

Phrase: "Sugiyama S,"

Phrase: "Ozawa T"

Phrase: ":"

Phrase: "Age-associated oxygen damage"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   812   C0010957:Damage [Injury or Poisoning]
   812   C1883709:Damage [Functional Concept]

Phrase: "and"

Phrase: "mutations in mitochondrial DNA"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   802   C2315666:Mitochondrial mutation [Genetic Function]
   770   C0026882:Mutations [Genetic Function]
   737 E C1705285:Mutation [Cell or Molecular Dysfunction]

Phrase: "in human hearts."
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   861   C0018787:Hearts [Body Part, Organ, or Organ Component]
   827 E C1281570:Heart [Body Part, Organ, or Organ Component]
Processing 00000000.tx.252: Biochem Biophys Res Commun189 :979 985,1992[Medline] Corral-Derinski M, Shoffner JM, Lott MT, Wallace DC: Association of mitochondrial DNA damage with aging and coronary atherosclerotic heart disease. 

Phrase: "Biochem Biophys Res Commun189"

Phrase: ":"

Phrase: "979 985,"

Phrase: "1992"

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "] Corral-Derinski M,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   827   C0441923:M+ [Intellectual Product]

Phrase: "Shoffner JM,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0022337:JM [Geographic Area]

Phrase: "Lott MT,"

Phrase: "Wallace DC"

Phrase: ":"

Phrase: "Association of mitochondrial DNA damage"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   760   C0004083:Association [Mental Process]
   760   C0439849:Association [Qualitative Concept]
   760   C0596306:Association [Phenomenon or Process]
   760   C0699792:association [Social Behavior]

Phrase: "with aging"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0001811:Ageing [Organism Function]

Phrase: "and"

Phrase: "coronary atherosclerotic heart disease."
Meta Candidates (Total=13; Excluded=3; Pruned=0; Remaining=10)
   923   C0010054:Atherosclerotic heart disease [Disease or Syndrome]
           coronary heart disease
   923   C0010068:Coronary heart disease [Disease or Syndrome]
           Coronary Disease
   861   C0018799:Heart disease [Disease or Syndrome]
   812   C0012634:Disease [Disease or Syndrome]
   812   C0018787:Heart [Body Part, Organ, or Organ Component]
           coronary
   812   C0333482:Atherosclerotic [Functional Concept]
   812   C1281570:Heart [Body Part, Organ, or Organ Component]
   756 E C1836721:MALS [Finding]
   756 E C3538764:MALS [Gene or Genome]
   756 E C3540595:MAL [Gene or Genome]
Processing 00000000.tx.253: Mutation Res275 :169 180,1992[Medline] Fukagawa NK, Li M, Liang P, Russell JC, Sobel BE, Absher PM: Aging and high concentrations of glucose potentiate injury to mitochondrial DNA. 

Phrase: "Mutation Res275"

Phrase: ":"

Phrase: "169 180,"

Phrase: "1992"

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "] Fukagawa NK,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0022688:NK [Cell]

Phrase: "Li M,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441923:M+ [Intellectual Product]

Phrase: "Liang P,"

Phrase: "Russell JC,"

Phrase: "Sobel"

Phrase: "BE"

Phrase: ","

Phrase: "Absher"

Phrase: "PM"

Phrase: ":"

Phrase: "Aging"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0001811:Ageing [Organism Function]

Phrase: "and"

Phrase: "high concentrations of glucose"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
   819   C0427743:concentrations glucose [Laboratory Procedure]
   819   C1287281:concentrations glucose [Laboratory or Test Result]
   770   C0086045:Concentrations [Mental Process]
   737 E C1446561:Concentration [Quantitative Concept]

Phrase: "potentiate"

Phrase: "injury to mitochondrial DNA."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   819   C0012860:DNA Injury [Cell or Molecular Dysfunction]
   770   C3263722:Injury [Injury or Poisoning]
   770   C3263723:Injury [Injury or Poisoning]
Processing 00000000.tx.254: Free Radic Biol Med27 :1437 1443,1999[Medline] Ozawa T, Tanaka M, Ikebe S, Ohno K, Kondo T, Mizuno Y: Quantitative determination of deleted mitochondrial DNA relative to normal DNA in parkinsonian striatum by kinetic PCR analysis. 

Phrase: "Free Radic Biol Med27"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   812   C1332786:MED27 [Gene or Genome]

Phrase: ":"

Phrase: "1437 1443,"

Phrase: "1999"

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "] Ozawa T,"

Phrase: "Tanaka M,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441923:M+ [Intellectual Product]

Phrase: "Ikebe S,"

Phrase: "Ohno K,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0597277:K+ [Element, Ion, or Isotope,Pharmacologic Substance]
   861   C1708601:K' [Quantitative Concept]

Phrase: "Kondo T,"

Phrase: "Mizuno Y"

Phrase: ":"

Phrase: "Quantitative determination of deleted mitochondrial DNA"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   753   C1148554:determination [Laboratory Procedure]

Phrase: "relative to normal DNA"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   770   C0080103:Relative [Family Group]
   770   C0205345:Relative [Qualitative Concept]
   770   C1547039:*Relative [Quantitative Concept]

Phrase: "in parkinsonian striatum"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0010097:Striatum [Body Part, Organ, or Organ Component]
   861   C0162512:Striatum [Body Part, Organ, or Organ Component]

Phrase: "by kinetic PCR analysis."
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   901   C0200931:PCR analysis [Laboratory Procedure]
   827   C0002778:Analysis [Laboratory Procedure]
   827   C0032520:PCR [Laboratory Procedure,Molecular Biology Research Technique]
   827   C0677874:pCR [Finding]
   827   C0936012:Analysis [Research Activity]
   827   C1524024:analysis [Functional Concept]
Processing 00000000.tx.255: Biochem Biophys Res Commun172 :483 489,1990[Medline] Davis RE, Miller S, Hernstadt C, Ghosh SS, Fahy E, Shinobu LA, Galasko D, Thal LJ, Beal MF, Howell N, Parker WD Jr: Mutations in mitochondrial cytochrome c oxidase genes segregate with large-onset Alzheimer disease. 

Phrase: "Biochem Biophys Res Commun172"

Phrase: ":"

Phrase: "483 489,"

Phrase: "1990"

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "] Davis RE,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C2986904:RE [Idea or Concept]

Phrase: "Miller S,"

Phrase: "Hernstadt C,"

Phrase: "Ghosh SS,"

Phrase: "Fahy E,"

Phrase: "Shinobu LA,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0023031:La [Element, Ion, or Isotope]

Phrase: "Galasko D,"

Phrase: "Thal LJ,"

Phrase: "Beal MF,"

Phrase: "Howell N,"

Phrase: "Parker WD Jr"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C1708595:Jr [Idea or Concept]
   827   C3280986:JR [Disease or Syndrome]

Phrase: ":"

Phrase: "Mutations in mitochondrial cytochrome c oxidase genes"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
   757   C0596611:gene mutations [Genetic Function]
   757   C2315666:Mitochondrial mutation [Genetic Function]
   748   C0026882:Mutations [Genetic Function]
   714 E C1705285:Mutation [Cell or Molecular Dysfunction]

Phrase: "segregate with large-onset Alzheimer disease."
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   790   C0002395:Alzheimer's Disease [Disease or Syndrome]
   790   C1521724:Alzheimer's Disease [Pathologic Function]
   783   C0277793:disease onset [Temporal Concept]
   753   C0012634:Disease [Disease or Syndrome]
   753   C0332162:Onset [Qualitative Concept]
   753   C0549177:Large [Quantitative Concept]
Processing 00000000.tx.256: Proc Natl Acad Sci U S A94 :4526 4531,1997[Abstract/Free FullText] Yowe DL, Ames BN: Quantitation of age-related mitochondrial DNA deletions in rat tissues shows that their pattern of accumulation differs from that of humans. 

Phrase: "Proc Natl Acad Sci U S A94"

Phrase: ":"

Phrase: "4526 4531,"

Phrase: "1997"

Phrase: "[Abstract/Free FullText"

Phrase: "] Yowe DL,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C3642216:/dL [Quantitative Concept]

Phrase: "Ames BN"

Phrase: ":"

Phrase: "Quantitation of age-related mitochondrial DNA deletions"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   748   C1709793:Quantitation [Quantitative Concept]

Phrase: "in rat tissues"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   861   C0040300:Tissues [Tissue]
   827 E C1547928:Tissue [Intellectual Product]

Phrase: "shows"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1547282:Show [Intellectual Product]

Phrase: "that"

Phrase: "their pattern of accumulation"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C0449774:Pattern [Spatial Concept]

Phrase: "differs from that of humans."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C0086418:Humans [Human]
Processing 00000000.tx.257: Gene209 :23 30,1998[Medline] Gadaleta MN, Rainaldi G, Lezza AMS, Milella F, Fracasso F, Cantatore P: Mitochondrial DNA copy number and mitochondrial DNA deletion in adult and senescent rats. 

Phrase: "Gene209"

Phrase: ":"

Phrase: "23 30,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0450348:23 [Quantitative Concept]

Phrase: "1998"

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "] Gadaleta MN,"

Phrase: "Rainaldi G,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0439267:g% [Quantitative Concept]

Phrase: "Lezza AMS,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C1860224:AMS [Disease or Syndrome]

Phrase: "Milella F,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0016327:F- [Inorganic Chemical,Pharmacologic Substance]
   861   C0439133:(f) [Intellectual Product]
   861   C1553038:[f] [Quantitative Concept]

Phrase: "Fracasso F,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0016327:F- [Inorganic Chemical,Pharmacologic Substance]
   861   C0439133:(f) [Intellectual Product]
   861   C1553038:[f] [Quantitative Concept]

Phrase: "Cantatore P"

Phrase: ":"

Phrase: "Mitochondrial DNA copy number"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   861   C1707513:Copy Number [Quantitative Concept]
   812   C0237753:*Number [Quantitative Concept]
   812   C0449788:Number [Quantitative Concept]
   812   C1948062:Copy [Manufactured Object]

Phrase: "and"

Phrase: "mitochondrial DNA deletion in adult"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   862   C0948051:mitochondrial dna deletion [Cell or Molecular Dysfunction]
   760   C1442161:Deletion [Cell or Molecular Dysfunction]
   760   C1511760:Deletion [Genetic Function]
   760   C1880274:Deletion [Activity]

Phrase: "and"

Phrase: "senescent rats."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0034693:rats [Mammal]
   861   C0034721:Rats [Mammal]
Processing 00000000.tx.258: Mutation Res275 :181 193,1992[Medline] Edris W, Burgett B, Stine OC, Filburn CR: Detection and quantitation by competitive PCR on an age-associated increase in a 4.8-kb deletion in rat mitochondrial DNA. 

Phrase: "Mutation Res275"

Phrase: ":"

Phrase: "181 193,"

Phrase: "1992"

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "] Edris W,"

Phrase: "Burgett B,"

Phrase: "Stine OC,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C1412791:OC [Gene or Genome]
   861   C3539565:OC [Gene or Genome]

Phrase: "Filburn CR"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0201975:Cr [Laboratory Procedure]
   861   C3539604:CR [Gene or Genome]

Phrase: ":"

Phrase: "Detection"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1511790:Detection [Therapeutic or Preventive Procedure]

Phrase: "and"

Phrase: "quantitation by competitive PCR"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C1709793:Quantitation [Quantitative Concept]

Phrase: "on an age-associated increase"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0442805:Increase [Functional Concept]

Phrase: "in a 4.8-kb deletion"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   812   C1442161:Deletion [Cell or Molecular Dysfunction]
   812   C1511760:Deletion [Genetic Function]
   812   C1880274:Deletion [Activity]

Phrase: "in rat mitochondrial DNA."
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   901   C0012929:DNA, Mitochondrial [Biologically Active Substance,Nucleic Acid, Nucleoside, or Nucleotide]
   901   C1819717:mitochondrial DNA [Cell Component]
   827   C0012854:DNA [Biologically Active Substance,Nucleic Acid, Nucleoside, or Nucleotide]
   827   C0026237:Mitochondrial [Cell Component]
   827   C0521451:Mitochondrial [Functional Concept]
Processing 00000000.tx.259: Mutation Res316 :69 78,1994[Medline] Aspnes LE, Lee CM, Weindruch R, Chung SS, Roecker EB, Aiken JM: Caloric restriction reduces fiber loss and mitochondrial abnormalities in aged rat muscle. 

Phrase: "Mutation Res316"

Phrase: ":"

Phrase: "69 78,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0450388:69 [Intellectual Product]

Phrase: "1994"

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "] Aspnes LE,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0439090:LE [Idea or Concept]
   861   C1423767:LE [Gene or Genome]

Phrase: "Lee CM,"

Phrase: "Weindruch R,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0205090:R- [Spatial Concept]
   861   C0684010:R. [Professional or Occupational Group]
   861   C2603358:R' [Clinical Attribute]

Phrase: "Chung SS,"

Phrase: "Roecker EB,"

Phrase: "Aiken JM"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0022337:JM [Geographic Area]

Phrase: ":"

Phrase: "Caloric restriction"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1135809:Caloric Restriction [Therapeutic or Preventive Procedure]
   861   C0443288:Restriction [Functional Concept]

Phrase: "reduces"

Phrase: "fiber loss"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C1517945:Loss [Quantitative Concept]

Phrase: "and"

Phrase: "mitochondrial abnormalities in aged rat muscle."
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   753   C0000768:Abnormalities [Congenital Abnormality]
   753   C0000769:abnormalities [Functional Concept]
   719 E C1704258:Abnormality [Finding]
Processing 00000000.tx.260: FASEB11 :573 581,1997[Abstract/Free FullText] Kuchino Y, Mori F, Kasai H, Inoue H, Iwai S, Miura K, Ohtsuki E, Mishimura S: Misreading of DNA templates containing 8-hydroxydeoxyguanosine at the modified base and at adjacent residues. 

Phrase: "FASEB11"

Phrase: ":"

Phrase: "573 581,"

Phrase: "1997"

Phrase: "[Abstract/Free FullText"

Phrase: "] Kuchino Y,"

Phrase: "Mori F,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0016327:F- [Inorganic Chemical,Pharmacologic Substance]
   861   C0439133:(f) [Intellectual Product]
   861   C1553038:[f] [Quantitative Concept]

Phrase: "Kasai H,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   861   C0033727:H+ [Element, Ion, or Isotope]
   861   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441932:H+ [Classification]
   861   C0564385:/h [Quantitative Concept]

Phrase: "Inoue H,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   861   C0033727:H+ [Element, Ion, or Isotope]
   861   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441932:H+ [Classification]
   861   C0564385:/h [Quantitative Concept]

Phrase: "Iwai S,"

Phrase: "Miura K,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0597277:K+ [Element, Ion, or Isotope,Pharmacologic Substance]
   861   C1708601:K' [Quantitative Concept]

Phrase: "Ohtsuki E,"

Phrase: "Mishimura S"

Phrase: ":"

Phrase: "Misreading of DNA templates"

Phrase: "containing"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0332256:Containing [Functional Concept]
  1000   C2700400:Containing [Activity]

Phrase: "8-hydroxydeoxyguanosine at the modified base"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   790   C0050078:8-Hydroxydeoxyguanosine [Biologically Active Substance,Nucleic Acid, Nucleoside, or Nucleotide]

Phrase: "and at adjacent residues."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   770   C0205117:Adjacent [Spatial Concept]
   770   C1515981:And [Idea or Concept]
   737   C1709915:Residue [Conceptual Entity]
   737   C1882936:RESIDUE [Phenomenon or Process]
Processing 00000000.tx.261: Nature327 :77 79,1987[Medline] Leinonen J, Lehtimaki T, Toyokuni S, Okada K, Tanaka T, Hiai H, Ochi H, Laippala P, Rantalaiho V, Wirta O, Pasternack A, Alho H: New biomarker evidence of oxidative DNA damage in patients with non-insulin-dependent diabetes mellitus. 

Phrase: "Nature327"

Phrase: ":"

Phrase: "77 79,"

Phrase: "1987"

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "] Leinonen J,"

Phrase: "Lehtimaki T,"

Phrase: "Toyokuni S,"

Phrase: "Okada K,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0597277:K+ [Element, Ion, or Isotope,Pharmacologic Substance]
   861   C1708601:K' [Quantitative Concept]

Phrase: "Tanaka T,"

Phrase: "Hiai H,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   861   C0033727:H+ [Element, Ion, or Isotope]
   861   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441932:H+ [Classification]
   861   C0564385:/h [Quantitative Concept]

Phrase: "Ochi H,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   861   C0033727:H+ [Element, Ion, or Isotope]
   861   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441932:H+ [Classification]
   861   C0564385:/h [Quantitative Concept]

Phrase: "Laippala P,"

Phrase: "Rantalaiho V,"

Phrase: "Wirta O,"

Phrase: "Pasternack A,"

Phrase: "Alho H"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   861   C0033727:H+ [Element, Ion, or Isotope]
   861   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441932:H+ [Classification]
   861   C0564385:/h [Quantitative Concept]

Phrase: ":"

Phrase: "New biomarker evidence of oxidative DNA damage"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   778   C0332120:Evidence of [Functional Concept]
           Evidence

Phrase: "in patients"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0030705:Patients [Patient or Disabled Group]

Phrase: "with non-insulin-dependent diabetes mellitus."
Meta Candidates (Total=17; Excluded=2; Pruned=0; Remaining=15)
  1000   C0011860:Diabetes Mellitus, Non-Insulin-Dependent [Disease or Syndrome]
           Non-Insulin Dependent Diabetes
  1000   C2697407:DIABETES MELLITUS, NONINSULIN-DEPENDENT [Gene or Genome]
   937   C0011854:Diabetes Mellitus, Insulin-Dependent [Disease or Syndrome]
           Insulin Dependent Diabetes
   840   C0011849:Diabetes Mellitus [Disease or Syndrome]
           Diabetes
   804   C0011847:Diabetes [Disease or Syndrome]
   804   C0021641:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   804   C0851827:Dependent [Qualitative Concept]
   804   C1518422:Non [Functional Concept]
   804   C1533581:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   804   C1579433:Insulin [Pharmacologic Substance]
   804   C1701901:Dependent [Qualitative Concept]
   804   C3244310:dependent [Functional Concept]
   748 E C0020884:Iletin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   721 E C3537244:Insulins [Pharmacologic Substance]
Processing 00000000.tx.262: FEBS Lett417 :150 152,1997[Medline] Dandona P, Thusu K, Cook S, Snyder B, Makowski J, Armstrong D, Nicotera T: Oxidative damage to DNA in diabetes mellitus. 

Phrase: "FEBS Lett417"

Phrase: ":"

Phrase: "150 152,"

Phrase: "1997"

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "] Dandona P,"

Phrase: "Thusu K,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0597277:K+ [Element, Ion, or Isotope,Pharmacologic Substance]
   861   C1708601:K' [Quantitative Concept]

Phrase: "Cook S,"

Phrase: "Snyder B,"

Phrase: "Makowski J,"

Phrase: "Armstrong D,"

Phrase: "Nicotera T"

Phrase: ":"

Phrase: "Oxidative damage to DNA"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   819   C0012860:DNA Damage [Cell or Molecular Dysfunction]
   770   C0010957:Damage [Injury or Poisoning]
   770   C1883709:Damage [Functional Concept]

Phrase: "in diabetes mellitus."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0011849:Diabetes Mellitus [Disease or Syndrome]
           Diabetes
   861   C0011847:Diabetes [Disease or Syndrome]
Processing 00000000.tx.263: Lancet348 :44 445,1996 Shigenaga MK, Gimeno CJ, Ames BN: Urinary 8-hydroxy-2'-deoxyguanosine as a biological marker of in vivo oxidative DNA damage. 

Phrase: "Lancet348"

Phrase: ":"

Phrase: "44 445,"

Phrase: "1996 Shigenaga MK,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C3539059:MK [Idea or Concept]

Phrase: "Gimeno CJ,"

Phrase: "Ames BN"

Phrase: ":"

Phrase: "Urinary 8-hydroxy-2'-deoxyguanosine as a biological marker"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   818   C0050078:8-Hydroxy-2'-deoxyguanosine [Biologically Active Substance,Nucleic Acid, Nucleoside, or Nucleotide]
   742   C0011503:Deoxyguanosine [Nucleic Acid, Nucleoside, or Nucleotide]

Phrase: "of in vivo oxidative DNA damage."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   840   C0012860:DNA Damage [Cell or Molecular Dysfunction]
   804   C0010957:Damage [Injury or Poisoning]
   804   C0012854:DNA [Biologically Active Substance,Nucleic Acid, Nucleoside, or Nucleotide]
   804   C1883709:Damage [Functional Concept]
Processing 00000000.tx.264: Proc Natl Acad Sci U S A86 :9697 9701,1989[Abstract] Shin CS, Moon BS, Park KS, Kim SY, Park SJ, Chung MH, Lee HK: Serum 8-hydroxy-guanine levels are increased in diabetic patients. 

Phrase: "Proc Natl Acad Sci U S A86"

Phrase: ":"

Phrase: "9697 9701,"

Phrase: "1989"

Phrase: "[Abstract"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0000857:Abstract [Occupational Activity]
  1000   C0600678:Abstract [Intellectual Product]
  1000   C1552863:Abstract [Idea or Concept]

Phrase: "] Shin CS,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C3540510:cs [Quantitative Concept]

Phrase: "Moon BS,"

Phrase: "Park KS,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C3541894:ks [Quantitative Concept]

Phrase: "Kim SY,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0039138:SY [Geographic Area]
   861   C1706466:SY [Intellectual Product]

Phrase: "Park SJ,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C1515101:SJ [Geographic Area]
   861   C2986905:SJ [Idea or Concept]

Phrase: "Chung MH,"

Phrase: "Lee HK"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0019907:HK [Geographic Area]
   861   C2681927:HK [Gene or Genome]
   861   C2987742:HK [Fish]

Phrase: ":"

Phrase: "Serum 8-hydroxy-guanine levels"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
   804   C0441889:Levels [Qualitative Concept]
   771 E C0456079:Level [Classification]
   771 E C1547707:Level [Geographic Area]
   771 E C2946261:Level [Pharmacologic Substance]

Phrase: "are"

Phrase: "increased in diabetic patients."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   770   C0030705:Patients [Patient or Disabled Group]
   770   C0205217:Increased [Quantitative Concept]
   770   C0241863:DIABETIC [Finding]
   770   C0442805:Increased [Functional Concept]
Processing 00000000.tx.265: Diabetes Care24 :733 737,2001[Abstract/Free FullText] Holt IJ, Harding AE, Morgan-Hughes JA: Deletions of muscle mitochondrial DNA in patients with mitochondrial myopathies. 

Phrase: "Diabetes Care24"

Phrase: ":"

Phrase: "733 737,"

Phrase: "2001"

Phrase: "[Abstract/Free FullText"

Phrase: "] Holt IJ,"

Phrase: "Harding AE,"

Phrase: "Morgan-Hughes JA"

Phrase: ":"

Phrase: "Deletions of muscle mitochondrial DNA"
Meta Candidates (Total=5; Excluded=2; Pruned=0; Remaining=3)
   844   C0948051:Mitochondrial DNA deletions [Cell or Molecular Dysfunction]
   797   C3151954:Mitochondrial deletions [Finding]
   760   C1880274:Deletions [Activity]
   726 E C1442161:Deletion [Cell or Molecular Dysfunction]
   726 E C1511760:Deletion [Genetic Function]

Phrase: "in patients"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0030705:Patients [Patient or Disabled Group]

Phrase: "with mitochondrial myopathies."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0162670:Mitochondrial Myopathies [Disease or Syndrome]
   861   C0026237:Mitochondrial [Cell Component]
   861   C0026848:Myopathies [Disease or Syndrome]
   861   C0521451:Mitochondrial [Functional Concept]
Processing 00000000.tx.266: Nature331 :717 719,1988[Medline] Lestienne P, Ponsot G: Kearns-Sayre syndrome with muscle mitochondrial DNA deletion (Letter). 

Phrase: "Nature331"

Phrase: ":"

Phrase: "717 719,"

Phrase: "1988"

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "] Lestienne P,"

Phrase: "Ponsot G"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0439267:g% [Quantitative Concept]

Phrase: ":"

Phrase: "Kearns-Sayre syndrome with muscle mitochondrial DNA deletion"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   800   C0022541:Kearns-Sayre syndrome [Disease or Syndrome]
           Kearns Syndrome
   800   C1416765:Kearns-Sayre syndrome [Gene or Genome]
   744   C0039082:Syndrome [Disease or Syndrome]

Phrase: "(Letter"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
  1000   C1096774:Letter [Intellectual Product]
  1000   C2360551:Letter [Clinical Attribute]
   944 E C0079691:Levothyroxine Sodium [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   916 E C0282413:letters [Intellectual Product]
   916 E C0728762:Synthroid [Amino Acid, Peptide, or Protein,Pharmacologic Substance]

Phrase: ")."
Processing 00000000.tx.267: Lancet1 :885 ,1988[Medline] Moraes CT, DiMauro S, Zeviani M, Lombes A, Shanske S, Miranda AF, Nakase H, Bonilla E, Werneck LC, Servidei S: Mitochondrial DNA deletions in progressive external opthalmoplegia and Kearns-Sayre syndrome. 

Phrase: "Lancet1"

Phrase: ":"

Phrase: "885 ,"

Phrase: "1988"

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "] Moraes CT,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C3540513:CT [Gene or Genome]

Phrase: "DiMauro S,"

Phrase: "Zeviani M,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441923:M+ [Intellectual Product]

Phrase: "Lombes A,"

Phrase: "Shanske S,"

Phrase: "Miranda AF,"

Phrase: "Nakase H,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   861   C0033727:H+ [Element, Ion, or Isotope]
   861   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441932:H+ [Classification]
   861   C0564385:/h [Quantitative Concept]

Phrase: "Bonilla E,"

Phrase: "Werneck LC,"

Phrase: "Servidei S"

Phrase: ":"

Phrase: "Mitochondrial DNA deletions in progressive external opthalmoplegia"
Meta Candidates (Total=5; Excluded=2; Pruned=0; Remaining=3)
   814   C0948051:Mitochondrial DNA deletions [Cell or Molecular Dysfunction]
   774   C3151954:Mitochondrial deletions [Finding]
   748   C1880274:Deletions [Activity]
   714 E C1442161:Deletion [Cell or Molecular Dysfunction]
   714 E C1511760:Deletion [Genetic Function]

Phrase: "and"

Phrase: "Kearns-Sayre syndrome."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0022541:Kearns-Sayre syndrome [Disease or Syndrome]
           Kearns Syndrome
  1000   C1416765:Kearns-Sayre syndrome [Gene or Genome]
   827   C0039082:Syndrome [Disease or Syndrome]
Processing 00000000.tx.268: N Engl J Med320 :1293 1299,1989[Abstract] Shoffner M, Lott MT, Volavec AS, Soueidan SA, Costigan DA, Wallace DC: Spontaneous Kearns-Sayre syndrome/chronic external progressive opthalmoplegia plus syndrome associated with a mitochondrial DNA deletion: a slip-replication model and metabolic therapy. 

Phrase: "N Engl J Med320"

Phrase: ":"

Phrase: "1293 1299,"

Phrase: "1989"

Phrase: "[Abstract"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0000857:Abstract [Occupational Activity]
  1000   C0600678:Abstract [Intellectual Product]
  1000   C1552863:Abstract [Idea or Concept]

Phrase: "] Shoffner M,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441923:M+ [Intellectual Product]

Phrase: "Lott MT,"

Phrase: "Volavec AS,"

Phrase: "Soueidan SA,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   861   C0036243:SA [Geographic Area]
   861   C1539696:SA [Gene or Genome]
   861   C1825840:SA [Gene or Genome]
   861   C3539736:Sa [Spatial Concept]

Phrase: "Costigan DA,"

Phrase: "Wallace DC"

Phrase: ":"

Phrase: "Spontaneous Kearns-Sayre syndrome/chronic external progressive opthalmoplegia plus syndrome"

Phrase: "associated with a mitochondrial DNA deletion"
Meta Candidates (Total=13; Excluded=2; Pruned=0; Remaining=11)
   833   C0948051:mitochondrial dna deletion [Cell or Molecular Dysfunction]
   790   C0012929:DNA, Mitochondrial [Biologically Active Substance,Nucleic Acid, Nucleoside, or Nucleotide]
   790   C0332281:Associated with [Qualitative Concept]
           Associated
   790   C1819717:mitochondrial DNA [Cell Component]
   753   C0012854:DNA [Biologically Active Substance,Nucleic Acid, Nucleoside, or Nucleotide]
   753   C0026237:Mitochondrial [Cell Component]
   753   C0521451:Mitochondrial [Functional Concept]
   753   C1442161:Deletion [Cell or Molecular Dysfunction]
   753   C1511760:Deletion [Genetic Function]
   753   C1880274:Deletion [Activity]
   719 E C0750490:Associate [Idea or Concept]
   719 E C1706221:Associate [Professional or Occupational Group]

Phrase: ":"

Phrase: "a slip-replication model"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C3161035:Model [Intellectual Product]

Phrase: "and"

Phrase: "metabolic therapy."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0587059:Metabolic therapy [Therapeutic or Preventive Procedure]
   861   C0039798:therapy [Functional Concept]
   861   C0087111:Therapy [Therapeutic or Preventive Procedure]
   861   C1363945:Therapy [Finding]
Processing 00000000.tx.269: Proc Natl Acad Sci U S A86 :7952 7956,1989[Abstract] Zhang C, Baumer A, Maxwell RJ, Linnane AW, Nagley P: Multiple mitochondrial DNA deletions in an elderly human individual. 

Phrase: "Proc Natl Acad Sci U S A86"

Phrase: ":"

Phrase: "7952 7956,"

Phrase: "1989"

Phrase: "[Abstract"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0000857:Abstract [Occupational Activity]
  1000   C0600678:Abstract [Intellectual Product]
  1000   C1552863:Abstract [Idea or Concept]

Phrase: "] Zhang C,"

Phrase: "Baumer A,"

Phrase: "Maxwell RJ,"

Phrase: "Linnane AW,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0282379:AW [Geographic Area]
   861   C0332281:AW [Qualitative Concept]

Phrase: "Nagley P"

Phrase: ":"

Phrase: "Multiple mitochondrial DNA deletions in an elderly human individual."
Meta Candidates (Total=5; Excluded=2; Pruned=0; Remaining=3)
   790   C0948051:Mitochondrial DNA deletions [Cell or Molecular Dysfunction]
   762   C3151954:Mitochondrial deletions [Finding]
   742   C1880274:Deletions [Activity]
   708 E C1442161:Deletion [Cell or Molecular Dysfunction]
   708 E C1511760:Deletion [Genetic Function]
Processing 00000000.tx.270: FEBS Lett297 :34 38,1992[Medline] Cortopassi GA, Shibata D, Soong N-W, Arnheim N: A pattern of accumulation of a somatic deletion of mitochondrial DNA in aging human tissues. 

Phrase: "FEBS Lett297"

Phrase: ":"

Phrase: "34 38,"

Phrase: "1992"

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "] Cortopassi GA,"

Phrase: "Shibata D,"

Phrase: "Soong N-W,"

Phrase: "Arnheim N"

Phrase: ":"

Phrase: "A pattern of accumulation of a somatic deletion of mitochondrial DNA"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   738   C0449774:Pattern [Spatial Concept]

Phrase: "in aging human tissues."
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
   901   C0440744:human tissues [Tissue]
   827   C0040300:Tissues [Tissue]
   827   C0086418:Human [Human]
   793 E C1547928:Tissue [Intellectual Product]
Processing 00000000.tx.271: Proc Natl Acad Sci U S A89 :7370 7374,1992[Abstract] Katsumata K, Hayakawa M, Tanaka M, Sugiyama S, Ozawa T: Fragmentation of human heart mitochondrial DNA associated with premature aging. 

Phrase: "Proc Natl Acad Sci U S A89"

Phrase: ":"

Phrase: "7370 7374,"

Phrase: "1992"

Phrase: "[Abstract"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0000857:Abstract [Occupational Activity]
  1000   C0600678:Abstract [Intellectual Product]
  1000   C1552863:Abstract [Idea or Concept]

Phrase: "] Katsumata K,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0597277:K+ [Element, Ion, or Isotope,Pharmacologic Substance]
   861   C1708601:K' [Quantitative Concept]

Phrase: "Hayakawa M,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441923:M+ [Intellectual Product]

Phrase: "Tanaka M,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441923:M+ [Intellectual Product]

Phrase: "Sugiyama S,"

Phrase: "Ozawa T"

Phrase: ":"

Phrase: "Fragmentation of human heart mitochondrial DNA"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   783   C0376669:DNA Fragmentation [Molecular Function]
   753   C0332472:Fragmentation [Anatomical Abnormality]
   753   C1881708:FRAGMENTATION [Phenomenon or Process]

Phrase: "associated with premature aging."
Meta Candidates (Total=7; Excluded=2; Pruned=0; Remaining=5)
   833   C0231341:Aging, Premature [Disease or Syndrome]
   833   C0332281:Associated with [Qualitative Concept]
           Associated
   770   C0001811:Ageing [Organism Function]
   770   C0205252:Premature [Temporal Concept]
   737 E C0750490:Associate [Idea or Concept]
   737 E C1706221:Associate [Professional or Occupational Group]
Processing 00000000.tx.272: Biochem Biophys Res Commun202 :102 110,1994[Medline] Kroemer G, Zamzami N, Susin SA: Mitochondrial control of apoptosis. 

Phrase: "Biochem Biophys Res Commun202"

Phrase: ":"

Phrase: "102 110,"

Phrase: "1994"

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "] Kroemer G,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0439267:g% [Quantitative Concept]

Phrase: "Zamzami N,"

Phrase: "Susin SA"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   861   C0036243:SA [Geographic Area]
   861   C1539696:SA [Gene or Genome]
   861   C1825840:SA [Gene or Genome]
   861   C3539736:Sa [Spatial Concept]

Phrase: ":"

Phrase: "Mitochondrial control of apoptosis."
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   770   C0243148:control [Qualitative Concept]
   770   C1550141:Control [Substance]
   770   C1882979:Control [Conceptual Entity]
   770   C2587213:Control [Functional Concept]
   770   C3274648:Control [Qualitative Concept]
Processing 00000000.tx.273: Immunol Today18 :44 51,1997[Medline] Richter C, Schweizer M, Cossarizza A, Franceschi C: Control of apoptosis by the cellular ATP level. 

Phrase: "Immunol Today18"

Phrase: ":"

Phrase: "44 51,"

Phrase: "1997"

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "] Richter C,"

Phrase: "Schweizer M,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441923:M+ [Intellectual Product]

Phrase: "Cossarizza A,"

Phrase: "Franceschi C"

Phrase: ":"

Phrase: "Control of apoptosis"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   790   C0243148:control [Qualitative Concept]
   790   C1550141:Control [Substance]
   790   C1882979:Control [Conceptual Entity]
   790   C2587213:Control [Functional Concept]
   790   C3274648:Control [Qualitative Concept]

Phrase: "by the cellular ATP level."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   827   C0441889:Level [Qualitative Concept]
   827   C0456079:Level [Classification]
   827   C1547707:Level [Geographic Area]
   827   C2946261:Level [Pharmacologic Substance]
Processing 00000000.tx.274: FEBS Lett378 :107 110,1996[Medline] Nishikawa T, Edelstein D, Du XL, Yamagishi S, Matsumura T, Kaneda Y, Yorek MA, Beebe D, Oates PJ, Hammes HP, Giardino I, Brownlee M: Normalizing mitochondrial superoxide production blocks three pathways of hyperglycaemic damage. 

Phrase: "FEBS Lett378"

Phrase: ":"

Phrase: "107 110,"

Phrase: "1996"

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "] Nishikawa T,"

Phrase: "Edelstein D,"

Phrase: "Du XL,"

Phrase: "Yamagishi S,"

Phrase: "Matsumura T,"

Phrase: "Kaneda Y,"

Phrase: "Yorek MA,"

Phrase: "Beebe D,"

Phrase: "Oates PJ,"

Phrase: "Hammes HP,"

Phrase: "Giardino I,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0021966:I- [Inorganic Chemical]
   861   C0221138:I NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]

Phrase: "Brownlee M"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441923:M+ [Intellectual Product]

Phrase: ":"

Phrase: "Normalizing mitochondrial superoxide production"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   812   C0033268:production [Occupational Activity]

Phrase: "blocks"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
  1000   C0028778:Block [Pathologic Function]
  1000   C0332206:Block [Functional Concept]
  1000   C1533157:Block [Substance]
  1000   C1706084:Block [Geographic Area]
  1000   C2828370:Block [Quantitative Concept]

Phrase: "three pathways of hyperglycaemic damage."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   760   C1704259:Pathways [Molecular Function]
   760   C1705987:Pathways [Conceptual Entity]
Processing 00000000.tx.275: Nature404 :787 790,2000[Medline] Inoguchi T, Li P, Umeda F, Yu HY, Kakimoto K, Imamura M, Aoki T, Etoh T, Hashimoto T, Naruse M, Sano H, Utsumi H, Nawata H: High glucose level and free fatty acid stimulate reactive oxygen spieces production through protein kinase C-dependent activation of NAD(P)H oxidase in cultured vascular cells. 

Phrase: "Nature404"

Phrase: ":"

Phrase: "787 790,"

Phrase: "2000"

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "] Inoguchi T,"

Phrase: "Li P,"

Phrase: "Umeda F,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0016327:F- [Inorganic Chemical,Pharmacologic Substance]
   861   C0439133:(f) [Intellectual Product]
   861   C1553038:[f] [Quantitative Concept]

Phrase: "Yu HY,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C1539791:HY [Gene or Genome]

Phrase: "Kakimoto K,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0597277:K+ [Element, Ion, or Isotope,Pharmacologic Substance]
   861   C1708601:K' [Quantitative Concept]

Phrase: "Imamura M,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441923:M+ [Intellectual Product]

Phrase: "Aoki T,"

Phrase: "Etoh T,"

Phrase: "Hashimoto T,"

Phrase: "Naruse M,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441923:M+ [Intellectual Product]

Phrase: "Sano H,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   861   C0033727:H+ [Element, Ion, or Isotope]
   861   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441932:H+ [Classification]
   861   C0564385:/h [Quantitative Concept]

Phrase: "Utsumi H,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   861   C0033727:H+ [Element, Ion, or Isotope]
   861   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441932:H+ [Classification]
   861   C0564385:/h [Quantitative Concept]

Phrase: "Nawata H"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   861   C0033727:H+ [Element, Ion, or Isotope]
   861   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441932:H+ [Classification]
   861   C0564385:/h [Quantitative Concept]

Phrase: ":"

Phrase: "High glucose level"
Meta Candidates (Total=8; Excluded=0; Pruned=0; Remaining=8)
   901   C0337438:glucose level [Laboratory Procedure]
   901   C0428548:Glucose level [Laboratory or Test Result]
   901   C0860803:high glucose [Finding]
   827   C0017725:Glucose [Biologically Active Substance,Carbohydrate,Pharmacologic Substance]
   827   C0441889:Level [Qualitative Concept]
   827   C0456079:Level [Classification]
   827   C1547707:Level [Geographic Area]
   827   C2946261:Level [Pharmacologic Substance]

Phrase: "and"

Phrase: "free fatty acid"
Meta Candidates (Total=8; Excluded=0; Pruned=0; Remaining=8)
  1000   C0015688:free fatty acid [Lipid]
  1000   C2698488:Free Fatty Acid [Laboratory Procedure]
   901   C0015684:Fatty acid [Lipid]
   827   C0001128:Acid [Chemical]
   827   C0202406:Acid [Laboratory Procedure]
   827   C0332296:free [Functional Concept]
   827   C1880497:Free [Qualitative Concept]
   827   C1996904:Free [Qualitative Concept]

Phrase: "stimulate"

Phrase: "reactive oxygen spieces production through protein kinase C-dependent activation"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   739   C0033268:production [Occupational Activity]

Phrase: "of NAD(P)H oxidase"
Meta Candidates (Total=8; Excluded=0; Pruned=0; Remaining=8)
  1000   C0068355:NAD(P)H oxidase [Amino Acid, Peptide, or Protein,Enzyme]
   875   C0027289:NAD(H) [Biologically Active Substance,Nucleic Acid, Nucleoside, or Nucleotide,Pharmacologic Substance]
   812   C0027270:NAD+ [Biologically Active Substance,Nucleic Acid, Nucleoside, or Nucleotide,Pharmacologic Substance]
   812   C0033727:H+ [Element, Ion, or Isotope]
   812   C0242417:Oxidase [Amino Acid, Peptide, or Protein,Enzyme]
   812   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   812   C0441932:H+ [Classification]
   812   C0564385:/h [Quantitative Concept]

Phrase: "in cultured vascular cells."
Meta Candidates (Total=10; Excluded=4; Pruned=0; Remaining=6)
   913   C0007600:cultured cells [Cell]
   913   C0007635:Cultured Cells [Cell]
   913   C3282338:Cells, Cultured [Cell]
   851   C0005773:Blood Cells [Cell]
   842 E C2328697:Hemal cell [Cell]
   827   C0007634:Cells [Cell]
   827   C3282337:Cells [Cell]
   793 E C1269647:Cell [Cell]
   793 E C1704653:Cell [Medical Device]
   793 E C1948049:Cell [Spatial Concept]
Processing 00000000.tx.276: Diabetes49 :1 7,2000[Abstract] Anson RM, Croteau DL, Stierum RH, Filburn C, Parsell R, Bohr VA: Homogenous repair of singlet oxygen-induced DNA damage in differentially transcribed regions and strands of human mitochondrial DNA. 

Phrase: "Diabetes49"

Phrase: ":"

Phrase: "1 7,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C3541329:1-7 [Gene or Genome]
   861   C2827734:1+ [Quantitative Concept]
   861   C2981698:1+ [Classification]

Phrase: "2000"

Phrase: "[Abstract"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0000857:Abstract [Occupational Activity]
  1000   C0600678:Abstract [Intellectual Product]
  1000   C1552863:Abstract [Idea or Concept]

Phrase: "] Anson RM,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C2951520:RM [Body Location or Region]

Phrase: "Croteau DL,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C3642216:/dL [Quantitative Concept]

Phrase: "Stierum RH,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0035493:Rh [Element, Ion, or Isotope]
   861   C2699077:Rh- [Classification]
   861   C2699078:Rh+ [Classification]

Phrase: "Filburn C,"

Phrase: "Parsell R,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0205090:R- [Spatial Concept]
   861   C0684010:R. [Professional or Occupational Group]
   861   C2603358:R' [Clinical Attribute]

Phrase: "Bohr VA"

Phrase: ":"

Phrase: "Homogenous repair of singlet oxygen-induced DNA damage"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   793   C0012899:DNA Damage Repair [Genetic Function]
           DNA Repair
   744   C0043240:Repair, NOS [Organism Function]
   744   C0374711:Repair [Therapeutic or Preventive Procedure]

Phrase: "in differentially transcribed regions"
Meta Candidates (Total=4; Excluded=2; Pruned=0; Remaining=2)
   793   C0017446:Region [Geographic Area]
   793   C0205147:Region [Spatial Concept]
   743 E C0205276:Regional [Spatial Concept]
   743 E C1947913:Regional [Spatial Concept]

Phrase: "and"

Phrase: "strands of human mitochondrial DNA."
Meta Candidates (Total=8; Excluded=0; Pruned=0; Remaining=8)
   806   C0012929:DNA, Mitochondrial [Biologically Active Substance,Nucleic Acid, Nucleoside, or Nucleotide]
   806   C1819717:mitochondrial DNA [Cell Component]
   760   C0012854:DNA [Biologically Active Substance,Nucleic Acid, Nucleoside, or Nucleotide]
   760   C0026237:Mitochondrial [Cell Component]
   760   C0086418:Human [Human]
   760   C0521451:Mitochondrial [Functional Concept]
   760   C1704972:Strand [Spatial Concept]
   760   C1704973:Strand [Nucleic Acid, Nucleoside, or Nucleotide]
Processing 00000000.tx.277: Nucleic Acids Res26 :662 668,1998[Abstract/Free FullText] Yakes FM, Van Houten B: Mitochondrial DNA damage is more extensive and persists longer than nuclear DNA damage in human cells following oxidative stress. 

Phrase: "Nucleic Acids Res26"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   734   C0028606:Nucleic Acids [Biologically Active Substance,Nucleic Acid, Nucleoside, or Nucleotide]

Phrase: ":"

Phrase: "662 668,"

Phrase: "1998"

Phrase: "[Abstract/Free FullText"

Phrase: "] Yakes FM,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C3540627:FM [Gene or Genome]

Phrase: "Van Houten B"

Phrase: ":"

Phrase: "Mitochondrial DNA damage"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   913   C1096176:Mitochondrial Damage [Pathologic Function]
   901   C0012860:DNA Damage [Cell or Molecular Dysfunction]
   827   C0010957:Damage [Injury or Poisoning]
   827   C1883709:Damage [Functional Concept]
   734   C0012929:DNA, Mitochondrial [Biologically Active Substance,Nucleic Acid, Nucleoside, or Nucleotide]
   734   C1819717:mitochondrial DNA [Cell Component]

Phrase: "is"

Phrase: "more extensive"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   861   C0205231:Extensive [Qualitative Concept]
   789 E C0439795:Extensiveness [Qualitative Concept]

Phrase: "and"

Phrase: "persists"

Phrase: "longer than nuclear DNA damage"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   726   C0205166:Long [Qualitative Concept]
   726   C1706317:Long [Qualitative Concept]

Phrase: "in human cells"
Meta Candidates (Total=6; Excluded=3; Pruned=0; Remaining=3)
  1000   C0427861:Human cells [Laboratory or Test Result]
   861   C0007634:Cells [Cell]
   861   C3282337:Cells [Cell]
   827 E C1269647:Cell [Cell]
   827 E C1704653:Cell [Medical Device]
   827 E C1948049:Cell [Spatial Concept]

Phrase: "following"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
  1000   C0332282:Following [Temporal Concept]
   966 E C0332283:follow [Temporal Concept]
   966 E C1719822:Follow [Intellectual Product]

Phrase: "oxidative stress."
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
  1000   C0242606:Oxidative Stress [Cell or Molecular Dysfunction]
   861   C0038435:Stress [Finding]
   861   C0311404:Oxidative [Functional Concept]
   789 E C0231297:Stressful [Functional Concept]
Processing 00000000.tx.278: Proc Natl Acad Sci U S A94 :514 519,1997[Abstract/Free FullText]

Phrase: "Proc Natl Acad Sci U S A94"

Phrase: ":"

Phrase: "514 519,"

Phrase: "1997"

Phrase: "[Abstract/Free FullText"

Phrase: "]"

